About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
3519 genotypes with 6742 annotations displayed of selected term and subterms
Searched Term: liver/biliary system phenotype
Allelic Composition
(Genetic Background)		 Annotated Term Reference
1700034E13Rikem1(IMPC)Mbp/1700034E13Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700034E13Rikem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
1700069L16Rikem1(IMPC)Mbp/1700069L16Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700069L16Rikem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
2010003K11Rikem1Cya/2010003K11Rikem1Cya
(C57BL/6-2010003K11Rikem1Cya/Cya) 		increased liver cholesterol level J:326325
increased liver triglyceride level J:326325
increased liver weight J:326325
increased susceptibility to diet-induced hepatic steatosis J:326325
2610008E11Rikem1(IMPC)Mbp/2610008E11Rikem1(IMPC)Mbp
(C57BL/6N-2610008E11Rikem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
2700097O09Riktm1.1(KOMP)Vlcg/2700097O09Riktm1.1(KOMP)Vlcg
(C57BL/6N-2700097O09Riktm1.1(KOMP)Vlcg/MbpMmucd) 		abnormal liver morphology J:211773
3930402G23Rikem1.1Gonz/3930402G23Rikem1.1Gonz
(C57BL/6J-3930402G23Rikem1.1Gonz) 		abnormal liver morphology J:340239
increased liver cholesterol level J:340239
increased liver free fatty acids level J:340239
increased liver triglyceride level J:340239
increased susceptibility to hepatic steatosis J:340239
4930524B15Rikem1(IMPC)Mbp/4930524B15Rikem1(IMPC)Mbp
(C57BL/6NCrl-4930524B15Rikem1(IMPC)Mbp/Mmucd) 		abnormal gallbladder morphology J:211773
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
herniated liver J:239583
a/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK) 		decreased liver weight J:168271
A1cftm1c(EUCOMM)Hmgu/A1cftm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6N * DBA) 		abnormal hepatobiliary system physiology J:281365
decreased liver triglyceride level J:281365
decreased liver weight J:281365
increased liver glycogen level J:281365
Ay/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK) 		decreased liver weight J:168271
Ay/A
(involves: C57BL/6) 		increased liver weight J:131039
AA467197em1Nyam/AA467197em1Nyam
(C57BL/6J-AA467197em1Nyam) 		liver inflammation J:347271
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J) 		macrovesicular hepatic steatosis J:64390
Abca1tm1Wpfl/Abca1tm1Wpfl
Npc1m1N/Npc1m1N
(involves: 129P2/OlaHsd * BALB/c) 		increased liver cholesterol level J:130969
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj) 		abnormal liver physiology J:99152
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR) 		abnormal liver morphology J:99152
Abcb1atm1Bor/Abcb1atm1Bor
Npc1m1N/Npc1m1N
(involves: 129/Ola * BALB/c) 		increased liver cholesterol level J:76395
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N)) 		abnormal bile canaliculus morphology J:15531, J:21232
abnormal bile composition J:15531
abnormal bile duct morphology J:15531
abnormal bile secretion J:15531
abnormal hepatobiliary system morphology J:21232
abnormal hepatobiliary system physiology J:21232
abnormal hepatocyte morphology J:15531
abnormal portal triad morphology J:21232
bile duct inflammation J:15531, J:21232
bile duct proliferation J:21232
biliary cirrhosis J:21232
cholestasis J:21232
dilated bile duct J:15531
enlarged liver J:21232
hepatic necrosis J:21232
increased hepatocellular carcinoma incidence J:21232
intrahepatic cholestasis J:15531
liver hemorrhage J:21232
liver inflammation J:15531
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N) 		abnormal hepatocyte morphology J:175015
bile duct inflammation J:175015
focal hepatic necrosis J:175015
intrahepatic cholestasis J:175015
liver inflammation J:175015
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J) 		abnormal bile composition J:100491, J:105357
abnormal bile duct morphology J:105357
abnormal gallbladder size J:105357
abnormal liver morphology J:105357
bile duct inflammation J:105357
dilated bile duct J:105357
enlarged liver J:105357
gallstones J:105357
increased hepatocellular carcinoma incidence J:217802
intrahepatic cholestasis J:105357
liver cirrhosis J:217802
liver fibrosis J:217802
portal hypertension J:217802
Abcb4tm1Bor/Abcb4tm1Bor
(C.129P2-Abcb4tm1Bor) 		liver fibrosis J:199949
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * BALB/c) 		bile duct inflammation J:168123
liver fibrosis J:168123
Abcb4tm1Bor/Abcb4tm1Bor
(CAnNCrl.12P2(FVB)-Abcb4tm1Bor) 		increased hepatocellular carcinoma incidence J:217802
liver cirrhosis J:217802
liver fibrosis J:217802
portal hypertension J:217802
Abcb4tm1Bor/Abcb4tm1Bor
Pemttm1J/Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		liver/biliary system phenotype J:175015
Abcb4tm1Bor/Abcb4tm1Bor
Portm1Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N) 		bile duct proliferation J:215915
cholestasis J:215915
increased hepatocyte proliferation J:215915
increased liver weight J:215915
liver fibrosis J:215915
Abcb4tm1Bor/Abcb4tm1Bor
Tg(ABCG5/ABCG8)14-2Hobb/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N * SJL) 		abnormal bile composition J:100491
Abcb7tm1Mdf/Y
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(either: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA)) 		abnormal hepatocyte mitochondrial morphology J:106838
abnormal hepatocyte morphology J:106838
abnormal liver morphology J:106838
Abcb10tm1.2Tafu/Abcb10tm1.2Tafu
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		abnormal hepatocyte morphology J:223428
abnormal liver morphology J:223428
abnormal liver physiology J:223428
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal bile canaliculus morphology J:67548
abnormal bile secretion J:67548
abnormal hepatocyte morphology J:67548
decreased liver glycogen level J:67548
enlarged liver J:67548
intrahepatic cholestasis J:67548
Abcc2tm1Ahs/Abcc2tm1Ahs
(involves: 129P2/OlaHsd * FVB) 		abnormal bile secretion J:107822
abnormal liver physiology J:107822
increased liver weight J:107822
Abcc2tm1Dgen/Abcc2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal bile composition J:134950
abnormal bile secretion J:134950
abnormal liver physiology J:134950
Abcc3tm1Kruh/Abcc3tm1Kruh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		liver/biliary system phenotype J:114229
Abcd3tm1Safe/Abcd3tm1Safe
(involves: 129S4/SvJae * C57BL/6J) 		abnormal bile composition J:217065
enlarged liver J:217065
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:122438
Abcg1tm1Dgen/Abcg1tm1Dgen
(B6.129P2-Abcg1tm1Dgen) 		hepatic steatosis J:117028
increased liver cholesterol level J:117028
increased liver triglyceride level J:117028
Abcg2em1Omw/Abcg2em1Omw
(C57BL/6J-Abcg2em1Omw) 		hepatic steatosis J:292268
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB) 		abnormal hepatocyte mitochondrial morphology J:201884
abnormal hepatocyte morphology J:201884
decreased liver glycogen level J:201884
liver inflammation J:201884
Abcg2tm1Ahs/Abcg2tm1Ahs
(either: (involves: 129P2/OlaHsd * FVB) or (involves: FVB)) 		abnormal bile color J:80519
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver physiology J:87209
enlarged liver J:87209
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd) 		abnormal bile secretion J:112995
abnormal liver physiology J:112995
increased liver weight J:112995
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
Abcg8tm1Elk/Abcg8+
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal hepatobiliary system physiology J:94759
Abcg8tm1Elk/Abcg8tm1Elk
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal hepatobiliary system physiology J:94759
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:199570
abnormal liver morphology J:199570
abnormal liver physiology J:199570
enlarged liver J:199570
hepatic steatosis J:199570
increased liver cholesterol level J:199570
increased liver free fatty acids level J:199570
increased liver triglyceride level J:199570
increased liver weight J:199570
liver fibrosis J:199570
liver inflammation J:199570
macrovesicular hepatic steatosis J:199570
microvesicular hepatic steatosis J:199570
pale liver J:199570
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:160725
increased liver triglyceride level J:160725
Abhd5tm1Rze/Abhd5tm1Rze
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased liver triglyceride level J:197835
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu) 		abnormal liver morphology J:234876
decreased liver triglyceride level J:234876
decreased liver weight J:234876
Abhd17cem1(IMPC)Mbp/Abhd17cem1(IMPC)Mbp
(C57BL/6N-Abhd17cem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J) 		abnormal hepatocyte morphology J:72875
abn/abn
(STOCK tlow) 		enlarged liver J:28671
Abtb2tm1Zgwg/Abtb2tm1Zgwg
(involves: 129/Sv * C57BL/6) 		impaired liver regeneration J:280009, J:278621
Acacatm1Jkus/Acacatm1Jkus
Tg(Fabp1-cre)1Mmt/0
(involves: 129X1/SvJ * C57BL/6J * SJL) 		decreased liver triglyceride level J:118861
Acacatm2Sjw/Acacatm2Sjw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S7/SvEvBrd * C57BL/6J * FVB) 		abnormal liver physiology J:110200
decreased liver triglyceride level J:110200
decreased susceptibility to hepatic steatosis J:110200
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified) 		decreased liver glycogen level J:68427
decreased liver triglyceride level J:68427
Acad8m1Ytc/Acad8m1Ytc
(involves: C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:222356
macrovesicular hepatic steatosis J:222356
microvesicular hepatic steatosis J:222356
Acadltm1Uab/Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac) 		abnormal bile composition J:51660
hepatic steatosis J:51660
macrovesicular hepatic steatosis J:72193, J:51660
microvesicular hepatic steatosis J:51660
Acadmtm1Uab/Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6) 		macrovesicular hepatic steatosis J:115759
microvesicular hepatic steatosis J:115759
Acadsdel-J/Acadsdel-J
(involves: BALB/cByJ) 		hepatic steatosis J:14707
Acadvltm1Uab/Acadvltm1Uab
(involves: 129S6/SvEvTac * C57BL/6) 		hepatic steatosis J:72193
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6) 		macrovesicular hepatic steatosis J:106714
Acancmd/Acancmd
(STOCK T tlow Itpr3tf) 		abnormal liver morphology J:5952
enlarged liver J:5952
Acbd5tm1a(EUCOMM)Wtsi/Acbd5tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Acbd5tm1a(EUCOMM)Wtsi/WtsiCnbc) 		abnormal hepatocyte morphology J:299448
abnormal liver morphology J:299448
Acetm3Keb/Acetm3Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver/biliary system phenotype J:83178
Acot7tm1.1Mwol/Acot7tm1.1Mwol
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		hepatic steatosis J:203753
increased liver triglyceride level J:203753
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:182660
Acot12em1Holi/Acot12em1Holi
(involves: C57BL/6J * C57BL/6N) 		increased hepatocellular carcinoma incidence J:335836
increased liver cholesterol level J:335836
increased liver triglyceride level J:335836
liver fibrosis J:335836
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6) 		decreased liver cholesterol level J:183258
decreased liver triglyceride level J:183258
decreased susceptibility to diet-induced hepatic steatosis J:183258
Acox1lampe1/Acox1lampe1
(involves: C57BL/6J) 		abnormal hepatocyte morphology J:174942
abnormal liver morphology J:174942
enlarged liver J:174942
increased hepatocellular carcinoma incidence J:174942
liver inflammation J:174942
microvesicular hepatic steatosis J:174942
Acox1tm1Jkr/Acox1+
(involves: 129P2/OlaHsd * C57BL/6J) 		microvesicular hepatic steatosis J:35794
Acox1tm1Jkr/Acox1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver physiology J:35794
abnormal liver regeneration J:48180
increased hepatocellular carcinoma incidence J:35794
increased hepatoma incidence J:48180
increased liver weight J:35794
microvesicular hepatic steatosis J:48180
pale liver J:35794
Acox2em1Jynz/Acox2em1Jynz
(involves: C57BL/6N) 		bile duct proliferation J:323193
increased liver tumor incidence J:323193
liver inflammation J:323193
Acoxlem1(IMPC)Mbp/Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Acsl5tm1.1(KOMP)Vlcg/Acsl5tm1.1(KOMP)Vlcg
(C57BL/6N-Acsl5tm1.1(KOMP)Vlcg/Ucd) 		decreased liver weight J:211773
Acta1tm1Jll/Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss) 		decreased liver glycogen level J:78070
Actbtm2(Tag)Arge/Actb+
Tg(Hsp70-1-cre)1Arge/0
(involves: 129S1/Sv * C57BL/6J * CBA) 		enlarged gallbladder J:87544
Actn4tm1a(EUCOMM)Wtsi/Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi) 		biliary cyst J:239583
dilated liver sinusoidal space J:239583
Acvr2btm1Enl/Acvr2btm1Enl
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6J)) 		abnormal liver morphology J:42018
Acvrl1tm1Enl/Acvrl1+
(involves: C57BL/6) 		abnormal hepatobiliary system morphology J:82115
dilated liver sinusoidal space J:82115
enlarged liver J:82115
Ad/Ad
(involves: Chr 7 marker stock * Wild stock) 		abnormal liver morphology J:6095
Ad/Ad+
(involves: Chr 7 marker stock * Wild stock) 		abnormal liver morphology J:6095
Adatm1Mw/Adatm1Mw
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:25085
abnormal liver morphology J:25085
decreased hepatocyte number J:25085
hepatic necrosis J:25085
increased hepatocyte karyomegaly J:25085
small liver J:25085
Adatm1Vlr/Adatm1Vlr
(either: 129P2/OlaHsd-Adatm1Vlr or (involves: (129P2/OlaHsd * FVB/N)) 		hepatic necrosis J:26731
intrahepatic cholestasis J:26731
Adam29em1Otin/Adam29em1Otin
(C57BL/6-Adam29em1Otin) 		abnormal hepatocyte morphology J:353244
decreased susceptibility to diet-induced hepatic steatosis J:353244
Adamts3tm1.2Itl/Adamts3tm1.2Itl
(involves: BALB/cJ * C57BL/6NTac * SJL) 		increased hepatocyte apoptosis J:245044
liver degeneration J:245044
small liver J:245044
Adamts3tm1b(KOMP)Wtsi/Adamts3tm1b(KOMP)Wtsi
(C57BL/6N-Adamts3tm1b(KOMP)Wtsi/Wtsi) 		abnormal liver parenchyma morphology J:239583
Adamts7tm1a(KOMP)Wtsi/Adamts7tm1a(KOMP)Wtsi
(C57BL/6-Adamts7tm1a(KOMP)Wtsi) 		abnormal oval cell physiology J:221183
decreased hepatocyte proliferation J:221183
Adarem1Stsn/Adartm1Olds
(involves: 129S/SvEv * C57BL/6J) 		abnormal liver morphology J:308678
Adartm1.1Knk/Adartm1.1Knk
(involves: 129S1/Sv * 129X1/SvJ) 		increased hepatocyte apoptosis J:87714
Adartm1.1Phs/Adartm2Phs
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		liver hypoplasia J:142338
Adartm1Knk/Adartm1Knk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal liver morphology J:87714
increased hepatocyte apoptosis J:87714
Adartm1Phs/Adartm1Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver development J:87715
small liver J:87715
Adartm1Phs/Adartm1Phs
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		abnormal liver development J:87715
small liver J:87715
Adartm2Knk/Adar+
(chimera involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		abnormal liver development J:65981
Adartm2Phs/Adartm2Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver development J:87715
small liver J:87715
Adartm2Phs/Adartm2Phs
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		abnormal liver development J:87715
small liver J:87715
Adck2tm1(KOMP)Vlcg/Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg) 		increased liver free fatty acids level J:280282
macrovesicular hepatic steatosis J:280282
Adcy3Jll/Adcy3+
(C57BL/6J-Adcy3Jll) 		decreased susceptibility to diet-induced hepatic steatosis J:223554
Adcy9tm1b(EUCOMM)Wtsi/Adcy9tm1b(EUCOMM)Wtsi
(C57BL/6N-Adcy9tm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
liver hemorrhage J:239583
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6)) 		decreased liver glycogen level J:71968
microvesicular hepatic steatosis J:71968
Add2tm1Llp/Add2tm1Llp
(involves: 129S4/SvJae * C57BL/6J) 		increased liver iron level J:71029
Adgrl4em1(IMPC)Mbp/Adgrl4em1(IMPC)Mbp
(C57BL/6N-Adgrl4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
(B6J.B6N-Adigtm1.1(KOMP)Vlcg) 		decreased susceptibility to diet-induced hepatic steatosis J:304292
Adip1LG/J/?
Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x LG/J)F1) 		increased liver weight J:153477
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J) 		increased liver triglyceride level J:111346
increased susceptibility to diet-induced hepatic steatosis J:111346
Adipoqtm1Far/Adipoqtm1Far
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver cholesterol level J:111346
decreased liver triglyceride level J:111346
decreased susceptibility to diet-induced hepatic steatosis J:111346
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J) 		liver/biliary system phenotype J:199264
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc) 		increased liver triglyceride level J:122027
Adipor1tm1Tka/Adipor1tm1Tka
Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6) 		increased liver triglyceride level J:117919
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen) 		decreased liver triglyceride level J:122027
Adktm1Bois/Adktm1Bois
(involves: 129P3/JEmsJ * C57BL/6) 		hepatic steatosis J:81518
macrovesicular hepatic steatosis J:81518
microvesicular hepatic steatosis J:81518
pale liver J:81518
Adm2em1Zhan/Adm2em1Zhan
(Not Specified) 		liver inflammation J:266495
Admtm1Hku/Admtm1Hku
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver vasculature morphology J:89608
liver hemorrhage J:89608
Adnp2em3(IMPC)Tcp/Adnp2+
(C57BL/6NCrl-Adnp2em3(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Adnp2em3(IMPC)Tcp/Adnp2em3(IMPC)Tcp
(C57BL/6NCrl-Adnp2em3(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver glycogen level J:87718
Adrb2em1(IMPC)Mbp/Adrb2em1(IMPC)Mbp
(C57BL/6N-Adrb2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Aebp1tm1Mdl/Aebp1tm1Mdl
(involves: 129S2/SvPas * C57BL/6) 		abnormal liver morphology J:70416
Afdnem1(IMPC)Mbp/Afdn+
(C57BL/6N-Afdnem1(IMPC)Mbp/MbpMmucd) 		abnormal gallbladder morphology J:211773
abnormal liver morphology J:211773
enlarged liver J:211773
Afg3l2Emv66/Afg3l2Emv66
(FVB.MEV2-Afg3l2Emv66/TyJ) 		liver/biliary system phenotype J:132285
Afg3l2par/Afg3l2par
(Not Specified) 		liver/biliary system phenotype J:132285
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H) 		liver/biliary system phenotype J:226537
Afptm1(Cebpa)Ndw/Afp+
(involves: 129S7/SvEvBrd) 		increased liver glycogen level J:103404
Agatm1Vk/Agatm1Vk
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		multifocal hepatic necrosis J:91114
Agap2tm1Kye/Agap2tm1Kye
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA/2) 		decreased liver cholesterol level J:174775
decreased liver free fatty acids level J:174775
decreased liver triglyceride level J:174775
Agltm1a(EUCOMM)Wtsi/Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		abnormal hepatocyte morphology J:212003
enlarged liver J:212003
increased liver glycogen level J:212003
liver fibrosis J:212003
Agltm1Geno/Agltm1Geno
(C57BL/6J-Agltm1Geno) 		abnormal hepatocyte morphology J:218471
abnormal liver morphology J:218471
enlarged liver J:218471
increased liver glycogen level J:218471
Agpat2em1(IMPC)Ccpcz/Agpat2+
(C57BL/6NCrl-Agpat2em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal liver morphology J:186035
enlarged liver J:186035
liver inflammation J:186035
microvesicular hepatic steatosis J:186035
pale liver J:186035
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac) 		hepatic steatosis J:146649
increased liver triglyceride level J:231617, J:146649
increased liver weight J:231617, J:146649
Agpat2tm1Garg/Agpat2tm1Garg
Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae * 129S6/SvEvTac) 		increased liver triglyceride level J:231617
increased liver weight J:231617
Agpat5Gt(OST62319)Lex/Agpat5Gt(OST62319)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		hepatic steatosis J:103485
Agrptm1Dgen/Agrptm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver physiology J:199803
decreased liver triglyceride level J:199803
Agttm1Ii/Agttm1Ii
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver weight J:30061
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:83597
liver hyperplasia J:33827
microvesicular hepatic steatosis J:33827
pale liver J:33827
small liver J:33827
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra) 		abnormal hepatocyte morphology J:64483
abnormal liver sinusoid morphology J:64483
decreased liver weight J:64483
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N) 		abnormal hepatocyte morphology J:44690, J:25048
abnormal liver morphology J:44690, J:25048
abnormal liver physiology J:25048
bile duct inflammation J:25048
decreased liver weight J:25048
increased hepatoma incidence J:44690
increased liver adenoma incidence J:44690
liver fibrosis J:44690, J:25048
Ahrtm1Yfk/Ahrtm1Yfk
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J * ICR) 		hepatic steatosis J:82937
Ahrtm2Bra/Ahrtm2Bra
(involves: 129/Sv * C57BL/6) 		decreased liver weight J:83597
Ahrtm4.1Bra/Ahrtm4.1Bra
(involves: 129/Sv * C57BL/6) 		microvesicular hepatic steatosis J:141978
small liver J:141978
Aidatm1.1Scli/Aidatm1.1Scli
(involves: C57BL/6 * FVB/N) 		increased liver glycogen level J:262001
increased liver weight J:262001
increased susceptibility to diet-induced hepatic steatosis J:262001
Aif1ltm1b(EUCOMM)Wtsi/Aif1ltm1b(EUCOMM)Wtsi
(C57BL/6N-Aif1ltm1b(EUCOMM)Wtsi/Bay) 		abnormal liver morphology J:211773
Aim2em1(IMPC)Ccpcz/Aim2em1(IMPC)Ccpcz
(C57BL/6N-Aim2em1(IMPC)Ccpcz/Ccpcz) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Aiptm1Bra/Aip+
(Not Specified) 		decreased liver weight J:167350
Aiptm2Bra/Aiptm2Bra
(involves: 129) 		decreased liver weight J:167350
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2(B6)-Airetm1.1Doi/Doi) 		liver inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(C.129S2-Airetm1.1Doi/Doi) 		liver inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(SJL.129S2-Airetm1.1Doi/Doi) 		liver inflammation J:107432
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6 * NOD) 		liver inflammation J:107432
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6) 		liver inflammation J:77873
Airetm1Pltn/Airetm1Pltn
(B6.129S4-Airetm1Pltn) 		liver inflammation J:115076
Akap12tm1Ihg/Akap12tm1Ihg
(involves: 129S4/SvJae * C57BL/6) 		liver inflammation J:138882
Akap13em1(IMPC)Mbp/Akap13em1(IMPC)Mbp
(C57BL/6N-Akap13em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129) 		hepatic steatosis J:208505
increased liver triglyceride level J:208505
increased liver weight J:208505
Akt1tm1.1Mjl/Akt1+
(chimera involves: 129S6/SvEvTac * C57BL/6) 		biliary cyst J:293971
dilated bile duct J:293971
Akt1tm1Mbb/Akt1tm1Mbb
(involves: 129P2/OlaHsd) 		decreased hepatocyte number J:96823
Akt1tm1Mjl/Akt1+
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sortm1(cre/ERT)Nat
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6) 		biliary cyst J:293971
dilated bile duct J:293971
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		decreased liver triglyceride level J:182721
decreased susceptibility to diet-induced hepatic steatosis J:182721
Akt2tm1.1Mbb/Akt2+
Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb) 		decreased liver triglyceride level J:155432
decreased liver weight J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd) 		decreased liver triglyceride level J:160759
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(B6.129P2-Akt2tm1.1Mbb) 		decreased liver triglyceride level J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb) 		decreased liver triglyceride level J:155432
decreased liver weight J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		abnormal liver morphology J:218587
decreased susceptibility to hepatic steatosis J:218587
liver/biliary system phenotype J:160759
Akt2tm1.2Mbb/Akt2tm1.2Mbb
Lepob/Lepob
Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL) 		decreased liver triglyceride level J:155432
decreased liver weight J:155432
Akt2tm1.2Mbb/Akt2tm1.2Mbb
Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL) 		decreased liver triglyceride level J:155432
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6N) 		liver inflammation J:276210
Aladem1(IMPC)Tcp/Alad+
(C57BL/6NCrl-Aladem1(IMPC)Tcp/Cmmr) 		abnormal liver morphology J:211773
Albtm1(cre/ERT2)Mtz/Alb+
Fth1tm1.1Lck/Fth1tm1.1Lck
(involves: 129/Sv * C57BL/6 * SJL) 		abnormal liver iron level J:166515
liver/biliary system phenotype J:166515
Albtm1(cre/ERT2)Mtz/Alb+
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6) 		increased cholangiocarcinoma incidence J:192740
Albtm1(cre/ERT2)Mtz/Alb+
Hcfc1tm1Lwh/Hcfc1+
(involves: 129S2/SvPas * C57BL/6) 		impaired liver regeneration J:231596
Albtm1(cre/ERT2)Mtz/Alb+
Krastm4Tyj/Kras+
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae) 		increased cholangiocarcinoma incidence J:254370
increased hepatocellular carcinoma incidence J:254370
Albtm1(cre/ERT2)Mtz/Alb+
Polr2mtm1.1Rgr/Polr2mtm1.1Rgr
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased hepatocyte karyomegaly J:291184
increased hepatocyte proliferation J:291184
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz
Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased liver cholesterol level J:197607
decreased liver triglyceride level J:197607
increased liver glycogen level J:197607
Aldh1a1tm1Gdu/Aldh1a1tm1Gdu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal hepatobiliary system physiology J:83957
Aldh1l2tm2e(KOMP)Wtsi/Aldh1l2tm2e(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		hepatic steatosis J:299012
liver/biliary system phenotype J:299012
Aldh2tm1.1Mak/Aldh2+
(involves: 129S6/SvEvTac * C57BL/6J) 		increased hepatocyte apoptosis J:223796
Aldh2tm1.1Mak/Aldh2tm1.1Mak
(involves: 129S6/SvEvTac * C57BL/6J) 		increased hepatocyte apoptosis J:223796
Aldobtm1(KOMP)Vlcg/Aldobtm1(KOMP)Vlcg
(C57BL/6NTac-Aldobtm1(KOMP)Vlcg) 		abnormal liver morphology J:220330
abnormal portal triad morphology J:220330
hepatic steatosis J:220330
liver fibrosis J:220330
liver inflammation J:220330
pale liver J:220330
Aldoctm1.1(KOMP)Vlcg/Aldoctm1.1(KOMP)Vlcg
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N) 		decreased liver cholesterol level J:346664
decreased liver triglyceride level J:346664
decreased liver weight J:346664
Alkbh1tm1b(EUCOMM)Hmgu/Alkbh1+
(C57BL/6N-Alkbh1tm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
Alkbh7tm1.1Klng/Alkbh7tm1.1Klng
(involves: 129S2/SvPas * C57BL/6J) 		increased liver weight J:198968
Alms1foz/Alms1foz
(involves: NOD) 		abnormal hepatocyte morphology J:107058
enlarged liver J:107058
hepatic steatosis J:107058
increased liver weight J:107058
liver fibrosis J:107058
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver weight J:100403
macrovesicular hepatic steatosis J:100403
microvesicular hepatic steatosis J:100403
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD) 		hepatic steatosis J:118221
Altretm1.1Hbgl/Altretm1.1Hbgl
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:342907
increased liver tumor incidence J:342907
increased susceptibility to diet-induced hepatic steatosis J:342907
liver fibrosis J:342907
Amacrtm1Jkh/Amacrtm1Jkh
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal bile composition J:90370
enlarged liver J:90370
hepatic necrosis J:90370
AmfrGt(IST12797A11)Tigm/AmfrGt(IST12797A11)Tigm
(C57BL/6-AmfrGt(IST12797A11)Tigm) 		abnormal hepatocyte morphology J:221247
abnormal liver morphology J:221247
hepatic steatosis J:221247
increased liver tumor incidence J:221247
liver cirrhosis J:221247
liver fibrosis J:221247
liver inflammation J:221247
Anapc2tm1Kna/Anapc2tm1Kna
Tg(Ttr-cre/Esr1*)1Vco/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal hepatocyte morphology J:87782
increased hepatocyte proliferation J:87782
liver failure J:87782
Anapc2tm1Kna/Anapc2tm2Kna
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:87782
abnormal liver physiology J:87782
decreased liver glycogen level J:87782
increased hepatocyte proliferation J:87782
liver failure J:87782
Angptl3tm1Kfuj/Angptl3tm1Kfuj
(B6.129S1-Angptl3tm1Kfuj) 		abnormal liver physiology J:107479
increased liver weight J:107479
Ank1ity16/Ank1+
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J) 		increased liver iron level J:199427
Ank1ity16/Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J) 		increased liver iron level J:199427
jaundice J:199427
liver abscess J:199427
Ank1M1Wlst/Ank1M1Wlst
(involves: 129S1/SvImJ * C3H/HeJ * C57BL/6) 		gallstones J:170562
jaundice J:170562
Ank1MRI23420/Ank1MRI23420
(SJL/J-Ank1MRI23420) 		jaundice J:187820
Ank1nb/Ank1nb
(either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re)) 		enlarged liver J:30699
gallstones J:6371
jaundice J:30699
Ank1nb/Ank1nb
(involves: C57BL/6J * WB/Re) 		increased liver iron level J:3122
Ank1nb/Ank1nb
((WB.Cg-Ank1nb/BrkJ x B6.Cg-Ank1nb/BrkJ)F1) 		enlarged liver J:162532
jaundice J:162532
Ank1Rbc2/Ank1Rbc2
(involves: 129S1/Sv * BALB/c) 		increased liver iron level J:148127
jaundice J:148127
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J) 		increased susceptibility to diet-induced hepatic steatosis J:222913
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J) 		increased susceptibility to diet-induced hepatic steatosis J:222913
Anks6b2b1801.1Clo/Anks6b2b1801.1Clo
(C57BL/6J-Anks6b2b1801.1Clo) 		abnormal liver morphology J:175213
Anks6tm1d(KOMP)Wtsi/Anks6tm1d(KOMP)Wtsi
(involves: C3H * C57BL/6 * C57BL/6N * FVB/N) 		abnormal bile duct development J:307271
abnormal bile duct epithelium morphology J:307271
abnormal bile duct morphology J:307271
abnormal cholangiocyte primary cilium morphology J:307271
abnormal hepatobiliary system development J:307271
abnormal portal lobule morphology J:307271
dilated bile duct J:307271
hepatic necrosis J:307271
liver fibrosis J:307271
small liver J:307271
anx/anx
(B6C3Fe a/a-anx/J) 		abnormal liver morphology J:7689
anx/anx
(involves: DW/J * M. m. domesticus poschiavinus * Swiss) 		abnormal liver morphology J:13936
Anxa7tm1Pll/Anxa7+
(B6.Cg-Anxa7tm1Pll) 		increased hepatocellular carcinoma incidence J:93685
ApcMin/Apc+
(C57BL/6J-ApcMin) 		hepatic steatosis J:86036
ApcMin/Apctm1Tno
Ctnnb1tm4.1Wbm/Ctnnb1+
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:156864
Apctm1Rak/Apc+
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:20443
Apctm1Tno/Apc+
(involves: 129 * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:156864
Apctm1Tno/Apctm1Tno
(involves: 129 * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:156864
Apctm2.1Cip/Apctm2.1Cip
(involves: 129P2/OlaHsd * C57BL/6N) 		increased hepatocellular carcinoma incidence J:94721
liver hyperplasia J:94721
Apctm2.1Cip/Apctm2.1Cip
Lect2tm1Ymg/Lect2tm1Ymg
Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco) 		abnormal liver morphology J:184496
hepatic necrosis J:184496
increased hepatocyte apoptosis J:184496
liver inflammation J:184496
Apctm2.1Cip/Apctm2.1Cip
Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco) 		abnormal liver morphology J:184496
enlarged liver J:184496
liver inflammation J:184496
Apctm2Rfo/Apc+
(B6.129P2-Apctm2Rfo) 		increased liver tumor incidence J:151494
Apctm2Rfo/Apc+
((C57BL/6J x 129P2/OlaHsd)F1) 		increased liver tumor incidence J:151494
Apctm2Rfo/Apc+
(129P2/OlaHsd-Apctm2Rfo) 		increased liver tumor incidence J:151494
Apctm2Tno/Apc+
(involves: C57BL/6J) 		hepatic steatosis J:86036
Apex1tm1Djc/Apex1+
(involves: 129X1/SvJ * NTac:NIHS) 		abnormal liver morphology J:92957
Apmaptm1.2Jgbs/Apmaptm1.2Jgbs
(B6.129P2-Apmaptm1.2Jgbs) 		liver/biliary system phenotype J:247647
Apoa1tm1(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver physiology J:81908
Apoa1tm1Unc/Apoa1tm1Unc
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Ldlrtm1Her Apoa1tm1Unc) 		abnormal liver morphology J:85174
decreased liver cholesterol level J:85174
Apoa1tm2(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver physiology J:81908
Apobtm1.1Zc/Apob+
(involves: 129X1/SvJ * C57BL/6) 		hepatic steatosis J:65191
Apobtm1.1Zc/Apobtm1.1Zc
(involves: 129X1/SvJ * C57BL/6) 		hepatic steatosis J:65191
Apobtm1Zc/Apob+
(involves: 129/Sv * C57BL/6) 		hepatic steatosis J:76047
Apobtm1Zc/Apobtm1.1Zc
(involves: 129/Sv * C57BL/6) 		hepatic steatosis J:76047
Apobtm1Zc/Apobtm1Zc
(involves: 129/Sv * C57BL/6) 		hepatic steatosis J:76047
Apobtm4Sgy/Apobtm4Sgy
(involves: 129S4/SvJae * C57BL/6) 		herniated liver J:46549
Apoc1tm1Lmh/Apoc1tm1Lmh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal bile composition J:117482
increased liver triglyceride level J:117482
Apoc1tm1Lmh/Apoc1tm1Lmh
Tg(CETP)5203Tall/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA/J) 		abnormal bile composition J:117482
increased liver triglyceride level J:117482
Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
(involves: 129P2/OlaHsd * C57BL/6) 		liver/biliary system phenotype J:48565
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev) 		decreased liver cholesterol level J:219838
decreased liver triglyceride level J:219838
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		abnormal liver physiology J:104609
Apoetm1Unc/Apoetm1Unc
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:184647
increased liver weight J:184647
increased susceptibility to age-related hepatic steatosis J:184647
Apoftm1(KOMP)Vlcg/Apoftm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased liver cholesterol level J:185314
Aqp11tm1.1Nlsn/Aqp11tm1.1Nlsn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:194939
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		increased liver triglyceride level J:98775
Arb2aem2(IMPC)Ccpcz/Arb2aem2(IMPC)Ccpcz
(C57BL/6NCrl-Arb2aem2(IMPC)Ccpcz/Ph) 		abnormal liver morphology J:211773
Arf6tm1Yaka/Arf6tm1Yaka
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatic cord morphology J:111404
abnormal liver development J:111404
abnormal liver morphology J:111404
decreased liver weight J:111404
liver hypoplasia J:111404
pale liver J:111404
Arg1tm1Rki/Arg1tm1Rki
(Not Specified) 		abnormal hepatobiliary system morphology J:83263
abnormal hepatocyte morphology J:83263
abnormal liver morphology J:83263
enlarged liver J:83263
pale liver J:83263
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac) 		liver hypoplasia J:101418
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6) 		liver hypoplasia J:119516
Arhgap31tm1.1Itl/Arhgap31tm1.2Itl
(involves: 129/SvEv * C57BL/6) 		pale liver J:253757
Arhgap31tm1.2Itl/Arhgap31tm1.2Itl
(involves: 129/SvEv * C57BL/6) 		pale liver J:253757
Arhgef2em1(IMPC)Mbp/Arhgef2em1(IMPC)Mbp
(C57BL/6N-Arhgef2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Arid3atm1Pwt/Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6) 		liver hypoplasia J:169178
Arid4atm1Alb/Arid4atm1Alb
(involves: 129S7/SvEvBrd) 		enlarged liver J:141004
Arid4atm1Alb/Arid4atm1Alb
Arid4btm1Alb/Arid4b+
(involves: 129S7/SvEvBrd) 		enlarged liver J:141004
Arih2tm1Mak/Arih2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		liver inflammation J:191066
Arih2tm1Mak/Arih2tm1Mak
(B6.129P2-Arih2tm1Mak) 		abnormal liver physiology J:191066
liver hypoplasia J:191066
Arl3Gt(OST263303)Lex/Arl3Gt(OST263303)Lex
(involves: 129S5/SvEvBrd) 		abnormal bile duct development J:107331
abnormal bile duct morphology J:107331
abnormal extrahepatic bile duct morphology J:107331
bile duct inflammation J:107331
dilated gallbladder J:107331
Armcx3tm1.1Eso/Y
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:345411
Arnt2em1Btlr/Arnt2em1Btlr
(C57BL/6J-Arnt2em1Btlr) 		hepatic steatosis J:268298
increased liver weight J:268298
Arnttm1Bra/Arnttm1Bra
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6) 		hepatic steatosis J:97652
Arnttm1Bra/Arnttm1Bra
Vhltm1Jae/Vhltm1Jae
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * BALB/c * C57BL/6 * DBA) 		liver/biliary system phenotype J:97652
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to hepatic steatosis J:179646
Arsgtm1Tdi/Arsgtm1Tdi
(involves: 129S2/SvPas * C57BL/6) 		abnormal hepatocyte morphology J:185592
abnormal liver sinusoidal endothelial cell morphology J:185592
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J) 		abnormal liver physiology J:263695
decreased liver cholesterol level J:263695
decreased liver free fatty acids level J:263695
decreased liver triglyceride level J:263695
decreased susceptibility to diet-induced hepatic steatosis J:263695
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		liver/biliary system phenotype J:241193
As3mttm1Djth/As3mttm1Djth
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver physiology J:162148
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6) 		liver fibrosis J:285931
Asah1tm1Esc/Asah1+
(involves: 129S1/Sv * C57BL/6) 		abnormal liver morphology J:74647
pale liver J:74647
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1) 		hepatic necrosis J:232306
Asgr1tm1Ishi/Asgr1tm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver physiology J:68876
Asic3em1(IMPC)Mbp/Asic3em1(IMPC)Mbp
(C57BL/6NCrl-Asic3em1(IMPC)Mbp/MbpMmucd) 		abnormal gallbladder morphology J:211773
abnormal liver morphology J:211773
enlarged gallbladder J:211773
small liver J:211773
Asnsd1Gt(OST460318)Lex/Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		liver/biliary system phenotype J:320329
Aspscr1em1(IMPC)Tcp/Aspscr1em1(IMPC)Tcp
(C57BL/6NCrl-Aspscr1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Asxl1tm1.1Mjxu/Asxl1+
(involves: 129 * C57BL/6) 		abnormal liver morphology J:208085
enlarged liver J:208085
Atad5Gt(RRF055)Byg/Atad5+
(involves: 129P2/OlaHsd) 		increased liver adenocarcinoma incidence J:176672
Atf2tm2Nicj/Atf2tm2Nicj
Atf7tm1Nicj/Atf7tm1Nicj
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:123909
increased hepatocyte apoptosis J:123909
liver hypoplasia J:123909
Atf4tm1Tow/Atf4tm1Tow
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss) 		decreased hepatocyte number J:74479
pale liver J:74479
Atf6tm1.1Rjk/Atf6tm1.1Rjk
(involves: C57BL/6 * FVB/N) 		hepatic steatosis J:124971
Atg5tm1Myok/Atg5tm1Myok
Tg(CAG-cre)13Miya/?
(involves: 129S/SvEv * C57BL/6) 		abnormal liver morphology J:110050
Atg5tm1Myok/Atg5tm1Myok
Tg(Mx1-cre)1Cgn/?
(involves: 129S/SvEv * C57BL/6 * CBA) 		abnormal liver morphology J:110050
Atg5tm1Nmz/Atg5tm1Nmz
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal hepatocyte morphology J:110050
abnormal liver morphology J:110050
Atg7tm1Tchi/Atg7tm1Tchi
Sqstm1tm1Keta/Sqstm1tm1Keta
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA * CBA/JNCrlj) 		abnormal hepatocyte morphology J:130839
decreased liver function J:130839
Atg7tm1Tchi/Atg7tm1Tchi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		abnormal hepatocyte mitochondrial morphology J:100199
abnormal hepatocyte morphology J:130839, J:100199
abnormal liver morphology J:100199
abnormal liver physiology J:100199
decreased liver function J:130839
enlarged liver J:100199
increased hepatocyte proliferation J:130839
increased liver weight J:130839, J:100199
Atl3em1(IMPC)Tcp/Atl3em1(IMPC)Tcp
(C57BL/6N-Atl3em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Atmtm1Awb/Atmtm1Awb
(A.129S6-Atmtm1Awb) 		increased hepatocellular carcinoma incidence J:208539
Atox1Gt(IRESBetageo)3Pgr/Atox1Gt(IRESBetageo)3Pgr
(B6.129(Cg)-Atox1Gt(IRESBetageo)3Pgr/Mmucd) 		decreased liver copper level J:74249
Atp5if1em1Jpy/Atp5if1em1Jpy
(C57BL/6J-Atp5if1em1Jpy) 		increased liver weight J:313048
Atp6ap2em1Nira/Y
(C57BL/6J-Atp6ap2em1Nira) 		decreased liver weight J:324587
Atp6ap2tm1.1Aich/Y
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J) 		abnormal hepatocyte morphology J:274386
abnormal hepatocyte physiology J:274386
enlarged liver J:274386
Atp6ap2tm1.1Aich/Atp6ap2tm1.1Aich
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J) 		abnormal hepatocyte morphology J:274386
abnormal hepatocyte physiology J:274386
enlarged liver J:274386
Atp6v0d1em1Nju/Atp6v0d1em1Nju
Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ) 		hepatic steatosis J:346448
increased liver cholesterol level J:346448
increased liver free fatty acids level J:346448
increased liver triglyceride level J:346448
increased liver weight J:346448
Atp7aMo-blo/Y
(involves: C57BL/6J) 		decreased liver copper level J:36268
Atp7aMo-blo/Atp7a+
(involves: C57BL/6J) 		decreased liver copper level J:36268
Atp7aMo-br/Y
(involves: C57BL) 		decreased liver copper level J:5462
Atp7aMo-brJ/Y
(involves: C3H/HeJ * C57BL/6J) 		decreased liver copper level J:33276
Atp7aMo-ml/Y
(involves: C3Hf/He) 		decreased liver copper level J:1132, J:12745
Atp7aMo-ms/Y
(Not Specified) 		decreased liver copper level J:168658
Atp7aMo-ms/Y
(involves: CBA/Kw) 		decreased liver copper level J:14875
Atp7btm1Tcg/Atp7btm1Tcg
(involves: 129S1/Sv) 		abnormal liver copper level J:57632
abnormal liver morphology J:57632
liver cirrhosis J:57632
liver/biliary system phenotype J:57632
Atp7btx-J/Atp7btx-J
(C3H/HeJ-Atp7btx-J/J) 		abnormal liver morphology J:130273, J:86701
liver cirrhosis J:24233
Atp7btx/Atp7btx
(DL-Atp7btx) 		abnormal hepatocyte morphology J:19226
decreased liver copper level J:7102
increased liver copper level J:40104, J:7102, J:19226
liver cirrhosis J:40104
Atp7btx/Atp7btx
(involves: C57BL/6 * DL) 		decreased liver copper level J:7102
increased liver copper level J:7102
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Atp8b1tm1Nbf/Atp8b1tm1Nbf
(involves: 129S1/SvImJ * 129S4/SvJae) 		abnormal bile secretion J:89817
abnormal liver physiology J:89817
enlarged liver J:89817
Atp8b1tm1Nbf/Atp8b1tm1Nbf
Portm1Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		abnormal bile secretion J:215915
bile duct proliferation J:215915
cholestasis J:215915
increased liver weight J:215915
Atp11atm1a(KOMP)Wtsi/Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
herniated liver J:239583
liver hypoplasia J:239583
Atp11cambr/Y
(C57BL/6-Atp11cambr) 		increased hepatocellular carcinoma incidence J:171924
Atrtm1Bal/Atrtm2Bal
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		abnormal liver morphology J:123200
Atrtm1Ofc/Atrtm1Ofc
(Not Specified) 		decreased liver weight J:151542
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:135320
increased liver glycogen level J:135320
Atxn2tm1Plt/Atxn2tm1Plt
(involves: 129X1/SvJ * C57BL/6) 		hepatic steatosis J:103805
intrahepatic cholestasis J:103805
AurkaGt(XQ0149)Wtsi/Aurka+
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatoma incidence J:143099
Aurkbtm1.2Mama/Aurkb+
(involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL) 		increased liver adenocarcinoma incidence J:173575
Auts2em1(IMPC)Wtsi/Auts2em1(IMPC)Wtsi
(C57BL/6N-Auts2em1(IMPC)Wtsi/Wtsi) 		biliary cyst J:239583
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		liver degeneration J:54681
Azin1Gt(Ayu17-689)Imeg/Azin1Gt(Ayu17-689)Imeg
(involves: C57BL/6 * CBA) 		abnormal liver parenchyma morphology J:146570
b2b386.2Clo/b2b386.2Clo
(C57BL/6J-b2b386.2Clo) 		abnormal liver morphology J:175213
b2b386Clo/b2b386Clo
(C57BL/6J-b2b386Clo) 		abnormal liver morphology J:175213
b2b1297Clo/b2b1297Clo
(C57BL/6J-b2b1297Clo) 		abnormal liver morphology J:175213
liver cyst J:175213
b2b1801Clo/b2b1801Clo
(C57BL/6J-b2b1801Clo) 		abnormal liver morphology J:175213
b2b2025Clo/b2b2025Clo
(C57BL/6J-b2b2025Clo) 		abnormal liver morphology J:175213
b2b2821Clo/b2b2821Clo
(C57BL/6J-b2b2821Clo) 		abnormal liver morphology J:175213
B2mtm1Unc/B2mtm1Unc
Hfetm2Nca/Hfetm2Nca
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver iron level J:62112
B2mtm1Unc/B2mtm1Unc
Prkdcscid/Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid) 		increased liver iron level J:102141
B9d1tm1a(EUCOMM)Wtsi/B9d1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * CD-1) 		abnormal bile duct development J:178421
abnormal liver morphology J:178421
bile duct hyperplasia J:178421
B9d1tm1d(EUCOMM)Wtsi/B9d1tm1d(EUCOMM)Wtsi
(involves: C57BL/6 * FVB/N * SJL) 		abnormal hepatobiliary system morphology J:178421
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		abnormal hepatocyte morphology J:123547
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		liver inflammation J:169839
B9d2/Tgfb1tm1Flv/B9d2+
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		liver inflammation J:169839
B9d2tm1a(EUCOMM)Wtsi/B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver morphology J:239583
Babam1em1(IMPC)Ccpcz/Babam1em1(IMPC)Ccpcz
(C57BL/6NCrl-Babam1em1(IMPC)Ccpcz/Ccpcz) 		increased liver weight J:211773
Bag1tm1Msd/Bag1tm1Msd
(involves: C57BL/6) 		liver hypoplasia J:95491
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl) 		decreased liver weight J:144416
hepatic steatosis J:144416
pale liver J:144416
Baz2bem1Hzhu/Baz2bem1Hzhu
(involves: 129 * C57BL/6) 		enhanced liver regeneration J:326413
Bbs2tm1.1Huss/Bbs2tm1.1Huss
(involves: 129S6/SvEv * C57BL/6) 		increased liver weight J:296033
Bbs2tm1Vcs/Bbs2tm1Vcs
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		hepatic steatosis J:94467
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd) 		abnormal liver morphology J:134093
abnormal liver physiology J:134093
enlarged liver J:134093
hepatic steatosis J:134093
Bcar1tm1Hhi/Bcar1tm1Hhi
(involves: 129S/SvEv * C57BL/6) 		small liver J:48967
Bckdhatm1a(EUCOMM)Hmgu/Bckdhatm1a(EUCOMM)Hmgu
Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6N * FVB) 		increased liver triglyceride level J:278806
increased liver weight J:278806
BckdkGt(VICT48)710Lex/BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex) 		increased liver weight J:117564
Bcl2l12tm1.1(KOMP)Vlcg/Bcl2l12tm1.1(KOMP)Vlcg
(C57BL/6N-Bcl2l12tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Bcl2l15tm1b(EUCOMM)Hmgu/Bcl2l15tm1b(EUCOMM)Hmgu
(C57BL/6N-Bcl2l15tm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		decreased liver triglyceride level J:271078
decreased liver weight J:271078
decreased susceptibility to diet-induced hepatic steatosis J:271078
Bcl6tm1Rdf/Bcl6tm1Rdf
(involves: 129S1/Sv) 		liver inflammation J:40769
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv) 		liver inflammation J:40769
Bco1tm1Dnp/Bco1tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6) 		macrovesicular hepatic steatosis J:128383
Bco2tm1Dnp/Bco2+
(involves: 129S6/SvEvTac * C57BL/6) 		increased liver triglyceride level J:170742
macrovesicular hepatic steatosis J:170742
Bco2tm1Dnp/Bco2tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal hepatocyte physiology J:170742
abnormal liver morphology J:166153
increased liver triglyceride level J:170742
macrovesicular hepatic steatosis J:170742
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas) 		abnormal liver parenchyma morphology J:23804
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(involves: 129 * 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:189652
decreased liver glycogen level J:189652
increased liver iron level J:189652
liver fibrosis J:189652
microvesicular hepatic steatosis J:189652
small liver J:189652
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp) 		abnormal hepatocyte mitochondrial morphology J:273501
abnormal hepatocyte morphology J:273501
abnormal liver morphology J:273501
abnormal liver physiology J:273501
abnormal portal triad morphology J:273501
hepatic necrosis J:273501
liver fibrosis J:273501
liver inflammation J:273501
Becn1tm1Blev/Becn1+
(involves: 129X1/SvJ * C57BL/6J) 		increased hepatocellular carcinoma incidence J:86953
Becn1tm1Htz/Becn1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:86982
Bhlha15tm2(Kras)Skz/Bhlha15+
(involves: 129S6/SvEvTac * C57BL/6) 		enlarged liver J:105076
increased hepatocellular carcinoma incidence J:105076
increased liver adenoma incidence J:105076
Bhlha15tm2(Kras)Skz/Bhlha15+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:105076
Bhmttm1.2Zei/Bhmttm1.2Zei
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:177569
hepatic steatosis J:177569
increased hepatocellular carcinoma incidence J:177569
increased liver adenoma incidence J:177569
increased liver tumor incidence J:177569
increased liver weight J:177569
Bicc1jcpk-67Gso/Bicc1jcpk-67Gso
T(2;10)67Gso/T(2;10)67Gso
(involves: 101/Rl * C3H/Rl * C57BL10a/E * SEC/RlGso) 		abnormal biliary ductule morphology J:75799
abnormal interlobular bile duct morphology J:75799
abnormal liver morphology J:75799
abnormal liver parenchyma morphology J:75799
biliary cyst J:75799
jaundice J:75799
Bicc1jcpk-bpk/Bicc1jcpk-bpk
(BALB/c-Bicc1jcpk-bpk) 		abnormal liver morphology J:13276
bile duct hyperplasia J:13276
Bicc1jcpk-bpk/Bicc1jcpk-bpk
(involves: BALB/c * CAST/EiJ) 		dilated gallbladder J:36348
pale liver J:36348
Bicc1jcpk/Bicc1jcpk-bpk
(involves: 101 * BALB/c * C3H * C57BL/6J * T STOCK) 		abnormal bile duct morphology J:36348
abnormal portal lobule morphology J:36348
abnormal portal triad morphology J:36348
dilated gallbladder J:36348
pale liver J:36348
Bicc1jcpk/Bicc1jcpk
(involves: 101 * C3H * C57BL/6J * T STOCK) 		abnormal bile duct morphology J:36348
abnormal portal triad morphology J:36348
Bicc1jcpk/Bicc1jcpk
(involves: 101 * C3H * T STOCK) 		dilated bile duct J:23047
enlarged gallbladder J:23047
Bicc1tm1Emdr/Bicc1tm1Emdr
(B6SJL-Bicc1tm1Emdr/J) 		biliary cyst J:158678
Bidtm1Sjk/Bidtm1Sjk
(involves: 129X1/Sv * C57BL/6) 		liver/biliary system phenotype J:132334
Bidtm1Sjk/Bidtm1Sjk
Relatm1Bal/Relatm1Bal
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:132334
liver hemorrhage J:132334
Bin3tm1Gcp/Bin3tm1Gcp
(involves: 129 * C57BL/6) 		abnormal hepatocyte morphology J:133313
liver inflammation J:133313
Birc6tm1Nai/Birc6tm1Nai
(involves: 129S4/SvJae * C57BL/6J) 		decreased hepatocyte number J:96768
Bloc1s2tm1.1(KOMP)Mbp/Bloc1s2tm1.1(KOMP)Mbp
(B6N(Cg)-Bloc1s2tm1.1(KOMP)Mbp/J) 		pale liver J:211773
Bloc1s4cno/Bloc1s4cno
(C3H/HeJ-Bloc1s4cno) 		abnormal liver physiology J:61187
Blvratm1.1Rsto/Blvratm1.1Rsto
(involves: C57BL/6) 		abnormal bile color J:331733
abnormal bile composition J:331733
abnormal gallbladder morphology J:331733
Blvratm1c(EUCOMM)Hmgu/Blvratm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6J * C57BL/6N) 		decreased liver glycogen level J:237631
hepatic steatosis J:237631
increased liver triglyceride level J:237631
Bmal1tm1.1Shbi/Bmal1tm1.1Shbi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * DBA) 		liver/biliary system phenotype J:177865
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J) 		increased liver triglyceride level J:177865
increased susceptibility to diet-induced hepatic steatosis J:177865
BmcaAKR/J/BmcaAKR/J
(involves: A/J * AKR/J) 		abnormal bile composition J:80014
Bmp4tm2Blh/Bmp4tm2Blh
(involves: 129S6/SvEvTac * Black Swiss) 		abnormal liver bud morphology J:71204
delayed hepatic development J:71204
Bmp5se-Ca/Bmp5se-Ca
(CBA/Ca-Bmp5se-Ca) 		abnormal liver morphology J:5086
Bmp5se-Ca/Bmp5se-Ca
(SEACGn.CB-Bmp5se-Ca) 		abnormal liver morphology J:5086
Bmp5se/Bmp5se
(Ab/Gn) 		decreased liver weight J:13091
Bmp5se/Bmp5se
(SEC/1Gn) 		abnormal liver morphology J:5086
Bmp5se/Bmp5se
(SEAC/Gn) 		abnormal liver morphology J:5086
Bmpr1bem1(IMPC)Mbp/Bmpr1bem1(IMPC)Mbp
(C57BL/6NCrl-Bmpr1bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
bpck/bpck
(B6C3Fe a/a-bpck/J) 		liver/biliary system phenotype J:144929
Bpnt1tm1Yrk/Bpnt1tm1Yrk
(involves: 129S/SvEv * C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:194247
abnormal hepatocyte morphology J:194247
enlarged liver J:194247
pale liver J:194247
Bpnt1tm1Yrk/Bpnt1tm1Yrk
Papss2bm/Papss2bm
(involves: 129S/SvEv * C57BL/6 * LDJ/Le) 		liver/biliary system phenotype J:194247
Braftm1Cpri/Braf+
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal liver morphology J:104375
Braftm1Mmcm/Braftm1Mmcm
Cd207tm2.1(cre)Bjec/Cd207+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		liver inflammation J:211690
Braftm1Mmcm/Braftm1Mmcm
Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		hepatosplenomegaly J:211690
Braftm1Tumg/Braf+
Tg(CAG-cre)2Osb/0
(involves: C57BL * C57BL/6J * DBA) 		decreased liver weight J:216228
hepatic necrosis J:216228
small liver J:216228
Braftm1Tumg/Braf+
Tg(CAG-cre)2Osb/0
(involves: BALB/c * C57BL * C57BL/6J * DBA) 		hepatic necrosis J:226977
Brca1tm2Cxd/Brca1tm2Cxd
Pkmtm1.1Mgvh/Pkmtm1.1Mgvh
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)4Mam/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		increased liver tumor incidence J:205213
Brca1tm3Cxd/Brca1tm3Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased hepatoma incidence J:94114
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased liver tumor incidence J:155810
Brd1tm1Hko/Brd1tm1Hko
(B6.129-Brd1tm1Hko) 		decreased hepatoblast number J:177092
small liver J:177092
Brd2em1(IMPC)Wtsi/Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg) 		abnormal gallbladder morphology J:239583
dilated liver sinusoidal space J:239583
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg) 		hepatic steatosis J:159964
Brd4Gt(pGT1.8TM)ST132Nimr/Brd4+
(involves: 129P2/Ola * C57BL/6J) 		abnormal hepatocyte morphology J:76662
Brf1tm1Arte/Brf1tm1Arte
Hprt1tm1(CAG-BRF1)Gu/Hprt1+
Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		liver/biliary system phenotype J:285667
Brf1tm1Arte/Brf1tm1Arte
Tg(Cyp1a1-cre)1Dwi/0
(involves: C57BL/6 * CBA) 		hepatic necrosis J:285667
increased hepatocyte apoptosis J:285667
liver inflammation J:285667
small liver J:285667
Brip1Gt(RRI409)Byg/Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		hepatic steatosis J:227115
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		enlarged liver J:183701
hepatic steatosis J:183701
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		enlarged liver J:173404
increased liver triglyceride level J:173404
liver/biliary system phenotype J:173404
macrovesicular hepatic steatosis J:173404
microvesicular hepatic steatosis J:173404
Bscl2tm1c(EUCOMM)Hmgu/Bscl2tm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ) 		increased liver triglyceride level J:260853
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno) 		enlarged liver J:200947
hepatic steatosis J:200947
increased liver triglyceride level J:200947
increased liver weight J:200947
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas * C57BL/6J) 		abnormal liver morphology J:46376
small liver J:46376
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129/Sv * 129S2/SvPas) 		abnormal liver morphology J:46376
small liver J:46376
Bst2em1(IMPC)Mbp/Bst2em1(IMPC)Mbp
(C57BL/6N-Bst2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Btbd2em1(IMPC)Mbp/Btbd2em1(IMPC)Mbp
(C57BL/6N-Btbd2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Btbd18em1(IMPC)Ccpcz/Btbd18em1(IMPC)Ccpcz
(C57BL/6NCrl-Btbd18em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Bub1tm1.1Tvd/Bub1tm1.1Tvd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased liver tumor incidence J:143035
Bub1tm1.1Tvd/Bub1tm1.1Tvd
(B6.129P2-Bub1tm1.1Tvd) 		hepatic necrosis J:143035
pale liver J:143035
Bub1tm2Jvd/Bub1tm2Jvd
(involves: 129/Sv * C57BL/6) 		increased hepatocellular carcinoma incidence J:135093
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:201641
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac * C57BL/6 * FVB) 		abnormal hepatocyte physiology J:234643
Bub1btm1Jvd/Bub1btm1Jvd
Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB) 		abnormal hepatocyte morphology J:234643
increased hepatocyte karyomegaly J:234643
C1qtnf1em1(IMPC)Mbp/C1qtnf1em1(IMPC)Mbp
(C57BL/6N-C1qtnf1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex) 		decreased liver cholesterol level J:241403
decreased liver triglyceride level J:241403
hepatic steatosis J:241403
increased liver triglyceride level J:241403
C1qtnf2tm1Lex/C1qtnf2tm1Lex
(B6.129S5-C1qtnf2tm1Lex) 		abnormal liver physiology J:282612
decreased liver cholesterol level J:282612
decreased liver triglyceride level J:282612
small liver J:282612
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased liver triglyceride level J:237401
decreased susceptibility to diet-induced hepatic steatosis J:237401
C1qtnf7tm1(KOMP)Vlcg/C1qtnf7tm1(KOMP)Vlcg
(C57BL/6N-C1qtnf7tm1(KOMP)Vlcg) 		decreased liver weight J:244352
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg) 		abnormal liver physiology J:212299
hepatic steatosis J:212299
increased liver triglyceride level J:212299
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm) 		hepatic steatosis J:284780
increased liver triglyceride level J:284780
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:152533
abnormal liver physiology J:152533
decreased hepatocyte proliferation J:152533
focal hepatic necrosis J:152533
hepatic steatosis J:152533
impaired liver regeneration J:152533
liver inflammation J:30152
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae) 		decreased susceptibility to alcohol-induced hepatic steatosis J:128218
C3tm1Hrc/C3tm1Hrc
(B6.129-C3tm1Hrc) 		impaired liver regeneration J:91917
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw) 		impaired liver regeneration J:91917
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6) 		liver inflammation J:30152
C5ar2tm1Gdy/C5ar2tm1Gdy
(involves: 129 * C57BL/6) 		abnormal liver morphology J:152533
focal hepatic necrosis J:152533
hepatic steatosis J:152533
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N) 		enlarged liver J:240357
liver inflammation J:240357
C9orf72tm1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N) 		enlarged liver J:240357
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N) 		enlarged liver J:240357
cab/cab
(STOCK Cacna1smdg) 		abnormal liver morphology J:6195, J:7797
Cacna1cem1(IMPC)Mbp/Cacna1c+
(C57BL/6N-Cacna1cem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Cacna1itm1b(KOMP)Wtsi/Cacna1itm1b(KOMP)Wtsi
(C57BL/6N-Cacna1itm1b(KOMP)Wtsi/Bay) 		small liver J:211773
Camk1dem1(IMPC)Mbp/Camk1dem1(IMPC)Mbp
(C57BL/6NCrl-Camk1dem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver parenchyma morphology J:239583
Cand1em1(IMPC)Mbp/Cand1+
(C57BL/6NCrl-Cand1em1(IMPC)Mbp/Mmucd) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
enlarged liver J:211773
Capza2tm1b(KOMP)Wtsi/Capza2tm1b(KOMP)Wtsi
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi) 		biliary cyst J:239583
dilated liver sinusoidal space J:239583
Casp8em1(IMPC)Ccpcz/Casp8+
(C57BL/6NCrl-Casp8em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
small liver J:211773
Casp8kuche/Casp8kuche
(involves: C57BL/6JAnu * C57BL/10SnJ) 		small liver J:104190
Casp8tm1.1Raz/Casp8tm1.1Raz
Ripk3tm1Vmd/Ripk3tm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		abnormal liver physiology J:170815
decreased hepatocyte apoptosis J:170814
Casp8tm1Clie/Casp8tm1Clie
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal biliary tract morphology J:218665
abnormal liver morphology J:218665
enlarged liver J:218665
hepatic necrosis J:218665
intrahepatic cholestasis J:218665
liver fibrosis J:218665
Casp8tm1Clie/Casp8tm1Clie
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal bile duct morphology J:160521
abnormal liver morphology J:160521
bile duct proliferation J:160521
focal hepatic necrosis J:160521
Casp8tm1Clie/Casp8tm1Clie
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		liver inflammation J:218665
Casp8tm1Raz/Casp8tm1Raz
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal liver morphology J:107455
Casz1Gt(CJ0565)Wtsi/Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		liver vascular congestion J:242127
Catb/Catb
(C3.Cg-Catb/Anl) 		increased hepatoma incidence J:154291
Cav1tm1Kur/Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6) 		abnormal liver physiology J:112452
decreased hepatocyte proliferation J:112452
decreased liver triglyceride level J:112452
impaired liver regeneration J:112452
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL) 		liver/biliary system phenotype J:75192
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls) 		abnormal liver physiology J:182288
decreased liver glycogen level J:182288
decreased susceptibility to diet-induced hepatic steatosis J:182288
increased liver glycogen level J:182288
increased liver weight J:182288
Cav1tm1Pesch/Cav1tm1Pesch
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(FVB.Cg-Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn) 		liver/biliary system phenotype J:182288
Cav3em1(IMPC)Kmpc/Cav3em1(IMPC)Kmpc
(C57BL/6NTac-Cav3em1(IMPC)Kmpc/Kmpc) 		absent liver J:211773
Cavin3tm1Pemi/Cavin3tm1Pemi
(B6.129S4-Cavin3tm1Pemi) 		hepatic steatosis J:202374
Cbfbtm1Lhc/Cbfbtm1Lhc
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal liver morphology J:105040
Cbfbtm1Ppl/Cbfb+
(either: (involves: 129/Sv * 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6)) 		pale liver J:36594
small liver J:36594
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)1Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1)) 		abnormal liver morphology J:80670
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)2Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster)) 		abnormal liver morphology J:80670
Cbfbtm1Tno/Cbfbtm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		abnormal liver development J:40963
Cbfbtm1Tok/Cbfbtm1Tok
(involves: 129P2/OlaHsd * C57BL/6J) 		pale liver J:36250
Cbfbtm3Ppl/Cbfb+
(involves: 129S6/SvEvTac * C57BL/6) 		pale liver J:160522
Cbfbtm4Ppl/Cbfb+
(involves: 129S6/SvEvTac * C57BL/6) 		pale liver J:160522
Cbltm1.1Hua/Cbltm1.1Hua
Lattm1Les/Lattm1Les
(involves: 129P2/OlaHsd) 		liver inflammation J:91369
Cbltm1.1Hua/Cbltm1.1Hua
Lcp2tm1Gak/Lcp2tm1Gak
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		liver inflammation J:91369
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6) 		decreased liver triglyceride level J:94416
Cbltm2Hua/Cbltm2Hua
Cblbtm1Hua/Cblbtm1Hua
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR) 		liver fibrosis J:80427
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi) 		abnormal hepatocyte morphology J:236022
Cbstm1Unc/Cbs+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:23321
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:23321
enlarged liver J:23321
hepatic steatosis J:101303
increased hepatocyte apoptosis J:101303
liver fibrosis J:101303
liver inflammation J:101303
microvesicular hepatic steatosis J:23321
pale liver J:23321
Cbstm1Unc/Cbstm1Unc
Tg(CBS)11181Eri/0
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver morphology J:165612
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal bile duct morphology J:239583
abnormal liver vasculature morphology J:239583
Cbx7tm1Afus/Cbx7+
(involves: C57BL/6J) 		increased hepatocellular carcinoma incidence J:184383
increased liver adenoma incidence J:184383
Cbx7tm1Afus/Cbx7tm1Afus
(involves: C57BL/6J) 		increased hepatocellular carcinoma incidence J:184383
increased liver adenoma incidence J:184383
increased liver tumor incidence J:184383
Ccar2Gt(XN876)Byg/Ccar2Gt(XN876)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver physiology J:156677
decreased susceptibility to diet-induced hepatic steatosis J:156677
Ccbe1em1(IMPC)Mbp/Ccbe1+
(C57BL/6NCrl-Ccbe1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Ccbe1em1(IMPC)Mbp/Ccbe1em1(IMPC)Mbp
(C57BL/6NCrl-Ccbe1em1(IMPC)Mbp/MbpMmucd) 		pale liver J:211773
Ccbe1tm1Mlkn/Ccbe1tm1Mlkn
(either: B6.129-Ccbe1tm1Mlkn or (involves: 129 * C57BL/6)) 		abnormal liver morphology J:196696
small liver J:196696
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J) 		decreased liver triglyceride level J:220560
decreased liver weight J:220560
decreased susceptibility to age-related hepatic steatosis J:220560
Ccdc25em1(IMPC)Mbp/Ccdc25+
(C57BL/6N-Ccdc25em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Ccdc39b2b2025.1Clo/Ccdc39b2b2025.1Clo
(C57BL/6J-Ccdc39b2b2025.1Clo) 		abnormal liver morphology J:175213
Ccdc80tm1.1Ftk/Ccdc80tm1.1Ftk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6N) 		increased hepatocellular carcinoma incidence J:216704
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp) 		decreased liver triglyceride level J:332421
decreased liver weight J:332421
decreased susceptibility to diet-induced hepatic steatosis J:332421
Ccdc124tm1b(KOMP)Wtsi/Ccdc124tm1b(KOMP)Wtsi
(C57BL/6N-Ccdc124tm1b(KOMP)Wtsi/Nju) 		small liver J:211773
Ccdc134tm1.2Jhua/Ccdc134tm1.2Jhua
(involves: C57BL/6NTac) 		decreased hepatocyte proliferation J:256995
liver hypoplasia J:256995
small liver J:256995
Ccdc154ntl/Ccdc154ntl
(involves: 129S7/SvEvBrd * C57BL/6J) 		enlarged liver J:226596
Ccdc198em1Iad/Ccdc198em1Iad
(FVB.Cg-Pde6b+ Tyrc-ch Ccdc198em1Iad/J) 		small liver J:337480
Cckartm1Kpn/Cckartm1Kpn
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ) 		gallstones J:53711
Cckartm1Kpn/Cckartm1Kpn
(involves: 129S/SvEv) 		abnormal bile composition J:91998
gallstones J:91998
increased gallbladder volume J:91998
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6J) 		increased liver iron level J:142455
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J) 		decreased susceptibility to diet-induced hepatic steatosis J:110277
Ccl28em1(IMPC)Ccpcz/Ccl28em1(IMPC)Ccpcz
(C57BL/6NCrl-Ccl28em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Ccn1tm3.1Lfl/Ccn1tm3.1Lfl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		liver fibrosis J:204032
liver/biliary system phenotype J:204032
Ccn2tm1.1Alea/Ccn2tm1.1Alea
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA) 		abnormal cholangiocyte morphology J:228499
increased liver weight J:228499
liver fibrosis J:228499
Ccn3em1(IMPC)Mbp/Ccn3em1(IMPC)Mbp
(C57BL/6N-Ccn3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Ccn3tm1Cabo/Ccn3+
(involves: 129S/SvEv) 		liver vascular congestion J:135676
Ccn3tm1Cabo/Ccn3tm1Cabo
(involves: 129S/SvEv) 		liver vascular congestion J:135676
Ccnd2tm1Wbg/Ccnd2tm1Wbg
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(Not Specified) 		abnormal liver development J:80994
Ccndbp1tm1Riet/Ccndbp1tm1Riet
(involves: 129P2/OlaHsd * C57BL/6) 		decreased hepatocyte proliferation J:121623
delayed liver regeneration J:121623
increased hepatocellular carcinoma incidence J:121623
increased liver adenoma incidence J:121623
Ccng1tm1Sst/Ccng1tm1Sst
(involves: 129S/SvEv * C57BL/6) 		abnormal liver regeneration J:106007
decreased hepatoma incidence J:106007
decreased liver weight J:106007
increased hepatoma incidence J:106007
Ccnytm1.1Smoc/Ccnytm1.1Smoc
(involves: C57BL/6) 		decreased liver triglyceride level J:224589
Ccr1tm1Gao/Ccr1tm1Gao
(involves: 129S4/SvJae) 		abnormal Kupffer cell morphology J:152548
Ccr2tm1Brv/Ccr2tm1Brv
(involves: 129S1/Sv * ICR) 		enlarged liver J:111517
liver inflammation J:111517
multifocal hepatic necrosis J:111517
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6) 		hepatic necrosis J:61542
increased hepatocyte apoptosis J:61542
liver hemorrhage J:61542
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte physiology J:100869
abnormal Ito cell morphology J:152548
abnormal Kupffer cell morphology J:152548
liver failure J:100869
Cd1d1tm1Luc/Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:93915
Cd36em1(IMPC)Mbp/Cd36em1(IMPC)Mbp
(C57BL/6N-Cd36em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe) 		abnormal liver physiology J:135594
decreased liver free fatty acids level J:135594
decreased liver triglyceride level J:135594
increased liver triglyceride level J:87372
Cd44tm1Mak/Cd44tm1Mak
(B6.129P2-Cd44tm1Mak) 		liver inflammation J:69351
Cd72c/Cd72c
Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp) 		liver inflammation J:204782
Cd72tm1Tsub/Cd72tm1Tsub
Faslpr/Faslpr
(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp) 		liver inflammation J:204782
Cdc20tm1.1Pzg/Cdc20+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased hepatoma incidence J:150421
Cdc73tm1Btt/Cdc73tm1Btt
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		hepatic necrosis J:135255
small liver J:135255
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst
(B6.Cg-Cdh5tm3(Cdh5/Ctnna1)Dvst) 		decreased liver weight J:213676
liver hypoplasia J:213676
small liver J:213676
Cdh5tm8Dvst/Cdh5tm8Dvst
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/10 * CBA/Ca) 		liver/biliary system phenotype J:213676
Cdh11em1(IMPC)Mbp/Cdh11em1(IMPC)Mbp
(C57BL/6N-Cdh11em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Cdk1tm2.1Kald/Cdk1tm2.1Kald
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL) 		abnormal hepatocyte morphology J:182141
decreased hepatocyte number J:182141
decreased hepatocyte proliferation J:182141
Cdk2tm1Kald/Cdk2tm1Kald
(involves: 129S1/Sv) 		decreased hepatocyte proliferation J:141249
Cdk2tm1Kald/Cdk2tm1Kald
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6) 		abnormal liver morphology J:108720
Cdk2tm1Sgo/Cdk2tm1Sgo
Cdk4tm1Bbd/Cdk4tm1Bbd
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver hypoplasia J:124678
Cdk2tm1Sgo/Cdk2tm1Sgo
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL) 		abnormal liver physiology J:125217
liver hypoplasia J:125217
Cdk2tm2Sgo/Cdk2tm2Sgo
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
Polr2atm1(cre/ERT2)Bbd/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		liver/biliary system phenotype J:125217
Cdk4tm1Bbd/Cdk4tm1Bbd
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1 * ICR) 		liver hypoplasia J:92529
Cdk5rap3tm1b(EUCOMM)Hmgu/Cdk5rap3tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * FVB/N) 		abnormal cholangiocyte morphology J:272566
abnormal hepatoblast differentiation J:272566
abnormal liver physiology J:272566
decreased hepatocyte proliferation J:272566
decreased liver weight J:272566
liver hypoplasia J:272566
small liver J:272566
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJaeSor * C57BL/6N * DBA) 		liver/biliary system phenotype J:272566
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu
Tg(Foxa3-cre)1Khk/0
(involves: 129S4/SvJaeSor * C57BL/6N * DBA) 		abnormal hepatic cord morphology J:272566
abnormal hepatocyte morphology J:272566
abnormal hepatocyte physiology J:272566
decreased liver weight J:272566
liver hypoplasia J:272566
small liver J:272566
Cdk10tm1.2Kald/Cdk10tm1.2Kald
(involves: 129 * C57BL/6 * FVB/N) 		abnormal liver morphology J:262333
Cdk12em1(IMPC)Tcp/Cdk12+
(C57BL/6NCrl-Cdk12em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Cdk13tm1a(EUCOMM)Hmgu/Cdk13tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		small liver J:291583
Cdk13tm1d(EUCOMM)Hmgu/Cdk13tm1d(EUCOMM)Hmgu
(involves: C57BL/6N * C57BL/6NTac) 		abnormal liver development J:291583
small liver J:291583
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj) 		decreased liver triglyceride level J:195460
increased liver triglyceride level J:195460
Cdkn1atm1(HBsAg)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1(HBsAg)Xya/Cdkn1atm1(HBsAg)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas) 		hepatic steatosis J:118516
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:138701
abnormal liver physiology J:138701
increased hepatocellular carcinoma incidence J:138701
increased hepatocyte apoptosis J:138701
increased hepatocyte proliferation J:138701
Cdkn1atm2(HBx)Xya/Cdkn1a+
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm2(HBx)Xya/Cdkn1atm2(HBx)Xya
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss)) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J) 		abnormal hepatocyte morphology J:33400
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn
Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd * FVB/N) 		increased liver tumor incidence J:131179
Cdkn2atm1.1Gsu/Cdkn2atm1.1Gsu
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		jaundice J:198619
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Rnf2tm1Mvi/Rnf2tm1Mvi
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA * SJL) 		enlarged liver J:130397
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		jaundice J:198619
Cdkn2atm2Brn/Cdkn2a+
Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd) 		enlarged liver J:132943
Cdkn2atm2Brn/Cdkn2atm2Brn
Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd) 		enlarged liver J:132943
Cebpatm1Dgt/Cebpatm1Dgt
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129S6/SvEvTac * C57BL/6) 		liver/biliary system phenotype J:105593
Cebpatm1Gjd/Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:28320
abnormal liver morphology J:28320
decreased liver glycogen level J:28320
Cebpatm1Gonz/Cebpatm1Gonz
Lepob/Lepob
Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased liver cholesterol level J:93579
decreased liver triglyceride level J:93579
decreased susceptibility to diet-induced hepatic steatosis J:93579
increased liver glycogen level J:93579
Cebpatm1Kgx/Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal bile canaliculus morphology J:35795
abnormal hepatocyte morphology J:35795
abnormal liver morphology J:35795
decreased liver glycogen level J:35795
Cebpatm1Timc/Cebpatm1Timc
(Not Specified) 		decreased hepatocyte proliferation J:163725
hepatic steatosis J:163725
Cebpatm5Nerl/Cebpatm5Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:120098
abnormal liver physiology J:120098
increased liver triglyceride level J:120098
liver/biliary system phenotype J:120098
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver physiology J:120098
decreased liver glycogen level J:120098
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		decreased hepatocyte number J:136134
liver failure J:136134
liver inflammation J:136134
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6 * MF1) 		impaired liver regeneration J:49673
Cebpbtm2.1Acle/Cebpbtm2.1Acle
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		impaired liver regeneration J:155795
Celtm1Dyh/Celtm1Dyh
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:124658
Celf4tm1a(EUCOMM)Wtsi/Celf4tm1a(EUCOMM)Wtsi
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal bile duct morphology J:239583
Cemip2tm1.1Cya/Cemip2tm1.1Cya
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA) 		abnormal liver sinusoid morphology J:317425
Cenpetm2Dwc/Cenpetm2Dwc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver regeneration J:81046
Cep290Gt(CC0582)Wtsi/Cep290Gt(CC0582)Wtsi
(129P2/OlaHsd-Cep290Gt(CC0582)Wtsi) 		liver/biliary system phenotype J:212182
Cers2Gt(S16-4B1)Sor/Cers2Gt(S16-4B1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		increased hepatocellular carcinoma incidence J:156841
increased liver tumor incidence J:156841
Ces1dtm1Reli/Ces1dtm1Reli
(involves: 129S6/SvEvTac) 		abnormal hepatocyte physiology J:158743
decreased liver triglyceride level J:158743
decreased liver weight J:158743
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6) 		abnormal hepatocyte physiology J:262803
hepatic steatosis J:262803
increased liver cholesterol level J:262803
increased liver triglyceride level J:262803
liver degeneration J:262803
Ces2atm1(KOMP)Vlcg/Ces2atm1(KOMP)Vlcg
(C57BL6/N-Ces2atm1(KOMP)Vlcg) 		increased liver cholesterol level J:335459
increased liver triglyceride level J:335459
increased liver weight J:335459
increased susceptibility to diet-induced hepatic steatosis J:335459
liver fibrosis J:335459
liver inflammation J:335459
Cfap45em1Hmd/Cfap45em1Hmd
(involves: C57BL/6) 		abnormal liver morphology J:297786
Cfap53em1(IMPC)Wtsi/Cfap53em1(IMPC)Wtsi
(C57BL/6N-Cfap53em1(IMPC)Wtsi/Wtsi) 		abnormal liver morphology J:239583
dilated liver sinusoidal space J:239583
herniated liver J:239583
Cfc1tm1Mms/Cfc1tm1Mms
(either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6J)) 		abnormal liver morphology J:58104
Cftrtm1Bay/Cftrtm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		enlarged gallbladder J:15244
Cftrtm1Eur/Cftrtm1Eur
(involves: 129P2/OlaHsd * FVB/N) 		abnormal gallbladder physiology J:28979
Cftrtm1Unc/Cftrtm1Unc
(involves: 129P2/OlaHsd) 		abnormal gallbladder morphology J:2079
dilated gallbladder J:2079
Cftrtm3Bay/Cftrtm3Bay
(involves: 129S7/SvEvBrd) 		liver/biliary system phenotype J:29656
Cftrtm3Hgu/Cftrtm3Hgu
(involves: 129P2/OlaHsd) 		abnormal bile duct morphology J:32766
abnormal hepatocyte morphology J:32766
bile duct epithelium hyperplasia J:32766
enlarged gallbladder J:32766
gallbladder inflammation J:32766
Chchd2em1(IMPC)Mbp/Chchd2em1(IMPC)Mbp
(C57BL/6NCrl-Chchd2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:146743
bile duct hyperplasia J:146743
hepatic necrosis J:146743
liver inflammation J:146743
Chdhem1Rmps/Chdhem1Rmps
(C57BL/6N-Chdhem1Rmps) 		liver/biliary system phenotype J:286033
ChkaGt(XH252)Byg/Chka+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver triglyceride level J:130726
Chmp2bem1(IMPC)Mbp/Chmp2b+
(C57BL/6NCrl-Chmp2bem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Chordc1tm1Mbra/Chordc1+
(involves: 129 * C57BL/6) 		enlarged liver J:222040
Chrm2tm1Jwe/Chrm2tm1Jwe
(involves: 129S4/SvJae * CF-1) 		abnormal gallbladder physiology J:125455
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * CF-1) 		abnormal gallbladder physiology J:125455
Chrm4tm1Jwe/Chrm4tm1Jwe
(involves: 129S6/SvEvTac * CF-1) 		abnormal gallbladder physiology J:125455
Chst2em1(IMPC)Mbp/Chst2em1(IMPC)Mbp
(C57BL/6N-Chst2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Chst14tm1.1Msch/Chst14tm1.1Msch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:203583
Chsy1em1(IMPC)Mbp/Chsy1em1(IMPC)Mbp
(C57BL/6NCrl-Chsy1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Chuktm1Mpa/Chuktm1Mpa
Ikbkbtm2Cgn/Ikbkbtm2Cgn
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		abnormal bile canaliculus morphology J:137861
abnormal bile duct morphology J:137861
intrahepatic cholestasis J:137861
jaundice J:137861
Chuktm1Ver/Chuktm1Ver
(involves: 129S4/SvJae * C57BL/6J) 		dilated gallbladder J:55415
Chuktm1Ver/Chuktm1Ver
Ikbkbtm1Ver/Ikbkbtm1Ver
(involves: 129S4/SvJae * C57BL/6J) 		increased hepatocyte apoptosis J:63443
liver degeneration J:63443
Ciapin1tm1Yzka/Ciapin1tm1Yzka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		small liver J:90889
Cidebtm1Pli/Cidebtm1Pli
(Not Specified) 		liver/biliary system phenotype J:126556
Cidectm1.1Gonz/Cidectm1.2Gonz
Tg(Fabp4-cre)#Abel/?
(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel) 		hepatic steatosis J:226899
Cidectm1Maka/Cidectm1Maka
(B6.129P2-Cidectm1Maka) 		decreased susceptibility to diet-induced hepatic steatosis J:140863
Clasp1em1(IMPC)Mbp/Clasp1+
(C57BL/6NCrl-Clasp1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Clca2tm1Dgen/Clca2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:101679
enlarged liver J:101679
increased liver weight J:101679
multifocal hepatic necrosis J:101679
Clcn3tm1Suc/Clcn3tm1Suc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver physiology J:96311, J:96150
Clcn5tm1Tjj/Y
(B6.129-Clcn5tm1Tjj) 		liver/biliary system phenotype J:77111
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg) 		increased liver weight J:279934
Cldn17em#Prso/Cldn17em#Prso
(C57BL/6-Cldn17em#Prso) 		liver/biliary system phenotype J:325994
Clec4gtm1.1Fhe/Clec4gtm1.1Fhe
(B6.129-Clec4gtm1.1Fhe) 		liver inflammation J:200968
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:160186
Clk2tm1.1Ppgr/Clk2tm1.1Ppgr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6NTac * FVB/N) 		decreased liver triglyceride level J:229283
Cln3tm1.1Mem/Cln3tm1.1Mem
(involves: 129S/SvEv * CD-1) 		abnormal hepatocyte morphology J:79615
Cln3tm1Mkat/Cln3tm1Mkat
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:57155
Cln8em1(IMPC)Mbp/Cln8em1(IMPC)Mbp
(C57BL/6N-Cln8em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt) 		abnormal hepatocyte physiology J:98343
hepatic steatosis J:98343
Clrn1tm1.1(KOMP)Vlcg/Clrn1tm1.1(KOMP)Vlcg
(C57BL/6N-Clrn1tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Clspntm1(KOMP)Vlcg/Clspn+
(C57BL/6N-Clspntm1(KOMP)Vlcg) 		enhanced liver regeneration J:332163
increased hepatocyte proliferation J:332163
increased liver weight J:332163
increased susceptibility to age-related hepatic steatosis J:332163
increased susceptibility to diet-induced hepatic steatosis J:332163
Cluhtm1.1Eir/Cluhtm1.1Eir
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/cJ * C57BL/6 * DBA * SJL) 		abnormal hepatocyte mitochondrial morphology J:249661
abnormal liver physiology J:249661
liver/biliary system phenotype J:249661
Cluhtm1.2Eir/Cluhtm1.2Eir
(involves: BALB/cJ * C57BL/6 * SJL) 		abnormal hepatocyte mitochondrial morphology J:249661
abnormal liver physiology J:249661
Cmiptm1a(EUCOMM)Wtsi/Cmiptm1a(EUCOMM)Wtsi
(C57BL/6N-Cmiptm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
Cndp2em1(IMPC)Mbp/Cndp2em1(IMPC)Mbp
(C57BL/6NCrl-Cndp2em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Cnot3em1(IMPC)Rbrc/Cnot3+
(C57BL/6NJcl-Cnot3em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya) 		decreased susceptibility to diet-induced hepatic steatosis J:180033
small liver J:180033
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya) 		decreased liver weight J:274297
decreased susceptibility to diet-induced hepatic steatosis J:274297
Cnot7em1(IMPC)Rbrc/Cnot7em1(IMPC)Rbrc
(C57BL/6NJcl-Cnot7em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Cnpy2tm1.2Zhli/Cnpy2tm1.2Zhli
(B6.Cg-Cnpy2tm1.2Zhli) 		decreased susceptibility to diet-induced hepatic steatosis J:277868
decreased susceptibility to hepatic steatosis J:277868
liver/biliary system phenotype J:277868
Cog6tm1a(EUCOMM)Wtsi/Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
Col1a1tm1(tetO-Deptor)Dmsa/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		hepatic steatosis J:187378
increased liver weight J:187378
Col1a1tm1(tetO-Fos)Wag/Col1a1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Alb1-cre)7Gsc/0
(involves: 129 * C57BL/6 * FVB/N) 		abnormal liver morphology J:210545
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		decreased susceptibility to diet-induced hepatic steatosis J:177113
increased hepatocyte proliferation J:166568
liver hyperplasia J:166568
Col1a1tm1(tetO-Tcfap2c)Hsc/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:174049
abnormal hepatocyte morphology J:174049
decreased liver glycogen level J:174049
increased hepatocyte apoptosis J:174049
increased hepatocyte proliferation J:174049
liver failure J:174049
microvesicular hepatic steatosis J:174049
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		abnormal liver morphology J:217463
increased hepatocellular carcinoma incidence J:217463
increased liver adenoma incidence J:217463
liver failure J:217463
liver fibrosis J:217463
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
Trp53tm1Gev/Trp53+
(B6.Cg-Trp53tm1Gev Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		decreased hepatocyte apoptosis J:217463
increased hepatocellular carcinoma incidence J:217463
Col1a1tm1(tetO-URI1)Ndj/Col1a1tm1(tetO-URI1)Ndj
Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		increased hepatocellular carcinoma incidence J:217463
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:141457
decreased hepatocyte apoptosis J:141457
enlarged liver J:141457
increased hepatocyte proliferation J:141457
increased liver weight J:141457
liver hyperplasia J:141457
Col1a1tm1Dab/Col1a1tm1Dab
(C.129S6-Col1a1tm1Dab) 		abnormal liver morphology J:170561
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		decreased liver triglyceride level J:210545
decreased susceptibility to diet-induced hepatic steatosis J:210545
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		liver fibrosis J:213764
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		abnormal liver morphology J:210545
decreased liver triglyceride level J:210545
decreased liver weight J:210545
decreased susceptibility to diet-induced hepatic steatosis J:210545
increased liver weight J:213764
liver inflammation J:210545
liver/biliary system phenotype J:213764
Col1a1tm4(tetO-Jun/Fosl2)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		decreased liver triglyceride level J:210545
decreased susceptibility to diet-induced hepatic steatosis J:210545
Col1a1tm5(tetO-Jun/Fos)Wag/Col1a1+
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Alb1-cre)7Gsc/0
(involves: 129 * C57BL/6 * FVB/N) 		abnormal liver morphology J:210545
Col1a1tm6(tetO-MSI2)Jae/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		increased liver weight J:163322
Col2a1tm1Prc/Col2a1tm1Prc
(involves: 129/Sv * C57BL/6) 		liver/biliary system phenotype J:30041
Col3a1tm1Jae/Col3a1tm1Jae
(involves: 129S4/SvJae) 		abnormal liver morphology J:39273
Col27a1em1(IMPC)Mbp/Col27a1em1(IMPC)Mbp
(C57BL/6N-Col27a1em1(IMPC)Mbp/MbpMmucd) 		pale liver J:211773
Colgalt1tm1.1Gpt/Colgalt1+
(Not Specified) 		abnormal liver physiology J:283330
Colgalt1tm1.1Gpt/Colgalt1tm1.1Gpt
(Not Specified) 		abnormal hepatocyte morphology J:283330
decreased hepatocyte proliferation J:283330
Commd1tm2.1Bvds/Commd1tm2.1Bvds
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA * SJL) 		increased liver copper level J:182331
Coq7tm1Hek/Coq7tm2Hek
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6NTac) 		abnormal liver physiology J:202240
liver/biliary system phenotype J:202240
Coro1ctm1a(KOMP)Wtsi/Coro1ctm1a(KOMP)Wtsi
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi) 		abnormal cystic duct morphology J:239583
dilated bile duct J:239583
dilated liver sinusoidal space J:239583
Cox5btm2b(EUCOMM)Hmgu/Cox5btm2b(EUCOMM)Hmgu
(C57BL/6N-Cox5btm2b(EUCOMM)Hmgu/Bay) 		abnormal liver size J:211773
pale liver J:211773
Cox6a1tm1(KOMP)Wtsi/Cox6a1tm1(KOMP)Wtsi
(involves: C57BL/6JJcl * C57BL/6N) 		abnormal liver physiology J:230212
Cpm1Btlr/Cpm1Btlr
(C57BL/6J-Cpm1Btlr) 		increased liver iron level J:173078
Cptm1Hrs/Cptm1Hrs
(involves: 129X1/SvJ * Black Swiss) 		abnormal liver copper level J:71807
increased liver iron level J:71807, J:57730
Cptm1Samd/Cptm1Samd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased liver iron level J:78092
Cptm1Yos/Cptm1Yos
(involves: 129P2/OlaHsd * BALB/c) 		abnormal hepatocyte morphology J:79916
abnormal Kupffer cell morphology J:79916
increased liver iron level J:79916
Cpt1ctm1Dhwu/Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J) 		increased liver triglyceride level J:148205
Cpt1ctm1Mdln/Cpt1ctm1Mdln
(involves: C57BL/6) 		hepatic steatosis J:109455
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp) 		abnormal liver morphology J:208570
decreased liver triglyceride level J:208570
decreased liver weight J:208570
decreased susceptibility to diet-induced hepatic steatosis J:208570
small liver J:208570
Creb3Gt1Mbac/Creb3+
(B6NTac.Cg-Creb3Gt1Mbac) 		decreased liver triglyceride level J:345514
decreased susceptibility to diet-induced hepatic steatosis J:345514
Crebbptm1Few/Crebbp+
(Not Specified) 		increased liver glycogen level J:91133
Crebbptm1Few/Crebbptm1Few
(Not Specified) 		increased liver glycogen level J:91133
Creg1em1Yal/Creg1em1Yal
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		decreased susceptibility to diet-induced hepatic steatosis J:263073
increased liver cholesterol level J:263073
increased liver free fatty acids level J:263073
increased liver weight J:263073
Creld2tm1.1Emass/Creld2tm1.1Emass
(B6.129P2(SJL)-Creld2tm1.1Emass) 		abnormal hepatocyte morphology J:316411
decreased liver weight J:316411
decreased susceptibility to diet-induced hepatic steatosis J:316411
dilated liver sinusoidal space J:316411
increased hepatocyte apoptosis J:316411
increased susceptibility to age-related hepatic steatosis J:316411
increased susceptibility to hepatic steatosis J:316411
liver/biliary system phenotype J:316411
Cremtm1Saco/Cremtm1Saco
(involves: 129/Sv * C57BL/6) 		impaired liver regeneration J:81370
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J) 		abnormal hepatocyte morphology J:208708
Crim1em1(IMPC)Wtsi/Crim1em1(IMPC)Wtsi
(C57BL/6N-Crim1em1(IMPC)Wtsi/WtsiOrl) 		herniated liver J:239583
Crkltm1Hkp/Crkltm1Hkp
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver morphology J:76680
Crlf2em1(IMPC)Mbp/Crlf2em1(IMPC)Mbp
(C57BL/6N-Crlf2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Crls1tm1Geno/Crls1tm1Geno
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		increased liver weight J:266083
Crls1tm1Geno/Crls1tm1Geno
Tg(Ucp1-cre/ERT2)426Biat/0
(involves: C57BL/6N) 		liver/biliary system phenotype J:266083
Crpem1Wuy/Crpem1Wuy
(C57BL/6-Crpem1Wuy) 		abnormal hepatocyte morphology J:341658
Crtc2tm1.1Khk/Crtc2tm1.1Khk
(involves: C57BL/6 * C57BL/6J * FVB/N) 		abnormal liver physiology J:151618
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:167211
Cry2tm1.1Yf/Cry2tm1.1Yf
Per2tm1Jt/Per2tm1Jt
(B6J.Cg-Cry2tm1.1Yf Per2tm1Jt) 		abnormal liver physiology J:224319
Csf1op/Csf1op
(B6C3Fe a/a-Csf1op/J) 		abnormal Kupffer cell morphology J:26978
Csf1op/Csf1op
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J) 		liver inflammation J:117880
Csf1tm1.2Sabw/Csf1tm1.2Sabw
(involves: 129S4/SvJaeSor * C57BL/6) 		abnormal Kupffer cell morphology J:180199
Csnk1a1tm1c(KOMP)Wtsi/Csnk1a1tm1c(KOMP)Wtsi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * CBA) 		abnormal liver morphology J:216977
abnormal liver physiology J:216977
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ) 		hepatic steatosis J:184220
Ctbstm1Tbec/Ctbstm1Tbec
(involves: 129S2/SvPas * C57BL/6N) 		abnormal Kupffer cell morphology J:185162
Cthtm1Iish/Cthtm1Iish
(B6.129-Cthtm1Iish/Iish) 		abnormal liver morphology J:166184
Cthrc1em1(IMPC)Mbp/Cthrc1em1(IMPC)Mbp
(C57BL/6NCrl-Cthrc1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Cthrc1tm1Vli/Cthrc1tm1Vli
(B6.Cg-Cthrc1tm1Vli) 		abnormal hepatocyte morphology J:192096
liver hypoplasia J:192096
macrovesicular hepatic steatosis J:192096
microvesicular hepatic steatosis J:192096
Cthrc1tm1Vli/Cthrc1tm1Vli
(129S6.Cg-Cthrc1tm1Vli) 		increased liver glycogen level J:192096
Ctla4tm1Saka/Ctla4tm1Saka
Foxp3tm1(cre)Saka/Y
(involves: BALB/c) 		abnormal liver morphology J:140085
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocyte apoptosis J:71744
liver hemorrhage J:71744
Ctnnb1tm1Mmt/Ctnnb1+
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased hepatoblastoma incidence J:112659
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased hepatoblastoma incidence J:112659
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1+
Tg(CMV-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		increased hepatocyte apoptosis J:71744
liver hemorrhage J:71744
Ctsatm1Adz/Ctsatm1Adz
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/NJ)) 		enlarged liver J:29674
Ctsgtm2.1(PML/RARA)Ley/Ctsg+
(involves: 129X1/SvJ * C57BL/6) 		enlarged liver J:84230
Ctslnkt/Ctslnkt
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2)) 		liver inflammation J:54856
Cul3tm1Jdsr/Cul3tm1Jdsr
(involves: 129S4/SvJaeSor) 		abnormal liver morphology J:122228
increased liver weight J:122228
Cul4atm1.1Pra/Cul4atm1.1Pra
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6NTac * DBA) 		decreased hepatocyte proliferation J:172043
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased liver tumor incidence J:170976
Cutaem1(IMPC)Mbp/Cutaem1(IMPC)Mbp
(C57BL/6N-Cutaem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Cwc22em1(IMPC)Mbp/Cwc22+
(C57BL/6NCrl-Cwc22em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Cxadrem1(IMPC)Mbp/Cxadr+
(C57BL/6N-Cxadrem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Cxcl12tm3.1(HBEGF/EGFP)Tng/Cxcl12+
(B6.Cg-Cxcl12tm3.1(HBEGF/EGFP)Tng) 		hepatic necrosis J:164657
liver hemorrhage J:164657
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA) 		decreased liver triglyceride level J:126841
decreased liver weight J:126841
Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
(involves: 129S2/SvPas * C57BL/6) 		small liver J:113489
Cyb5atm1Wolf/Cyb5atm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		liver/biliary system phenotype J:143097
Cybrd1tm1Nca/Cybrd1tm1Nca
(involves: 129S4/SvJae * 129S6/SvEvTac) 		decreased liver iron level J:119528
increased liver weight J:119528
Cygbtm1Nka/Cygbtm1Nka
(B6.Cg-Cygbtm1Nka) 		abnormal liver physiology J:174134
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn) 		abnormal liver physiology J:88957
increased liver weight J:163973
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:122409
Cyp1a1tm4.1Dwn/Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn) 		increased liver weight J:163973
Cyp1a2tm1Dwn/Cyp1a2tm1Dwn
(B6.129P2-Cyp1a2tm1Dwn) 		abnormal liver physiology J:88957
Cyp1a2tm1Gonz/Cyp1a2tm1Gonz
(involves: 129S4/SvJae) 		liver/biliary system phenotype J:25724
Cyp1atm1Dwn/Cyp1atm1Dwn
Tg(CYP1A1,CYP1A2)1Dwn/Tg(CYP1A1,CYP1A2)1Dwn
(B6.Cg-Cyp1atm1Dwn Tg(CYP1A1,CYP1A2)1Dwn) 		enlarged liver J:122409
Cyp2a12em1Utr/Cyp2a12em1Utr
Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2a12em1Utr Cyp2c70em1Utr) 		abnormal bile composition J:302190
abnormal bile duct morphology J:302190
abnormal liver morphology J:302190
increased liver weight J:302190
Cyp2b10tm1a(KOMP)Wtsi/Cyp2b10tm1a(KOMP)Wtsi
(C57BL/6N-Cyp2b10tm1a(KOMP)Wtsi) 		increased susceptibility to alcohol-induced hepatic steatosis J:339440
Cyp2c70em1Sjka/Cyp2c70em1Sjka
(C57BL/6-Cyp2c70em1Sjka) 		abnormal hepatobiliary system morphology J:330641
abnormal liver morphology J:330641
increased liver weight J:330641
liver fibrosis J:330641
liver inflammation J:330641
Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2c70em1Utr) 		abnormal bile duct morphology J:302190
abnormal liver morphology J:302190
hepatic necrosis J:302190
increased liver cholesterol level J:302190
increased liver weight J:302190
liver inflammation J:302190
Cyp2ctm1104Arte/Cyp2ctm1104Arte
(B6NTac(Cg)-Cyp2ctm1104Arte/Arte) 		liver inflammation J:241121
Cyp2ctm1897.1(Alb-CYP2C9)Arte/Cyp2ctm1897.1(Alb-CYP2C9)Arte
(B6(Cg)-Cyp2ctm1897.1(Alb-CYP2C9)Arte/Arte) 		liver inflammation J:241121
Cyp2e1tm1Gonz/Cyp2e1tm1Gonz
(involves: 129S4/SvJae) 		abnormal hepatocyte morphology J:118150
hepatic steatosis J:112076
Cyp4v3em1(IMPC)Mbp/Cyp4v3em1(IMPC)Mbp
(C57BL/6NCrl-Cyp4v3em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Cyp7a1tm1Rus/Cyp7a1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal bile composition J:34870
abnormal liver morphology J:34342
abnormal liver physiology J:34342
Cyp8b1tm1Rus/Cyp8b1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal bile secretion J:100206
abnormal liver physiology J:100246, J:100206
Cyp11a1tm1b(EUCOMM)Hmgu/Cyp11a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp11a1tm1b(EUCOMM)Hmgu/Wtsi) 		dilated bile duct J:239583
dilated liver sinusoidal space J:239583
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver weight J:147610
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac) 		enlarged liver J:65805
hepatic steatosis J:65805
pale liver J:65805
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver lobule morphology J:79603
abnormal liver physiology J:79603
hepatic steatosis J:79603, J:82070
Cyp27a1tm1.1(KOMP)Vlcg/Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd) 		increased liver weight J:211773
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(involves: 129/Sv * C57BL/6J) 		abnormal bile composition J:115373, J:48127
enlarged liver J:115373
increased liver triglyceride level J:115373
increased liver weight J:115373
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(B6.129-Cyp27a1tm1Elt/J) 		enlarged liver J:223194
Cyp27a1tm1Elt/Cyp27a1tm1Elt
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		enlarged liver J:223194
Cyribm1Ivdi/Cyribm1Ivdi
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J) 		liver abscess J:282597
Cys1cpk/Cys1+
(involves: C57BL/6J * CD-1) 		liver cyst J:33739
liver fibrosis J:33739
Cys1cpk/Cys1+
(C.B6(Cg)-Cys1cpk) 		liver cyst J:99616
liver fibrosis J:99616
Cys1cpk/Cys1cpk
(involves: C57BL/6J * CD-1) 		biliary cyst J:33739
liver cyst J:33739
Cys1cpk/Cys1cpk
(C.B6(Cg)-Cys1cpk) 		biliary cyst J:99616
dilated bile duct J:99616
liver fibrosis J:99616
Cys1cpk/Cys1cpk
(D2J.B6(Cg)-Cys1cpk) 		abnormal bile duct morphology J:99620
liver fibrosis J:99620
Cys1cpk/Cys1cpk
(129.B6-Cys1cpk) 		liver inflammation J:116210
Cysltr2em1(IMPC)Mbp/Cysltr2em1(IMPC)Mbp
(C57BL/6N-Cysltr2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi) 		abnormal liver physiology J:272118
decreased liver glycogen level J:272118
decreased liver triglyceride level J:272118
D930028M14Riktm1a(EUCOMM)Wtsi/D930028M14Riktm1a(EUCOMM)Wtsi
(C57BL/6N-D930028M14Riktm1a(EUCOMM)Wtsi/Wtsi) 		herniated liver J:239583
Daglatm1a(EUCOMM)Wtsi/Daglatm1a(EUCOMM)Wtsi
(C57BL/6N-Daglatm1a(EUCOMM)Wtsi/Nju) 		small liver J:211773
Dancrem1.1Bcgen/Dancrem1.1Bcgen
(involves: C57BL/6) 		abnormal liver morphology J:329926
Daw1b2b1584Clo/Daw1b2b1584Clo
(C57BL/6J-Daw1b2b1584Clo) 		abnormal liver morphology J:175213
Dbitm1Smdp/Dbitm1Smdp
(B6JBomTac.129-Dbitm1Smdp) 		increased liver cholesterol level J:168744
increased liver triglyceride level J:168744
Dbitm1Smdp/Dbitm1Smdp
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver physiology J:204137
increased liver cholesterol level J:204137
increased liver triglyceride level J:204137
Dbitm2.1Smdp/Dbitm2.2Smdp
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		abnormal liver physiology J:204137
increased liver cholesterol level J:204137
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6NCrl-Dbn1tm1b(KOMP)Wtsi/Wtsi) 		abnormal liver morphology J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1tm1b(KOMP)Wtsi
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas) 		enlarged liver J:129710
Dcaf8em1(IMPC)Ccpcz/Dcaf8em1(IMPC)Ccpcz
(C57BL/6N-Dcaf8em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Dcaf11tm1d(KOMP)Wtsi/Dcaf11tm1d(KOMP)Wtsi
(B6(Cg)-Dcaf11tm1d(KOMP)Wtsi) 		abnormal liver physiology J:351189
Ddit3tm1.1Irt/Ddit3tm1.1Irt
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(Mup3-Plau)350-2Eps/?
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:233146
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J) 		hepatic steatosis J:214136
Ddrgk1tm1b(EUCOMM)Hmgu/Ddrgk1tm1b(EUCOMM)Hmgu
(involves: C57BL/6N) 		liver hypoplasia J:231701
Ddx6em1(IMPC)Mbp/Ddx6+
(C57BL/6N-Ddx6em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
Decr1tm1Jkh/Decr1tm1Jkh
(B6.129X1-Decr1tm1Jkh) 		increased liver weight J:151622
microvesicular hepatic steatosis J:151622
pale liver J:151622
Deddtm1Tmiy/Deddtm1Tmiy
(B6.Cg-Deddtm1Tmiy) 		decreased liver weight J:119734
Degs1Gt(OST368559)Lex/Degs1Gt(OST368559)Lex
(involves: 129S5/SvEvBrd) 		decreased liver function J:203554
Del(1)1Brk/Steap3tm1.1Mdf
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J) 		increased liver iron level J:103440
Del(1)1Brk/Del(1)1Brk
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J) 		abnormal liver iron level J:100202
enlarged liver J:100202
Del(1)1Brk/Del(1)1Brk
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J) 		increased liver iron level J:103440
Del(4C4-C5)1Lap/+
(involves: 129S6/SvEvTac) 		enlarged liver J:158126
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac) 		enlarged liver J:158126
Del(5Gtf2i-Fkbp6)1Vcam/+
(B6.129-Del(5Gtf2i-Fkbp6)1Vcam(J:204278)) 		hepatic steatosis J:216195
Del(6Slco1b2-Slco1a5)1Nki/+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal bile secretion J:163765
jaundice J:163765
Del(7Cyp2s1-Cyp2a5)1Ding/Del(7Cyp2s1-Cyp2a5)1Ding
(involves: BALB/cJ * C57BL/6) 		abnormal liver physiology J:190445
Del(11Hoxb3-Hoxb4)1Karl/Del(11Hoxb3-Hoxb4)1Karl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:83563
Del(11Irf1-D11Mit23)1Rub/Del(11Irf1-D11Mit23)1Rub
(129/Sv-Del(11Irf1-D11Mit23)1Rub) 		enlarged liver J:60187
hepatic steatosis J:60187
increased liver cholesterol level J:60187
increased liver triglyceride level J:60187
increased liver weight J:60187
pale liver J:60187
Del(11Jmjd6-Mettl23)1Ysfk/Del(11Jmjd6-Mettl23)1Ysfk
(involves: C57BL/6) 		liver hypoplasia J:90288
Del(16Lipi-Usp25)1Dja/+
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:184302
Del(17Abcg5-Abcg8)1Hobb/Del(17Abcg5-Abcg8)1Hobb
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal bile composition J:80679
decreased liver cholesterol level J:80679
increased liver cholesterol level J:80679
Dennd1aem1Jgfu/Dennd1aem1Jgfu
(Not Specified) 		abnormal cholangiocyte morphology J:276703
abnormal liver development J:276703
decreased hepatocyte proliferation J:276703
pale liver J:276703
small liver J:276703
Dennd5bem1Smgo/Dennd5bem1Smgo
(involves: C57BL/6 * CBA) 		decreased liver cholesterol level J:276600
decreased liver free fatty acids level J:276600
Deptortm1.1Mala/Deptortm1.1Mala
Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 x DBA) 		decreased liver glycogen level J:275931
liver/biliary system phenotype J:275931
Derl2tm1.1Hpl/Derl2tm1.1Hpl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		liver/biliary system phenotype J:170650
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver cholesterol level J:111346
decreased liver triglyceride level J:111346
decreased susceptibility to diet-induced hepatic steatosis J:111346
Dgat2tm1Far/Dgat2tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver glycogen level J:88742
decreased liver triglyceride level J:88742
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N) 		abnormal hepatocyte morphology J:294620
abnormal liver physiology J:294620
decreased hepatocyte mitochondrial DNA content J:294620
enhanced liver regeneration J:294620
increased hepatocyte karyomegaly J:294620
increased hepatocyte proliferation J:294620
increased liver weight J:294620
Dhcr7tm1.1Sbpa/Dhcr7tm1.1Sbpa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Dhcr7tm1.1Sbpa Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal bile composition J:303316
decreased liver cholesterol level J:303316
Dhcr7tm1Gst/Dhcr7tm1Gst
(involves: 129P2/OlaHsd) 		decreased liver cholesterol level J:71611
Dhcr7tm1Gst/Dhcr7tm1Gst
Tg(APOE-DHCR7)2Hoyu/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N) 		decreased liver cholesterol level J:141730
Dhcr24tm1c(EUCOMM)Wtsi/Dhcr24tm1c(EUCOMM)Wtsi
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * C57BL/6N) 		abnormal bile composition J:304449
Dhcr24tm1c(EUCOMM)Wtsi/Dhcr24tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Dhcr24tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal bile composition J:304449
abnormal liver morphology J:304449
decreased liver cholesterol level J:304449
Dhfrorana/Dhfrorana
(involves: C57BL/6JAnu) 		liver hypoplasia J:236197
pale liver J:236197
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6) 		increased liver glycogen level J:267178
Dhx36tm1.2Pmt/Dhx36tm1.2Pmt
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * C57BL/10 * CBA/Ca) 		enlarged liver J:185179
pale liver J:185179
Dicer1tm1Bdh/Dicer1tm1Bdh
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ) 		liver inflammation J:138683
Dicer1tm1Bdh/Dicer1tm1Bdh
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ) 		liver inflammation J:138683
Dicer1tm1Bdh/Dicer1tm1Bdh
Tg(Foxp3-EGFP/icre)1aJbs/0
(involves: 129 * NOD/ShiLt) 		liver inflammation J:138808
Dicer1tm1Gz/Dicer1tm1Gz
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:97770
Dido1tm3Cmar/Dido1tm3.1Cmar
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6) 		abnormal hepatocyte morphology J:328215
enlarged liver J:328215
increased hepatocyte karyomegaly J:328215
liver inflammation J:328215
Dio3tm1Dmst/Dio3tm1Dmst
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased hepatocyte proliferation J:218350
liver/biliary system phenotype J:218350
Disp3em1(IMPC)Mbp/Disp3em1(IMPC)Mbp
(C57BL/6N-Disp3em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
Dlk1tm1Hsul/Dlk1tm1Hsul
(either: (involves: 129 * BALB/c) or (involves: 129 * C57BL/6J)) 		enlarged liver J:77909
hepatic steatosis J:77909
Dmdmdx-3Cv/Y
Utrntm1Ked/Utrntm1Ked
(involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus) 		liver/biliary system phenotype J:116348
Dmdmdx-3Cv/Dmdmdx-3Cv
Utrntm1Ked/Utrntm1Ked
(involves: 129 * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus) 		liver/biliary system phenotype J:116348
Dmtf1tm1Cjs/Dmtf1+
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased cholangiocarcinoma incidence J:126002
Dna2tm1.1Lzhg/Dna2+
(involves: 129S1/Sv) 		increased hepatoma incidence J:198831
Dnaaf3b2b1739Clo/Dnaaf3b2b1739Clo
(C57BL/6J-Dnaaf3b2b1739Clo) 		abnormal liver morphology J:175213
Dnaaf11tm1.2Hmd/Dnaaf11tm1.2Hmd
(involves: 129S6/SvEvTac * C57BL/6NCrl) 		abnormal liver morphology J:258369
Dnah5b2b016Clo/Dnah5b2b016Clo
(C57BL/6J-Dnah5b2b016Clo) 		abnormal liver morphology J:175213
Dnah5hlb612/Dnah5hlb612
(involves: C57BL/6J) 		abnormal liver morphology J:130755
Dnah11b2b1289Clo/Dnah11b2b1289Clo
(C57BL/6J-Dnah11b2b1289Clo) 		abnormal liver morphology J:175213
Dnah11b2b1775Clo/Dnah11b2b1775Clo
(C57BL/6J-Dnah11b2b1775Clo) 		abnormal biliary tract morphology J:175213
Dnah11iv/Dnah11iv
(SI/Col Tyrp1b Dnah11iv/J) 		abnormal liver morphology J:148465, J:4058
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(129P2/OlaHsd-Dnajb9Gt(KST256)Byg) 		decreased liver glycogen level J:226674
decreased liver weight J:226674
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg) 		decreased liver glycogen level J:226674
decreased liver weight J:226674
Dnajc7tm1.2Neg/Dnajc7tm1.2Neg
(involves: 129S/SvEv * C57BL/6 * CBA) 		hepatic steatosis J:225381
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg) 		decreased liver cholesterol level J:204025
decreased susceptibility to hepatic steatosis J:204025
increased liver glycogen level J:204025
increased liver weight J:204025
Dnase1l3em1(IMPC)Mbp/Dnase1l3em1(IMPC)Mbp
(C57BL/6NCrl-Dnase1l3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Dnm1lPy/Dnm1l+
(involves: BALB/cAnNCrl * C3H/HeH) 		liver vascular congestion J:161510
Dnm1ltm1.2Miha/Dnm1ltm1.2Miha
(involves: C57BL/6J) 		delayed hepatic development J:158142
Dnmbpem1(IMPC)Mbp/Dnmbpem1(IMPC)Mbp
(C57BL/6N-Dnmbpem1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
Dnmt3btm1Enl/Dnmt3btm1Enl
(involves: 129S4/SvJae * C57BL/6) 		small liver J:106540
Dnttip1em1Shmc/Dnttip1em1Shmc
(C57BL/6J-Dnttip1em1Shmc) 		liver/biliary system phenotype J:291786
Dohhtm1.1Sbal/Dohhtm1.1Sbal
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		focal hepatic necrosis J:236582
hepatic necrosis J:236582
Dph1tm2Bhr/Dph1tm2Bhr
(either: 129/Sv or (involves: 129/Sv * C57BL/6)) 		abnormal hepatoblast morphology J:88090
liver degeneration J:88090
Dram1tm1.1(KOMP)Vlcg/Dram1tm1.1(KOMP)Vlcg
(C57BL/6N-Dram1tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low/J) 		decreased liver weight J:106832
Drgxem1(IMPC)Mbp/Drgx+
(C57BL/6N-Drgxem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		liver inflammation J:138683
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		liver inflammation J:138683
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		liver inflammation J:138683
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl) 		liver inflammation J:151605
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6) 		decreased liver weight J:129718
decreased susceptibility to age-related hepatic steatosis J:129718
decreased susceptibility to diet-induced hepatic steatosis J:129718
small liver J:129718
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht) 		liver inflammation J:213253
Dusp26em1Jhxia/Dusp26em1Jhxia
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal liver morphology J:279111
decreased liver glycogen level J:279111
increased liver cholesterol level J:279111
increased liver free fatty acids level J:279111
increased liver triglyceride level J:279111
increased liver weight J:279111
liver fibrosis J:279111
Dync1li1em1(IMPC)Tcp/Dync1li1+
(C57BL/6NCrl-Dync1li1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Dyrk1atm1Mla/Dyrk1a+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver weight J:78597
Dzip1lwarpy/Dzip1lwarpy
(involves: C57BL/6 * CD-1) 		bile duct proliferation J:249936
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6) 		liver inflammation J:76318
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:145228
Ebf1em1(IMPC)Mbp/Ebf1+
(C57BL/6N-Ebf1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Ebf1tm1Rug/Ebf1tm1Rug
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		hepatic steatosis J:147179
Ebf2em1(IMPC)Mbp/Ebf2+
(C57BL/6N-Ebf2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Efemp1tm2Lmar/Efemp1tm2Lmar
(involves: 129X1/SvJ * C57BL/6) 		decreased liver weight J:132043
liver degeneration J:132043
Efstm1Kale/Efstm1Kale
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J)) 		liver inflammation J:103757
Egfrtm1Mag/Egfrtm1Mag
(involves: 129S2/SvPas * CD-1) 		abnormal hepatocyte morphology J:26833
abnormal liver morphology J:26833
Egfrtm1Msi/Egfrtm1Msi
Tg(Alb1-cre)7Gsc/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		delayed liver regeneration J:125912
Egfrtm1Msi/Egfrtm1Msi
Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		delayed liver regeneration J:125912
Egln1tm1Kael/Egln1tm1Kael
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N) 		liver vascular congestion J:179490
Egln1tm2.1Fsl/Egln1tm2.1Fsl
Pax3tm1(cre)Joe/Pax3+
(involves: 129 * C57BL/6) 		abnormal liver vasculature morphology J:202737
increased liver weight J:202737
Egln1tm2Fong/Egln1tm2Fong
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:132720
dilated liver sinusoidal space J:133568
enlarged liver J:132720
Egln2tm1Fong/Egln2tm1Fong
Egln3tm1Fong/Egln3tm1Fong
(involves: 129S6/SvEvTac * C57BL/6) 		enlarged liver J:132720
Egr1tm1Jmi/Egr1tm1Jmi
(B6.129-Egr1tm1Jmi) 		abnormal liver physiology J:128421
liver inflammation J:128421
liver/biliary system phenotype J:128421
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6) 		abnormal liver physiology J:105638
abnormal liver size J:105638
impaired liver regeneration J:93996
increased liver triglyceride level J:105638
liver/biliary system phenotype J:105638
Ehbp1l1tm1a(EUCOMM)Wtsi/Ehbp1l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ehbp1l1tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal bile duct morphology J:239583
abnormal cystic duct morphology J:239583
dilated liver sinusoidal space J:239583
Ehhadhtm1Jkr/Ehhadhtm1Jkr
Hsd17b4tm1Baes/Hsd17b4tm1Baes
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J) 		microvesicular hepatic steatosis J:89945
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * FVB/NJ) 		abnormal liver morphology J:207678
increased liver triglyceride level J:207678
Ei24tm1Hzha/Ei24tm1Hzha
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte mitochondrial morphology J:193420
abnormal hepatocyte morphology J:193420
abnormal liver lobule morphology J:193420
abnormal liver morphology J:193420
enlarged liver J:193420
Eif2ak3tm1Drc/Eif2ak3tm1Drc
(involves: 129S6/SvEvTac) 		increased liver glycogen level J:76661
Eif2ak4tm1Drc/Eif2ak4tm1Drc
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver weight J:92545
Eif2ak4tm1Drc/Eif2ak4tm1Drc
(B6.129S6-Eif2ak4tm1Drc) 		decreased liver weight J:92545
Eif3etm1Fshb/Eif3e+
(C57BL/6N-Eif3etm1Fshb) 		small liver J:265010
Eif3mtm1.1Nju/Eif3m+
(involves: 129 * FVB/N) 		decreased liver weight J:204915
liver/biliary system phenotype J:204915
Eif3mtm1Nju/Eif3mtm1Nju
(involves: 129) 		abnormal liver morphology J:204915
Eif4btm1.2Smoc/Eif4btm1.2Smoc
(Not Specified) 		small liver J:311140
Eif6tm1Sbif/Eif6+
(involves: 129 * C57BL/6) 		abnormal hepatocyte physiology J:141257
decreased liver weight J:141257
liver hypoplasia J:141257
Eloaem1(IMPC)Mbp/Eloa+
(C57BL/6N-Eloaem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Eloatm1Aso/Eloatm1Aso
(involves: 129S/SvEv * C57BL/6) 		delayed hepatic development J:119126
Elovl5Gt(DTM098)Byg/Elovl5Gt(DTM098)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver physiology J:149093
hepatic steatosis J:149093
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal hepatocyte physiology J:130031
abnormal liver morphology J:130031
hepatic steatosis J:130031
Embtm1b(KOMP)Wtsi/Emb+
(C57BL/6N-Embtm1b(KOMP)Wtsi/Ucd) 		abnormal liver morphology J:211773
Enhotm1.1Butl/Enho+
(B6.Cg-Enhotm1.1Butl) 		hepatic steatosis J:225402
increased liver triglyceride level J:225402
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl) 		hepatic steatosis J:225402
increased liver triglyceride level J:225402
Enkurtm1Hmf/Enkurtm1Hmf
(involves: 129 * C57BL/6J) 		abnormal liver development J:253966
abnormal liver morphology J:253966
Enpp1asj/Enpp1asj
(C57BL/6J-Enpp1asj/GrsrJ) 		abnormal liver vasculature morphology J:201689
Entpd1tm1Rdr/Entpd1tm1Rdr
(involves: 129S2/SvPas) 		liver fibrosis J:57505
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal hepatocyte morphology J:163795
abnormal Kupffer cell morphology J:163795
abnormal oval cell morphology J:163795
abnormal oval cell physiology J:163795
enlarged liver J:163795
increased hepatocellular carcinoma incidence J:163795
increased hepatocyte apoptosis J:163795
increased hepatocyte proliferation J:163795
increased liver adenoma incidence J:163795
liver inflammation J:163795
Entr1em1(IMPC)Mbp/Entr1em1(IMPC)Mbp
(C57BL/6N-Entr1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Epas1tm1Rus/Epas1tm1Rus
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)) 		liver vascular congestion J:50964
Epb41tm1Cnby/Epb41tm1Cnby
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ) 		increased liver iron level J:77852
Epg5tm1Ygz/Epg5tm1Ygz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) 		liver/biliary system phenotype J:196603
Epha3em1(IMPC)Mbp/Epha3em1(IMPC)Mbp
(C57BL/6N-Epha3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Epha3tm1Abn/Epha3tm1Abn
(involves: 129S1/Sv * 129S1/SvImJ) 		liver vascular congestion J:119874
Epha6tm1b(KOMP)Wtsi/Epha6tm1b(KOMP)Wtsi
(C57BL/6N-Epha6tm1b(KOMP)Wtsi/Tcp) 		abnormal liver morphology J:211773
enlarged liver J:211773
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J) 		hepatic steatosis J:173769
increased liver cholesterol level J:173769
increased liver triglyceride level J:173769
Epm2aip1Gt(BA0314)Wtsi/Epm2aip1Gt(BA0314)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver glycogen level J:204966
hepatic steatosis J:204966
Epotm1Jae/Epotm1Jae
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		increased hepatocyte apoptosis J:29254
pale liver J:29254
small liver J:29254
Eportm1Cos/Eportm1Cos
(involves: 129S/SvEv * C57BL/6J) 		pale liver J:31156
small liver J:31156
Eportm1Jae/Epor+
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		pale liver J:29254
Eportm1Jae/Eportm1Jae
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		increased hepatocyte apoptosis J:29254
pale liver J:29254
small liver J:29254
Eportm1Lizon/Eportm1Lizon
(involves: 129S4/SvJae * C57BL/6) 		increased hepatocyte apoptosis J:35594
liver hypoplasia J:35594
pale liver J:35594
small liver J:35594
Erap1tm2b(EUCOMM)Wtsi/Erap1tm2b(EUCOMM)Wtsi
(C57BL/6N-Erap1tm2b(EUCOMM)Wtsi/Kmpc) 		abnormal liver morphology J:211773
Ercc1tm1Dwm/Ercc1+
(involves: 129P2/OlaHsd * BALB/c) 		abnormal liver physiology J:15422
decreased liver function J:15422
Ercc1tm1Dwm/Ercc1tm1Dwm
(involves: 129P2/OlaHsd * BALB/c) 		decreased liver function J:15422
liver degeneration J:15422
Ercc1tm1Dwm/Ercc1tm2Dwm
Hrhr/Hrhr
Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J * MF1) 		abnormal hepatocyte morphology J:115849
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: C57BL/6 * FVB/N) 		abnormal liver physiology J:92471
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased hepatocyte proliferation J:117488
hepatic steatosis J:117488
increased hepatocyte apoptosis J:117488
increased liver triglyceride level J:117488
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:206925
Ercc1tm1Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:206925
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:41161
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:206925
Ercc4tm1Fwa/Ercc4tm1Fwa
(involves: 129S6/SvEvTac) 		abnormal liver morphology J:87684
increased hepatocyte karyomegaly J:87684
Ercc5tm1Shm/Ercc5tm1Shm
(involves: 129S2/SvPas * C57BL/6J) 		abnormal hepatocyte morphology J:53756
small liver J:53756
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Hvs/Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh) 		hepatic steatosis J:122013
increased liver glycogen level J:122013
Erfetm1Lex/Erfe+
(B6;129S5-Erfetm1Lex/Mmucd) 		abnormal liver physiology J:211331
Erfetm1Lex/Erfetm1Lex
(B6;129S5-Erfetm1Lex/Mmucd) 		abnormal liver physiology J:211331
Erfetm1Lex/Erfetm1Lex
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6) 		decreased liver iron level J:211331
Erlin1em1(IMPC)Tcp/Erlin1em1(IMPC)Tcp
(C57BL/6N-Erlin1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Ern1tm1Rjk/Ern1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		liver hypoplasia J:106975
Ern1tm1Rjk/Ern1tm2.1Rjk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:171230
hepatic steatosis J:171230
increased hepatocyte apoptosis J:171230
increased liver triglyceride level J:171230
Ern1tm2.1Tiw/Ern1tm2.2Tiw
Meox2tm1(cre)Sor/Meox2+
(involves: 129S4/SvJae * C57BL/6) 		liver/biliary system phenotype J:153222
Errfi1tm1Gvw/Errfi1tm1Gvw
(Not Specified) 		liver/biliary system phenotype J:100927
Espl1tm1.1Kna/Espl1tm1.1Kna
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:107916
abnormal liver regeneration J:107916
Esr1tm1Ksk/Esr1tm1Ksk
Inhatm1Bay/Inhatm1Bay
(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd) 		abnormal hepatocyte morphology J:84989
hepatic necrosis J:84989
liver inflammation J:84989
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		enlarged liver J:83617
Esr2tm1Unc/Esr2tm1Unc
Inhatm1Bay/Inhatm1Bay
(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd) 		abnormal liver morphology J:84989
Esrp2tm1(KOMP)Vlcg/Esrp2tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		abnormal hepatocyte morphology J:228040
abnormal liver development J:228040
abnormal liver morphology J:228040
increased hepatocyte proliferation J:228040
Etv6em1(IMPC)Rbrc/Etv6+
(C57BL/6NJcl-Etv6em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
small liver J:211773
Evc2em1(IMPC)Mbp/Evc2em1(IMPC)Mbp
(C57BL/6N-Evc2em1(IMPC)Mbp/MbpMmucd) 		abnormal gallbladder morphology J:211773
Exoc3l2tm1b(KOMP)Wtsi/Exoc3l2tm1b(KOMP)Wtsi
(C57BL/6N-Exoc3l2tm1b(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
herniated liver J:239583
Extl3em1(IMPC)Mbp/Extl3+
(C57BL/6N-Extl3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
F2rtm1Ajc/F2rtm1Ajc
(involves: 129S4/SvJae * C57BL/6) 		abnormal gallbladder physiology J:123689
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6) 		abnormal gallbladder physiology J:123689
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd) 		liver inflammation J:102762
F5tm2Dgi/F5tm2Dgi
(B6.129S2-F5tm2Dgi) 		liver fibrosis J:66260
F9tm1Emg/Y
(involves: 129S/SvEv * C57BL/6J) 		liver/biliary system phenotype J:48501
F11tm1Gjb/F11tm1Gjb
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:67398
hepatic necrosis J:67398
liver fibrosis J:67398
liver hemorrhage J:67398
Fabp1tm1Bin/Fabp1tm1Bin
(involves: 129/Ola * C57BL/6) 		abnormal hepatobiliary system physiology J:83875
Fabp1tm1Ddsn/Fabp1tm1Ddsn
(involves: 129X1/SvJ * C57BL/6) 		decreased liver triglyceride level J:87278
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto) 		decreased liver weight J:64975
increased liver weight J:64975
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased liver glycogen level J:167535
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob) 		decreased liver triglyceride level J:111878
decreased susceptibility to hepatic steatosis J:111878
small liver J:111878
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota) 		decreased liver weight J:81609
Fabp6tm1Lbal/Fabp6tm1Lbal
(B6.129-Fabp6tm1Lbal) 		decreased liver cholesterol level J:195544
decreased liver weight J:195544
Faddtm1Mpa/Faddtm1Mpa
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		liver inflammation J:118336
liver/biliary system phenotype J:118336
Fads2tm1Mtna/Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J) 		enlarged liver J:153293
increased liver triglyceride level J:153293
increased liver weight J:153293
Fads3tm1a(KOMP)Wtsi/Fads3tm1a(KOMP)Wtsi
(C57BL/6-Fads3tm1a(KOMP)Wtsi) 		decreased liver free fatty acids level J:256005
increased liver free fatty acids level J:256005
Faf2tm1Tfji/Faf2tm1Tfji
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * CBA * DBA) 		macrovesicular hepatic steatosis J:235325
Fahem1(IMPC)Mbp/Fah+
(C57BL/6N-Fahem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * PT) 		abnormal liver physiology J:77295
jaundice J:77295
pale liver J:77295
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:138701
abnormal liver physiology J:138701
abnormal liver regeneration J:138701
decreased hepatocyte proliferation J:138701
impaired liver regeneration J:138701
increased hepatocellular carcinoma incidence J:138701
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd) 		decreased hepatocyte apoptosis J:105440
liver failure J:105440
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL) 		abnormal hepatocyte mitochondrial morphology J:27735
abnormal hepatocyte morphology J:27735
abnormal hepatocyte physiology J:27735
abnormal liver lobule morphology J:27735
increased hepatocellular carcinoma incidence J:27735
increased hepatoma incidence J:27735
increased liver adenoma incidence J:27735
increased liver tumor incidence J:27735
liver inflammation J:27735
liver/biliary system phenotype J:27735
Fahtm1Mgo/Fahtm1Mgo
Hgdaku/Hgd+
(involves: 129S7/SvEvBrd * NB) 		abnormal hepatocyte morphology J:77295
abnormal liver morphology J:77295
abnormal liver physiology J:77295
jaundice J:77295
pale liver J:77295
Fahtm1Mgo/Fahtm1Mgo
Hgdaku/Hgdaku
(involves: 129S7/SvEvBrd * NB) 		liver/biliary system phenotype J:77295
Faimtm1Kplm/Faimtm1Kplm
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocyte apoptosis J:164184
liver failure J:164184
liver hemorrhage J:164184
liver inflammation J:164184
Fam20bGt(GST_4283_D8)Lex/Fam20bGt(GST_4283_D8)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		delayed hepatic development J:186384
Fam83hem1(IMPC)Ccpcz/Fam83h+
(C57BL/6N-Fam83hem1(IMPC)Ccpcz/Ccpcz) 		abnormal gallbladder morphology J:211773
Fam167aem1(IMPC)Ccpcz/Fam167aem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam167aem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Fam219aem1(IMPC)Ccpcz/Fam219aem1(IMPC)Ccpcz
(C57BL/6N-Fam219aem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Fan1tm1d(KOMP)Wtsi/Fan1tm1d(KOMP)Wtsi
(involves: C57BL/6N * FVB/N) 		decreased liver function J:232402
increased hepatocyte karyomegaly J:232402
Fancctm1Mab/Fancctm1Mab
Sod1tm1Cep/Sod1tm1Cep
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal hepatocyte physiology J:71134
microvesicular hepatic steatosis J:71134
pale liver J:71134
Fancmtm1.1Htr/Fancmtm1.1Htr
(involves: C57BL/6 * FVB) 		increased hepatoma incidence J:151714
Faslpr/Fas+
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * MRL/Mp) 		liver inflammation J:72817
liver/biliary system phenotype J:72817
Faslpr/Faslpr
(B6.MRL-Faslpr/J) 		abnormal hepatocyte morphology J:135830
abnormal liver physiology J:135830, J:120559
decreased hepatocyte apoptosis J:135830
focal hepatic necrosis J:135830
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp) 		liver inflammation J:122222
Faslpr/Faslpr
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Fastm1Ach/Fastm1Ach
Tg(Itgax-cre,-EGFP)4097Ach/?
(Not Specified) 		abnormal liver morphology J:123556
Fastm1Cgn/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn) 		liver inflammation J:114948
Fastm1Osa/Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:64296
liver hyperplasia J:64296
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J) 		abnormal hepatocyte morphology J:135830
decreased hepatocyte apoptosis J:135830
focal hepatic necrosis J:135830
liver inflammation J:135830
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6) 		increased liver tumor incidence J:153501
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6) 		enlarged liver J:87990
Fasntm1Sem/Fasntm1Sem
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased liver cholesterol level J:127793
hepatic steatosis J:127793
increased liver weight J:127793
Fbn2em1(IMPC)Rbrc/Fbn2em1(IMPC)Rbrc
(C57BL/6NJcl-Fbn2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Fbrsl1em1(IMPC)Tcp/Fbrsl1em1(IMPC)Tcp
(C57BL/6N-Fbrsl1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Fbxl3em1(IMPC)Ccpcz/Fbxl3em1(IMPC)Ccpcz
(C57BL/6NCrl-Fbxl3em1(IMPC)Ccpcz/Ccpcz) 		decreased liver weight J:211773
Fbxl4tm1.2Lrsn/Fbxl4tm1.2Lrsn
(involves: C57BL/6N) 		liver degeneration J:303084
liver inflammation J:303084
Fbxl5Gt(OST386421)Lex/Fbxl5+
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased liver iron level J:193752
Fbxl5tm1Kei/Fbxl5tm1Kei
Ireb2tm1Roua/Ireb2tm1Roua
(B6.129-Fbxl5tm1Kei Ireb2tm1Roua) 		decreased liver iron level J:176655
Fbxl5tm2.1Kei/Fbxl5tm2.1Kei
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal hepatocyte mitochondrial morphology J:176655
abnormal hepatocyte morphology J:176655
abnormal liver physiology J:176655
hepatic steatosis J:176655
increased liver iron level J:176655
liver failure J:176655
liver hemorrhage J:176655
liver inflammation J:176655
pale liver J:176655
Fbxo4tm1.1Jadi/Fbxo4+
(Not Specified) 		increased hepatic hemangioma incidence J:178645
increased hepatocellular carcinoma incidence J:178645
Fbxo4tm1.1Jadi/Fbxo4tm1.1Jadi
(Not Specified) 		increased hepatic hemangioma incidence J:178645
increased hepatocellular carcinoma incidence J:178645
Fbxo38em1Crmk/Fbxo38em1Crmk
(C57BL/6N-Fbxo38em1Crmk) 		decreased liver weight J:326445
Fbxw7tm1Iken/Fbxw7+
Krastm4Tyj/Kras+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N * DBA) 		bile duct hyperplasia J:258194
dilated bile duct J:258194
Fbxw7tm1Iken/Fbxw7tm1Iken
Krastm4Tyj/Kras+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N * DBA) 		increased cholangiocarcinoma incidence J:258194
Fbxw7tm1Iken/Fbxw7tm1Iken
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		bile duct hyperplasia J:258194
dilated bile duct J:258194
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk) 		liver inflammation J:64152
Fdx2em1(IMPC)Rbrc/Fdx2em1(IMPC)Rbrc
(C57BL/6NJcl-Fdx2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch) 		chronic liver inflammation J:244082
hepatic steatosis J:244082
increased hepatocellular carcinoma incidence J:244082
increased liver iron level J:244082
increased liver tumor incidence J:244082
Fechm1Pas/Fechm1Pas
(involves: 129/Sv * BALB/c) 		increased liver weight J:2021
jaundice J:2021
Fechm1Pas/Fechm1Pas
hem6/hem6+
(involves: 129 * BALB/c * C57BL/6) 		increased liver weight J:142791
Fechm1Pas/Fechtm1.1(FECH*)Emi
(involves: 129 * BALB/cJ * C57BL/6J) 		abnormal bile canaliculus morphology J:239515
abnormal liver morphology J:239515
enlarged liver J:239515
jaundice J:239515
Fen1tm1Bhsh/Fen1tm1Bhsh
(involves: 129S1/Sv) 		pale liver J:121378
Fen1tm2.1Bhsh/Fen1tm2.1Bhsh
(involves: 129S1/Sv) 		increased liver tumor incidence J:218627
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified) 		increased liver tumor incidence J:231218
Festm2Mcs/Fes+
(chimera involves: 129X1/SvJ * C57BL/6) 		liver hemorrhage J:76509
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver triglyceride level J:141957
Ffar1tm1Heed/Ffar1tm1Heed
(Not Specified) 		decreased susceptibility to diet-induced hepatic steatosis J:129843
Ffar3em1(IMPC)Mbp/Ffar3em1(IMPC)Mbp
(C57BL/6NCrl-Ffar3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Ffar3tm1Reh/Ffar3tm1Reh
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased liver triglyceride level J:143567
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6) 		hepatic steatosis J:182599
increased liver triglyceride level J:182599
increased liver weight J:182599
Fgatm1Jld/Fgatm1Jld
(involves: 129P2/OlaHsd * CF-1) 		focal hepatic necrosis J:36591
liver hemorrhage J:28436
Fgatm1Jld/Fgatm1Jld
(B6.129P2-Fgatm1Jld) 		liver hemorrhage J:28436
Fgatm1Jld/Fgatm1Jld
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss * CF-1) 		abnormal liver morphology J:36591
focal hepatic necrosis J:36591
Fgd5em1(IMPC)Mbp/Fgd5+
(C57BL/6NCrl-Fgd5em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
decreased liver weight J:211773
small liver J:211773
Fgf20em1(IMPC)Ccpcz/Fgf20em1(IMPC)Ccpcz
(C57BL/6NCrl-Fgf20em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf) 		abnormal liver physiology J:157309
hepatic steatosis J:157309
increased liver glycogen level J:157309
increased liver triglyceride level J:157309
increased liver weight J:157309
Fgf21tm1Nit/Fgf21tm1Nit
(C57BL/6-Fgf21tm1Nit) 		increased liver weight J:157334
Fgfr2tm2.3Dsn/Fgfr2+
(involves: 129 * C57BL/6 * FVB/N) 		abnormal liver development J:72517
Fgfr4tm1Cxd/Fgfr4tm1Cxd
Tg(Myl2-FGF19)1Dfre/0
(involves: 129S6/SvEvTac * FVB/N) 		decreased liver tumor incidence J:187236
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal liver weight J:199844
increased liver triglyceride level J:199844
macrovesicular hepatic steatosis J:199844
Fhip2bem1Wwan/Fhip2bem1Wwan
(involves: C57BL/6) 		hepatic steatosis J:302658
increased liver cholesterol level J:302658
increased liver triglyceride level J:302658
increased liver weight J:302658
liver inflammation J:302658
Fhittm1Tko/Fhittm1Tko
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:93269
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver weight J:212437
pale liver J:212437
Fkbp1atm1Zuk/Fkbp1atm1Zuk
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)) 		hepatic necrosis J:45536
liver hemorrhage J:45536
Fkrptm1.1Pg/Fkrptm1.1Pg
(involves: 129P2/OlaHsd) 		liver/biliary system phenotype J:285924
Fl1saA/J/?
(involves: A/JSlc * SM/JNshm) 		increased liver triglyceride level J:124974
increased liver weight J:124974
Fl1saSM/JNshm/Fl1saSM/JNshm
(A/J-Chr 12SM/J/Nshm) 		decreased liver triglyceride level J:124974
decreased liver weight J:124974
decreased susceptibility to diet-induced hepatic steatosis J:124974
Fl2saA/JNshm/Fl2saA/JNshm
(involves: A/JSlc * SM/JNshm) 		increased liver weight J:124974
Fli1tm1Dkw/Fli1tm1Dkw
(either: B6.Cg-Fli1tm1Dkw or (involves: CD-1) or (involves: 129S6/SvEvTac * C57BL/6)) 		pale liver J:63242
small liver J:63242
Flnatm1.2Caw/Flna+
(involves: 129S4/SvJae * C57BL/6) 		hepatic necrosis J:118252
Flt4Chy/Flt4+
(involves: C3H) 		abnormal liver morphology J:72387
fm/fm
(involves: CBA/H) 		abnormal liver morphology J:5417, J:275
Fmnl1tm1.2Sdb/Fmnl1tm1.2Sdb
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo
(involves: C3H * C57BL/6 * FVB/N) 		abnormal Kupffer cell morphology J:250144
Fmo5em1(IMPC)Mbp/Fmo5em1(IMPC)Mbp
(C57BL/6N-Fmo5em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Fn1tm1.1Sakai/Fn1tm1.1Sakai
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		abnormal liver physiology J:214945
Fndc5em21Gpt/Fndc5em21Gpt
(C57BL/6JGpt-Fndc5em21Cd/Gpt) 		increased susceptibility to diet-induced hepatic steatosis J:247171
increased susceptibility to hepatic steatosis J:247171
Fnip1em1(IMPC)Ccpcz/Fnip1em1(IMPC)Ccpcz
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz) 		increased liver weight J:211773
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1) 		increased liver glycogen level J:187318
Fosl1tm2Wag/Fosl1tm2Wag
Meox2tm1(cre)Sor/Meox2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6) 		liver/biliary system phenotype J:213764
Foxa1tm1Khk/Foxa1tm1Khk
Foxa2tm1Khk/Foxa2tm1Khk
Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased hepatocellular carcinoma incidence J:181296
Foxa2tm1Dnl/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver triglyceride level J:95662
Foxc1tm1Blh/Foxc1+
Foxc2tm1Blh/Foxc2+
(involves: 129S6/SvEvTac * Black Swiss) 		enlarged liver J:57677
Foxf1em1Vvk/Foxf1+
(involves: C57BL/6 * DBA/2) 		abnormal gallbladder morphology J:296328
absent gallbladder J:296328
Foxm1tm1.1Rhc/Foxm1tm1.1Rhc
(involves: 129X1/SvJ) 		abnormal hepatic cord morphology J:94883
abnormal hepatoblast morphology J:94883
abnormal intrahepatic bile duct morphology J:94883
abnormal liver sinusoid morphology J:94883
decreased hepatoblast number J:94883
Foxm1tm1Cle/Foxm1tm1Cle
(Not Specified) 		abnormal hepatocyte morphology J:95612
Foxm1tm1Rhc/Foxm1tm1Rhc
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:89472
Foxm1tm1Rhc/Foxm1tm1Rhc
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:89472, J:81015
abnormal liver regeneration J:81015
decreased liver tumor incidence J:89472
Foxm1tm1Rhc/Foxm1tm1Rhc
Tg(Alb1-cre)1Khk/0
(involves: 129X1/SvJ * C57BL/6 * SJL) 		abnormal hepatic cord morphology J:94883
abnormal hepatoblast morphology J:94883
abnormal intrahepatic bile duct morphology J:94883
abnormal liver sinusoid morphology J:94883
decreased hepatoblast number J:94883
Foxn1nu/Foxn1nu
(Not Specified) 		abnormal liver morphology J:5043
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo3tm1Rdp/Foxo3tm1Rdp
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased hepatic hemangioma incidence J:118179
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo4tm1Rdp/Foxo4tm1Rdp
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased hepatic hemangioma incidence J:118179
Foxo1tm1Whb/Foxo1+
(Not Specified) 		decreased liver glycogen level J:79560
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified) 		decreased liver triglyceride level J:179687
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(B6.Cg-Foxo1tm2.1Dac) 		decreased liver cholesterol level J:179687
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg) 		abnormal Kupffer cell morphology J:236585
decreased liver triglyceride level J:236585
decreased susceptibility to diet-induced hepatic steatosis J:236585
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR)) 		abnormal hepatic cord morphology J:11262
abnormal liver morphology J:11262
dilated liver sinusoidal space J:11262
enlarged liver J:11262
jaundice J:11262
liver inflammation J:11262
multifocal hepatic necrosis J:11262
Foxp3sf/Y
(involves: 101/H * C3H/HeH * STOCK MR) 		abnormal liver morphology J:10398
enlarged liver J:10398
pale liver J:10398
Foxp3sf/?
(Not Specified) 		liver inflammation J:138808
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver inflammation J:117743
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver inflammation J:117743
Foxp3tm3(HBEGF/GFP)Ayr/Foxp3tm3(HBEGF/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver inflammation J:117743
fpw/fpw
(involves: C3H/HeJ * C57BL/6J) 		decreased hepatocyte proliferation J:151726
Frem1eyes2/Frem1eyes2
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal gallbladder morphology J:192553
Fstl3tm1.1(KOMP)Vlcg/Fstl3tm1.1(KOMP)Vlcg
(C57BL/6N-Fstl3tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		decreased liver glycogen level J:119526
hepatic steatosis J:119526
liver/biliary system phenotype J:119526
macrovesicular hepatic steatosis J:119526
microvesicular hepatic steatosis J:119526
Fth1tm1.1Lck/Fth1tm1.1Lck
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Fth1tm1.1Lck Tg(Mx1-cre)1Cgn) 		increased liver weight J:166515
liver hemorrhage J:166515
liver inflammation J:166515
macrovesicular hepatic steatosis J:166515
Ftl1tm1.1Ruvi/Ftl1tm1.1Ruvi
(involves: 129 * C57BL/6) 		decreased liver iron level J:244236
Ftotm1Urt/Ftotm1Urt
Lepob/Lepob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		hepatic steatosis J:219118
increased liver weight J:219118
Ftsj1tm1Tomik/Y
(Not Specified) 		liver/biliary system phenotype J:328916
Fubp1tm1.1Dlev/Fubp1tm1.1Dlev
(involves: 129 * C57BL/6) 		pale liver J:229985
small liver J:229985
Furintm1Jwmc/Furintm1.1Jwmc
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * C57BL/6J * CBA) 		liver/biliary system phenotype J:118515
Fut8em1(IMPC)Wtsi/Fut8em1(IMPC)Wtsi
(C57BL/6N-Fut8em1(IMPC)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
Fuzb2b1273Clo/Fuzb2b1273Clo
(C57BL/6J-Fuzb2b1273Clo) 		abnormal liver morphology J:175213
Fzr1tm1.1Mama/Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL) 		increased liver tumor incidence J:137456
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal liver morphology J:209000
decreased liver triglyceride level J:209000
decreased liver weight J:209000
decreased susceptibility to diet-induced hepatic steatosis J:209000
liver/biliary system phenotype J:232077
G0s2tm1Jgte/G0s2tm1Jgte
(involves: 129S7/SvEvBrd) 		decreased liver triglyceride level J:219653
decreased liver weight J:219653
decreased susceptibility to diet-induced hepatic steatosis J:219653
G6pc1em1Jyc/G6pc1em1Jyc
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver sinusoid morphology J:320697
enlarged liver J:320697
hepatic steatosis J:320697
increased liver glycogen level J:320697
increased liver triglyceride level J:320697
G6pc1tm1.1Ics/G6pc1tm1.1Ics
Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6J) 		abnormal hepatocyte morphology J:195257
enlarged liver J:195257
hepatic steatosis J:195257
increased liver adenoma incidence J:195257
increased liver glycogen level J:195257
increased liver triglyceride level J:195257
increased liver weight J:195257
pale liver J:195257
G6pc1tm1Jyc/G6pc1tm1Jyc
(involves: 129S4/SvJae) 		enlarged liver J:33212
hepatic necrosis J:33212
hepatic steatosis J:33212
increased liver glycogen level J:33212
G6pc1tm2.2Jyc/G6pc1tm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		increased liver glycogen level J:155990
increased liver weight J:155990
Gaatm1Rabn/Gaatm1Rabn
(involves: 129X1/SvJ * C57BL/6) 		increased liver glycogen level J:235790
Gaatm1Rabn/Gaatm1Rabn
Stbd1tm1Bsn/Stbd1tm1Bsn
(involves: 129X1/SvJ * C57BL/6) 		increased liver glycogen level J:235790
Gab1tm1Wbm/Gab1tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver weight J:68751
Gab1tm2Wbm/Gab1tm2Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1) 		decreased liver weight J:125303
Gab1tm2Wbm/Gab1tm3Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1) 		decreased liver weight J:125303
Gab1tm3Wbm/Gab1tm3Wbm
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1) 		decreased liver weight J:125303
Gaktm2Legr/Gaktm2Legr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		abnormal bile duct morphology J:180119
abnormal hepatoblast differentiation J:180119
abnormal liver morphology J:180119
decreased liver glycogen level J:180119
jaundice J:180119
Gal3st1em1(IMPC)Rbrc/Gal3st1em1(IMPC)Rbrc
(C57BL/6NJcl-Gal3st1em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
small liver J:211773
Galctwi/Galctwi
Glb1tm1Adz/Glb1+
(involves: 129P2/OlaHsd * C57BL/6J * CE/J) 		liver/biliary system phenotype J:63197
Galctwi/Galctwi
Glb1tm1Adz/Glb1tm1Adz
(involves: 129P2/OlaHsd * C57BL/6J * CE/J) 		abnormal liver morphology J:63197
enlarged liver J:63197
GaltGt(E285B04)Wrst/GaltGt(E285B04)Wrst
(involves: 129P2/OlaHsd * C57BL/6J) 		liver inflammation J:234753
GapdhM6Neu/GapdhM6Neu
(C3.Cg-GapdhM6Neu) 		liver/biliary system phenotype J:126359
Gapvd1em1(IMPC)Mbp/Gapvd1+
(C57BL/6N-Gapvd1em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Garem1em1(IMPC)Mbp/Garem1em1(IMPC)Mbp
(C57BL/6N-Garem1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Gas2l2tm1a(KOMP)Wtsi/Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi) 		biliary cyst J:239583
dilated liver sinusoidal space J:239583
Gas2l3tm1d(EUCOMM)Hmgu/Gas2l3tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N) 		liver/biliary system phenotype J:244087
Gata1Plt13/Y
(BALB/c-Gata1Plt13) 		small liver J:113720
Gata1tm1Mym/Y
(involves: 129P2/OlaHsd * BALB/c) 		pale liver J:40321
Gata1tm2Sho/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		abnormal liver morphology J:78348
Gata1tm2Sho/Gata1tm2Sho
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		abnormal liver morphology J:78348
Gata1tm7Sho/Y
(involves: 129S1/Sv * C57BL/6) 		liver hypoplasia J:99310
pale liver J:99310
Gata1tm7Sho/Gata1tm7Sho
(involves: 129S1/Sv * C57BL/6) 		liver hypoplasia J:99310
pale liver J:99310
Gata1tm8.2Sho/Y
(involves: 129S1/Sv) 		liver hypoplasia J:99310
pale liver J:99310
Gata1tm8.2Sho/Gata1tm8.2Sho
(involves: 129S1/Sv) 		liver hypoplasia J:99310
pale liver J:99310
Gata4tm1Eno/Gata4+
Gata6tm1Eno/Gata6+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6) 		small liver J:111824
Gata6tm1Sad/Gata6tm1Sad
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver bud morphology J:97579
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb) 		decreased liver triglyceride level J:191142
decreased susceptibility to diet-induced hepatic steatosis J:191142
Gba1tm1.1Pmis/Gba1tm1.1Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		enlarged liver J:167081
increased liver weight J:167081
Gba1tm1.1Pmis/Gba1tm1.2Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		enlarged liver J:167081
increased liver weight J:167081
Gba1tm1Clk/Gba1tm1.1Clk
Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6J) 		abnormal liver morphology J:117763
Gba1tm1Karl/Gba1tm1.1Karl
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		enlarged liver J:113751
pale liver J:113751
Gba1tm1Rlp/Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6) 		abnormal Kupffer cell morphology J:76409
enlarged liver J:76409
increased hepatocyte apoptosis J:76409
increased liver weight J:76409
liver inflammation J:76409
Gba1tm2Ggb/Gba1tm1Nsb
(involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6) 		abnormal liver physiology J:86334
Gba1tm2Ggb/Gba1tm2Ggb
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal liver physiology J:86334
Gba1tm3Ggb/Gba1tm1Nsb
(involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6) 		abnormal liver physiology J:86334
Gba1tm3Ggb/Gba1tm3Ggb
(involves: 129S5/SvEvBrd) 		abnormal liver physiology J:86334
Gba1tm4Ggb/Gba1tm1Nsb
(involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6) 		abnormal liver physiology J:86334
Gba1tm4Ggb/Gba1tm4Ggb
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal liver physiology J:86334
Gbe1m1Yty/Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty) 		liver vascular congestion J:167233
Gbe1tm1.1Hoa/Gbe1tm1.1Hoa
(involves: 129S7/SvEvBrd) 		decreased liver glycogen level J:176889
Gbe1tm1Hoa/Gbe1tm1Hoa
(involves: 129S7/SvEvBrd) 		abnormal liver morphology J:176889
increased liver glycogen level J:176889
Gbe1tm2.1Hoa/Gbe1tm2.1Hoa
(involves: 129S7/SvEvBrd) 		increased liver glycogen level J:226481
liver fibrosis J:226481
Gbe1tm2Hoa/Gbe1tm2Hoa
(involves: 129S7/SvEvBrd) 		increased liver glycogen level J:226481
Gbvq1CAST/EiJ/Gbvq1CAST/EiJ
(involves: 129S1/SvImJ * CAST/Ei) 		increased gallbladder volume J:84711
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc) 		abnormal liver physiology J:300368
increased liver weight J:300368
Gcgrtm1.1(KOMP)Vlcg/Gcgrtm1.1(KOMP)Vlcg
(C57BL/6N-Gcgrtm1.1(KOMP)Vlcg/Ucd) 		increased liver weight J:211773
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp) 		decreased liver weight J:176507
decreased susceptibility to age-related hepatic steatosis J:176507
Gcgrtm1Mjch/Gcgrtm1Mjch
Leprtm1Jke/Leprtm1Jke
(involves: 129 * 129X1/SvJ * C57BL/6J * SJL) 		increased liver triglyceride level J:216393
Gch1em1Ypt/Gch1em1Ypt
(C57BL/6-Gch1em1Ypt) 		abnormal liver morphology J:295169
GckRgsc210/GckRgsc210
(involves: C57BL/6J * DBA/2J) 		decreased liver glycogen level J:88919
hepatic steatosis J:88919
GckRgsc392/GckRgsc392
(involves: C57BL/6J * DBA/2J) 		decreased liver glycogen level J:88919
hepatic steatosis J:88919
GckRgsc702/GckRgsc702
(involves: C57BL/6J * DBA/2J) 		decreased liver glycogen level J:88919
hepatic steatosis J:88919
Gcktm1.1Mgn/Gcktm1.1Mgn
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased liver glycogen level J:51826
hepatic steatosis J:51826
Gcktm1.2Mgn/Gck+
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver glycogen level J:51826
hepatic steatosis J:51826
Gcktm1.2Mgn/Gcktm1.2Mgn
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver glycogen level J:51826
hepatic steatosis J:51826
Gcktm1Tka/Gcktm1Tka
(involves: 129X1/SvJ * ICR) 		hepatic steatosis J:30334
Gcktm1Ts/Gcktm1Ts
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J)) 		decreased liver glycogen level J:29255
microvesicular hepatic steatosis J:29255
Gckrtm1Bms/Gckrtm1Bms
(involves: 129S1/Sv * ICR) 		decreased liver glycogen level J:58949
Gclctm1Dwn/Gclc+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver physiology J:66499
Gclctm1Tdal/Gclctm1Tdal
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		abnormal liver morphology J:202376
hepatic steatosis J:202376
Gdf1tm1Sjl/Gdf1tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:60755
Gdf15tm1Sjl/Gdf15tm1Sjl
Leprdb/Leprdb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BLKS/J) 		increased liver weight J:202996
Gfertm1(KOMP)Mbp/Gfer+
(involves: C57BL/6J * C57BL/6N) 		abnormal hepatocyte mitochondrial morphology J:224792
abnormal hepatocyte physiology J:224792
decreased hepatocyte mitochondrial DNA content J:224792
decreased hepatocyte proliferation J:224792
impaired liver regeneration J:224792
Gfertm1.1Crg/Gfertm1.1Crg
(involves: 129 * C57BL/6) 		abnormal hepatocyte morphology J:227242
Gfertm1.1Crg/Gfertm1.1Crg
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA) 		abnormal hepatocyte mitochondrial morphology J:227242
abnormal liver morphology J:227242
abnormal liver physiology J:227242
abnormal oval cell physiology J:227242
decreased liver cholesterol level J:227242
focal hepatic necrosis J:227242
hepatic necrosis J:227242
hepatic steatosis J:227242
increased hepatocellular carcinoma incidence J:227242
increased hepatocyte apoptosis J:227242
increased hepatocyte proliferation J:227242
increased liver cholesterol level J:227242
increased liver triglyceride level J:227242
increased liver weight J:227242
liver fibrosis J:227242
liver inflammation J:227242
macrovesicular hepatic steatosis J:227242
microvesicular hepatic steatosis J:227242
pale liver J:227242
GhSma1/Gh+
(C3HeB/FeJ-GhSma1) 		small liver J:89518
GhSma1/GhSma1
(C3HeB/FeJ-GhSma1) 		small liver J:89518
Ghitmem1Ltk/Ghitmem1Ltk
(C57BL6J-Ghitmem1Ltk) 		abnormal hepatocyte mitochondrial morphology J:327550
Ghrtm1.1Jero/Ghrtm1.1Jero
(B6.129X1-Ghrtm1.1Jero) 		decreased liver weight J:155335
Ghrtm1.1Masp/Ghrtm1.1Masp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJaeSor * C57BL/6 * DBA) 		decreased liver triglyceride level J:152627
hepatic steatosis J:152627
increased liver weight J:152627
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd) 		decreased liver weight J:95149
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		decreased liver weight J:105686, J:60207
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		decreased liver weight J:107763
Ghrtm2Mwat/Ghrtm2Mwat
(involves: 129X1/SvJ * C57BL) 		decreased liver weight J:95149
Ghrhtm1Salv/Ghrhtm1Salv
(involves: 129 * C57BL/6) 		abnormal liver physiology J:91828
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J) 		abnormal liver morphology J:160090
liver/biliary system phenotype J:160090
Gimap5m1Btlr/Gimap5m1Btlr
(either: (involves: BALB/cJ * C57BL/6J) or (involves: C3H/HeN * C57BL/6J) or (C57BL/6J * DBA/2J) or (involves: C57BL/6J * FVB/NJ) or (involves: C57BL/6J * NOD/ShiLtJ)) 		abnormal liver morphology J:160090
Gimap5tm1Wlr/Gimap5tm1Wlr
(either: B6.129-Gimap5tm1Wlr or C.129-Gimap5tm1Wlr) 		abnormal liver development J:143620
abnormal liver parenchyma morphology J:143620
hepatic necrosis J:143620
liver degeneration J:143620
liver/biliary system phenotype J:143620
pale liver J:143620
Giptm1Nina/Giptm1Nina
(involves: C57BL/6) 		abnormal liver morphology J:298236
Gjb1tm1Kwi/Y
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver physiology J:36146
increased liver glycogen level J:36146
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:36146
Gjb3tm1.1(KOMP)Vlcg/Gjb3tm1.1(KOMP)Vlcg
(C57BL/6N-Gjb3tm1.1(KOMP)Vlcg/Ucd) 		pale liver J:211773
Gjb4tm1.1(KOMP)Vlcg/Gjb4tm1.1(KOMP)Vlcg
(C57BL/6N-Gjb4tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Gktm1Wjc/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		hepatic steatosis J:43449
Glatm1Kul/Y
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:39394
Glb1tm1Jmat/Glb1tm1Jmat
(involves: C57BL/6 * CBA * ICR) 		abnormal hepatocyte morphology J:102576
small liver J:43534
GlmpGt(P084H04)Wrst/GlmpGt(P084H04)Wrst
(involves: 129S2/SvPas * C57BL/6) 		abnormal hepatocyte physiology J:208774
abnormal Kupffer cell morphology J:208774
abnormal liver physiology J:208774
increased hepatocyte apoptosis J:208774
increased liver iron level J:208774
liver fibrosis J:208774
liver inflammation J:208774
GlmpGt(P084H04)Wrst/GlmpGt(P084H04)Wrst
(involves: 129S2/SvPas) 		abnormal hepatocyte morphology J:280713
abnormal liver morphology J:280713
abnormal liver sinusoidal endothelial cell morphology J:280713
abnormal liver vasculature morphology J:280713
Glmptm1Lex/Glmptm1Lex
(B6;129S5-Glmptm1Lex/Mmucd) 		liver inflammation J:171883
small liver J:171883
Gls2em1(IMPC)Tcp/Gls2em1(IMPC)Tcp
(C57BL/6N-Gls2em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Glultm1.1Geno/Glultm1.1Geno
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * DBA) 		liver/biliary system phenotype J:221031
Gm572b2b1167Clo/Gm572b2b1167Clo
(C57BL/6J-Gm572b2b1167Clo) 		abnormal liver morphology J:175213
Gm15441em1Gonz/Gm15441em1Gonz
(C57BL/6-Gm15441em1Gonz) 		liver/biliary system phenotype J:299830
Gm16364tm1Zhaoy/Gm16364tm1Zhaoy
(involves: C57BL/6) 		decreased liver weight J:322340
decreased susceptibility to diet-induced hepatic steatosis J:322340
Gm16364tm2Zhaoy/Gm16364tm2Zhaoy
(involves: C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:322340
Gm26330em1Liuq/Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq) 		hepatic steatosis J:341056
Gna11tm1Soff/Gna11tm1Soff
(involves: 129S7/SvEvBrd) 		hepatic steatosis J:172091
increased liver triglyceride level J:172091
Gna15em1(IMPC)Mbp/Gna15em1(IMPC)Mbp
(C57BL/6N-Gna15em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Gnai2tm1Lbi/Gnai2+
Tg(WTbeta2)4Wjk/0
(B6.Cg-Gnai2tm1Lbi Tg(WTbeta2)4Wjk) 		abnormal liver morphology J:125581
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased liver glycogen level J:102504
increased liver weight J:102504
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Fabp4-cre)1Abel/0
(involves: FVB) 		decreased liver triglyceride level J:159612
Gnf4C57BL/6J/?
(involves: M16i * M16i.B6-(D2Mit306-D2Mit52)) 		decreased liver weight J:99312
Gnmttm1Ymac/Gnmt+
(involves: 129/Sv * C57BL/6) 		decreased liver weight J:147857
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6) 		abnormal liver morphology J:147857
dilated liver sinusoidal space J:147857
enlarged liver J:147857
hepatic necrosis J:147857
hepatic steatosis J:146081
increased hepatic hemangioma incidence J:146081
increased hepatocellular carcinoma incidence J:146081
increased liver glycogen level J:147857
increased liver weight J:147857
liver degeneration J:147857
liver vascular congestion J:147857
Golga2tm1(KOMP)Vlcg/Golga2tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal hepatocyte morphology J:270564
abnormal liver morphology J:270564
liver fibrosis J:270564
Golm1Gt(KST273)Byg/Golm1Gt(KST273)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:151282
hepatic steatosis J:151282
liver inflammation J:151282
Gp2em1(IMPC)Mbp/Gp2em1(IMPC)Mbp
(C57BL/6N-Gp2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Gpamtm1.1Dali/Gpamtm1.1Dali
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal hepatocyte morphology J:134068
abnormal liver physiology J:134068
decreased liver triglyceride level J:134068
Gpamtm1Rcol/Gpamtm1Rcol
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased liver triglyceride level J:84541
Gpat3tm1Reg/Gpat3tm1Reg
(involves: C57BL/6) 		increased liver cholesterol level J:213618
increased liver weight J:213618
Gpbar1tm1Gvas/Gpbar1tm1Gvas
(involves: 129S1/SvImJ * C57BL/6) 		abnormal bile composition J:115877
abnormal bile duct development J:115877
abnormal gallbladder morphology J:115877
gallstones J:115877
liver/biliary system phenotype J:115877
Gpc1em1(IMPC)Mbp/Gpc1em1(IMPC)Mbp
(C57BL/6N-Gpc1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Gpd2tm1Tka/Gpd2tm1Tka
Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.Cg-Gpd2tm1Tka Slc25a13tm1Lct) 		hepatic steatosis J:124766
increased liver triglyceride level J:124766
Gper1tm1135.2Arte/Gper1tm1135.2Arte
(involves: C57BL/6 * C57BL/6N) 		decreased liver weight J:145794
Gpi1b-m1Neu/Gpi1b-m1Neu
(C3.Cg-Gpi1b-m1Neu) 		increased liver weight J:35956
Gpi1b-m2Neu/Gpi1b-m2Neu
(C3.Cg-Gpi1b-m2Neu) 		increased liver weight J:35956
Gpr12tm1Dgen/Gpr12tm1Dgen
(B6.129P2-Gpr12tm1Dgen) 		increased liver triglyceride level J:111942
increased liver weight J:111942
Gpr61tm1Dgen/Gpr61tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver triglyceride level J:302257
increased liver weight J:302257
Gpr83em1(IMPC)Ccpcz/Gpr83em1(IMPC)Ccpcz
(C57BL/6NCrl-Gpr83em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Gpr132tm1Witt/Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c) 		liver inflammation J:69473
Gprc5btm1b(EUCOMM)Wtsi/Gprc5btm1b(EUCOMM)Wtsi
(C57BL/6N-Gprc5btm1b(EUCOMM)Wtsi/Ucd) 		abnormal liver morphology J:211773
Gprc6atm1Ldq/Gprc6atm1Ldq
(involves: 129X1/SvJ * C57BL/6) 		hepatic steatosis J:144372
increased liver triglyceride level J:144372
Gpx4tm1.1Qra/Gpx4tm1.1Qra
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * SJL) 		increased hepatocyte apoptosis J:183246
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:193993
Gramd1ctm1a(KOMP)Wtsi/Gramd1ctm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Gramd1ctm1a(KOMP)Wtsi/JMmucd) 		abnormal liver physiology J:347902
increased liver cholesterol level J:347902
increased liver triglyceride level J:347902
Gramd2aem1(IMPC)Tcp/Gramd2aem1(IMPC)Tcp
(C57BL/6NCrl-Gramd2aem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Grb10Gt(Betageo)1Ward/Grb10+
(involves: C57BL/6 * CBA) 		enlarged liver J:84425
increased liver glycogen level J:84425
Grb10Gt(Betageo)1Ward/Grb10Gt(Betageo)1Ward
(involves: C57BL/6 * CBA) 		enlarged liver J:84425
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Adipoq-cre)#Pesch/0
(involves: 129S/SvEv * FVB) 		hepatic steatosis J:213603
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Fabp4-cre)1Rev/0
(involves: 129S/SvEv) 		hepatic steatosis J:213603
Grb14tm1Daly/Grb14tm1Daly
(involves: 129X1/SvJ * C57BL/6) 		decreased liver weight J:87892
Greb1lem1Cjea/Greb1lem1Cjea
(involves: C57BL/6J) 		liver hypoplasia J:248902
Grik5em1(IMPC)Mbp/Grik5em1(IMPC)Mbp
(C57BL/6N-Grik5em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6J) 		increased liver weight J:268827
Grntm1.1Geno/Grntm1.1Geno
(involves: 129 * C57BL/6J) 		abnormal hepatocyte morphology J:188420
abnormal hepatocyte physiology J:188420
abnormal liver morphology J:188420
abnormal liver parenchyma morphology J:188420
increased hepatocyte karyomegaly J:188420
Gsk3atm1.1Jrw/Gsk3atm1.1Jrw
(involves: 129S6/SvEvTac * C57BL/6) 		increased liver glycogen level J:130033
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased liver glycogen level J:98263
Gsk3btm1Jrw/Gsk3btm1Jrw
(involves: 129 * C57BL/6J) 		abnormal hepatocyte morphology J:63274
abnormal liver morphology J:63274
Gstz1tm1Jmfc/Gstz1tm1Jmfc
(129S4/SvJae-Gstz1tm1Jmfc) 		abnormal liver morphology J:77040
hepatic steatosis J:77040
macrovesicular hepatic steatosis J:77040
microvesicular hepatic steatosis J:77040
Gstz1tm1Pgb/Gstz1tm1Pgb
(BALB/c-Gstz1tm1Pgb/AnuApb) 		abnormal hepatocyte mitochondrial morphology J:91519
hepatic necrosis J:91519
increased liver weight J:91519
liver inflammation J:91519
macrovesicular hepatic steatosis J:91519
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sortm1(cre/ERT2)Tyj
Nus1tm1.1Qrm/Nus1tm1.1Qrm
(involves: 129 * C57BL/6 * SJL) 		hepatic steatosis J:243753
increased liver free fatty acids level J:243753
increased liver triglyceride level J:243753
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
Chrna7tm2.1(cre)Swr/Chrna7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		enlarged liver J:223063
Gt(ROSA)26Sortm1(DTA)Riet/Gt(ROSA)26Sor+
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd) 		liver degeneration J:92789
Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA) 		enlarged liver J:129039
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ) 		enlarged liver J:167612
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+
Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N) 		decreased liver triglyceride level J:169459
decreased liver weight J:169459
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ) 		hepatic steatosis J:237232
increased liver weight J:237232
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(tetO-Xbp1_is)#Pesch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB) 		abnormal liver morphology J:194290
decreased liver glycogen level J:194290
hepatic steatosis J:194290
increased liver triglyceride level J:194290
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(CAG-cre)1Nagy/0
Tg(tetO-Vegfa)90Ala/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR) 		hepatic peliosis J:99607
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc3)12740Njen/0
(involves: C3H * C57BL/6J) 		increased hepatocellular carcinoma incidence J:153656
increased liver adenoma incidence J:153656
increased liver tumor incidence J:153656
Gt(ROSA)26Sortm1(Tfrc*)Nca/Gt(ROSA)26Sor+
Hfetm2Nca/Hfetm2Nca
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		increased liver iron level J:133221
Gt(ROSA)26Sortm1(Tfrc*)Nca/Gt(ROSA)26Sortm1(Tfrc*)Nca
(involves: 129S4/SvJae * FVB/N) 		increased liver iron level J:133221
Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/Gt(ROSA)26Sor+
Tg(Nes-cre)1Wmz/0
(involves: 129 * C57BL/6 * FVB/N * SJL/J) 		enlarged liver J:185598
Gt(ROSA)26Sortm1.1(Aco1*)Mwh/Gt(ROSA)26Sortm1.1(Aco1*)Mwh
(B6.129P2(129S1)-Gt(ROSA)26Sortm1.1(Aco1*)Mwh) 		increased liver iron level J:196374
Gt(ROSA)26Sortm1.1(CAG-Upp1,-GFP)Gp/Gt(ROSA)26Sor+
(involves: C57BL/6 * FVB/N) 		microvesicular hepatic steatosis J:195165
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N) 		enlarged liver J:202090
liver inflammation J:202090
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA) 		enlarged liver J:202090
liver inflammation J:202090
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		abnormal liver morphology J:207306
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Lck-cre)I57Jxm/0
(involves: 129S6/SvEvTac * ICR) 		abnormal liver morphology J:207306
Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		enlarged liver J:137122
Gt(ROSA)26Sortm2(OVA/EGFP)Dwir/Gt(ROSA)26Sor+
Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129P2/OlaHsd * 129S2/SvPas) 		abnormal hepatocyte physiology J:173806
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
TgTn(sb-T2/Onc)68Dla/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		abnormal liver morphology J:147264
increased hepatocellular carcinoma incidence J:147264
increased liver adenoma incidence J:147264
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J) 		liver cirrhosis J:153656
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
Trp53tm3Tyj/Trp53+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
TgTn(sb-T2/Onc)68Dla/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		abnormal liver morphology J:147264
increased hepatocellular carcinoma incidence J:147264
increased liver adenoma incidence J:147264
Gt(ROSA)26Sortm2Bet/Gt(ROSA)26Sortm2Bet
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: BALB/c * C57BL/6 * DBA) 		abnormal bile duct development J:174261
abnormal bile duct morphology J:174261
abnormal intrahepatic bile duct morphology J:174261
abnormal liver morphology J:174261
decreased hepatocyte number J:174261
increased hepatocyte proliferation J:174261
increased liver weight J:174261
Gt(ROSA)26Sortm3(HIF1A*)Kael/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:144666
microvesicular hepatic steatosis J:144666
Gt(ROSA)26Sortm3(HIF1A*)Kael/Gt(ROSA)26Sortm4(HIF2A*)Kael
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		abnormal liver morphology J:144666
hepatic steatosis J:144666
increased hepatocyte proliferation J:144666
increased liver weight J:144666
Gt(ROSA)26Sortm4(CAG-hsb5)Nki/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
Tg(Tal1-tTA)19Dgt/0
Tg(tetO-BCR/ABL1)2Dgt/0
TgTn(pb-sb-GrOnc)#aGsva/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA/J * DBA/2 * FVB/N) 		increased liver weight J:227558
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		abnormal liver morphology J:144666
hepatic steatosis J:144666
increased hepatocyte proliferation J:144666
increased liver weight J:144666
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N) 		liver vascular congestion J:179490
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sor+
Tg(CAG-cre/Esr1*)5Amc/0
(B6.Cg-Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky Tg(CAG-cre/Esr1*)5Amc) 		hepatic steatosis J:264410
liver hemorrhage J:264410
Gt(ROSA)26Sortm9(cre/ESR1)Arte/?
Tnfaip3tm1Homy/Tnfaip3tm1Homy
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac) 		abnormal liver morphology J:212681
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ) 		enlarged liver J:181546
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		enlarged liver J:181546
Gtf2ird1Tg(Alb1-Myc)166.8Sst/0
Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		increased hepatocellular carcinoma incidence J:4527
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
(involves: C57BL/6 * CBA) 		abnormal hepatocyte morphology J:34434
increased hepatocellular carcinoma incidence J:34434, J:101128
increased liver adenoma incidence J:34434
increased liver tumor incidence J:101128
increased liver weight J:34434
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:101128
increased liver tumor incidence J:101128
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1+
Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		abnormal hepatocyte morphology J:34434
increased hepatocellular carcinoma incidence J:34434
increased hepatocyte apoptosis J:34434
increased hepatocyte karyomegaly J:34434
increased liver adenoma incidence J:34434
increased liver weight J:34434
multifocal hepatic necrosis J:34434
Gucy1b1tm1.1Frb/Gucy1b1tm1.1Frb
(involves: 129 * C57BL/6 * FVB/N) 		dilated gallbladder J:121321
Gucy2ctm1Gar/Gucy2ctm1Gar
(B6.129S6-Gucy2ctm1Gar) 		hepatic steatosis J:178241
increased liver triglyceride level J:178241
Gulosfx/Gulosfx
(BALB/cBy-Gulosfx/J) 		liver/biliary system phenotype J:66648
Gys1Gt(OST33395)Lex/Gys1Gt(OST33395)Lex
(involves: 129S5/SvEvBrd * 129X1/SvJ * C57BL/6J) 		liver hemorrhage J:92245
Gys2tm1.1Arte/Gys2+
(Not Specified) 		abnormal hepatocyte physiology J:208923
increased liver triglyceride level J:208923
Gys2tm1.1Arte/Gys2tm1.1Arte
(Not Specified) 		abnormal hepatocyte physiology J:208923
decreased liver glycogen level J:208923
increased liver triglyceride level J:208923
Gys2tm1.1Pro/Gys2tm1.1Pro
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		decreased liver weight J:162043
increased liver triglyceride level J:162043
Gys2tm1a(KOMP)Wtsi/Gys2+
(B6J.B6N-Gys2tm1a(KOMP)Wtsi) 		liver/biliary system phenotype J:208923
Gys2tm1a(KOMP)Wtsi/Gys2tm1a(KOMP)Wtsi
(B6J.B6N-Gys2tm1a(KOMP)Wtsi) 		decreased liver glycogen level J:208923
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl) 		abnormal liver morphology J:88055
enlarged liver J:88055
liver hemorrhage J:88055
H2b/H2d
((C57BL/6 x DBA/2)F1) 		abnormal liver physiology J:106141
H2d/H2d
(DBA/2) 		abnormal liver physiology J:106141
H13tm1b(KOMP)Wtsi/H13tm1b(KOMP)Wtsi
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
dilated liver sinusoidal space J:239583
H19tm1Tilg/H19+
Tg(CRP-TAg)60-3Urt/0
(involves: 129S/SvEv * BALB/c * C57BL/6 * SJL) 		increased liver tumor incidence J:90036
Habp2tm1Lex/Habp2tm1Lex
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6) 		liver fibrosis J:207454
liver inflammation J:207454
Hacd3em1(IMPC)Mbp/Hacd3em1(IMPC)Mbp
(C57BL/6N-Hacd3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
small liver J:211773
Hadhatm1Jib/Hadha+
(involves: 129X1/SvJ * NIH Black Swiss) 		abnormal hepatocyte mitochondrial morphology J:101304
hepatic steatosis J:101304
macrovesicular hepatic steatosis J:101304
microvesicular hepatic steatosis J:101304
Hadhatm1Jib/Hadhatm1Jib
(involves: 129X1/SvJ * NIH Black Swiss) 		abnormal hepatocyte mitochondrial morphology J:69846
abnormal hepatocyte morphology J:69846
enlarged liver J:69846
hepatic steatosis J:69846
Hadhbm1Ytc/Hadhbm1Ytc
(C57BL/6J-Hadhbm1Yuan) 		hepatic steatosis J:117738
Hamptm2.1Svl/Hamptm2.1Svl
(involves: FVB/N) 		increased liver iron level J:211683
Hand2tm1Cse/Hand2+
Tg(DBH-cre)1Cse/0
(involves: 129S1/Sv) 		liver vascular congestion J:155265
Hat1tm1.1Mrpa/Hat1+
(B6.Cg-Hat1tm1.1Mrpa) 		increased liver tumor incidence J:296531
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow
Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow
(Not Specified) 		abnormal Kupffer cell morphology J:134980
abnormal liver morphology J:134980
focal hepatic necrosis J:134980
increased liver iron level J:134980
liver vascular congestion J:134980
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow
Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow
Slc12a4Rbc10/Slc12a4+
(involves: 129 * BALB/c * C57BL/6J) 		abnormal liver morphology J:227339
hepatic necrosis J:227339
liver inflammation J:227339
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow
Hbbtm2(HBG1,HBB*)Tow/Hbbtm3(HBG1,HBB)Tow
(Not Specified) 		liver/biliary system phenotype J:134980
Hbatm1Paz/Hbatm1Paz
Hbbtm1Tow/Hbbtm1Tow
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		liver hypoplasia J:204029
small liver J:204029
Hbatm1Paz/Hbatm1Paz
Hbbtm1Tow/Hbbtm1Tow
Tg(HBA-HBBs)41Paz/?
(involves: 129S2/SvPas * 129S7/SvEvBrd * Black Swiss * C57BL/6 * DBA/2* FVB/N) 		abnormal liver vasculature morphology J:44161
increased liver iron level J:44161
Hbb-b1MommeD7/Hbb-b1MommeD7
(involves: FVB/N) 		abnormal liver morphology J:190446
liver hypoplasia J:190446
Hbb-b1Rbc13/Hbb-b1Rbc13
(involves: BALB/c * C57BL/6) 		abnormal liver morphology J:190446
liver hypoplasia J:190446
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased liver iron level J:185154
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
Tmprss6tm1Otin/Tmprss6+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		abnormal liver iron level J:185154
Hbbd3th/Hbbd3th
Tg(HBB-AR-HBA2,-HBB*)58Rub/0
Tg(LCR-HBA2,LCR-HBB)11Cos/0
(involves: FVB/N * Swiss Webster) 		abnormal liver morphology J:94190
enlarged liver J:94190
liver fibrosis J:94190
Hbbtm1.1(HBG1,HBB*)Ryan/Hbb+
(involves: C57BL/6J) 		increased liver iron level J:147906
Hbbtm2Unc/Hbb+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver iron level J:64295
Hc0/Hc0
(B10.D2-Hc0) 		liver fibrosis J:100159
Hcif1C57BL/6J/Hcif1C57BR/cdJ
Hcif2C57BL/6J/Hcif2C57BR/cdJ
(involves: C57BL/6J * C57BR/cdJ) 		increased hepatoma incidence J:33543
Hcif1C57BR/cdJ/?
(involves: C57BL/6J * C57BR/cdJ) 		increased hepatoma incidence J:33543
Hcs1C3H/He/?
(involves: A/J * C3H/He) 		increased hepatoma incidence J:3657
Hcs2C3H/He/?
(involves: A/J * C3H/He) 		increased hepatoma incidence J:3657
Hcs3A/J/?
(involves: A/J * C3H/He) 		increased hepatoma incidence J:3657
Hcs4C3H/He/Hcs4C57BL/6ByJ
(involves: C3H/He * C57BL/6JBy * M. spretus) 		increased hepatoma incidence J:20738
Hcs5C3H/He/?
(involves: C3H/He * C57BL/6ByJ * M. spretus) 		increased hepatoma incidence J:20738
Hcs6M. spretus/?
(involves: C3H/He * C57BL/6ByJ * M. spretus) 		increased hepatoma incidence J:20738
Hcs7C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		increased hepatoma incidence J:31507
Hcs7C3H/HeJ/Hcs7C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		increased hepatoma incidence J:91132
Hcs7C3H/HeJ/Hcs7C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased hepatoma incidence J:91132
Hcs7C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		decreased liver tumor incidence J:31507
Hcs8CBA/J/Hcs8CBA/J
(involves: C57BL/6J * CBA/J) 		increased hepatoma incidence J:91132
Hcs9C57BR/cdJ/Hcs9C57BR/cdJ
(B6.BR-(D1Mit5-D1Mit17)) 		increased hepatoma incidence J:91132
Hdac1tm1.1Mrl/Hdac1tm1.1Mrl
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		liver/biliary system phenotype J:197818
Hdac3tm1.1Laz/Hdac3tm1.1Laz
(involves: C57BL/6) 		hepatic steatosis J:206152
Hdac3tm1Swh/Hdac3tm1.1Swh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:134288
decreased liver glycogen level J:134288
enlarged liver J:134288
hepatic steatosis J:134288
increased hepatocyte proliferation J:134288
increased liver triglyceride level J:134288
increased liver weight J:134288
pale liver J:134288
Hdac3tm1Swh/Hdac3tm1.1Swh
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:134288
decreased liver glycogen level J:134288
enlarged liver J:134288
hepatic steatosis J:134288
increased liver weight J:134288
Hddc3tm1.1(KOMP)Vlcg/Hddc3tm1.1(KOMP)Vlcg
(C57BL/6N-Hddc3tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Hdl37C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		gallstones J:38473
Hdl39C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		gallstones J:38473
Hectd3tm1(NCOM)Cmhd/Hectd3tm1(NCOM)Cmhd
(C57BL/6N-Hectd3tm1(NCOM)Cmhd/Nju) 		small liver J:211773
Helz2tm1Tesa/Helz2tm1Tesa
(B6.Cg-Helz2tm1Tesa) 		abnormal liver size J:218127
decreased liver triglyceride level J:218127
hepatic steatosis J:218127
Hemgnem1Xguo/Hemgnem1Xguo
(Not Specified) 		decreased liver weight J:326018
Hephsla/Y
Hfetm2Nca/Hfetm2Nca
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver iron level J:62112
Hephsla/Hephsla
Hfetm2Nca/Hfetm2Nca
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver iron level J:62112
Hes1tm1Fgu/Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal bile duct development J:87397
abnormal cystic duct morphology J:87397
absent gallbladder J:87397
Hes1tm1Fgu/Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal bile duct development J:151981
abnormal bile duct morphology J:151981
abnormal common bile duct morphology J:151981
abnormal extrahepatic bile duct morphology J:151981
Hexatm1Cota/Hexatm1Cota
(involves: 129S2/SvPas * C57BL/6) 		abnormal hepatocyte morphology J:30435
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:29268
abnormal liver morphology J:29268
Hey2tm1Kkb/Hey2tm1Kkb
(involves: 129S7/SvEvBrd * C57BL/6) 		liver vascular congestion J:97120
Hey2tm1Mtc/Hey2tm1Mtc
(involves: 129X1/SvJ) 		liver vascular congestion J:80681
Hey2tm1Mtc/Hey2tm1Mtc
(involves: 129X1/SvJ * C57BL/6) 		liver vascular congestion J:80681
hf/hf
(MA/MyJ-hf) 		abnormal hepatobiliary system morphology J:83
abnormal liver development J:83
liver/biliary system phenotype J:83
Hfetm1.1Jrco/Hfetm1.1Jrco
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:201948
Hfetm1.1Nca/Hfetm1.1Nca
(Not Specified) 		increased liver iron level J:62112
Hfetm1.1Nca/Hfetm1.1Nca
Tfrctm1Nca/Tfrc+
(Not Specified) 		increased liver iron level J:62112
Hfetm1.1Wsr/Hfetm1.1Wsr
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver iron level J:132134, J:132141, J:141745
Hfetm1Gfn/Hfetm1Gfn
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver iron level J:262906, J:68025
Hfetm1Sly/Hfetm1Sly
(Not Specified) 		increased liver iron level J:88143
Hfetm1Sly/Hfetm2Sly
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:88143
Hfetm1Wsr/Hfetm1Wsr
Tg(Alb1-cre)7Gsc/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased liver iron level J:132134
Hfetm2Nca/Hfe+
(involves: 129S6/SvEvTac) 		increased liver iron level J:62112
Hfetm2Nca/Hfetm2Nca
(involves: 129S6/SvEvTac) 		increased liver iron level J:62112, J:133221
Hfetm2Nca/Hfetm2Nca
Slc11a2mk/Slc11a2mk
(involves: 129S6/SvEvTac * C57BL/6J * MK/ReJ) 		decreased liver iron level J:62112
Hfetm2Nca/Hfetm2Nca
Slc11a2tm1Nca/Slc11a2tm1Nca
(involves: 129S6/SvEvTac * 129S6.129S4-Slc11a2tm1Nca) 		increased liver iron level J:98088
Hfetm2Nca/Hfetm2Nca
Tfrctm1Nca/Tfrc+
(involves: 129S6/SvEvTac) 		increased liver iron level J:62112
Hfetm2Nca/Hfetm2Nca
Tg(Ttr-Hfe)1Nca/0
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver iron level J:133221
Hfetm2Nca/Hfetm2Nca
Urodtm1Kush/Urod+
(involves: C57BL/6J) 		increased liver iron level J:66704
Hfetm2Sly/Hfetm2Sly
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:88143
Hfetm2Sly/Hfetm3Sly
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:88143
Hfetm3Sly/Hfetm3Sly
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:88143
Hfib1BALB/cJ/Hfib1BALB/cJ
(involves: A/J * BALB/cJ) 		abnormal liver morphology J:80619
Hgftm1Cbm/Hgf+
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:23170
Hgftm1Cbm/Hgftm1Cbm
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:23170
abnormal liver morphology J:23170
dilated liver sinusoidal space J:23170
dissociated hepatocytes J:23170
liver hypoplasia J:23170
small liver J:23170
Hgftm1Jmw/Hgftm1Jmw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased hepatocyte proliferation J:97145
Hgftm1Jmw/Hgftm1Jmw
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased hepatocyte proliferation J:97145
impaired liver regeneration J:97145
Hgftm1Jmw/Hgftm1Jmw
Tg(Mx1-cre)29-4Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		decreased hepatocyte proliferation J:97145
impaired liver regeneration J:97145
Hgftm1Kita/Hgftm1Kita
(involves: 129S4/SvJae * C57BL/6) 		small liver J:23171
Hgsnattm1a(EUCOMM)Wtsi/Hgsnattm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		abnormal hepatocyte morphology J:235361
abnormal Kupffer cell morphology J:235361
enlarged liver J:235361
increased liver weight J:235361
Hhextm1Cwb/Hhextm1Cwb
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver development J:93580
absent liver J:93580
Hhextm1Cwb/Hhextm2Cwb
Tg(Alb1-cre)1Khk/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal bile duct development J:124126
abnormal liver morphology J:124126
liver cyst J:124126
Hhextm1Cwb/Hhextm2Cwb
Tg(Foxa3-cre)1Khk/?
(involves: 129X1/SvJ * C57BL/6 * DBA * SJL) 		abnormal extrahepatic bile duct morphology J:124126
abnormal hepatic duct morphology J:124126
abnormal intrahepatic bile duct morphology J:124126
abnormal liver morphology J:124126
absent gallbladder J:124126
biliary cyst J:124126
liver cyst J:124126
liver hypoplasia J:124126
Hhextm1Ngu/Hhextm1Ngu
(involves: 129/Sv * C57BL/6) 		abnormal hepatocyte morphology J:65105
abnormal liver bud morphology J:65105
abnormal liver development J:65105
Hhextm1Rbe/Hhextm1Rbe
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatic diverticulum morphology J:62027
abnormal hepatoblast migration J:62027
absent liver J:62027
Hhextm2Cwb/Hhextm2Cwb
Tg(Alb1-cre)1Khk/?
(involves: 129S1/Sv * C57BL/6 * SJL) 		liver cyst J:124126
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:81448
Hif1atm3Rsjo/Hif1atm3Rsjo
(involves: 129S1/Sv * 129X1/SvJ) 		decreased hepatocyte proliferation J:152724
decreased liver glycogen level J:152724
delayed liver regeneration J:152724
Hif1atm3Rsjo/Hif1atm3Rsjo
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6) 		hepatic steatosis J:97652
increased hepatic hemangioma incidence J:97652
Hif1atm3Rsjo/Hif1atm3Rsjo
Vhltm1Jae/Vhltm1Jae
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * BALB/c * C57BL/6 * DBA) 		hepatic steatosis J:97652
Hif1anem1(IMPC)Mbp/Hif1anem1(IMPC)Mbp
(C57BL/6N-Hif1anem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Hif1antm1.2Rsjo/Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo) 		decreased liver triglyceride level J:160941
decreased liver weight J:160941
decreased susceptibility to diet-induced hepatic steatosis J:160941
Hikeshiem1(IMPC)Rbrc/Hikeshi+
(C57BL/6NJcl-Hikeshiem1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Hint2tm1.1Geno/Hint2tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J) 		abnormal hepatocyte mitochondrial morphology J:237329
abnormal hepatocyte physiology J:237329
abnormal liver morphology J:237329
increased liver triglyceride level J:237329
increased liver weight J:237329
macrovesicular hepatic steatosis J:237329
Hip1tm4Tsr/Hip1+
Runx1tm3Dow/Runx1+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		abnormal liver morphology J:151974
abnormal liver parenchyma morphology J:151974
enlarged liver J:151974
increased liver weight J:151974
Hip1tm4Tsr/Hip1+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased hepatocellular carcinoma incidence J:151974
increased liver tumor incidence J:151974
Hjvtm1Arbr/Hjvtm1Arbr
(involves: 129S4/SvJae * 129X1/SvJ) 		increased liver iron level J:100173
Hjvtm1Kpan/Hjvtm1Kpan
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased liver iron level J:231428
Hjvtm1Nca/Hjv+
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		decreased liver iron level J:160248
Hjvtm1Nca/Hjvtm1Nca
(involves: 129S4/SvJae * 129S6/SvEvTac) 		increased liver iron level J:100178
Hjvtm1Nca/Hjvtm1Nca
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal hepatocyte morphology J:160248
increased liver iron level J:160248
Hjvtm1Nca/Hjvtm1Nca
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		increased liver iron level J:231428
Hjvtm1Nca/Hjvtm1Nca
Tmprss6tm1Dgen/Tmprss6+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal hepatocyte morphology J:160248
increased liver iron level J:160248
Hjvtm1Nca/Hjvtm1Nca
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		abnormal hepatocyte morphology J:160248
increased liver iron level J:160248
Hk1dea/Hk1dea
(A/J-Hk1dea/J) 		increased liver iron level J:72146
Hkdc1tm1a(KOMP)Wtsi/Hkdc1+
(involves: C57BL/6N) 		decreased liver triglyceride level J:240354
Hlxtm1Rph/Hlxtm1Rph
(involves: 129P2/OlaHsd) 		abnormal liver bud morphology J:31553
abnormal liver development J:31553
absent gallbladder J:31553
liver hypoplasia J:31553
Hlxtm1Rph/Hlxtm1Rph
(FVB.129P2-Hlxtm1Rph) 		abnormal liver development J:119681
Hmbstm1.1Rjde/Hmbstm1.1Rjde
(involves: 129/Sv * C57BL/6) 		abnormal liver morphology J:275245
Hmbstm2Uam/Hmbstm3Uam
(C57BL/6-Hmbstm2Uam/Hmbstm3Uam) 		abnormal liver morphology J:275245
Hmgcltm1Gam/Hmgcl+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)) 		abnormal hepatocyte morphology J:52117
Hmgcltm1Gam/Hmgcltm1Gam
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)) 		abnormal hepatocyte mitochondrial morphology J:52117
abnormal hepatocyte morphology J:52117
Hmgcltm2Gam/Hmgcltm2Gam
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Hmgcltm2Gam Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal hepatocyte mitochondrial morphology J:204294
abnormal hepatocyte physiology J:204294
Hmgcrtm2Ishi/Hmgcrtm2Ishi
Tg(Alb1-cre)1Dlr/0
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal liver parenchyma morphology J:201488
abnormal liver physiology J:201488
decreased liver cholesterol level J:201488
enlarged liver J:201488
hepatic necrosis J:201488
increased liver triglyceride level J:201488
increased liver weight J:201488
jaundice J:201488
liver failure J:201488
microvesicular hepatic steatosis J:201488
pale liver J:201488
Hmgcs2em1(IMPC)Tcp/Hmgcs2+
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp) 		increased liver weight J:326918
microvesicular hepatic steatosis J:326918
Hmgcs2em1(IMPC)Tcp/Hmgcs2em1(IMPC)Tcp
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp) 		enlarged liver J:326918
hepatic steatosis J:326918
increased liver triglyceride level J:326918
increased liver weight J:326918
microvesicular hepatic steatosis J:326918
pale liver J:326918
Hmox1tm1.1Hes/Hmox1tm1.1Hes
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N) 		decreased susceptibility to diet-induced hepatic steatosis J:214639
Hmox1tm1.1Hes/Hmox1tm1.1Hes
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA) 		decreased susceptibility to diet-induced hepatic steatosis J:214639
Hmox1tm1.2Gkl/Hmox1tm1.2Gkl
(involves: 129 * BALB/cJ * C57BL/6) 		liver inflammation J:148498
Hmox1tm1Mlee/Hmox1tm1Mlee
(involves: 129S2/SvPas * BALB/c) 		liver failure J:153083
Hmox1tm1Poss/Hmox1tm1Poss
(involves: 129S2/SvPas * C57BL/6) 		liver fibrosis J:79254
liver inflammation J:79254
Hnf1atm1.1Ylee/Hnf1atm1.1Ylee
(involves: 129X1/SvJ * C57BL/6J) 		abnormal hepatocyte morphology J:47008
enlarged liver J:47008
Hnf1atm1.1Ylee/Hnf1atm2Ylee
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:81639
enlarged liver J:81639
hepatic steatosis J:81639
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas) 		decreased liver function J:31627
enlarged liver J:31627
hepatic steatosis J:31627
increased hepatocyte proliferation J:31627
increased liver weight J:31627
jaundice J:31627
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas) 		decreased liver function J:31627
enlarged liver J:31627
hepatic steatosis J:31627
increased hepatocyte proliferation J:31627
increased liver weight J:31627
jaundice J:31627
Hnf1btm1Mya/Hnf1btm3Mya
Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		abnormal bile duct physiology J:75935
abnormal cystic duct morphology J:75935
abnormal extrahepatic bile duct morphology J:75935
abnormal gallbladder epithelium morphology J:75935
abnormal hepatobiliary system morphology J:75935
abnormal hepatobiliary system physiology J:75935
abnormal interlobular bile duct morphology J:75935
abnormal intrahepatic bile duct morphology J:75935
decreased liver function J:75935
enlarged liver J:75935
hepatic necrosis J:75935
intrahepatic cholestasis J:75935
jaundice J:75935
liver inflammation J:75935
Hnf4atm1(cre)Sdv/Hnf4a+
Myctm2.1Atp/Myctm2.1Atp
(involves: 129P2/OlaHsd * 129S/SvEv) 		liver/biliary system phenotype J:137630
Hnf4atm1.1Gonz/Hnf4atm1.1Gonz
Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * FVB/N) 		abnormal hepatocyte mitochondrial morphology J:67396
abnormal hepatocyte morphology J:67396
abnormal liver morphology J:67396
enlarged liver J:67396
Hnf4atm1Sad/Hnf4atm1Sad
Tg(Alb1-cre)1Khk/0
(involves: C57BL/6 * SJL) 		abnormal hepatocyte morphology J:84076
abnormal liver development J:84076
abnormal liver morphology J:84076
decreased liver glycogen level J:84076
dissociated hepatocytes J:84076
Hnf4atm2.1Mwei/Hnf4atm2.1Mwei
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		hepatic steatosis J:106993
Hoga1tm2a(KOMP)Wtsi/Hoga1tm2a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal liver physiology J:231386
Hoxa4em1(IMPC)Mbp/Hoxa4em1(IMPC)Mbp
(C57BL/6N-Hoxa4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Hptm1Skl/Hptm1Skl
Hpxtm1Altr/Hpxtm1Altr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J) 		liver inflammation J:80539
Hpcal1em1Ylzg/Hpcal1em1Ylzg
(C57BL/6J-Hpcal1em1Ylzg) 		increased liver weight J:331711
Hpcr1C57BL/6J/Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Hpcr1C57BL/6J/Hpcr1DBA/2J
Hpcr2C57BL/6J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Hpcr1DBA/2J/Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Hpcr2C57BL/6J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Hpcr2DBA/2J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J) 		decreased hepatoma incidence J:22501
Hprt1tm1(CUX1)Anep/Hprt1+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * FVB)) 		abnormal liver morphology J:113393
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6) 		hepatic steatosis J:97652
increased hepatic hemangioma incidence J:97652
Hprt1tm1(UBC-UBB)Rrk/Y
Ubctm1Rrk/Ubctm1Rrk
(involves: 129 * C57BL/6J) 		liver/biliary system phenotype J:122574
Hprt1tm1(UBC-UBB)Rrk/Hprt1tm1(UBC-UBB)Rrk
Ubctm1Rrk/Ubctm1Rrk
(involves: 129 * C57BL/6J) 		liver/biliary system phenotype J:122574
Hprt1tm1Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		hepatic steatosis J:44728
Hprt1tm1Detl/Hprt1tm1Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		hepatic steatosis J:44728
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2)) 		abnormal hepatocyte morphology J:21316
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn) 		increased liver triglyceride level J:107191
Hs2st1tm1.1Je/Hs2st1tm1.1Je
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Hs2st1tm1.1Je Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal hepatocyte physiology J:158299
Hs3st3b1em2(IMPC)Mbp/Hs3st3b1em2(IMPC)Mbp
(C57BL/6N-Hs3st3b1em2(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Hsd3b7tm1Rus/Hsd3b7tm1Rus
(involves: 129S/SvEv * C57BL/6J) 		increased liver triglyceride level J:122973
Hsd11b1tm1Ggla/Hsd11b1tm1Ggla
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		liver/biliary system phenotype J:189059
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1) 		hepatic steatosis J:72402
increased liver glycogen level J:45085
Hsd17b13tm1Lex/Hsd17b13tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6N) 		hepatic steatosis J:273927
increased liver triglyceride level J:273927
liver inflammation J:273927
macrovesicular hepatic steatosis J:273927
microvesicular hepatic steatosis J:273927
Hspa12atm1.1Zdi/Hspa12atm1.1Zdi
(involves: 129 * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:302786
Hspg2tm1Ref/Hspg2tm1Ref
(involves: 129S1/Sv * 129X1/SvJ) 		dilated liver sinusoidal space J:80720
Htatip2tm1Hx/Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:87066
Htatip2tm1Hx/Htatip2tm1Hx
(involves: 129P2/OlaHsd * C57BL/6J) 		increased hepatocellular carcinoma incidence J:87066
hubb/hubb
(involves: ICR) 		increased liver weight J:8170
jaundice J:8170
Hyal1tm1Stn/Hyal1tm1Stn
(involves: 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:136860
Hyal2tm1.1Bfla/Hyal2tm1.1Bfla
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased liver iron level J:146040
Iah1em1Kobam/Iah1em1Kobam
(involves: A/J * SM/JNshm) 		liver/biliary system phenotype J:289414
Iars1em2Nsas/Iars1em2Nsas
(C57BL/6-Iars1em2Nsas) 		increased liver triglyceride level J:340986
liver/biliary system phenotype J:340986
microvesicular hepatic steatosis J:340986
Icmttm1Hzo/Icmttm1Hzo
(involves: 129S/SvEv) 		abnormal liver bud morphology J:77742
abnormal liver development J:77742
absent liver J:77742
delayed hepatic development J:77742
Id1tm1Zhu/Id1tm1Zhu
(either: 129/Sv-Id1tm1Zhu or (involves: 129S1/Sv * C57BL/6)) 		liver/biliary system phenotype J:44278
Id3em1(IMPC)Mbp/Id3em1(IMPC)Mbp
(C57BL/6N-Id3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Idstm1Muen/Y
(involves: C57BL/6) 		increased liver weight J:259752
Iduatm1Clk/Iduatm1Clk
(involves: 129S1/Sv * 129X1/SvJ) 		pale liver J:39522
Ifih1Rgsc422/Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422) 		chronic liver inflammation J:209917
Ifitm1tm1.1Ieg/Ifitm1tm1.1Ieg
(B6.129P2-Ifitm1tm1.1Ieg) 		increased liver weight J:192287
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas) 		liver hemorrhage J:144400
Ifngtm1Ts/Ifngtm1Ts
Tgfb1tm1Doe/Tgfb1tm1Doe
(C.129-Ifngtm1Ts Tgfb1tm1Doe) 		liver inflammation J:69346
liver/biliary system phenotype J:69346
Ifngtm1Yiw/Ifngtm1Yiw
(involves: 129X1/SvJ * C57BL/6) 		hepatic necrosis J:41632
Ifngtm1Yiw/Ifngtm1Yiw
(B6.129X1-Ifngtm1Yiw) 		abnormal liver morphology J:50405
focal hepatic necrosis J:91691
liver inflammation J:50405
Ifngtm1Yiw/Ifngtm1Yiw
(C.129X1-Ifngtm1Yiw) 		diffuse hepatic necrosis J:91691
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd) 		increased hepatocyte proliferation J:38363
liver abscess J:174397
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * C57BL/6) 		liver/biliary system phenotype J:120559
Ift88Tg737Rpw/Ift88Tg737Rpw
(FVB/N-Ift88Tg737Rpw) 		abnormal bile duct morphology J:18508, J:37149
abnormal liver parenchyma morphology J:18508, J:37149
liver fibrosis J:18508, J:37149
Ift88Tg737Rpw/Ift88Tg737Rpw
(C3.FVB-Ift88Tg737Rpw) 		abnormal bile duct morphology J:73583, J:18508
abnormal oval cell physiology J:18508
absent oval cells J:73583
liver fibrosis J:73583, J:18508
Ift88Tg737Rpw/Ift88Tg737Rpw
(involves: C3H * FVB/N) 		abnormal liver morphology J:73583
Ift88Tg737Rpw/Ift88Tg737Rpw
(involves: 129/Sv * FVB/N) 		abnormal bile duct morphology J:62025
Ift88Tg737Rpw/Ift88tm1Rpw
(involves: 129/Sv * FVB/N) 		abnormal bile duct morphology J:62025
abnormal liver morphology J:62025
Igf1rhyft/Igf1rhyft
(Not Specified) 		abnormal liver morphology J:75360
Igf1rtm1Jcbr/Igf1rtm1Jcbr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6) 		increased hepatocyte proliferation J:221618
Igf1rtm1Jcbr/Igf1rtm1Jcbr
Tg(Fabp4-cre)1Abel/?
(involves: C57BL/6 * FVB/N) 		increased liver weight J:141321
Igf1sl1C3H/HeJ/Igf1sl1C3H/HeJ
(B6.C3-(D6Mit93-D6Mit150)) 		abnormal hepatobiliary system physiology J:99471
Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * C57BL/6J) 		increased hepatocyte proliferation J:77413
increased liver weight J:77413
Igf2bp1Gt(OST33739)Lex/Igf2bp1Gt(OST33739)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal liver lobule morphology J:89882
hepatic steatosis J:89882
Igf2bp2tm1Mini/Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini) 		abnormal liver triglyceride level J:271356
decreased susceptibility to diet-induced hepatic steatosis J:271356
increased liver weight J:271356
Igf2rtm1Arge/Igf2r+
(involves: 129) 		enlarged liver J:34584
liver hyperplasia J:34584
Igf2rtm1Arge/Igf2rtm1Arge
(involves: 129) 		enlarged liver J:34584
liver hyperplasia J:34584
Igf2rtm1Rlj/Igf2r+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129/Sv * C57BL/6 * DBA) 		liver/biliary system phenotype J:80932
Igf2rtm2Arge/Igf2r+
(involves: 129) 		enlarged liver J:34584
liver hyperplasia J:34584
Igf2rtm2Arge/Igf2rtm2Arge
(involves: 129) 		enlarged liver J:34584
liver hyperplasia J:34584
Igfbp1tm1Taub/Igfbp1tm1Taub
(involves: 129X1/SvJ * C57BL/6) 		delayed liver regeneration J:81817
focal hepatic necrosis J:81123
hepatic necrosis J:81817, J:81123
hepatic steatosis J:81123
impaired liver regeneration J:81817
increased hepatocyte apoptosis J:81123
liver inflammation J:81123
Igfbp2tm1Jep/Igfbp2tm1Jep
(either: (involves: 129P1/ReJ * 129S/SvEv) or (involves: 129S/SvEv * C57BL/6)) 		increased liver weight J:64338
Igfbp3tm1Lex/Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased liver weight J:168345
Ightm1(Myc)Janz/Igh+
Mdm4tm1.1Wahl/Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6) 		enlarged liver J:150341
Ightm1(PAX5)Mbu/Igh+
(B6.Cg-Ightm1(PAX5)Mbu) 		abnormal liver morphology J:118111
Ightm1(PAX5)Mbu/Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu) 		abnormal liver morphology J:118111
Iglon5em1(IMPC)Mbp/Iglon5em1(IMPC)Mbp
(C57BL/6NCrl-Iglon5em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Iigp1cem1Btlr/Iigp1cem1Btlr
(C57BL/6J-Iigp1cem1Btlr) 		decreased liver free fatty acids level J:333470
hepatic steatosis J:333470
increased liver triglyceride level J:333470
increased liver weight J:333470
Iigp1cM1Btlr/Iigp1c+
(C57BL/6J-Iigp1cM1Btlr) 		increased liver triglyceride level J:333470
Iigp1cM1Btlr/Iigp1cM1Btlr
(C57BL/6J-Iigp1cM1Btlr) 		hepatic steatosis J:333470
increased liver triglyceride level J:333470
Iigp1cM2Btlr/Iigp1c+
(C57BL/6J-Iigp1cM2Btlr) 		increased liver triglyceride level J:333470
Iigp1cM2Btlr/Iigp1cM2Btlr
(C57BL/6J-Iigp1cM2Btlr) 		increased liver triglyceride level J:333470
Ikbkbtm1Mka/Ikbkbtm1Mka
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal hepatocyte morphology J:55737
liver degeneration J:55737
Ikbkbtm1Trk/Ikbkbtm1Trk
(involves: 129S1/Sv * C57BL/6) 		abnormal hepatocyte morphology J:55680
increased hepatocyte apoptosis J:55680
liver degeneration J:55680
Ikbkbtm1Ver/Ikbkbtm1Ver
(involves: 129S4/SvJae * C57BL/6J) 		dissociated hepatocytes J:54323
increased hepatocyte apoptosis J:54323
liver degeneration J:54323
liver hemorrhage J:54323
small liver J:54323
Ikbkbtm2Cgn/Ikbkbtm2Cgn
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		liver/biliary system phenotype J:118336
Ikbkgtm1.1Chtr/Y
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL) 		abnormal liver morphology J:151485
hepatic steatosis J:151485
increased hepatocellular carcinoma incidence J:151485
increased hepatocyte apoptosis J:151485
increased liver weight J:151485
liver inflammation J:151485
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		increased hepatocyte apoptosis J:160521
increased hepatocyte proliferation J:160521
liver/biliary system phenotype J:160521
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL) 		abnormal liver morphology J:151485
hepatic necrosis J:151485
hepatic steatosis J:151485
increased hepatocellular carcinoma incidence J:151485
increased hepatocyte apoptosis J:151485
increased liver weight J:151485
liver inflammation J:151485
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
(involves: FVB/N) 		abnormal liver morphology J:160521
increased hepatocellular carcinoma incidence J:160521
increased hepatocyte apoptosis J:160521
increased hepatocyte proliferation J:160521
liver fibrosis J:160521
liver/biliary system phenotype J:160521
Ikbkgtm1.1Dwat/Y
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		abnormal hepatocyte morphology J:202106
abnormal liver physiology J:202106
abnormal liver regeneration J:202106
hepatic steatosis J:202106
liver fibrosis J:202106
liver inflammation J:202106
macrovesicular hepatic steatosis J:202106
microvesicular hepatic steatosis J:202106
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		abnormal hepatocyte mitochondrial morphology J:118336
abnormal hepatocyte morphology J:118336
abnormal liver morphology J:118336
hepatic steatosis J:118336
increased hepatocellular carcinoma incidence J:118336
liver inflammation J:118336
Ikbkgtm1Mak/Y
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocyte apoptosis J:61666
liver hemorrhage J:61666
Ikbkgtm1Mka/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:63054
increased hepatocyte apoptosis J:63054
Ikbkgtm1Mka/Ikbkg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased hepatocyte apoptosis J:63054
Ikzf1plstc/Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc) 		liver hypoplasia J:84569
Ikzf1plstc/Ikzf1plstc
(C57BL/6JSfdAnu-Ikzf1plstc) 		liver hypoplasia J:84569
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		multifocal hepatic necrosis J:20671
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c) 		multifocal hepatic necrosis J:20671
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J) 		increased liver weight J:108634
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor) 		liver inflammation J:29799
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak) 		liver inflammation J:113547
Il4tm2Nnt/Il4tm2Nnt
Tgfb1tm1Doe/Tgfb1tm1Doe
(C.Cg-Tgfb1tm1Doe Il4tm2Nnt) 		liver inflammation J:69346
Il4ratm1Fbb/Il4ratm1Fbb
(involves: BALB/cJ) 		liver inflammation J:114751
Il4ratm1Fbb/Il4ratm2Fbb
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * BALB/c) 		liver fibrosis J:114751
liver inflammation J:114751
Il5tm1Kopf/Il5tm1Kopf
(C57BL/6-Il5tm1Kopf) 		liver fibrosis J:107418
Il6tm1Kopf/Il6+
Ncoa5tm1Hxia/Ncoa5+
(involves: 129S2/SvPas * C57BL/6) 		increased hepatocellular carcinoma incidence J:207622
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6) 		hepatic necrosis J:122816
liver degeneration J:122816
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas) 		abnormal oval cell physiology J:66448
Il6tm1Poli/Il6tm1Poli
(involves: 129S/SvEv * C57BL/6) 		abnormal liver morphology J:37026
hepatic necrosis J:37026
impaired liver regeneration J:37026
liver failure J:37026
Il6ratm1.1Jcbr/Il6ratm1.1Jcbr
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		decreased liver glycogen level J:166367
Il6ratm1.2Jcbr/Il6ratm1.2Jcbr
(involves: C57BL/6) 		decreased hepatocyte proliferation J:202764
increased hepatocyte apoptosis J:202764
liver inflammation J:202764
Il6sttm1Ard/Il6sttm1Wme
Tg(Alb1-cre)7Gsc/?
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * FVB/N) 		abnormal liver physiology J:97327
abnormal liver regeneration J:135290
Il6sttm1Ern/Il6sttm1Wme
Tg(Alb1-cre)7Gsc/?
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * FVB/N) 		abnormal liver regeneration J:135290
liver/biliary system phenotype J:97327
Il6sttm1Kish/Il6sttm1Kish
(involves: 129P2/OlaHsd * ICR) 		decreased liver glycogen level J:54660
Il6sttm1Wme/Il6sttm1Wme
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal liver regeneration J:135290
Il9em1(IMPC)Mbp/Il9em1(IMPC)Mbp
(C57BL/6NCrl-Il9em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Il9rem1(IMPC)Mbp/Il9rem1(IMPC)Mbp
(C57BL/6N-Il9rem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver physiology J:129479
increased hepatocyte apoptosis J:110238
increased liver triglyceride level J:129479
Il10tm1Roer/Il10tm1Roer
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2) 		liver inflammation J:94537
Il10rbtm1Agt/Il10rbtm1Agt
Tg(Cd4-TGFBR2)16Flv/?
(involves: 129S2/SvPas * C3H * C57BL/6) 		liver inflammation J:134156
Il12rb2tm1Jm/Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J) 		liver inflammation J:106805
Il17aem1(IMPC)Mbp/Il17aem1(IMPC)Mbp
(C57BL/6N-Il17aem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Il17raem1(IMPC)Mbp/Il17raem1(IMPC)Mbp
(C57BL/6NCrl-Il17raem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Il18bptm1.1(KOMP)Vlcg/Il18bptm1.1(KOMP)Vlcg
(involves: C57BL/6N) 		enlarged liver J:261967
Il22tm1.1Lex/Il22tm1.1Lex
(involves: 129S5/SvEvBrd) 		multifocal hepatic necrosis J:161073
Il22tm1Flv/Il22tm1Flv
(B6.Cg-Il22tm1Flv) 		liver inflammation J:126103
Il27ratm1Mak/Il27ratm1Mak
(B6.129P2-Il27ratm1Mak) 		hepatic necrosis J:88618
Ilruntm1a(KOMP)Wtsi/Ilruntm1a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal liver physiology J:302091
decreased liver cholesterol level J:302091
decreased liver triglyceride level J:302091
decreased liver weight J:302091
Imebt1DU6/?
(involves: DU6 * DUKs) 		increased liver weight J:99475
Imebt2DU6/?
(involves: DU6 * DUKs) 		increased liver weight J:99475
In(7Oca2;7Sox6)100H/In(7Oca2;7Sox6)100H
(Not Specified) 		abnormal liver morphology J:115753
Ing5tm1.1Avo/Ing5tm1.1Avo
(B6.Cg-Ing5tm1.1Avo) 		liver hypoplasia J:345308
Inhatm1Bay/Inhatm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:20450
chronic liver inflammation J:20450
diffuse hepatic necrosis J:20450
Inhbctm1Zuk/Inhbctm1Zuk
(either: (involves: 129S5/SvEvBrd * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)) 		liver/biliary system phenotype J:110815
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas) 		enlarged liver J:40377
hepatic steatosis J:40377
Ins2Akita/?
(involves: C57BL/6NSlc) 		decreased liver triglyceride level J:130021
Ins2tm1Delt/Ins2+
(involves: 129S2/SvPas * Black Swiss) 		hepatic steatosis J:94589
Insig1tm1Mbjg/Insig1tm1Mbjg
Insig2tm1Mbjg/Insig2tm1Mbjg
Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL) 		abnormal hepatobiliary system physiology J:101203
abnormal liver morphology J:101203
increased liver cholesterol level J:101203
increased liver triglyceride level J:101203
pale liver J:101203
Insrtm1Dac/Insrtm1Dac
(involves: 129S4/SvJae * C57BL/6) 		hepatic steatosis J:33408
Insrtm1Dac/Insrtm1Dac
Tg(TTR-INSR)L2Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		abnormal liver physiology J:91350
decreased liver glycogen level J:91350
enlarged liver J:91350
hepatic steatosis J:91350
liver degeneration J:91350
Insrtm1Dac/Insrtm1Dac
Tg(TTR-INSR)L3Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		abnormal liver physiology J:91350
decreased liver glycogen level J:91350
enlarged liver J:91350
hepatic steatosis J:91350
liver degeneration J:91350
Insrtm1Jja/Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased liver glycogen level J:32538
enlarged liver J:32538
hepatic steatosis J:32538, J:80773
Insrtm1Jja/Insrtm1Jja
Tg(PAH-INSR)1Rjv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * DBA/2) 		decreased liver glycogen level J:80773
hepatic steatosis J:80773
Insrtm1Khn/Insrtm1Khn
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Pomc1-cre)16Lowl/0
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N) 		liver inflammation J:192274
Insrtm1Khn/Insrtm1Khn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB) 		abnormal hepatocyte morphology J:63878
abnormal liver morphology J:63878
abnormal liver physiology J:63878
enlarged gallbladder J:63878
small liver J:63878
Insrtm1Khn/Insrtm1Khn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		abnormal hepatocyte physiology J:234643
abnormal liver morphology J:234643
abnormal liver physiology J:234643
decreased liver glycogen level J:234643
Insrtm1Khn/Insrtm1Khn
Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB) 		decreased liver glycogen level J:169404
hepatic steatosis J:169404
Insrtm1Shs/Insr+
(involves: C57BL/6CrSlc) 		abnormal liver physiology J:98723
Invsinv/Invs+
(FVB/N-Invsinv) 		abnormal liver morphology J:48533
Invsinv/Invsinv
(involves: FVB/N) 		abnormal biliary tract morphology J:50117
jaundice J:4934, J:132552, J:50117
Invsinv/Invsinv
(FVB/N-Invsinv) 		abnormal liver morphology J:48533
Iqgap1tm1Aber/Iqgap1tm1Aber
Iqgap2tm1Vs/Iqgap2tm1Vs
(involves: 129S4/SvJae) 		increased hepatocellular carcinoma incidence J:132670
Iqgap2tm1Vs/Iqgap2tm1Vs
(either: 129S4/SvJae-Iqgap2tm1Vs or B6.129S4-Iqgap2tm1Vs) 		abnormal hepatocyte mitochondrial morphology J:132670
decreased hepatocyte number J:132670
increased hepatocellular carcinoma incidence J:132670
increased hepatocyte apoptosis J:132670
Iqgap2tm1Vs/Iqgap2tm1Vs
(involves: 129S4/SvJae) 		increased hepatocellular carcinoma incidence J:205882
Irag1em1(IMPC)Ccpcz/Irag1em1(IMPC)Ccpcz
(C57BL/6NCrl-Irag1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
Ireb2tm1.1Eal/Ireb2tm1.1Eal
(B6J.129-Ireb2tm1.1Eal) 		increased liver iron level J:217335
Ireb2tm1.2Mwh/Ireb2tm1.2Mwh
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL) 		increased liver iron level J:103414
Ireb2tm1Mwh/Ireb2tm1Mwh
(involves: 129P2/OlaHsd * C57BL/6J) 		increased liver iron level J:105124
Ireb2tm1Roua/Ireb2tm1Roua
(involves: C57BL/6) 		increased liver iron level J:67313
liver/biliary system phenotype J:67313
Ireb2tm1Roua/Ireb2tm1Roua
(B6.Cg-Ireb2tm1Roua) 		increased liver iron level J:176655
Irf2bp2Gt(IST11591C1)Tigm/Irf2bp2Gt(IST11591C1)Tigm
(involves: C57BL/6 * C57BL/6N * FVB/N) 		abnormal liver morphology J:228010
Irf8tm1Hor/Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		hepatosplenomegaly J:36038
Irs1tm1Jos/Irs1tm1Jos
Irs3tm1Lhd/Irs3tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		liver/biliary system phenotype J:80976
Irs1tm1Mfw/Irs1tm1Mfw
Irs2tm2Mfw/Irs2tm2Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased liver glycogen level J:137845
Irs2tm2Mfw/Irs2tm2Mfw
Irs4tm1.1Mfw/Y
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		hepatic steatosis J:221293
Irx3tm1Hui/Irx3tm1Hui
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to diet-induced hepatic steatosis J:208887
Irx6tm1b(KOMP)Mbp/Irx6tm1b(KOMP)Mbp
(C57BL/6N-Irx6tm1b(KOMP)Mbp/Kmpc) 		abnormal liver morphology J:211773
Itchtm1b(EUCOMM)Hmgu/Itchtm1b(EUCOMM)Hmgu
(C57BL/6N-Itchtm1b(EUCOMM)Hmgu/H) 		enlarged gallbladder J:211773
Itgb1tm1Ross/Itgb1tm1Ross
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss) 		liver vascular congestion J:82534
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6) 		hepatic necrosis J:52262
Itih4tm1Mish/Itih4tm1Mish
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6 * NIH Black Swiss) 		decreased hepatocyte apoptosis J:132133
decreased hepatocyte proliferation J:132133
decreased liver tumor incidence J:132133
Itprid2tm1Sawa/Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa) 		decreased liver triglyceride level J:144968
decreased susceptibility to diet-induced hepatic steatosis J:144968
Jag1Ndr/Jag1Ndr
(involves: C3HeB/FeJ * C57BL/6) 		abnormal bile duct development J:277897
abnormal bile duct morphology J:277897
abnormal cholangiocyte morphology J:277897
abnormal liver morphology J:277897
abnormal liver physiology J:277897
abnormal liver vasculature morphology J:277897
jaundice J:277897
Jag1tm1Frad/Jag1tm1Frad
Tg(Cdh5-cre)7Mlia/0
(B6.Cg-Jag1tm1Frad Tg(Cdh5-cre)7Mlia) 		liver/biliary system phenotype J:166890
Jag1tm1Frad/Jag1tm1Frad
Tg(Tagln-cre)1Her/0
(B6.Cg-Jag1tm1Frad Tg(Tagln-cre)1Her) 		abnormal bile duct development J:166890
abnormal bile duct morphology J:166890
abnormal bile secretion J:166890
cholestasis J:166890
hepatic necrosis J:166890
jaundice J:166890
liver hemorrhage J:166890
Jag1tm1Grid/Jag1+
Notch2tm1Grid/Notch2+
(involves: 129S1/Sv * C57BL/6J) 		abnormal bile duct development J:74574
abnormal liver morphology J:74574
cholestasis J:74574
jaundice J:74574
Jag1tm1Grid/Jag1+
Notch2tm1Grid/Notch2+
(involves: 129S1/Sv) 		abnormal bile duct development J:133171
abnormal bile duct morphology J:133171
Jag1tm1Grid/Jag1+
Notch2tm3.1Grid/Notch2+
(B6.129S1-Jag1tm1Grid Notch2tm3.1Grid) 		abnormal bile duct morphology J:171432
abnormal biliary tract morphology J:171432
Jag1tm1Grid/Jag1+
Poglut1Gt(IST10323G11)Tigm/Poglut1+
(B6.Cg-Jag1tm1Grid Poglut1Gt(IST10323G11)Tigm) 		abnormal bile duct morphology J:171432
abnormal biliary tract morphology J:171432
Jag1tm1Grid/Jag1tm1.1Loo
Tg(Alb1-cre)1Khk/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal bile secretion J:149131
bile duct proliferation J:149131
dilated bile duct J:149131
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda) 		abnormal hepatocyte morphology J:199153
abnormal liver morphology J:199153
abnormal liver vasculature morphology J:199153
dilated liver sinusoidal space J:199153
enhanced liver regeneration J:199153
liver hyperplasia J:199153
Jak2tm2.1Kpf/Jak2tm2.1Kpf
(involves: 129P2/OlaHsd) 		small liver J:207710
Jarid2jumonji/Jarid2jumonji
(C.129P2-Jarid2jumonji) 		abnormal liver morphology J:42772
abnormal liver physiology J:85152
decreased hepatocyte number J:85152
dilated liver sinusoidal space J:42772
hepatic necrosis J:42772
liver hypoplasia J:42772
small liver J:85152
Jarid2jumonji/Jarid2jumonji
(either: B6.129P2-Jarid2jumonji or D2.129P2-Jarid2jumonji) 		liver hypoplasia J:42772
Jchaintm1Jse/Jchaintm1Jse
(involves: 129X1/SvJ) 		abnormal bile composition J:75843
Juntm1Wag/Juntm1Wag
(involves: 129S2/SvPas * C57BL/6) 		decreased hepatocyte proliferation J:55508
increased hepatocyte apoptosis J:55508
Juntm1Wag/Juntm1Wag
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6)) 		abnormal bile duct development J:14538
abnormal liver development J:14538
dissociated hepatocytes J:14538
hepatic necrosis J:14538
increased hepatocyte apoptosis J:14538
Juntm1Wag/Juntm1Wag
Tg(Junb)1598Angl/0
(involves: 129S2/SvPas * C57BL/6) 		liver/biliary system phenotype J:75359
Juntm4Wag/Juntm4Wag
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal liver regeneration J:75863
decreased liver weight J:75863
Juntm4Wag/Juntm4Wag
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal liver regeneration J:75863
Juntm5.1(Junb)Wag/Juntm5.1(Junb)Wag
(involves: 129P2/OlaHsd * C57BL/6) 		liver/biliary system phenotype J:75359
Juntm6.1(Jund)Wag/Juntm6.1(Jund)Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver/biliary system phenotype J:175212
Jundtm1Mya/Jundtm1Mya
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)) 		liver inflammation J:65879
Jundtm1Mya/Jundtm1Mya
(involves: 129S2/SvPas * C57BL/6J) 		decreased liver triglyceride level J:210545
decreased liver weight J:210545
decreased susceptibility to diet-induced hepatic steatosis J:210545
Jundtm1Mya/Jundtm1Mya
Tg(H2-K-Fosl1)1Wag/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		liver vascular congestion J:95691
Juptm1.1Shou/Juptm1.1Shou
Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6J) 		liver vascular congestion J:177567
Juptm1Kem/Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ) 		small liver J:38047
Juptm1Kem/Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		small liver J:38047
Juptm1Ruiz/Juptm1Ruiz
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:64280
Kat6atm1Iki/Kat6atm1Iki
(Not Specified) 		liver hypoplasia J:108699
small liver J:108699
Kat8em1(IMPC)Mbp/Kat8+
(C57BL/6N-Kat8em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Katnb1tm1a(EUCOMM)Hmgu/Katnb1tm1a(EUCOMM)Hmgu
(C57BL/6-Katnb1tm1a(EUCOMM)Hmgu) 		pale liver J:220901
Kbtbd2m1Btlr/Kbtbd2m1Btlr
(C57BL/6J-Kbtbd2m1Btlr) 		enlarged liver J:236520
hepatic steatosis J:236520
increased liver triglyceride level J:236520
increased liver weight J:236520
pale liver J:236520
Kcnh8em1(IMPC)Mbp/Kcnh8em1(IMPC)Mbp
(C57BL/6N-Kcnh8em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
Kcnn4em1(IMPC)Ccpcz/Kcnn4em1(IMPC)Ccpcz
(C57BL/6NCrl-Kcnn4em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
small liver J:211773
Kcnq1ot1tm1.1Mjh/Kcnq1ot1+
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		decreased liver weight J:79882
Kdm1atm1(NCOM)Mfgc/Kdm1a+
(C57BL/6N-Kdm1atm1(NCOM)Mfgc/Nju) 		small liver J:211773
Kdm1atm1.1Sho/Kdm1atm1.1Sho
Eportm1.1(EGFP/icre)Uk/Epor+
(involves: 129 * BALB/cJ) 		abnormal liver morphology J:201572
pale liver J:201572
Kdm3atm1.1Yzha/Kdm3atm1.1Yzha
(B6.129P2-Kdm3atm1.1Yzha) 		hepatic steatosis J:147295
Kdrtm1Jrt/Kdr+
Tg(tetO-Kdr*)4377.5Rwng/0
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * NMRI) 		abnormal liver development J:100427
Kif9em1(IMPC)Mbp/Kif9em1(IMPC)Mbp
(C57BL/6N-Kif9em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Kifbptm1a(KOMP)Wtsi/Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
Kiss1tm1Coll/Kiss1tm1Coll
(involves: 129S/SvEv * 129S6/SvEvTac) 		decreased liver weight J:122381
Kiss1rtm1.1Lex/Kiss1rtm1.1Lex
(involves: 129S4/SvJae) 		decreased liver weight J:181650
KitMhdasco5/KitMhdasco5
(C3HeB/FeJ-KitMhdasco5) 		hepatic steatosis J:125831
Kittm1Alf/KitMhdasow3
(involves: 129S2/SvPas * C3HeB/FeJ) 		hepatic steatosis J:125831
KitW/KitW-v
(involves: C57BL/6J) 		hepatic steatosis J:125831
KitWhc1/KitWhc1
(involves: C3HeB/Fe * C57BL/6) 		hepatic steatosis J:125831
KitlSl-20J/KitlSl-20J
(C57BL/6J-KitlSl-20J/J) 		pale liver J:86436
Kitltm1.1Sjm/Kitl+
(BKa.129S6-Kitltm1.1Sjm) 		liver hypoplasia J:180431
Kitltm1.1Sjm/Kitltm1.1Sjm
(BKa.129S6-Kitltm1.1Sjm) 		liver hypoplasia J:180431
Kitltm2.1Sjm/Kitltm2.1Sjm
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6 * C57BL/Ka * SJL) 		liver hypoplasia J:180431
Klkl/Klkl
(involves: C3H/J * C57BL/6J) 		abnormal liver physiology J:66078
decreased liver weight J:66078
Klbtm1.2Sakl/Klb+
Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		decreased liver cholesterol level J:189018
decreased liver triglyceride level J:189018
decreased liver weight J:189018
decreased susceptibility to diet-induced hepatic steatosis J:189018
Klbtm1.2Sakl/Klbtm1.2Sakl
Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		abnormal liver morphology J:189018
Klbtm1Yin/Klbtm1Yin
(involves: C57BL/6 * CBA) 		abnormal liver physiology J:100209
small gallbladder J:100209
Klf1Nan/Klf1+
(involves: 101/H * C3H/HeH * PT) 		increased liver iron level J:13933
Klf1tm1Nimr/Klf1tm1Nimr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CBA) or (involves: 129P2/OlaHsd * FVB)) 		pale liver J:25650
small liver J:25650
Klf2tm1Ling/Klf2tm1Ling
(involves: 129P2/OlaHsd * C57BL/6J) 		pale liver J:51402
Klf3Gt(CH0516)Wtsi/Klf3Gt(CH0516)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver weight J:206507
Klf3Gt(XS0187)Wtsi/Klf3Gt(XS0187)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver weight J:206507
Klf6tm1Fdmn/Klf6+
(Not Specified) 		increased liver weight J:122903
Klf6tm1Fdmn/Klf6tm1Fdmn
(involves: C57BL/6) 		abnormal liver development J:122926
Klf15tm1Jain/Klf15tm1Jain
(B6.129X1-Klf15tm1Jain) 		abnormal hepatocyte physiology J:129763
decreased liver glycogen level J:129763
Klk11em1(IMPC)Ccpcz/Klk11em1(IMPC)Ccpcz
(C57BL/6N-Klk11em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Klrb1tm1b(EUCOMM)Wtsi/Klrb1tm1b(EUCOMM)Wtsi
(C57BL/6N-Klrb1tm1b(EUCOMM)Wtsi/Ieg) 		abnormal liver morphology J:211773
Klrc1tm1Mmka/Klrc1tm1Mmka
(B6.129-Klrc1tm1Mmka) 		liver inflammation J:222503
Kmt2atm1(MLL1/ERT)Divo/?
(involves: 129S4/SvJae * C57BL/6) 		enlarged liver J:189329
Kmt2atm1.1(Sh3gl1)Lcc/Kmt2a+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		enlarged liver J:205605
Kmt2atm1.1Brad/Kmt2atm1.1Brad
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver development J:149811
Kmt2atm1.1Mlc/Kmt2atm1.1Mlc
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:183048
Kmt2atm2(MLLT3)Thr/Kmt2a+
(involves: 129P2/OlaHsd) 		enlarged liver J:56340
Kmt2bGena263/Kmt2b+
(involves: BALB/c * C3H/HeH) 		abnormal hepatocyte morphology J:203736
hepatic steatosis J:203736
increased liver free fatty acids level J:203736
increased liver triglyceride level J:203736
increased liver weight J:203736
Kmt2bm1H/Kmt2b+
(involves: BALB/c * C3H/HeH) 		increased liver weight J:203736
Kmt2btm1Afst/Kmt2b+
(involves: 129P2/OlaHsd) 		liver/biliary system phenotype J:203736
Kpna1tm1.2Yyo/Kpna1tm1.2Yyo
(involves: 129S2/SvPas * C57BL/6 * SJL) 		liver/biliary system phenotype J:188099
Krastm1Mok/Krastm1Mok
(involves: 129S/SvEv * C57BL/6J) 		liver/biliary system phenotype J:42943
Krastm1Tyj/Kras+
Nrastm1Rak/Nrastm1Rak
(involves: 129/Sv * C57BL/6) 		abnormal hepatocyte morphology J:43433
Krastm1Tyj/Krastm1Tyj
(involves: 129S2/SvPas) 		liver hypoplasia J:43433
pale liver J:43433
small liver J:43433
Krastm4Tyj/Kras+
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		hepatosplenomegaly J:247853
Krastm4Tyj/Kras+
Krt19tm1(cre/ERT)Ggu/Krt19+
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac) 		abnormal cystic duct morphology J:254370
abnormal extrahepatic bile duct morphology J:254370
abnormal gallbladder morphology J:254370
abnormal liver morphology J:254370
dilated gallbladder J:254370
Krastm4Tyj/Kras+
Meox2tm1(cre)Sor/Meox2+
(involves: 129S4/SvJae * 129S4/SvJaeSor) 		increased hepatocyte apoptosis J:119477
liver hypoplasia J:119477
Krastm4Tyj/Kras+
Pggt1btm1Mbrg/Pggt1b+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:122107
Krastm4Tyj/Kras+
Ptentm2Mak/Pten+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:254370
increased hepatocellular carcinoma incidence J:254370
increased liver tumor incidence J:254370
Krastm4Tyj/Kras+
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		bile duct hyperplasia J:254370
enlarged liver J:254370
increased cholangiocarcinoma incidence J:254370
increased liver tumor incidence J:254370
jaundice J:254370
Krastm4Tyj/Kras+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:184949
increased liver tumor incidence J:254370
Krastm4Tyj/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA) 		abnormal hepatobiliary system morphology J:88163
Krastm4Tyj/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		enlarged liver J:87429
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		dilated gallbladder J:116129
hepatic necrosis J:116129
jaundice J:116129
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:184949
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased cholangiocarcinoma incidence J:184949
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		cholestasis J:98936
Krastm4Tyj/Krastm4Tyj
Yap1tm1.1Dupa/Yap1tm1.1Dupa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:162628
Krt8tm1Rgo/Krt8tm1Rgo
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:106541, J:44938, J:86719, J:121813
hepatic necrosis J:86719, J:22116
hepatic steatosis J:86719
liver hemorrhage J:86719
Krt18tm1Tmm/Krt18+
(involves: 129P2/OlaHsd) 		abnormal hepatocyte morphology J:309021
abnormal liver morphology J:309021
hepatic steatosis J:309021
increased liver tumor incidence J:309021
liver inflammation J:309021
Mallory bodies J:309021
Krt18tm1Tmm/Krt18tm1Tmm
(involves: 129/Sv * 129P2/OlaHsd * MF1) 		enlarged liver J:46610
Krt18tm1Tmm/Krt18tm1Tmm
(involves: 129P2/OlaHsd) 		abnormal hepatocyte morphology J:309021
abnormal liver morphology J:309021
abnormal liver parenchyma morphology J:309021
focal hepatic necrosis J:309021
hepatic steatosis J:309021
increased hepatocellular carcinoma incidence J:309021
increased hepatocyte apoptosis J:309021
increased liver tumor incidence J:309021
liver hemorrhage J:309021
liver inflammation J:309021
Mallory bodies J:309021
Krt72em1(IMPC)Ccpcz/Krt72em1(IMPC)Ccpcz
(C57BL/6N-Krt72em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Lactb2Tg(Igh-Meis1)2770Amb/Lactb2Tg(Igh-Meis1)2770Amb
(FVB/NJ-Lactb2Tg(Igh-Meis1)2770Amb) 		enlarged liver J:79618
microvesicular hepatic steatosis J:79618
pale liver J:79618
Lama4tm1Ktry/Lama4tm1Ktry
(either: B6.129X1-Lama4tm1Ktry or (involves: 129X1/SvJ * C57BL/6)) 		jaundice J:74287
Lamp2tm1Amcu/Y
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal liver physiology J:215605
decreased liver function J:215605
decreased liver glycogen level J:215605
enlarged liver J:215605
hepatic steatosis J:215605
increased hepatocyte apoptosis J:215605
increased liver triglyceride level J:215605
increased liver weight J:215605
pale liver J:215605
Larp1em1(IMPC)Mbp/Larp1+
(C57BL/6N-Larp1em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas) 		liver inflammation J:125722
Lats1tm1Noj/Lats1tm1Noj
Lats2tm1.1Dupa/Lats2tm1.1Dupa
(involves: 129P2/OlaHsd * 129S2/SvPas) 		abnormal bile duct epithelium morphology J:223215
enlarged liver J:223215
increased liver weight J:223215
Lats1tm1Noj/Lats1tm1Noj
Lats2tm1.1Dupa/Lats2tm1.1Dupa
Wwtr1tm1.2Eno/Wwtr1tm1.2Eno
Yap1tm1.1Dupa/Yap1tm1.1Dupa
(involves: 129P2/OlaHsd * 129S/SvEv * 129S2/SvPas) 		abnormal bile duct epithelium morphology J:223215
enlarged liver J:223215
Lbptm1Buru/Lbptm1Buru
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver physiology J:126676
Lcattm1Hgc/Lcattm1Hgc
Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL) 		enlarged liver J:93775
Lcn2tm1Aade/Lcn2tm1Aade
(B6.129P2-Lcn2tm1Aade) 		hepatic steatosis J:169355
increased liver triglyceride level J:169355
increased liver weight J:169355
Ldhaa-m1Neu/Ldhaa-m1Neu
(C3.Cg-Ldhaa-m1Neu) 		increased liver weight J:14326
LdlrHlb301/LdlrHlb301
(C57BL/6J-LdlrHlb301/J) 		gallstones J:82961
Ldlrtm1Her/Ldlr+
Lepob/Lepob
(B6.Cg-Lepob Ldlrtm1Her) 		increased liver cholesterol level J:72027
increased liver triglyceride level J:72027
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		increased hepatocyte apoptosis J:175559
increased liver cholesterol level J:175559
increased liver triglyceride level J:175559
increased liver weight J:175559
liver fibrosis J:175559
liver inflammation J:175559
macrovesicular hepatic steatosis J:175559
microvesicular hepatic steatosis J:175559
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her) 		hepatic steatosis J:130278
increased liver cholesterol level J:72027
increased liver triglyceride level J:130278
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her/J) 		abnormal liver physiology J:106146
hepatic steatosis J:85174
increased liver cholesterol level J:85174
Ldlrtm1Her/Ldlrtm1Her
Lepob/Lepob
(B6.Cg-Lepob Ldlrtm1Her) 		increased liver cholesterol level J:72027
increased liver triglyceride level J:72027
Ldlrtm1Her/Ldlrtm1Her
Npc1m1N/Npc1m1N
(involves: 129S7/SvEvBrd * BALB/c) 		increased liver cholesterol level J:130969
Ldlrtm1Her/Ldlrtm1Her
Npc1m1N/Npc1m1N
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6) 		increased liver weight J:100351
Ldlrtm1Her/Ldlrtm1Her
Nr1h3tm1.1Djm/Nr1h3tm1.1Djm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * DBA) 		increased liver cholesterol level J:184536
Ldlrtm1Her/Ldlrtm1Her
Nr5a2tm3.1Sjns/Nr5a2tm3.1Sjns
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N) 		abnormal bile secretion J:215556
increased liver cholesterol level J:215556
Ldlrtm1Her/Ldlrtm1Her
Scd1ab-2J/Scd1ab-2J
(B6.Cg-Ldlrtm1Her Scd1ab-2J) 		decreased liver triglyceride level J:130278
liver/biliary system phenotype J:130278
Ldlrtm1Her/Ldlrtm1Her
Scd1ab-J/Scd1ab-J
(B6.Cg-Ldlrtm1Her Scd1ab-J) 		decreased liver triglyceride level J:130278
liver/biliary system phenotype J:130278
Leap2em1Jmz/Leap2em1Jmz
(C57BL/6N-Leap2em1Jmz) 		macrovesicular hepatic steatosis J:322589
Lect2tm1Ymg/Lect2tm1Ymg
(involves: 129P2/OlaHsd * C57BL/6J) 		liver inflammation J:90961
Lect2tm1Ymg/Lect2tm1Ymg
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Lect2tm1Ymg Tg(Pklr-Myc)73Ak) 		increased hepatocellular carcinoma incidence J:184496
Lefty1tm1Hmd/Lefty1tm1Hmd
(involves: 129P2/OlaHsd * C57BL/6Cr) 		abnormal liver morphology J:49052
Lefty2tm2Hmd/Lefty2tm2Hmd
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:70483
Lepm1Yst/Lepm1Yst
(C57BL/6J-Lepm1Yst) 		hepatic steatosis J:167736
increased liver weight J:167736
pale liver J:167736
Lepob/Lep+
(involves: 129X1/SvJ * C57BL/6) 		increased liver weight J:76479
Lepob/Lepob
(involves: C57BL/6J) 		hepatic steatosis J:219118
increased liver weight J:219118
Lepob/Lepob
(B6.Cg-Lepob/J) 		abnormal liver weight J:22377
Lepob/Lepob
(involves: 129X1/SvJ * C57BL/6) 		increased liver weight J:107169
Lepob/Lepob
(involves: 129 * C57BL/6) 		hepatic steatosis J:121534
Lepob/Lepob
(B6.Cg-Lepob/OlaHsd) 		liver inflammation J:124815
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs) 		decreased liver triglyceride level J:199803
decreased susceptibility to hepatic steatosis J:199803
increased liver triglyceride level J:199803
Lepob/Lepob
(involves: C57BL/6) 		increased liver cholesterol level J:72027
increased liver triglyceride level J:72027
Lepob/Lepob
(B6.Cg-Lepob/JRj) 		abnormal hepatocyte physiology J:220381
hepatic steatosis J:277927
increased hepatocyte apoptosis J:277927
liver fibrosis J:277927
liver inflammation J:277927
macrovesicular hepatic steatosis J:277927
Lepob/Lepob
Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae) 		increased liver triglyceride level J:231617
Lepob/Lepob
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(B6.Cg-Nfe2l2tm1Mym Lepob) 		decreased liver triglyceride level J:208590
hepatic steatosis J:208590
Lepob/Lepob
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased liver weight J:107169
Lepob/Lepob
Pmchtm1Emf/Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6) 		hepatic steatosis J:85176
Lepob/Lepob
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6) 		hepatic steatosis J:116568
increased liver weight J:116568
Lepob/Lepob
Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6) 		abnormal liver morphology J:121534
decreased liver triglyceride level J:121534
hepatic steatosis J:121534
Lepob/Lepob
Rcan2tm1Ypt/Rcan2tm1Ypt
(involves: 129 * C57BL/6) 		decreased liver weight J:169558
Lepob/Lepob
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:189021
increased liver triglyceride level J:189021
Lepob/Lepob
Slc22a18tm1Tgot/Slc22a18tm1Tgot
(involves: C57BL/6) 		decreased liver weight J:349247
Lepob/Lepob
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd) 		hepatic steatosis J:187736
Lepob/Lepob
Tg(Eno2-Pomc)1Mobb/?
(involves: C3H * C57BL/6) 		abnormal liver size J:86303
Lepob/Lepob
Tg(Pmch-ATXN3*)3Rck/0
(involves: C57BL/6J * FVB/NJ) 		liver/biliary system phenotype J:104264
Leprdb-9J/Leprdb-9J
(involves: C57BL/6 * CBA * SWR) 		hepatic steatosis J:129982
increased liver glycogen level J:129982
Leprdb-lb/Leprdb-lb
(C57BL/6NCrl-Leprdb-lb/Crl) 		hepatic steatosis J:171755
Leprdb-Nokl/Leprdb-Nokl
(C57BL/6N-Leprdb-Nokl) 		increased liver triglyceride level J:313303
increased susceptibility to diet-induced hepatic steatosis J:313303
Leprdb-Pas/Leprdb-Pas
(involves: DW/Pas) 		enlarged liver J:174584
Leprdb/Leprdb-Nokl
(B6NTac.Cg-Leprdb Leprdb-Nokl) 		increased liver triglyceride level J:313303
increased susceptibility to diet-induced hepatic steatosis J:313303
Leprdb/Leprdb
(involves: C57BLKS/J) 		increased liver weight J:232827
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/OlaHsd) 		liver inflammation J:124815
Leprdb/Leprdb
(B6.BKS(D)-Leprdb/JOrlRj) 		hepatic steatosis J:277927
increased hepatocyte apoptosis J:277927
liver fibrosis J:277927
liver inflammation J:277927
macrovesicular hepatic steatosis J:277927
microvesicular hepatic steatosis J:277927
Leprdb/Leprdb
(B6NTac.BKS(D)-Leprdb) 		increased liver triglyceride level J:313303
increased susceptibility to diet-induced hepatic steatosis J:313303
Leprdb/Leprdb
Tg(SHBG)4-aGlha/0
(involves: C57BL/6 * C57BLKS/J * CBA) 		hepatic steatosis J:232827
increased liver triglyceride level J:232827
increased liver weight J:232827
Leprm1Clo/Leprm1Clo
(STOCK Leprm1Clo/GrsrJ) 		hepatic steatosis J:232775
Leprm5Btlr/Leprm5Btlr
(C57BL/6-Leprm5Btlr) 		increased liver weight J:166105
Leprm8Btlr/Leprm8Btlr
(C57BL/6J-Leprm8Btlr) 		hepatic steatosis J:267679
LeprTg(Mth11)1Aig/LeprTg(Mth11)1Aig
(involves: Him:OF1) 		enlarged liver J:61119
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Agrp-cre)1Gsb/0
(involves: 129 * FVB/N) 		decreased liver triglyceride level J:199803
Leprtm1b(EUCOMM)Wtsi/Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H) 		enlarged liver J:211773
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ * C57BL/6J) 		increased liver triglyceride level J:184572
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ) 		increased liver triglyceride level J:216393
Leprtm1Jke/Leprtm1Jke
Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased liver triglyceride level J:184572
increased liver triglyceride level J:184572
Leprtm1Rck/Leprtm1.1Rck
Tg(Syn1-cre)671Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		hepatic steatosis J:72241
Leprottm1.2Damj/Leprottm1.2Damj
(involves: 129S2/SvPas * C57BL/6N * FVB/N) 		decreased susceptibility to diet-induced hepatic steatosis J:349250
Letm1Gt(CC0204)Wtsi/Letm1+
(129S.129P2-Letm1Gt(CC0204)Wtsi) 		abnormal liver physiology J:222017
Letm1Gt(DD0926)Wtsi/Letm1+
(129S.129P2-Letm1Gt(DD0926)Wtsi) 		abnormal liver physiology J:222017
Letmd1em1Mbp/Letmd1em1Mbp
(C57BL/6J-Letmd1em1Mbp) 		hepatic steatosis J:321533
increased liver weight J:321533
Lexis1tm1.1Pton/Lexis1tm1.1Pton
(B6.Cg-Lexis1tm1.1Pton) 		hepatic steatosis J:233670
increased liver cholesterol level J:233670
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1) 		abnormal hepatocyte morphology J:116073
abnormal liver morphology J:221030, J:116073
focal hepatic necrosis J:221030, J:116073
hepatic steatosis J:221030, J:116073
increased hepatocellular carcinoma incidence J:221030
increased liver triglyceride level J:116073
increased liver weight J:116073
liver fibrosis J:221030
liver inflammation J:221030
Mallory bodies J:116073
Lgmntm1Ihn/Lgmntm1Ihn
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver weight J:143886
Lgr4Gt(pGT0TMpfs)1Wcs/Lgr4Gt(pGT0TMpfs)1Wcs
(involves: 129P2/Ola * C57BL/6) 		decreased liver weight J:92077
Lhcgrtm1(KOMP)Vlcg/Lhcgrtm1(KOMP)Vlcg
(C57BL/6N-Lhcgrtm1(KOMP)Vlcg/Nju) 		small liver J:211773
Lhx2tm1Dra/Lhx2tm1Dra
(involves: 129S4/SvJae) 		liver hypoplasia J:64676
small liver J:64676
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * BALB/c) 		abnormal hepatocyte morphology J:136940
hepatic necrosis J:136940
liver hemorrhage J:136940
liver vascular congestion J:136940
Lifrtm1Imx/Lifrtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd * C57BL/6) 		increased liver glycogen level J:25253
Lig1m1Anu/Lig1m1Anu
(involves: C3H/HeH * C57BL/6JAnu) 		pale liver J:199856
Lig1tm1Dwm/Lig1tm1Dwm
(involves: 129P2/OlaHsd * BALB/c) 		abnormal liver development J:76371
liver hypoplasia J:76371
small liver J:76371
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		liver inflammation J:157574
Lima1tm1Blsg/Lima1tm1Blsg
Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2) 		decreased liver cholesterol level J:263730
Lims1tm1.1Chen/Lims1tm1.1Chen
Lims2tm1.1Chen/Lims2tm1.1Chen
Tg(Tnnt2-cre)5Blh/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		enlarged liver J:167114
liver vascular congestion J:167114
Lingo2em1(IMPC)Kmpc/Lingo2em1(IMPC)Kmpc
(C57BL/6NTac-Lingo2em1(IMPC)Kmpc/Kmpc) 		abnormal liver morphology J:211773
Lipatm1c(EUCOMM)Hmgu/Lipatm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		abnormal hepatocyte morphology J:270182
decreased liver triglyceride level J:270182
enlarged liver J:270182
hepatic steatosis J:270182
increased liver cholesterol level J:270182
increased liver weight J:270182
liver fibrosis J:270182
liver inflammation J:270182
pale liver J:270182
Lipatm1Hodu/Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1) 		abnormal hepatocyte morphology J:49674, J:68812
abnormal Kupffer cell morphology J:68812
abnormal liver morphology J:49674
abnormal liver sinusoid morphology J:49674
hepatic steatosis J:68812
hepatosplenomegaly J:68812
increased liver cholesterol level J:49674
increased liver triglyceride level J:49674
increased liver weight J:49674, J:68812
Lipetm1Gam/Lipetm1Gam
(involves: 129S4/SvJae * BALB/c) 		decreased liver triglyceride level J:82299
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased liver triglyceride level J:74644
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd) 		decreased liver triglyceride level J:84822
Lipilpd1/Lipilpd1
(involves: CD-1) 		hepatic steatosis J:46789
increased liver triglyceride level J:46789
Lith1AKR/J/Lith1C57L/J
(involves: AKR/J * C57L/J) 		gallstones J:66646
Lith1C57L/J/Lith1C57L/J
(involves: AKR/J * C57L/J) 		gallstones J:66646
Lith2AKR/J/Lith2C57L/J
(involves: AKR/J * C57L/J) 		gallstones J:66646
Lith2C57L/J/Lith2C57L/J
(involves: AKR/J * C57L/J) 		gallstones J:66646
Lith3AKR/J/Lith3AKR/J
(involves: A/J * AKR/J) 		gallstones J:80014
Lith4DBA/2J/Lith4PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith4PERA/EiJ/Lith4PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith5AKR/J/Lith5SWR/J
(involves: AKR/J * SWR/J) 		gallstones J:72264
Lith5SWR/J/Lith5SWR/J
(involves: AKR/J * SWR/J) 		gallstones J:72264
Lith7I/LnJ/Lith7I/LnJ
(involves: I/LnJ * PERA/EiJ) 		gallstones J:84582
Lith8I/LnJ/Lith8I/LnJ
(involves: I/LnJ * PERA/EiJ) 		gallstones J:84582
Lith9I/LnJ/Lith9PERA/EiJ
(involves: I/LnJ * PERA/EiJ) 		gallstones J:84582
Lith9PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ) 		gallstones J:97424
Lith9PERA/EiJ/Lith9PERA/EiJ
(involves: I/LnJ * PERA/EiJ) 		gallstones J:84582
Lith10DBA/2J/Lith10DBA/2J
(involves: CAST/Ei * DBA/2J) 		gallstones J:85813
Lith11DBA/2J/Lith11DBA/2J
(involves: CAST/Ei * DBA/2J) 		gallstones J:85813
Lith12DBA/2J/Lith12PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith12PERA/EiJ/Lith12PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith15DBA/2J/Lith15PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith15PERA/EiJ/Lith15PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith16DBA/2J/Lith16PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith16PERA/EiJ/Lith16PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith17NZB/BlNJ/Lith17SM/J
(involves: NZB/BlNJ * SM/J) 		gallstones J:97646
Lith17SM/J/Lith17SM/J
(involves: NZB/BlNJ * SM/J) 		gallstones J:97646
Lith18NZB/BlNJ/Lith18SM/J
(involves: NZB/BlNJ * SM/J) 		gallstones J:97646
Lith18SM/J/?
Lith22NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J) 		gallstones J:97646
Lith18SM/J/Lith18SM/J
(involves: NZB/BlNJ * SM/J) 		gallstones J:97646
Lith19SM/J/?
Lith23SM/J/?
(involves: NZB/BlNJ * SM/J) 		gallstones J:97646
Lith19SM/J/Lith19SM/J
(involves: NZB/BlNJ * SM/J) 		gallstones J:97646
Lith20SM/J/Lith20SM/J
(involves: NZB/BlNJ * SM/J) 		gallstones J:97646
Lith21NZB/BlNJ/Lith21NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		gallstones J:97646
Lith24CAST/Ei/Lith24DBA/2J
(involves: CAST/Ei * DBA/2J) 		gallstones J:85813
Lith24DBA/2J/Lith24DBA/2J
(involves: CAST/Ei * DBA/2J) 		gallstones J:85813
Lith25CAST/EiJ/Lith25+
Lith6DBA/2J/Lith6+
(involves: CAST/Ei * DBA/2J) 		gallstones J:85813
Lith25CAST/EiJ/Lith25CAST/EiJ
(involves: CAST/Ei * DBA/2J) 		gallstones J:85813
Lith28DBA/2J/Lith28PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith28PERA/EiJ/Lith28PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith29DBA/2J/Lith29PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Lith29PERA/EiJ/Lith29PERA/EiJ
(involves: DBA/2J * PERA/EiJ) 		gallstones J:97424
Livq1MH/?
(involves: C57BL/6J * MH) 		increased liver weight J:55483
Livq2MH/?
(involves: C57BL/6J * MH) 		increased liver weight J:55483
Livq3MH/?
(involves: C57BL/6J * MH) 		decreased liver weight J:55483
Lmf1cld/Lmf1cld
(STOCK T/tw73) 		liver hemorrhage J:7083
Lmnaem1Fenz/Lmna+
(C57BL/6-Lmnaem1Fenz) 		hepatic steatosis J:338760
increased liver triglyceride level J:338760
LmnaGt(S7-1F1)Sor/LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased liver glycogen level J:221850
Lmnatm1Stw/Lmna+
(involves: 129S1/Sv * C57BL/6J) 		liver/biliary system phenotype J:75101
Lmo2tm2(cre)Thr/Lmo2+
Kmt2atm1Thr/Kmt2a+
Mllt1tm1Thr/Mllt1+
(involves: 129S/SvEv) 		pale liver J:84518
Lmr3BALB/cHeA/?
(involves: BALB/cHeA * STS/A) 		enlarged liver J:82715
Lmr14CcS16/Dem/?
(involves: BALB/cHeA * STS/A) 		enlarged liver J:82716
Lmr15CcS16/Dem/?
(involves: BALB/cHeA * STS/A) 		enlarged liver J:82716
Lncenc1em1Smoc/Lncenc1em1Smoc
(C57BL/6J-Lncenc1em1Smoc) 		decreased liver cholesterol level J:306153
decreased liver triglyceride level J:306153
decreased liver weight J:306153
decreased susceptibility to diet-induced hepatic steatosis J:306153
Loricrintm1.1(KOMP)Vlcg/Loricrin+
(C57BL/6N-Loricrintm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Loxl2tm1.2Acan/Loxl2tm1.2Acan
(Not Specified) 		abnormal liver vasculature morphology J:220689
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL) 		abnormal liver physiology J:220827
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * SJL) 		hepatic steatosis J:220827
increased liver cholesterol level J:220827
increased liver triglyceride level J:220827
Lpin1fld-2J/Lpin1fld-2J
(C3H/HeJ-Lpin1fld-2J/J) 		enlarged liver J:66739
hepatic steatosis J:66739
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld) 		enlarged liver J:82882, J:63448
increased liver triglyceride level J:147417, J:82882
pale liver J:82882
Lpin1fld/Lpin1fld
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J) 		decreased liver triglyceride level J:220917
Lpin1fld/Lpin1fld
Lpin3tm1Reue/Lpin3tm1Reue
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J) 		decreased liver triglyceride level J:220917
Lpin2tm1Reue/Lpin2tm1Reue
(involves: C57BL/6J) 		increased liver triglyceride level J:189894
Lpltm1Bres/Lpltm1Bres
(involves: 129S4/SvJae * C57BL/6J) 		abnormal liver morphology J:30062
Lpltm1Sem/Lpltm1Sem
(involves: 129P2/OlaHsd * C57BL/6J) 		liver vascular congestion J:25652
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL) 		abnormal liver parenchyma morphology J:307289
abnormal liver vasculature morphology J:307289
gallbladder inflammation J:307289
liver inflammation J:307289
Lpptm1b(KOMP)Wtsi/Lpptm1b(KOMP)Wtsi
(C57BL/6NCrl-Lpptm1b(KOMP)Wtsi/Ccpcz) 		abnormal liver morphology J:211773
Lrp1tm2Ajmr/Lrp1tm2Ajmr
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:144146
Lrp1tm2Her/Lrp1tm2Her
(involves: 129S7/SvEvBrd) 		abnormal liver physiology J:76281
Lrp1tm2Her/Lrp1tm2Her
Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased liver triglyceride level J:127398
Lrp1tm2Her/Lrp1tm2Her
Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		abnormal liver physiology J:83443
Lrp1tm3Ajmr/Lrp1tm3Ajmr
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver perisinusoidal space morphology J:144146
decreased hepatocyte number J:144146
liver degeneration J:144146
Lrp5tm1Jsak/Lrp5tm1Jsak
(involves: C57BL/6 * CBA) 		abnormal liver physiology J:81174
Lrp6Gt(LST067)Byg/Lrp6+
(B6.Cg-Lrp6Gt(LST067)Byg) 		abnormal liver morphology J:182772
abnormal liver physiology J:182772
decreased liver triglyceride level J:182772
Lrp6tm1Arma/Lrp6tm1Arma
(C57BL/6-Lrp6tm1Arma) 		abnormal liver morphology J:225450
enlarged liver J:210538
hepatic steatosis J:210538, J:225450
increased liver cholesterol level J:210538, J:225450
increased liver triglyceride level J:210538
liver fibrosis J:225450
liver inflammation J:225450
Lrrc8ctm1Maim/Lrrc8ctm1Maim
(B6J.129S2-Lrrc8ctm1Maim) 		decreased liver weight J:247160
Lrrc17em1(IMPC)Ccpcz/Lrrc17em1(IMPC)Ccpcz
(C57BL/6N-Lrrc17em1(IMPC)Ccpcz/Ccpcz) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Lrrtm2em1(IMPC)Mbp/Lrrtm2em1(IMPC)Mbp
(C57BL/6N-Lrrtm2em1(IMPC)Mbp/MbpMmucd) 		abnormal gallbladder morphology J:211773
abnormal liver morphology J:211773
Lsrtm1Mdar/Lsrtm1Mdar
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * MF1)) 		liver hypoplasia J:92354
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129 * C57BL/6J) 		enlarged liver J:112797
hepatic steatosis J:112797
increased liver weight J:112797
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129 * C57BL/6J) 		enlarged liver J:112797
hepatic steatosis J:112797
increased liver weight J:112797
Ltahlb382/Ltahlb382
(C57BL/6J-Ltahlb382/J) 		liver inflammation J:134498
Ltatm1Dch/Ltatm1Dch
(involves: 129S2/SvPas * C57BL/6J) 		liver/biliary system phenotype J:112797
Ltbtm1Kpf/Ltbtm1Kpf
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:42508
Ltbp1tm1Rawe/Ltbp1tm1Rawe
(B6.129X1-Ltbp1tm1Rawe) 		liver fibrosis J:133255
Ltftm1Omc/Ltftm1Omc
(either: 129S/SvEv or (involves: 129S/SvEv * C57BL/6)) 		increased liver iron level J:81005
Luc7lem1(IMPC)Mbp/Luc7lem1(IMPC)Mbp
(C57BL/6N-Luc7lem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Lwq9CAST/EiJ/Lwq9CAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		increased liver weight J:117545
Lwq14L6/Lwq14L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq15L6/Lwq15L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq15L6/Lwq15M16i
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq16L6/Lwq16L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq17L6/Lwq17L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq17L6/Lwq17M16i
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq18L6/Lwq18L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq19L6/Lwq19L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq19L6/Lwq19M16i
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq20L6/Lwq20L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq21L6/Lwq21L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq22L6/Lwq22L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq23L6/Lwq23L6
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq23L6/Lwq23M16i
(involves: L6 * M16i) 		decreased liver weight J:87793
Lwq24NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased liver weight J:122125
Ly6etm1c(EUCOMM)Hmgu/Ly6etm1c(EUCOMM)Hmgu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio) 		abnormal liver morphology J:291868
hepatic necrosis J:291868
pale liver J:291868
Lyntm1.1Calo/Lyntm1.1Calo
Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		liver inflammation J:200745
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor) 		liver inflammation J:146161
Lynweeb/Lynweeb
(C57BL/6-Lynweeb) 		liver inflammation J:146161
Lyplal1em1Espel/Lyplal1em1Espel
(C57BL/6J-Lyplal1em1Espel) 		decreased liver triglyceride level J:340413
decreased susceptibility to diet-induced hepatic steatosis J:340413
Lyz2tm1(HBEGF)Mtka/Lyz2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:145285
Lztfl1tm1.2Zpl/Lztfl1tm1.2Zpl
Tg(Camk2a-cre)#Stl/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL * C57BL/6 * C57BL/6N) 		abnormal interlobular bile duct morphology J:287261
hepatic steatosis J:287261
Lztfl1tm1.3Zpl/Lztfl1tm1.3Zpl
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N) 		abnormal interlobular bile duct morphology J:287261
hepatic steatosis J:287261
Lzts1tm1Cro/Lzts1+
(involves: 129 * C57BL/6J) 		increased hepatocellular carcinoma incidence J:119989
Lzts1tm1Cro/Lzts1tm1Cro
(involves: 129 * C57BL/6J) 		increased hepatocellular carcinoma incidence J:119989
Macroh2a1tm1Mbou/Macroh2a1tm1Mbou
(involves: 129P2/OlaHsd * C57BL/6) 		macrovesicular hepatic steatosis J:195833
Macroh2a2em1(IMPC)Hmgu/Macroh2a2em1(IMPC)Hmgu
(C57BL/6NCrl-Macroh2a2em1(IMPC)Hmgu/Ieg) 		abnormal liver morphology J:211773
decreased liver weight J:211773
Mad1l1tm1.1Ktj/Mad1l1+
(involves: BALB/c * C57BL/6J) 		increased hepatocellular carcinoma incidence J:117337
Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac) 		abnormal hepatocyte physiology J:234643
abnormal liver physiology J:234643
decreased liver glycogen level J:234643
decreased liver triglyceride level J:234643
Mad2l1bptm1.2Itl/Mad2l1bptm1.2Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		abnormal hepatocyte morphology J:234643
decreased liver glycogen level J:234643
Maf1tm1.1Lnh/Maf1tm1.1Lnh
(involves: C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:222253
Mafem1(IMPC)Mbp/Maf+
(C57BL/6N-Mafem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Mafem1(IMPC)Mbp/Mafem1(IMPC)Mbp
(C57BL/6N-Mafem1(IMPC)Mbp/MbpMmucd) 		abnormal liver size J:211773
Malrd1C57BL/6ByJ/Malrd1C57BL/6ByJ
(involves: A/J * C57BL/6J) 		abnormal hepatobiliary system physiology J:73640
Malrd1C57BL/6ByJ/Malrd1C57BL/6ByJ
(involves: C57BL/6ByJ * CAST/Ei) 		abnormal gallbladder physiology J:73640
Malrd1em1(IMPC)Mbp/Malrd1em1(IMPC)Mbp
(C57BL/6N-Malrd1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Man2a1tm1Jxm/Man2a1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver inflammation J:74579
Man2a1tm1Jxm/Man2a1tm1Jxm
Man2a2tm1Mfu/Man2a2tm1Mfu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:111055
Man2b1tm1Psa/Man2b1tm1Psa
(involves: 129 * C57BL/6J) 		abnormal hepatocyte morphology J:56659
abnormal Kupffer cell morphology J:56659
abnormal liver morphology J:56659
Man2c1tm1.1Tbec/Man2c1+
(B6N.129P2-Man2c1tm1.1Tbec) 		hepatic steatosis J:205550
Man2c1tm1.1Tbec/Man2c1tm1.1Tbec
(B6N.129P2-Man2c1tm1.1Tbec) 		abnormal hepatocyte morphology J:205550
hepatic steatosis J:205550
increased liver glycogen level J:205550
Manbatm1Khf/Manbatm1Khf
(B6.129-Manbatm1Khf) 		abnormal hepatocyte morphology J:105427
abnormal Kupffer cell morphology J:105427
abnormal liver sinusoidal endothelial cell morphology J:105427
Map2k4tm1Lizon/Map2k4tm1Lizon
(involves: 129S1/Sv) 		abnormal liver bud morphology J:48772
abnormal liver development J:48772
decreased hepatocyte number J:48772
dilated liver sinusoidal space J:48772
increased hepatocyte apoptosis J:48772
liver hemorrhage J:48772
Map2k4tm1Pngr/Map2k4tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver development J:51597
Map3k7tm1Aki/Map3k7tm1Aki
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal bile duct morphology J:160521
abnormal hepatocyte morphology J:160521
focal hepatic necrosis J:160521
increased hepatocyte proliferation J:160521
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal bile duct morphology J:160521
abnormal hepatocyte morphology J:160521
abnormal liver morphology J:160521
bile duct proliferation J:160521
focal hepatic necrosis J:160521
increased hepatocellular carcinoma incidence J:160521
increased hepatocyte apoptosis J:160521
increased hepatocyte proliferation J:160521
intrahepatic cholestasis J:160521
liver fibrosis J:160521
liver inflammation J:160521
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:238318
Map3k14aly/Map3k14aly
(involves: C57BL/6J) 		abnormal bile duct morphology J:48224
abnormal hepatobiliary system morphology J:48224
bile duct hyperplasia J:48224
bile duct inflammation J:48224
bile duct proliferation J:48224
dilated bile duct J:48224
liver inflammation J:48224
Mapk1tm1Melo/Mapk1+
Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
Tg(Tek-cre)12Flv/0
(involves: 129S2/SvPas * C3H * C57BL/6 * FVB/N) 		hepatic necrosis J:142212
Mapk3tm1Gpg/Mapk3+
Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
Tg(Tek-cre)12Flv/0
(involves: 129/Sv * C3H * C57BL/6 * FVB/N) 		hepatic necrosis J:142212
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
Tg(Tek-cre)12Flv/0
(involves: 129/Sv * C3H * C57BL/6 * FVB/N) 		hepatic necrosis J:142212
Mapk6tm1Melo/Mapk6tm1Melo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:153218
Mapk8tm1Flv/Mapk8tm1Flv
(B6.129S1-Mapk8tm1Flv/J) 		liver/biliary system phenotype J:113452
Mapk8tm1Jcbr/Mapk8tm1Jcbr
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased liver triglyceride level J:158650
decreased liver weight J:158650
decreased susceptibility to diet-induced hepatic steatosis J:158650
Mapk8ip1tm3.1Rjd/Mapk8ip1tm3.1Rjd
(B6.129S6-Mapk8ip1tm3.1Rjd) 		abnormal liver morphology J:163808
decreased liver triglyceride level J:163808
decreased liver weight J:163808
decreased susceptibility to diet-induced hepatic steatosis J:163808
Mapk9tm1Flv/Mapk9tm1Flv
(B6.129S2-Mapk9tm1Flv/J) 		abnormal liver physiology J:113452
Mapk11tm1Jsca/Mapk11tm1Jsca
Mapk14tm2Nbr/Mapk14tm2Nbr
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal liver morphology J:176023
increased hepatocyte apoptosis J:176023
small liver J:176023
Mapk14tm1Mka/Mapk14tm1Mka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		pale liver J:63425
small liver J:63425
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to age-related hepatic steatosis J:120128
Mark3tm1Hpw/Mark3tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		abnormal liver physiology J:163905
decreased liver glycogen level J:163905
decreased susceptibility to diet-induced hepatic steatosis J:163905
Marveld2tm1.1Sria/Marveld2tm1.1Sria
(involves: 129X1/SvJ * C57BL/6J) 		increased liver weight J:201580
Marveld2tm1Sats/Marveld2tm1Sats
(B6.Cg-Marveld2tm1Sats) 		liver/biliary system phenotype J:261357
Mat1atm1Jmm/Mat1atm1Jmm
(involves: 129/Sv * C57BL/6) 		abnormal liver morphology J:69408
abnormal liver physiology J:69408
increased liver weight J:69408
liver inflammation J:69408
macrovesicular hepatic steatosis J:69408
Mbd5tm1.2Gxu/Mbd5tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J) 		decreased liver weight J:192212
Mbtd1tm1Homy/Mbtd1tm1Homy
(B6.Cg-Ptprca Mbtd1tm1Homy) 		abnormal liver development J:169112
liver hypoplasia J:169112
Mbtps1tm1Jdh/Mbtps1tm1Jdh
Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL) 		decreased liver triglyceride level J:72930
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J) 		increased hepatocellular carcinoma incidence J:177386
increased liver triglyceride level J:177386
increased liver weight J:177386
liver fibrosis J:177386
liver inflammation J:177386
microvesicular hepatic steatosis J:177386
Mc4rtm1Matsu/Mc4rtm1Matsu
(C57BL/6J-Mc4rtm1Matsu) 		hepatic steatosis J:285412
increased liver triglyceride level J:285412
increased liver weight J:285412
liver fibrosis J:285412
liver inflammation J:285412
Mcm3tm1.1Geno/Mcm3tm1.1Geno
(involves: 129S2/SvPas * C57BL/6) 		abnormal liver physiology J:227638
Mcm4chaos3/Mcm4chaos3
(C3.B6-Mcm4chaos3) 		increased hepatocellular carcinoma incidence J:117494
Mcm9Gt(AW0655)Wtsi/Mcm9Gt(AW0655)Wtsi
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		increased hepatocellular carcinoma incidence J:177420
Mcm9Gt(AW0655)Wtsi/Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		increased hepatocellular carcinoma incidence J:177420
Mcm9Gt(XG743)Byg/Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		increased hepatocellular carcinoma incidence J:177420
Mcutm1.1Jmol/Mcutm1.1Jmol
Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		liver/biliary system phenotype J:298361
Mdktm1Tmu/Mdktm1Tmu
(B6.129S2-Mdktm1Tmu) 		decreased hepatocyte number J:102069
decreased liver weight J:102069
Mdm2tm1.1Ypz/Mdm2tm1.1Ypz
Tg(IghMyc)22Bri/0
(B6.Cg-Mdm2tm1.1Ypz Tg(IghMyc)22Bri) 		enlarged liver J:164200
Mdm2tm1Bay/Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased liver weight J:81065
Mdm2tm1Mep/Mdm2tm1.1Mep
(involves: 129S7/SvEvBrd * C57BL/6 * FVB) 		decreased liver weight J:81065
Mdm2tm2.1Snj/Mdm2tm2.1Snj
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:189297
Mdm2tm3.1Glo/Mdm2tm3.1Glo
Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo) 		increased liver adenocarcinoma incidence J:164201
increased liver adenoma incidence J:164201
Mdm2tm4.1Glo/Mdm2tm4.1Glo
Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm4.1Glo Trp53tm3.1Glo) 		increased liver adenocarcinoma incidence J:164201
Mecomtm1Mmor/Mecomtm1Mmor
(involves: 129S2/SvPas * CF-1) 		abnormal liver bud morphology J:42030
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased liver triglyceride level J:198551
Mecp2tm1.1Irsf/Mecp2+
(involves: 129S2/SvPas * C57BL/6) 		increased liver weight J:220859
Mecp2tm1.1Jae/Y
(B6.Cg-Mecp2tm1.1Jae) 		increased liver triglyceride level J:198551
Med1tm1Jkr/Med1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6) 		dilated liver sinusoidal space J:74328
Med1tm1Rgr/Med1tm1Rgr
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * 129X1/SvJ)) 		abnormal liver development J:61840
Med1tm2Jkr/Med1tm2Jkr
Tg(Alb1-cre)1Dlr/0
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:94123
Med13tm1Eno/Med13tm1Eno
Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6 * FVB/N) 		increased liver triglyceride level J:186193
increased liver weight J:186193
Med16tm1b(KOMP)Wtsi/Med16tm1b(KOMP)Wtsi
(C57BL/6N-Med16tm1b(KOMP)Wtsi/Ucd) 		pale liver J:211773
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		abnormal liver physiology J:298822
enlarged liver J:298822
hepatic steatosis J:298822
increased liver triglyceride level J:298822
increased liver weight J:298822
pale liver J:298822
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae
(B6.129S6-Mefvtm5.1(MEFV)Chae) 		liver inflammation J:172117
Meg3tm1Kono/Meg3+
(involves: 129P2/OlaHsd * C57BL/6N * DBA/2) 		hepatic necrosis J:147577
Megf8hlb611/Megf8hlb611
(involves: C57BL/6J * C3H/HeJ) 		abnormal liver morphology J:146957
Meis1tm1Mtor/Meis1tm1Mtor
(involves: CD-1) 		liver hypoplasia J:98307
Meis1tm1Ngc/Meis1tm1Ngc
(involves: 129 * C57BL/6NCr) 		abnormal liver morphology J:87890
Meis2tm1.2Zkoz/Meis2tm1.2Zkoz
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J) 		abnormal liver morphology J:229604
increased hepatocyte apoptosis J:229604
small liver J:229604
Meis3tm1b(EUCOMM)Hmgu/Meis3tm1b(EUCOMM)Hmgu
(C57BL/6N-Meis3tm1b(EUCOMM)Hmgu/Ccpcz) 		abnormal liver morphology J:211773
small liver J:211773
Men1tm1Zqw/Men1tm1Zqw
(either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		delayed hepatic development J:83882
Meox2tm1(cre)Sor/Meox2+
Ptrh2tm1Eruo/Ptrh2tm1.1Eruo
(B6.Cg-Ptrh2tm1Eruo Ptrh2tm1.1Eruo Meox2tm1(cre)Sor) 		abnormal hepatocyte morphology J:220518
Meox2tm1(cre)Sor/Meox2+
Slc40a1tm2Nca/Slc40a1tm2Nca
(involves: 129S4/SvJae * 129S6/SvEvTac) 		abnormal liver iron level J:129846
Mesdtm2Bch/Mesdtm2Bch
(involves: C57BL/6 * C57BL/6J) 		liver/biliary system phenotype J:209024
Mettm1.1Sst/Mettm1.1Sst
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver development J:89236
Mettm1Cbm/Mettm1Cbm
(involves: 129P2/OlaHsd) 		decreased liver weight J:68751
Mettm1Cbm/Mettm1Cbm
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver parenchyma morphology J:28570
small liver J:28570
Mettm1Kln/Mettm1Kln
(involves: 129/Sv * C57BL/6 * CD-1) 		abnormal liver development J:94030
decreased liver weight J:94030
dilated liver sinusoidal space J:94030
Mettm1Sst/Mettm1Sst
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte physiology J:89236
impaired liver regeneration J:89236
increased hepatocyte apoptosis J:89236
liver failure J:89236
liver hemorrhage J:89236
Mettm2Cbm/Mettm2.1Cbm
Tg(Mx1-cre)1Cgn/?
(involves: C57BL/6 * CBA) 		impaired liver regeneration J:91484
microvesicular hepatic steatosis J:91484
Mettm2Kln/Mettm2Kln
(involves: 129/Sv * C57BL/6 * CD-1) 		abnormal liver development J:94030
decreased liver weight J:94030
dilated liver sinusoidal space J:94030
Metrnltm1d(KOMP)Wtsi/Metrnltm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		liver inflammation J:268270
Mettl23em1(IMPC)Hmgu/Mettl23em1(IMPC)Hmgu
(C57BL/6NCrl-Mettl23em1(IMPC)Hmgu/Ieg) 		increased liver weight J:211773
Mfsd1em1(IMPC)Tcp/Mfsd1em1(IMPC)Tcp
(C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Mfsd1tm1a(KOMP)Wtsi/Mfsd1tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal hepatocyte morphology J:280713
abnormal liver morphology J:280713
abnormal liver parenchyma morphology J:280713
abnormal liver perisinusoidal space morphology J:280713
abnormal liver sinusoid morphology J:280713
abnormal liver sinusoidal endothelial cell morphology J:280713
abnormal liver vasculature morphology J:280713
increased liver tumor incidence J:280713
liver fibrosis J:280713
Mfsd1tm1d(KOMP)Wtsi/Mfsd1tm1d(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal liver morphology J:280713
Mfsd2atm1Dls/Mfsd2atm1Dls
(B6.Cg-Mfsd2atm1Dls) 		abnormal liver morphology J:194781
decreased susceptibility to hepatic steatosis J:194781
Mfsd8tm1a(EUCOMM)Hmgu/Mfsd8tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		abnormal liver morphology J:211608
Mgat3tm1Pst/Mgat3tm1Pst
(involves: 129/Sv * C57BL/6 * CD-1 * SJL) 		decreased hepatocyte proliferation J:86643
decreased liver weight J:86643
impaired liver regeneration J:86643
Mgat4atm1.1Jxm/Mgat4atm1.1Jxm
(B6.Cg-Mgat4atm1.1Jxm) 		hepatic steatosis J:117542
mgb/mgb
(involves: C57BL/6 * FVB/N) 		abnormal liver morphology J:130545
Mglltm1.1Rzim/Mglltm1.1Rzim
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver triglyceride level J:172679
Mia2tm1Zhxu/Mia2tm1Zhxu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:268333
abnormal liver morphology J:268333
abnormal liver physiology J:268333
enlarged liver J:268333
hepatic steatosis J:268333
increased liver cholesterol level J:268333
increased liver triglyceride level J:268333
pale liver J:268333
Mideasem1Shmc/Mideasem1Shmc
(C57BL/6J-Mideasem1Shmc) 		liver/biliary system phenotype J:291786
Mir32em1Gpt/Mir32em1Gpt
Albem1(icre)Gpt/Alb+
(C57BL/6JGpt-Mir32em1Gpt Albem1(icre)Gpt) 		abnormal liver physiology J:344660
decreased liver cholesterol level J:344660
decreased liver triglyceride level J:344660
decreased liver weight J:344660
decreased susceptibility to diet-induced hepatic steatosis J:344660
Mir100em1Nju/Mir100em1Nju
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased hepatocyte karyomegaly J:281439
liver inflammation J:281439
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6) 		abnormal Ito cell morphology J:190066
abnormal liver morphology J:190066
decreased liver glycogen level J:190066
hepatic steatosis J:190066
increased hepatocellular carcinoma incidence J:190066
increased liver cholesterol level J:190066
increased liver triglyceride level J:190066
liver fibrosis J:190066
liver inflammation J:190066
Mir122tm1.1Kgh/Mir122+
(involves: 129S1/Sv * 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:190067
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ) 		hepatic steatosis J:190067
increased hepatocellular carcinoma incidence J:190067
increased liver triglyceride level J:190067
liver fibrosis J:190067
liver inflammation J:190067
Mir122tm1.2Kgh/Mir122+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:190067
Mir122tm1.2Kgh/Mir122tm1.2Kgh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal liver physiology J:190067
abnormal oval cell physiology J:190067
bile duct proliferation J:190067
decreased liver glycogen level J:190067
increased hepatocellular carcinoma incidence J:190067
increased liver triglyceride level J:190067
increased liver tumor incidence J:190067
liver fibrosis J:190067
liver inflammation J:190067
microvesicular hepatic steatosis J:190067
Mir149em1Ydw/Mir149em1Ydw
(C57BL/6J-Mir149em1Ydw) 		increased hepatocyte apoptosis J:294318
increased hepatocyte proliferation J:294318
Mir378atm1.1Eno/Mir378atm1.1Eno
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:190154
Mirc13tm1.1Mtm/Mirc13tm1.1Mtm
(Not Specified) 		decreased liver triglyceride level J:256444
decreased liver weight J:256444
decreased susceptibility to diet-induced hepatic steatosis J:256444
Mirc36tm1.1Jcav/Mirc36+
(B6.129-Mirc36tm1.1Jcav) 		increased liver glycogen level J:216177
Mirc54tm1.1Syu/Mirc54tm1.1Syu
(Not Specified) 		decreased liver triglyceride level J:310890
decreased susceptibility to diet-induced hepatic steatosis J:310890
MitfTg(Tff3-Tmem207)2Tamo/Mitf+
(involves: C57BL/6) 		liver cyst J:244533
MitfTg(Tff3-Tmem207)2Tamo/MitfTg(Tff3-Tmem207)2Tamo
(involves: C57BL/6) 		liver cyst J:244533
Mks1hlb614/Mks1hlb614
(involves: C3H * C57BL/6) 		abnormal liver morphology J:167534
liver cyst J:167534
Mks1krc/Mks1krc
(involves: C3HeB/FeJ * C57BL/6 * CD-1) 		abnormal bile duct development J:154075
abnormal bile duct morphology J:154075
Mks1tm1a(EUCOMM)Wtsi/Mks1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		liver fibrosis J:196290
Mllt6em1(IMPC)Tcp/Mllt6em1(IMPC)Tcp
(C57BL/6NCrl-Mllt6em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Mllt10em1(IMPC)Mbp/Mllt10+
(C57BL/6N-Mllt10em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Mlxipltm1Kuy/Mlxipltm1Kuy
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal liver physiology J:89865
increased liver glycogen level J:89865
increased liver weight J:89865
Mlxipltm1Kuy/Mlxipltm1Kuy
(B6.129S6-Mlxipltm1Kuy/J) 		decreased liver triglyceride level J:273754
Mmetm1Cge/Mmetm1Cge
(involves: 129S4/SvJae * C57BL/6) 		diffuse hepatic necrosis J:70516
Mmp21b2b2458Clo/Mmp21b2b2458Clo
(C57BL/6J-Mmp21b2b2458Clo) 		abnormal liver morphology J:175213
Mmuttm1Cpv/Mmuttm1Cpv
(Not Specified) 		abnormal liver morphology J:147338
Mmuttm1Cpv/Mmuttm1Cpv
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		abnormal hepatocyte mitochondrial morphology J:147313
hepatic steatosis J:147313
Mmuttm1Cpv/Mmuttm1Cpv
Tg(Alb-Mut)#Cpv/0
(involves: C57BL/6) 		liver/biliary system phenotype J:200689
Mmuttm1Pai/Mmuttm1Pai
(involves: 129S1/Sv * C57BL/6) 		abnormal liver parenchyma morphology J:87081
Mmuttm1Pai/Mmuttm1Pai
Tg(MUT)AHlps/0
Tg(MUT*R403X)#Hlps/0
(involves: 129S1/Sv * C57BL/6) 		increased liver weight J:191879
Moap1tm1Vcy/Moap1tm1Vcy
(B6.129-Moap1tm1Vcy) 		decreased hepatocyte apoptosis J:238373
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased hepatobiliary system tumor incidence J:228499
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Mob1bGt(CC0690)Wtsi Mob1atm1.1Asuz Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal bile duct physiology J:228499
abnormal cholangiocyte morphology J:228499
enlarged liver J:228499
increased cholangiocarcinoma incidence J:228499
increased hepatobiliary system tumor incidence J:228499
increased hepatocellular carcinoma incidence J:228499
increased hepatocyte number J:228499
increased hepatocyte proliferation J:228499
increased liver adenoma incidence J:228499
jaundice J:228499
liver fibrosis J:228499
liver/biliary system phenotype J:228499
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tgfbr2tm1Roes/Tgfbr2tm1Roes
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal cholangiocyte morphology J:228499
increased liver weight J:228499
liver fibrosis J:228499
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Wwtr1tm1Hku/Wwtr1tm1Hku
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal cholangiocyte morphology J:228499
increased liver weight J:228499
liver fibrosis J:228499
Mob1atm1.1Asuz/Mob1atm1.1Asuz
Mob1bGt(CC0690)Wtsi/Mob1bGt(CC0690)Wtsi
Yap1tm1c(KOMP)Mbp/Yap1tm1c(KOMP)Mbp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * DBA) 		abnormal cholangiocyte morphology J:228499
increased liver weight J:228499
liver fibrosis J:228499
Mob1atm1.2Asuz/Mob1atm1.2Asuz
Mob1bGt(CC0690)Wtsi/Mob1b+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver tumor incidence J:193981
Mocosem2(IMPC)Ics/Mocos+
(involves: C57BL/6N) 		decreased liver weight J:336718
Mocosem2(IMPC)Ics/Mocosem2(IMPC)Ics
(involves: C57BL/6N) 		decreased liver weight J:336718
Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae) 		liver/biliary system phenotype J:231617
Mogat2tm1Far/Mogat2tm1Far
(B6.129S4-Mogat2tm1Far) 		decreased susceptibility to hepatic steatosis J:149373
Morc2aem1(IMPC)Wtsi/Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu) 		abnormal common bile duct morphology J:239583
abnormal liver morphology J:239583
abnormal liver vasculature morphology J:239583
liver cyst J:239583
Morf4l1tm1Kto/Morf4l1tm1Kto
(involves: 129S7/SvEvBrd) 		liver vascular congestion J:97640
mpc186H/mpc186H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		hepatic steatosis J:234901
mpc295H/mpc295H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		jaundice J:234901
Mpdk2C57BL/6J/Mpdk2CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk2CAST/Ei/Mpdk2CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk6CAST/Ei/Mpdk6CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		dilated bile duct J:99468
Mpdk7C57BL/6J/Mpdk7CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk7CAST/Ei/Mpdk7CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk8C57BL/6J/Mpdk8CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpdk8CAST/Ei/Mpdk8CAST/Ei
(involves: C57BL/6J * CAST/Ei) 		bile duct inflammation J:99468
Mpv17/Mpv17
(CFW-Mpv17/J) 		abnormal hepatocyte morphology J:143355
abnormal liver lobule morphology J:143355
abnormal liver sinusoid morphology J:143355
abnormal portal triad morphology J:143355
decreased hepatocyte mitochondrial DNA content J:143355
liver/biliary system phenotype J:143355
Mpzl3rc/Mpzl3rc
(C57BL/6J-Mpzl3rc/J) 		abnormal liver morphology J:210832
liver inflammation J:93038
Mpzl3tm1Tacz/Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz) 		abnormal liver morphology J:199257
abnormal liver physiology J:199257
decreased liver triglyceride level J:199257
decreased susceptibility to diet-induced hepatic steatosis J:199257
Mrap2tm1.1Maj/Mrap2tm1.1Maj
(either: B6.129-Mrap2tm1.1Maj or (involves: 129 * 129S6/SvEvTac)) 		hepatic steatosis J:199365
Mraptm1.2Geno/Mraptm1.2Geno
(involves: C57BL/6) 		decreased liver glycogen level J:278935
Mrgprb2em1(IMPC)Tcp/Mrgprb2em1(IMPC)Tcp
(C57BL/6NCrl-Mrgprb2em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Mrps12em1.2Afi/Mrps12em1.2Afi
(B6N(Cg)-Mrps12em1.2Afi) 		abnormal hepatocyte morphology J:284101
increased hepatocyte proliferation J:284101
Mrps34m1Anu/Mrps34m1Anu
(C57BL/6J-Mrps34m1Anu) 		hepatic steatosis J:222643
liver fibrosis J:222643
Mrs2em1Muma/Mrs2em1Muma
(B6.Cg-Mrs2em1Muma) 		abnormal hepatocyte morphology J:298361
abnormal hepatocyte physiology J:298361
MrtfbGt(RRJ478)Byg/MrtfbGt(RRJ478)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver morphology J:117226
liver hemorrhage J:117226
Mrtfbtm1.1Msp/Mrtfbtm1.1Msp
(involves: 129) 		liver hemorrhage J:187713
Ms4a7em1.1Jddl/Ms4a7em1.1Jddl
(B6.Cg-Ms4a7em1.1Jddl) 		abnormal liver morphology J:347975
decreased hepatocyte apoptosis J:347975
decreased susceptibility to diet-induced hepatic steatosis J:347975
Ms4a7em1Jddl/Ms4a7em1Jddl
Lyz2tm1(cre)Ifo/Lyz2+
(B6.Cg-Lyz2tm1(cre)Ifo Ms4a7em1Jddl) 		abnormal liver morphology J:347975
decreased susceptibility to diet-induced hepatic steatosis J:347975
Msh2tm1Htr/Msh2+
(involves: 129P2/OlaHsd) 		increased liver tumor incidence J:45433
Msh2tm1Rak/Msh2+
(involves: 129P2/OlaHsd) 		increased liver adenoma incidence J:64667
Msi2em1(IMPC)Mbp/Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Msmpem1Jzx/Msmpem1Jzx
(C57BL/6-Msmpem1Jzx) 		liver inflammation J:311042
Mss51tm1(KOMP)Vlcg/Mss51tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		hepatic steatosis J:280597
increased liver weight J:280597
Mst1tm1Jab/Mst1tm1Jab
(involves: 129P2/OlaHsd * Black Swiss) 		abnormal hepatocyte morphology J:46185
liver/biliary system phenotype J:46185
Mst1rtm2(Mst1r*)Sew/Mst1rtm2(Mst1r*)Sew
(FVB.129P2(Cg)-Mst1rtm2(Mst1r*)Sew) 		hepatic necrosis J:215969
Mstnlean/Mstnlean
(C57BL/6J-Mstnlean) 		decreased susceptibility to diet-induced hepatic steatosis J:146513
Mstntm1Sjl/Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:75178
Msx1tm2.1(cre/ERT2)Bero/Msx1tm1Bero
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		abnormal liver development J:194129
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri) 		abnormal liver morphology J:16487
hepatic necrosis J:16487
liver degeneration J:16487
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd) 		abnormal hepatocyte morphology J:120459
abnormal liver zinc level J:34407
hepatic necrosis J:120459
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		decreased hepatocyte proliferation J:109814
enlarged liver J:126620
impaired liver regeneration J:109814
Mt1tm1Rch/Mt1tm1Rch
Mt2tm1Rch/Mt2tm1Rch
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:120459
hepatic necrosis J:120459
mt-Tl1m1Jiha
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		abnormal liver physiology J:344247
hepatic steatosis J:344247
Mta1em1(IMPC)Ccpcz/Mta1+
(C57BL/6NCrl-Mta1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
small liver J:211773
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		liver inflammation J:137101
Mtapem1(IMPC)Mbp/Mtap+
(C57BL/6N-Mtapem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
MtapGt(RRK081)Byg/Mtap+
(129P2/OlaHsd-MtapGt(RRK081)Byg) 		abnormal liver morphology J:123675
Mtarc1tm1.1Vlcg/Mtarc1tm1.1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac) 		abnormal liver morphology J:346201
decreased liver triglyceride level J:346201
liver/biliary system phenotype J:346201
Mtbcq2NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased liver weight J:122125
Mtbcq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased liver weight J:122125
Mtbcq6NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		decreased liver weight J:122125
Mtch2tm2Atgr/Mtch2tm2.1Atgr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		liver failure J:209127
Mtdhtm1.2Dsar/Mtdhtm1.2Dsar
(either: B6.129(FVB)-Mtdhtm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)) 		decreased liver tumor incidence J:216688
Mtf1tm1Wsc/Mtf1tm1Wsc
(involves: 129 * C57BL/6) 		hepatic necrosis J:48216
Mtf1tm1Wsc/Mtf1tm1Wsc
(Not Specified) 		dilated liver sinusoidal space J:91119
hepatic necrosis J:91119
Mtf1tm2Wsc/Mtf1tm2Wsc
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA) 		abnormal liver physiology J:102512
Mtfmtem1Heb/Mtfmt+
(C57BL/6-Mtfmtem1Heb) 		abnormal liver morphology J:334467
abnormal liver physiology J:334467
decreased liver triglyceride level J:334467
Mtgq4NMRI8/Fbn/?
(involves: DBA/2OlaHsd * NMRI8/Fbn) 		increased liver weight J:122125
Mthfd2tm1b(EUCOMM)Wtsi/Mthfd2tm1b(EUCOMM)Wtsi
(C57BL/6N-Mthfd2tm1b(EUCOMM)Wtsi/Bay) 		pale liver J:211773
Mthfd2tm1Rmk/Mthfd2tm1Rmk
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		pale liver J:76786
small liver J:76786
Mthfrtm1Rzn/Mthfr+
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		microvesicular hepatic steatosis J:67779
Mthfrtm1Rzn/Mthfrtm1Rzn
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		microvesicular hepatic steatosis J:67779
Mtm1tm1Itl/Y
(B6.Cg-Mtm1tm1Itl) 		liver/biliary system phenotype J:179741
Mtss1Gt(CSC156)Byg/Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg) 		enlarged liver J:186118
Mttptm1Sgy/Mttp+
(involves: 129S4/SvJae) 		hepatic steatosis J:48934
increased liver cholesterol level J:48934
increased liver triglyceride level J:48934
Mttptm2Sgy/Mttptm2Sgy
Tg(Mx1-cre)1Cgn/Tg(Mx1-cre)1Cgn
(involves: 129S4/SvJae * C57BL/6 * CBA) 		abnormal liver physiology J:83459
increased liver cholesterol level J:83459
increased liver triglyceride level J:83459
increased liver weight J:83459
Muc1tm1Gend/Muc1tm1Gend
(involves: FVB) 		abnormal gallbladder physiology J:88633
gallstones J:88633
Muc5bem1(IMPC)Mbp/Muc5bem1(IMPC)Mbp
(C57BL/6N-Muc5bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Mug1tm1Vln/Mug1tm1Vln
(B.129P2-Mug1tm1Vln) 		hepatic necrosis J:57485
liver inflammation J:57485
Mug1tm2Vln/Mug1tm2Vln
Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln Mug1tm2Vln) 		hepatic necrosis J:57485
liver inflammation J:57485
Mybtm1Jof/Mybtm1Jof
(involves: 129/Sv * C57BL/6) 		abnormal liver development J:85344
Mybtm1Jof/Mybtm1Ssp
(involves: 129/Sv * C57BL/6) 		abnormal liver development J:85344
Mybtm1Ssp/Mybtm1Ssp
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)) 		abnormal liver sinusoid morphology J:43747
small liver J:43747
Mybphltm1b(KOMP)Wtsi/Mybphltm1b(KOMP)Wtsi
(C57BL/6N-Mybphltm1b(KOMP)Wtsi/Wtsi) 		abnormal common bile duct morphology J:239583
dilated liver sinusoidal space J:239583
Myctm2.1Atp/Myctm2.1Atp
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		liver hypoplasia J:137630
Myctm2.1Atp/Myctm2.1Atp
Tg(Tek-cre)1Rwng/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal liver morphology J:137630
liver hypoplasia J:137630
small liver J:137630
Mycntm1Fwa/Mycntm1Fwa
(involves: 129S/SvEv) 		abnormal liver development J:46520
abnormal liver morphology J:46520
increased hepatocyte apoptosis J:46520
liver hypoplasia J:46520
small liver J:46520
Mycntm1Knd/Mycntm1Knd
(involves: 129P2/OlaHsd * BALB/c) 		abnormal liver development J:11859
small liver J:11859
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd) 		decreased liver tumor incidence J:103464
Myh6tm1Jse/Myh6+
Tg(Myh6-TNNI3*G203S)1Chs/0
(involves: 129X1/SvJ * C57BL/6) 		liver inflammation J:153302
liver vascular congestion J:153302
Myh10tm2Rsad/Myh10tm2Rsad
(involves: 129S4/SvJae * C57BL/6J) 		abnormal liver morphology J:44181
liver vascular congestion J:44181
Myh10tm3.1Rsad/Myh10+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		herniated liver J:245570
Myh10tm3.1Rsad/Myh10tm3.1Rsad
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		dilated liver sinusoidal space J:245570
herniated liver J:245570
liver hemorrhage J:245570
liver vascular congestion J:245570
Myl1tm1(cre)Sjb/0
Ndufab1tm1Xiwa/Ndufab1tm1Xiwa
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		decreased liver glycogen level J:293657
Myl2tm1(cre)Krc/Myl2+
Txnrd2tm1Marc/Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6) 		liver vascular congestion J:94136
Myl9tm1Mzhu/Myl9tm1Mzhu
Tg(Acta2-cre)#Xya/0
(involves: C57BL/6 * CBA) 		abnormal liver morphology J:308237
Myo10m1J/Myo10m1J
(involves: C57BL/6J) 		absent liver J:256438
Myo18atm1b(KOMP)Wtsi/Myo18atm1b(KOMP)Wtsi
(C57BL/6N-Myo18atm1b(KOMP)Wtsi/Tcp) 		pale liver J:211773
Mzf1tm1Ppp/Mzf1tm1Ppp
(involves: 129) 		increased hepatocellular carcinoma incidence J:70407
Naa10em1(IMPC)Mbp/Y
(C57BL/6NCrl-Naa10em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Naa40tm1Qwzh/Naa40tm1Qwzh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh) 		decreased liver free fatty acids level J:183119
decreased liver triglyceride level J:183119
decreased susceptibility to age-related hepatic steatosis J:183119
Nab2tm1b(EUCOMM)Hmgu/Nab2tm1b(EUCOMM)Hmgu
(C57BL/6N-Nab2tm1b(EUCOMM)Hmgu/Ics) 		abnormal liver morphology J:211773
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		increased hepatocellular carcinoma incidence J:195140
Nadk2tm1a(EUCOMM)Wtsi/Nadk2tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		abnormal liver physiology J:255700
enlarged liver J:255700
hepatic steatosis J:255700
increased liver triglyceride level J:255700
liver degeneration J:255700
liver fibrosis J:255700
pale liver J:255700
Naglutm1Efn/Naglutm1Efn
(either: (involves: 129S/SvEv * C57BL/6) or (involves: C57BL/6)) 		abnormal hepatocyte morphology J:58950
abnormal Kupffer cell morphology J:58950
Nbntm1Zqw/Nbn+
(involves: 129S2/SvPas * C57BL/6) 		increased liver adenocarcinoma incidence J:86563
increased liver adenoma incidence J:86563
Ncf1tm1Hbd/Ncf1tm1Hbd
(involves: 129) 		abnormal bile duct morphology J:74593
liver abscess J:74593
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6) 		abnormal liver morphology J:141377
liver inflammation J:141377
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo
(involves: 129S/SvEv * C57BL/6J) 		increased liver glycogen level J:161276
increased liver triglyceride level J:161276
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased liver weight J:144060
decreased susceptibility to diet-induced hepatic steatosis J:144060
small liver J:144060
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6) 		abnormal liver morphology J:207622
chronic liver inflammation J:207622
hepatic steatosis J:207622
increased hepatocellular carcinoma incidence J:207622
increased hepatocyte apoptosis J:207622
increased hepatocyte proliferation J:207622
increased liver triglyceride level J:207622
liver fibrosis J:207622
Ncoa5tm1Hxia/Ncoa5+
(C.129(B6)-Ncoa5tm1Hxia) 		increased hepatocellular carcinoma incidence J:207622
Ncoa6tm1.1Jkr/Ncoa6tm1.1Jkr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal liver bud morphology J:81217
abnormal liver morphology J:81217
decreased hepatocyte number J:81217
increased hepatocyte apoptosis J:81217
small liver J:81217
Ncoa6tm1Hhs/Ncoa6tm1Hhs
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6)) 		abnormal liver development J:91083
Ncoa6tm2Jxu/Ncoa6tm2Jxu
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal hepatocyte morphology J:129067
abnormal liver morphology J:129067
increased liver weight J:129067
Ncor1tm1.1Ics/Ncor1tm1.1Ics
(involves: 129 * C57BL/6J) 		decreased liver glycogen level J:206152
hepatic steatosis J:206152
Ncor1tm1Rsd/Ncor1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal hepatocyte morphology J:65417
small liver J:65417
Ncor2Gt(RRM275)Byg/Ncor2+
(B6.129P2-Ncor2Gt(RRM275)Byg) 		decreased susceptibility to diet-induced hepatic steatosis J:164558
Ncor2tm1.1Ics/Ncor2tm1.1Ics
(involves: 129S2/SvPas * C57BL/6J) 		liver/biliary system phenotype J:206152
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal bile duct morphology J:116617
abnormal liver morphology J:116617
increased liver weight J:116617
Ndfip2tm1a(EUCOMM)Hmgu/Ndfip2tm1a(EUCOMM)Hmgu
(C57BL/6N-Ndfip2tm1a(EUCOMM)Hmgu) 		abnormal liver iron level J:235779
decreased liver iron level J:235779
increased liver iron level J:235779
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rpl11tm1.1Srn/Rpl11tm1.1Srn
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1) 		increased liver iron level J:292575
Ndrg2tm1Kmori/Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased hepatocellular carcinoma incidence J:210264
Ndrg2tm1Kmori/Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased hepatocellular carcinoma incidence J:210264
Ndst1tm1Je/Ndst1tm1Je
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte physiology J:158299
Ndst1tm1Je/Ndst1tm1Je
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		herniated liver J:208012
Ndufa1tm1.1Nay/Y
(involves: 129S1/SvImJ * 129S4/SvJaeSor * 129S6/SvEvTac) 		decreased liver cholesterol level J:257477
Negr1m1H/Negr1m1H
(C3.Cg-Negr1m1H) 		decreased liver triglyceride level J:189719
decreased liver weight J:189719
Neil1tm1Rsld/Neil1tm1Rsld
(involves: 129S1/Sv * C57BL/6) 		abnormal liver morphology J:106077
enlarged liver J:106077
hepatic steatosis J:106077
pale liver J:106077
Neu1a/Neu1a
(SM/J) 		abnormal Kupffer cell morphology J:147881
Neu1tm1Adz/Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI)) 		abnormal Kupffer cell morphology J:76937
Neu2em1Kyp/Neu2em1Kyp
(C57BL/6J-Neu2em1Kyp) 		hepatic steatosis J:321653
increased liver free fatty acids level J:321653
liver fibrosis J:321653
Neurl3em1Luda/Neurl3em1Luda
(B6N.Cg-Neurl3em1Luda) 		hepatic necrosis J:344721
Neurl4em1(IMPC)Mbp/Neurl4em1(IMPC)Mbp
(C57BL/6NCrl-Neurl4em1(IMPC)Mbp/Mmucd) 		abnormal gallbladder morphology J:211773
abnormal liver morphology J:211773
enlarged gallbladder J:211773
Nf1tm1Fcr/Nf1+
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Nf1tm1Fcr Ptentm1Hwu) 		abnormal liver morphology J:232645
enlarged liver J:232645
increased liver weight J:232645
Nf1tm1Fcr/Nf1tm1Fcr
(either: (involves: 129S/SvEv) or (involves: 129S/SvEv * C57BL/6J)) 		delayed hepatic development J:18048
focal hepatic necrosis J:18048
liver hemorrhage J:18048
liver hypoplasia J:18048
pale liver J:18048
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * C57BL/6) 		increased hepatoma incidence J:18542
Nf1tm1Tyj/Nf1+
Suz12Gt(Betageo)1Khe/Suz12+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased hepatocellular carcinoma incidence J:217077
Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd) 		abnormal bile duct epithelium morphology J:223215
enlarged liver J:132943
Nf2tm2Gth/Nf2tm2Gth
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal liver morphology J:162628
bile duct hyperplasia J:162628
bile duct proliferation J:162628
enlarged liver J:162628
increased hepatobiliary system tumor incidence J:162628
increased hepatocellular carcinoma incidence J:162628
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		enlarged liver J:132943
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		enlarged liver J:132943
Nf2tm2Gth/Nf2tm2Gth
Yap1tm1.1Dupa/Yap1+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		enlarged liver J:162628
liver/biliary system phenotype J:162628
Nf2tm2Gth/Nf2tm2Gth
Yap1tm1.1Dupa/Yap1tm1.1Dupa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		liver/biliary system phenotype J:162628
Nf2tm2Gth/Nf2tm2Gth
Yap1tm2.1Dupa/Yap1tm2.1Dupa
(involves: 129P2/OlaHsd) 		abnormal bile duct epithelium morphology J:223215
abnormal bile duct physiology J:223215
enlarged liver J:223215
Nfatc1tm3Glm/Nfatc1tm3Glm
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		liver inflammation J:144598
Nfe2l1tm1Jefc/Nfe2l1tm1Ywk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J) 		hepatic necrosis J:97188
hepatic steatosis J:97188
increased hepatocellular carcinoma incidence J:97188
increased liver adenoma incidence J:97188
liver fibrosis J:97188
liver inflammation J:97188
Nfe2l1tm1Mym/Nfe2l1tm1Mym
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		hepatic steatosis J:143468
Nfe2l1tm1Ywk/Nfe2l1tm1Ywk
(involves: 129X1/SvJ * C57BL/6J) 		pale liver J:46990
small liver J:46990
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd) 		increased liver iron level J:95372
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocyte apoptosis J:136120
liver inflammation J:136120
macrovesicular hepatic steatosis J:136120
Nfe2l2tm1Mym/Nfe2l2tm1Mym
Tg(Alb1-cre)1Dlr/0
n-TUtca2tm2Mym/n-TUtca2tm2.1Mym
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		abnormal hepatocyte morphology J:130723
increased hepatocyte apoptosis J:130723
liver degeneration J:130723
pale liver J:130723
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(involves: 129X1/SvJ) 		abnormal liver physiology J:130473
decreased hepatocyte proliferation J:130473
decreased liver weight J:130473
delayed liver regeneration J:130473
Nfkb1tm1Brv/Nfkb1tm1Brv
(involves: 129S1/Sv) 		liver inflammation J:46912
Nfkb2Lym1/Nfkb2+
(BALB/c-Nfkb2Lym1) 		liver inflammation J:154812
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c) 		liver inflammation J:154812
Ngfrtm1Jae/Ngfrtm1Jae
(B6.129S4-Ngfrtm1Jae) 		abnormal Kupffer cell morphology J:120368
Ngfrtm1Jae/Ngfrtm1Jae
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		hepatic necrosis J:120368
increased hepatocyte apoptosis J:120368
increased hepatocyte proliferation J:120368
Nhil1C57BL/6JOla/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
Nhil2SWR/Ola/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
Nhil3SWR/Ola/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
Nhil4SWR/Ola/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
Nhil5SWR/Ola/?
(involves: C57BL/6JOla * SWR/Ola) 		increased liver iron level J:114755
Nhlrc1tm1Bmin/Nhlrc1tm1Bmin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr) 		increased liver glycogen level J:181674
Nhlrc2em1Rhtl/Nhlrc2tm1a(KOMP)Wtsi
(C57BL/6N-Nhlrc2em1Rhtl Nhlrc2tm1a(KOMP)Wtsi) 		liver/biliary system phenotype J:299152
Ninj2em1Cqxu/Ninj2em1Cqxu
(C57BL/6-Ninj2em1Cqxu) 		decreased liver glycogen level J:332575
increased susceptibility to diet-induced hepatic steatosis J:332575
liver/biliary system phenotype J:332575
Nlrp1aNeut1/Nlrp1a+
(C.B6-Nlrp1aNeut1) 		liver inflammation J:191055
Nlrp1aNeut1/Nlrp1aNeut1
(C.B6-Nlrp1aNeut1) 		liver inflammation J:191055
Nlrp3tm1Bhk/Nlrp3tm1Bhk
(B6.129S6-Nlrp3tm1Bhk/J) 		abnormal liver morphology J:256504
hepatic steatosis J:256504
increased liver triglyceride level J:256504
increased liver weight J:256504
Nlrp3tm1Wstr/Nlrp3+
(involves: C57BL/6) 		enlarged liver J:150053
Nme1tm1Jyd/Nme1tm1Jyd
(involves: 129/Sv * C57BL/6) 		impaired liver regeneration J:109190
Nme2tm1.1(KOMP)Vlcg/Nme2tm1.1(KOMP)Vlcg
(C57BL/6N-Nme2tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Nmf15/Nmf15+
(C57BL/6J-Nmf15/J) 		hepatic steatosis J:82238
nmf356/nmf356
(C57BL/6J-nmf356/J) 		liver degeneration J:87349
Nmutm1Mko/Nmutm1Mko
(involves: 129 * C57BL/6) 		hepatic steatosis J:93213
Nocttm1Bjc/Nocttm1Bjc
(B6.129S2-Nocttm1Bjc) 		decreased susceptibility to hepatic steatosis J:122301
Nodaltm1Hmd/Nodal+
Tg(Rr443-Lefty1,-lacZ)36Hmd/0
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) or (involves: 129S1/Sv * 129T2/SvEms * 129X1/SvJ)) 		abnormal liver morphology J:82703
Nodaltm1Hmd/Nodaltm1Hmd
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) or (involves: 129S1/Sv * 129T2/SvEms * 129X1/SvJ)) 		abnormal liver morphology J:82703
Nodaltm1Mku/Nodaltm1.1Mku
(either: (involves: 129S1/Sv * FVB/N) or (involves: 129S1/Sv * C57BL/6J * FVB/N)) 		pale liver J:73506
small liver J:73506
NonoGt(YHA266)Byg/Y
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver physiology J:193286
NonoGt(YHA266)Byg/Y
(involves: 129P2/OlaHsd) 		decreased liver weight J:294120
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:133437
abnormal liver morphology J:133437, J:104558
Nos1tm1Plh/Nos1tm1Plh
Nos2tm1Mrl/Nos2tm1Mrl
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		liver vascular congestion J:100308
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6) 		liver fibrosis J:94156
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:133437
abnormal liver morphology J:133437
abnormal liver physiology J:133437
hepatic steatosis J:133437
Nos3tm2.1Plh/Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6) 		increased liver weight J:198075
Notch1tm2Rko/Notch1tm3(cre)Rko
(involves: 129X1/SvJ * C57BL/6) 		abnormal hepatic cord morphology J:171829
abnormal liver lobule morphology J:171829
abnormal liver morphology J:171829
abnormal liver parenchyma morphology J:171829
chronic liver inflammation J:171829
dilated liver sinusoidal space J:171829
pale liver J:171829
Notch2tm1Grid/Notch2tm1Grid
(involves: 129S1/Sv * C57BL/6J) 		abnormal bile duct development J:74574
Notch2tm2Grid/Notch2tm3Grid
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		abnormal bile duct morphology J:133171
focal hepatic necrosis J:133171
Notch2tm3.1Grid/Notch2+
Poglut1Gt(IST10323G11)Tigm/Poglut1+
(B6.Cg-Notch2tm3.1Grid Poglut1Gt(IST10323G11)Tigm) 		liver/biliary system phenotype J:171432
Notch2tm3Grid/Notch2tm3.1Grid
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		abnormal bile duct morphology J:133171
focal hepatic necrosis J:133171
Notch3tm1.1(KOMP)Vlcg/Notch3tm1.1(KOMP)Vlcg
(C57BL/6N-Notch3tm1.1(KOMP)Vlcg/Ucd) 		decreased liver weight J:211773
Npbwr1tm1Rck/Npbwr1tm1Rck
(involves: 129P/Ola * C57BL/6J) 		enlarged liver J:94820
hepatic steatosis J:94820
Npc1m1N/Npc1m1N
(involves: BALB/c) 		enlarged liver J:91430
hepatic steatosis J:100351
increased liver cholesterol level J:130969
increased liver weight J:76733
pale liver J:91430
Npc1m1N/Npc1m1N
(involves: 129S1/Sv * BALB/c * C57BL/6) 		increased liver cholesterol level J:89617
Npc1m1N/Npc1m1N
(BALB/cNctr-Npc1m1N/J) 		decreased liver cholesterol level J:179744
enlarged liver J:179744
increased liver cholesterol level J:179744
Npc1m1N/Npc1m1N
(B6.C-Npc1m1N) 		increased liver cholesterol level J:221855
Npc1m1N/Npc1m1N
(BALB/c-Npc1m1N) 		abnormal hepatocyte morphology J:221855
increased liver cholesterol level J:221855
Npc1m1N/Npc1m1N
Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * BALB/c * C57BL/6) 		increased liver cholesterol level J:89617
Npc1nmf164/Npc1nmf164
(C57BL/6J-Npc1nmf164/J) 		decreased liver cholesterol level J:179744
enlarged liver J:179744
increased liver cholesterol level J:179744
Npc1spm/Npc1spm
(C57BLKS/J-Npc1spm/J) 		enlarged liver J:7245
increased liver cholesterol level J:102782, J:7245
Npc1tm1.1Dso/Npc1tm1.1Dso
(B6.129-Npc1tm1.1Dso) 		abnormal hepatocyte morphology J:221855
increased liver cholesterol level J:221855
Npc1tm1Mbjg/Npc1tm1Mbjg
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver cholesterol level J:176587
Npc1tm1Tacf/Npc1tm1Tacf
(B6(Cg)-Npc1tm1Tacf) 		abnormal liver morphology J:266795
dilated liver sinusoidal space J:266795
increased liver cholesterol level J:266795
Npc1tm1Tacf/Npc1tm2Tacf
(B6(Cg)-Npc1tm1Tacf Npc1tm2Tacf) 		increased liver cholesterol level J:266795
Npc1l1tm1Swa/Npc1l1tm1Swa
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver cholesterol level J:89712
Npc1l1tm1Yaio/Npc1l1tm1Yaio
(C57BL/6-Npc1l1tm1Yaio) 		abnormal gallbladder physiology J:98568
decreased susceptibility to diet-induced hepatic steatosis J:98568
Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * BALB/c * C57BL/6) 		increased liver cholesterol level J:89617
Npm1tm1Gsva/Npm1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		enlarged liver J:172071
increased liver weight J:172071
Npm1tm1Ppp/Npm1tm1Ppp
(involves: 129S1/Sv * C57BL/6) 		absent liver J:101494
Nprl2tm1.2Bpt/Nprl2tm1.2Bpt
(involves: C57BL/6) 		pale liver J:224837
Nprl3tm1.1Drhi/Nprl3tm1.1Drhi
(involves: 129P2/OlaHsd) 		herniated liver J:183988
Npy5rtm1Rpa/Npy5rtm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		hepatic steatosis J:87803
Npy6rtm1Hhzg/Npy6rtm1Hhzg
(involves: 129S/SvEvBrd * C57BL/6) 		hepatic steatosis J:210546
increased liver weight J:210546
Npytm1(rtTA,tetO-cre/EGFP)Snby/Npy+
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased liver triglyceride level J:162000
Nr0b2tm1Ddm/Nr0b2tm1Ddm
(involves: 129 * C57BL/6) 		increased liver triglyceride level J:77065
Nr0b2tm1Rus/Nr0b2tm1Rus
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver physiology J:102129
Nr1d1tm1Schb/Nr1d1tm1Schb
(involves: 129S2/SvPas) 		decreased liver cholesterol level J:153064
decreased liver triglyceride level J:153064
Nr1h2tm1Djm/Nr1h2tm1Djm
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac) 		increased liver cholesterol level J:64343
Nr1h3tm1.1Djm/Nr1h3tm1.1Djm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA) 		increased liver cholesterol level J:184536
increased liver weight J:184536
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		enlarged liver J:82096
increased liver cholesterol level J:82096
pale liver J:82096
Nr1h3tm1Dgen/Nr1h3tm1Dgen
(Not Specified) 		abnormal hepatobiliary system physiology J:112995
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6) 		hepatic steatosis J:47971
increased liver cholesterol level J:243753, J:47971
increased liver weight J:47971
liver degeneration J:47971
pale liver J:47971
Nr1h3tm1Djm/Nr1h3tm1Djm
Nus1tm1.1Qrm/Nus1tm1.1Qrm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL) 		increased liver cholesterol level J:243753
Nr1h3tm1Wexi/Nr1h3tm1Wexi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		hepatic steatosis J:155709
Nr1h4tm1.1Mbj/Nr1h4tm1.1Mbj
(B6N.B6-Nr1h4tm1.1Mbj) 		abnormal liver perisinusoidal space morphology J:200842
abnormal liver physiology J:200842
abnormal liver sinusoid morphology J:200842
enlarged gallbladder J:200842
hepatic steatosis J:200842
increased liver triglyceride level J:200842
increased liver weight J:200842
jaundice J:200842
liver degeneration J:200842
liver inflammation J:200842
Nr1h4tm1.2Auw/Nr1h4tm1.2Auw
(involves: 129 * C57BL/6J) 		abnormal hepatocyte morphology J:157882
increased hepatocyte apoptosis J:157882
increased hepatocyte proliferation J:157882
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N) 		abnormal liver morphology J:64792
enlarged liver J:121075
hepatic steatosis J:64792
increased hepatocellular carcinoma incidence J:121075
increased hepatocyte apoptosis J:121075
increased hepatocyte proliferation J:121075
increased liver adenoma incidence J:121075
increased liver cholesterol level J:64792
increased liver triglyceride level J:64792
increased liver tumor incidence J:121075
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ) 		abnormal bile composition J:129978
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:118204
enlarged liver J:118204
focal hepatic necrosis J:118204
increased hepatocellular carcinoma incidence J:118204
increased hepatocyte apoptosis J:118204
increased liver adenoma incidence J:118204
increased liver tumor incidence J:118204
liver inflammation J:118204
Nr1h4tm1Kok/Nr1h4tm1Kok
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal bile composition J:86154
abnormal bile secretion J:86154
Nr1i2tm1(NR1I2)Arte/Nr1i2tm1(NR1I2)Arte
(involves: C57BL/6) 		liver/biliary system phenotype J:140975
Nr1i2tm1Sakl/Nr1i2tm1Sakl
(involves: 129S1/Sv * 129X1/SvJ) 		decreased hepatocyte proliferation J:157882
Nr1i2tm3Arte/Nr1i2tm3Arte
(involves: C57BL/6) 		liver/biliary system phenotype J:140975
Nr1i3tm1(NR1I3)Arte/Nr1i3tm1(NR1I3)Arte
(involves: C57BL/6) 		liver/biliary system phenotype J:140975
Nr1i3tm1.1Arte/Nr1i3tm1.1Arte
(involves: C57BL/6NTac) 		liver/biliary system phenotype J:140975
Nr2c2tm1Amj/Nr2c2tm1Amj
(B6.129-Nr2c2tm1Amj) 		decreased liver triglyceride level J:169333
decreased susceptibility to age-related hepatic steatosis J:169333
decreased susceptibility to diet-induced hepatic steatosis J:169333
Nr3c1Gt(ESKN92)Hgs/Nr3c1+
(B6.Cg-Nr3c1Gt(ESKN92)Hgs) 		increased liver triglyceride level J:141205
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver physiology J:27441
Nr4a1tm1Jmi/Nr4a1tm1Jmi
Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		enlarged liver J:121903
Nr5a2tm1Sakl/Nr5a2tm1Sakl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA) 		abnormal bile composition J:135822
Nrastm1.1Emfu/Nrastm1.1Emfu
(involves: 129S1/Sv * FVB/N) 		pale liver J:189834
Nrastm1Tyj/Nras+
Meox2tm1(cre)Sor/Meox2+
(B6.Cg-Nrastm1Tyj Meox2tm1(cre)Sor) 		hepatic necrosis J:305401
small liver J:305401
Nrbf2Gt(Ayu21-W143)Imeg/Nrbf2Gt(Ayu21-W143)Imeg
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		abnormal liver morphology J:220500
focal hepatic necrosis J:220500
increased hepatocyte apoptosis J:220500
Nrbp1tm1.1Dja/Nrbp1tm1.1Dja
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J) 		abnormal liver morphology J:184685
Nrbp1tm1.1Dja/Nrbp1tm1.2Dja
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		abnormal liver morphology J:184685
Nrsn2em1(IMPC)Kmpc/Nrsn2em1(IMPC)Kmpc
(C57BL/6NTac-Nrsn2em1(IMPC)Kmpc/Kmpc) 		abnormal liver morphology J:211773
Nsmce2Gt(AA0032)Wtsi/Nsmce2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver tumor incidence J:227197
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		abnormal liver physiology J:213427
Nt5c2em1(IMPC)Hmgu/Nt5c2em1(IMPC)Hmgu
(C57BL/6N-Nt5c2em1(IMPC)Hmgu/Ieg) 		abnormal liver morphology J:211773
Nthl1em1(IMPC)Mbp/Nthl1em1(IMPC)Mbp
(C57BL/6NCrl-Nthl1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Ntmt1tm1(NCOM)Mfgc/Ntmt1tm1(NCOM)Mfgc
(involves: C57BL/6J * C57BL/6NCrl) 		abnormal liver morphology J:239287
liver degeneration J:239287
Ntrk2tm1Mini/Ntrk2+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:210229
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		hepatic steatosis J:210229
increased liver weight J:210229
Nucb1em1(IMPC)Mbp/Nucb1em1(IMPC)Mbp
(C57BL/6NCrl-Nucb1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Nucks1tm1.2Vter/Nucks1tm1.2Vter
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NSlc * FVB/N * SJL) 		hepatic steatosis J:211777
Nudt1tm1Tts/Nudt1tm1Tts
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased liver tumor incidence J:71836
Nup35m1Apb/Nup35m1Apb
(involves: C57BL/6N) 		liver/biliary system phenotype J:235141
Nup210em1(IMPC)Mbp/Nup210em1(IMPC)Mbp
(C57BL/6NCrl-Nup210em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Nus1tm1.1Qrm/Nus1tm1.1Qrm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL) 		decreased liver cholesterol level J:243753
increased liver free fatty acids level J:243753
increased liver triglyceride level J:243753
Nxntm1b(EUCOMM)Wtsi/Nxntm1b(EUCOMM)Wtsi
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
herniated liver J:239583
Nynrinem1(IMPC)Mbp/Nynrinem1(IMPC)Mbp
(C57BL/6N-Nynrinem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Obrq13A/J/Obrq13A/J
(C57BL/6J-Chr 17A/J/NaJ) 		decreased susceptibility to hepatic steatosis J:145148
Obrq14A/J/Obrq14A/J
(C57BL/6J-Chr 17A/J/NaJ) 		hepatic steatosis J:145148
Obrq16A/J/Obrq16A/J
(C57BL/6J-Chr 17A/J/NaJ) 		decreased liver triglyceride level J:145148
Oca2p-23DFiOD/Oca2p-x
(Not Specified) 		increased liver weight J:66645
Oca2p-30PUb/Oca2p-x
(Not Specified) 		hepatic steatosis J:89922
increased liver weight J:89922
Ociad1tm1.1Msin/Ociad1tm1.1Msin
(involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj) 		abnormal liver morphology J:279239
Odad3tm1b(EUCOMM)Hmgu/Odad3tm1b(EUCOMM)Hmgu
(C57BL/6N-Odad3tm1b(EUCOMM)Hmgu/Cnrm) 		abnormal liver morphology J:278798
Ogg1tm1Tno/Ogg1tm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		liver/biliary system phenotype J:84649
Ola1Gt(OST312288)Lex/Ola1Gt(OST312288)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		delayed hepatic development J:236306
Oma1tm1Otin/Oma1tm1Otin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr) 		hepatic steatosis J:184716
Onecut1tm1Flem/Onecut1tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		abnormal bile duct development J:75933
abnormal biliary tract morphology J:75933
abnormal hepatoblast differentiation J:100352
absent gallbladder J:75933
biliary cyst J:100352
jaundice J:75933
Onecut1tm1Flem/Onecut1tm1Flem
Onecut2tm1Flem/Onecut2tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		abnormal hepatic cord morphology J:100352
abnormal hepatoblast differentiation J:100352
Onecut2tm1Flem/Onecut2tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		abnormal bile duct development J:100352
abnormal liver morphology J:100352
Opa3m1Votr/Opa3m1Votr
(involves: C3H * C57BL/6JCrl) 		abnormal liver morphology J:181670
decreased liver glycogen level J:181670
increased liver triglyceride level J:188346
increased liver weight J:188346
macrovesicular hepatic steatosis J:188346
Oprl1em1(IMPC)Mbp/Oprl1em1(IMPC)Mbp
(C57BL/6N-Oprl1em1(IMPC)Mbp/MbpMmucd) 		small liver J:211773
Or1e1cem1(IMPC)Mbp/Or1e1cem1(IMPC)Mbp
(C57BL/6NCrl-Or1e1cem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Or4m1em1Tshu/Or4m1em1Tshu
(involves: C57BL/6J) 		decreased liver cholesterol level J:279017
decreased liver triglyceride level J:279017
Or9g4em1(IMPC)Mbp/Or9g4em1(IMPC)Mbp
(C57BL/6N-Or9g4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Or12d17em1Cya/Or12d17em1Cya
(C57BL/6N-Or12d17em1Cya) 		decreased liver weight J:321591
decreased susceptibility to diet-induced hepatic steatosis J:321591
Orc1tm1.1Gle/Orc1tm1.1Gle
Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6 * SJL) 		decreased hepatocyte number J:272584
increased hepatocyte karyomegaly J:272584
liver/biliary system phenotype J:272584
Orc1tm1.1Gle/Orc1tm1.1Gle
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		decreased hepatocyte number J:272584
increased hepatocyte karyomegaly J:272584
increased hepatocyte proliferation J:272584
liver/biliary system phenotype J:272584
Orc1tm1.1Gle/Orc1tm1.2Gle
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		decreased hepatocyte number J:272584
increased hepatocyte karyomegaly J:272584
Orgwq3M16i/?
(involves: CAST/Ei * M16i) 		increased liver weight J:78471
Orgwq4M16i/?
(involves: CAST/Ei * M16i) 		increased liver weight J:78471
Orgwq7M16i/?
(involves: CAST/Ei * M16i) 		increased liver weight J:78471
Orgwq8M16i/?
(involves: CAST/Ei * M16i) 		increased liver weight J:78471
Orm2em1Bcgen/Orm2+
(involves: C57BL/6J) 		increased liver triglyceride level J:333118
Orm2em1Bcgen/Orm2em1Bcgen
(involves: C57BL/6J) 		hepatic steatosis J:333118
increased liver triglyceride level J:333118
increased liver weight J:333118
liver fibrosis J:333118
liver inflammation J:333118
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan) 		decreased liver glycogen level J:214124
hepatic steatosis J:214124
increased liver cholesterol level J:214124
increased liver triglyceride level J:214124
increased liver weight J:214124
Otcspf-ash/Y
(Not Specified) 		enlarged liver J:26976
increased liver weight J:26976
Otcspf/Y
(Not Specified) 		abnormal liver morphology J:23017
Otcspf/Y
(involves: CD-1) 		abnormal liver morphology J:21306
P2ry13tm1Loma/P2ry13tm1Loma
(B6.129-P2ry13tm1Loma) 		abnormal bile secretion J:166205
abnormal hepatocyte physiology J:166205
decreased liver cholesterol level J:166205
Padi4em1(IMPC)Mbp/Padi4em1(IMPC)Mbp
(C57BL/6N-Padi4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
small liver J:211773
Pafah2tm1Arai/Pafah2tm1Arai
(B6.129P2-Pafah2tm1Arai) 		hepatic necrosis J:130728
Pank1em1(IMPC)Mbp/Pank1em1(IMPC)Mbp
(C57BL/6N-Pank1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pank1tm1.1Suja/Pank1tm1.1Suja
(involves: 129S/SvEv * C57BL/6J) 		abnormal liver physiology J:161798
decreased liver triglyceride level J:161798
hepatic steatosis J:161798
increased liver triglyceride level J:161798
Pank1tm1.1Suja/Pank1tm1.1Suja
Pank2tm1.1Suja/Pank2tm1.1Suja
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		decreased liver weight J:189609
hepatic steatosis J:189609
increased liver triglyceride level J:189609
small liver J:189609
Pank4em1(IMPC)Kmpc/Pank4em1(IMPC)Kmpc
(C57BL/6NTac-Pank4em1(IMPC)Kmpc/Kmpc) 		abnormal liver morphology J:211773
Pappa2tm1Lex/Pappa2tm1Lex
(C57BL/6-Pappa2tm1Lex) 		increased liver weight J:174887
Parltm1Bdes/Parltm1Bdes
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		liver degeneration J:269785
Pasktm1Weng/Pasktm1Weng
(B6.129S6-Pasktm1Weng) 		decreased susceptibility to diet-induced hepatic steatosis J:125307
Pax6em1(IMPC)Mbp/Pax6+
(C57BL/6N-Pax6em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pbrm1tm1Rtj/Pbrm1tm1Rtj
(Not Specified) 		small liver J:95332
Pbx1em1Dunw/Pbx1em1Dunw
(C57BL/6J-Pbx1em1Dunw) 		liver hypoplasia J:320934
Pbx1tm1Mlc/Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6) 		liver hypoplasia J:71996
Pbx1tm1Mlc/Pbx1tm2.1Mlc
(involves: 129S6/SvEvTac) 		abnormal liver development J:132963
Pccatm1Tmiy/Pccatm1Tmiy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver glycogen level J:71660
hepatic steatosis J:71660
Pck1tm1.1Lre/Pck1tm1.1Lre
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		decreased liver triglyceride level J:73977
Pck1tm1.1Mgn/Pck1tm1.1Mgn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac) 		decreased liver glycogen level J:63929
enlarged liver J:63929
increased liver triglyceride level J:63929
increased liver weight J:63929
pale liver J:63929
Pck1tm1.2Mgn/Pck1tm1.2Mgn
(involves: 129S6/SvEvTac) 		decreased liver glycogen level J:63929
pale liver J:63929
Pck1tm1Mgn/Pck1tm1.2Mgn
(involves: 129S6/SvEvTac) 		enlarged liver J:63929
pale liver J:63929
Pck1tm1Mgn/Pck1tm1Mgn
(involves: 129S6/SvEvTac) 		enlarged liver J:63929
Pck1tm1Rwh/Pck1tm1Rwh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:145210
decreased liver glycogen level J:145210
hepatic steatosis J:145210
Pcsk9tm1.2Prat/Pcsk9tm1.2Prat
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver regeneration J:169834
impaired liver regeneration J:169834
Pctptm1Bor/Pctptm1Bor
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal bile canaliculus morphology J:115285
abnormal bile composition J:115285
abnormal gallbladder physiology J:115285
gallstones J:115285
Pctptm1Bor/Pctptm1Bor
(involves: 129P2/OlaHsd * FVB/NJ) 		abnormal bile canaliculus morphology J:115285
abnormal bile secretion J:115285
abnormal gallbladder physiology J:115285
Pcxtm1c(EUCOMM)Wtsi/Pcxtm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA * SJL) 		abnormal liver physiology J:332296
hepatic steatosis J:332296
increased liver triglyceride level J:332296
Pcyt2tm1.1Suja/Pcyt2tm1.1Suja
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		hepatic steatosis J:155630
increased liver cholesterol level J:155630
increased liver triglyceride level J:155630
pale liver J:155630
Pdcd1tm1Hon/Pdcd1tm1Hon
(C.129S2(B6)-Pdcd1tm1Hon) 		enlarged liver J:66979
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas) 		hepatic necrosis J:222944
Pdcd1tm1Hon/Pdcd1tm1Hon
Vsirtm1Lex/Vsirtm1Lex
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6) 		hepatic necrosis J:222944
Pdcd7em1(IMPC)Mbp/Pdcd7+
(C57BL/6NCrl-Pdcd7em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pde5aem1(IMPC)Mbp/Pde5a+
(C57BL/6N-Pde5aem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pdgfbtm1Cbet/Pdgfbtm1Cbet
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:20017
Pdgfctm1b(EUCOMM)Hmgu/Pdgfc+
(C57BL/6N-Pdgfctm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
Pdik1lem1(IMPC)Mbp/Pdik1lem1(IMPC)Mbp
(C57BL/6NCrl-Pdik1lem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Pdk2em1(IMPC)Mbp/Pdk2em1(IMPC)Mbp
(C57BL/6N-Pdk2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Pdk4tm1Rhar/Pdk4tm1Rhar
(B6.129-Pdk4tm1Rhar) 		decreased liver glycogen level J:115895
Pdlim7em1(IMPC)Mbp/Pdlim7em1(IMPC)Mbp
(C57BL/6N-Pdlim7em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pdlim7Gt(OST445990)Lex/Pdlim7Gt(OST445990)Lex
(B6.129S5-Pdlim7Gt(OST445990)Lex) 		liver/biliary system phenotype J:209780
Pdss1em1(IMPC)Mbp/Pdss1+
(C57BL/6NCrl-Pdss1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Pdss2kd/Pdss2kd
(CBA/H-Pdss2kd) 		decreased hepatocyte mitochondrial DNA content J:197578
Pdx1tm1Cvw/Pdx1tm1Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		abnormal bile duct development J:32017
abnormal liver development J:32017
Pdx1tm1Macd/Pdx1+
Tg(tetO-Sox17,-EGFP)1Jaw/0
(involves: 129S1/Sv * 129X1/SvJ) 		liver/biliary system phenotype J:151981
Pdx1tm1Macd/Pdx1tm1Macd
(involves: 129S1/Sv * 129X1/SvJ) 		liver/biliary system phenotype J:151981
Pdx1tm1Ted/Pdx1tm1Ted
(involves: 129P2/OlaHsd) 		liver/biliary system phenotype J:20779
Pdx1tm2Cvw/Pdx1tm2Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		abnormal bile duct development J:32017
abnormal liver development J:32017
Pdzk1tm1Dls/Pdzk1tm1Dls
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal liver morphology J:107125
Pebp1em1(IMPC)Tcp/Pebp1em1(IMPC)Tcp
(C57BL/6NCrl-Pebp1em1(IMPC)Tcp/Tcp) 		abnormal gallbladder morphology J:211773
abnormal liver morphology J:211773
Pecam1tm1Mak/Pecam1tm1Mak
(B6.129P2-Pecam1tm1Mak) 		liver inflammation J:95226
liver vascular congestion J:95226
Pemttm1J/Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:83870
abnormal liver morphology J:83870, J:73735
abnormal liver physiology J:83870, J:81995
hepatic steatosis J:83870
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac) 		abnormal liver morphology J:278655
bile duct proliferation J:278655
cholestasis J:278655
decreased liver glycogen level J:278655
enlarged liver J:278655
hepatic necrosis J:278655
increased liver adenoma incidence J:278655
increased liver cholesterol level J:278655
increased liver triglyceride level J:278655
liver fibrosis J:278655
liver inflammation J:278655
Pex1tm1.1Sjms/Pex1tm1.1Sjms
(involves: 129 * C57BL/6N) 		bile duct proliferation J:210296
cholestasis J:210296
microvesicular hepatic steatosis J:210296
Pex2tm1Plf/Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster) 		abnormal bile composition J:87591
abnormal liver morphology J:83644
abnormal liver physiology J:87591
cholestasis J:83644
decreased liver cholesterol level J:87591
hepatic steatosis J:83644
Pex2tm1Plf/Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:44975
Pex5tm1Baes/Pex5tm1Baes
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver morphology J:42719
Pex5tm1Pec/Pex5tm1Pec
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal liver morphology J:112503
enlarged liver J:112503
increased liver tumor incidence J:112503
liver hyperplasia J:112503
liver/biliary system phenotype J:112503
Pex7tm1Nbra/Pex7tm1Nbra
(involves: 129S/SvEv * C57BL/6) 		enlarged liver J:158845
hepatic steatosis J:158845
liver degeneration J:158845
liver inflammation J:158845
Pex11atm1Itl/Pex11atm1Itl
(C57BL/6-Pex11atm1Itl) 		abnormal hepatocyte morphology J:195940
hepatic steatosis J:195940
increased liver triglyceride level J:195940
Pex11atm1Sjg/Pex11atm1Sjg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:80124
Pex11btm1Sjg/Pex11btm1Sjg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver glycogen level J:76782
delayed hepatic development J:76782
Pex13tm1.1Crne/Pex13tm1.1Crne
(involves: 129T2/SvEms * C57BL/6J) 		macrovesicular hepatic steatosis J:84795
Pfkmem1(IMPC)Mbp/Pfkm+
(C57BL/6N-Pfkmem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pgrmc1em1Ejho/Pgrmc1em1Ejho
(involves: C57BL/6N) 		hepatic steatosis J:268130
increased liver triglyceride level J:268130
liver fibrosis J:268130
liver inflammation J:268130
PhexMhdabap024/Y
(C3HeB/FeJ-PhexMhdabap024) 		liver/biliary system phenotype J:264682
PhipGt(RRJ571)Byg/PhipGt(RRJ571)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:164354
Phkbem1(IMPC)J/Phkb+
(C57BL/6NJ-Phkbem1(IMPC)J/Mmjax) 		abnormal liver morphology J:330539
decreased liver triglyceride level J:330539
enlarged liver J:330539
increased liver glycogen level J:330539
increased liver weight J:330539
Phkg1tm1.1(KOMP)Vlcg/Phkg1tm1.1(KOMP)Vlcg
(C57BL/6N-Phkg1tm1.1(KOMP)Vlcg/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Phyhtm1Safe/Phyhtm1Safe
(involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N) 		liver degeneration J:142512
liver inflammation J:142512
macrovesicular hepatic steatosis J:142512
microvesicular hepatic steatosis J:142512
Picalmtm1Towa/Picalmtm1Towa
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj) 		abnormal hepatocyte physiology J:185312
Pierce1Gt(OST3440)Lex/Pierce1Gt(OST3440)Lex
(either: (involves: 129S5/SvEvBrd * C57BL/6J) or (involves: 129S5/SvEvBrd * C57BL/6J * FVB/N)) 		abnormal liver lobule morphology J:252050
Pignem1(IMPC)Mbp/Pign+
(C57BL/6N-Pignem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pik3c2gtm1Ehi/Pik3c2gtm1Ehi
(involves: 129 * C57BL/6) 		decreased liver glycogen level J:223018
decreased liver weight J:223018
hepatic steatosis J:223018
liver/biliary system phenotype J:223018
Pik3c3tm1c(EUCOMM)Wtsi/Pik3c3tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		abnormal liver morphology J:182628
decreased liver glycogen level J:182628
enlarged liver J:182628
hepatic steatosis J:182628
pale liver J:182628
Pik3c3tm1c(EUCOMM)Wtsi/Pik3c3tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: C57BL/6 * C57BL/6N * C57BL/6NCrj * DBA) 		abnormal liver physiology J:182628
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(B6.129P2-Pik3cbtm1.1Ehi) 		decreased liver glycogen level J:152332
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6) 		hepatic necrosis J:65523
Pik3r1tm2Dfr/Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6)) 		hepatic necrosis J:94077
Pilratm1Osb/Pilratm1Osb
(B6.129-Pilratm1Osb) 		abnormal hepatic cord morphology J:191085
abnormal hepatocyte physiology J:191085
liver hemorrhage J:191085
Pinx1tm1.1Kplu/Pinx1+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased liver tumor incidence J:171997
Pinx1tm1.1Kplu/Pinx1+
Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased hepatocellular carcinoma incidence J:171997
increased liver tumor incidence J:171997
Pinx1tm1.1Kplu/Pinx1+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased hepatocellular carcinoma incidence J:171997
increased liver tumor incidence J:171997
Pip4k2ctm1b(KOMP)Wtsi/Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		chronic liver inflammation J:234283
pale liver J:234283
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd) 		abnormal hepatocyte morphology J:85204
microvesicular hepatic steatosis J:85204
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd) 		abnormal hepatocyte morphology J:85204
microvesicular hepatic steatosis J:85204
Pitx2tm1Rsd/Pitx2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver morphology J:57673
Pitx3eyl/Pitx3eyl
(involves: C3H/He * C57BL/6) 		hepatic steatosis J:156878
Pja1em1(IMPC)Mbp/Y
(C57BL/6NCrl-Pja1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Pkd1tm1.1Djmp/Pkd1tm1.2Djmp
Tg(Cdh16-cre/ERT2)F427Djmp/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N) 		liver cyst J:130079
Pkd1tm1.1Fqi/Pkd1tm1.1Fqi
(B6.129S6-Pkd1tm1.1Fqi) 		abnormal common bile duct morphology J:127628
Pkd1tm1Bdgz/Pkd1+
(involves: 129S1/Sv * 129X1/SvJ) 		liver cyst J:130086
Pkd1tm1Djmp/Pkd1tm1Djmp
(involves: 129P2/OlaHsd * C57BL/6) 		biliary cyst J:94582
dilated bile duct J:94582
Pkd1tm1Ggg/Pkd1+
Pkhd1tm1.1Ggg/Pkhd1tm1.1Ggg
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:125113
liver cyst J:125113
Pkd1tm1Hung/Pkd1tm1Hung
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB)) 		liver/biliary system phenotype J:104361
Pkd1tm1Jzh/Pkd1+
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)) 		abnormal bile duct morphology J:52573
bile duct inflammation J:52573
decreased liver function J:52573
dissociated hepatocytes J:52573
liver cyst J:52573
Pkd1tm1Jzh/Pkd1tm1Jzh
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)) 		liver/biliary system phenotype J:43193
Pkd1tm1Rsa/Pkd1+
(involves: 129S4/SvJaeSor) 		liver cyst J:72238
Pkd1tm1Som/Pkd1+
Pkd2tm2Som/Pkd2+
(involves: 129/Sv * C57BL/6 * SJL) 		liver cyst J:78422
Pkd1tm2Ggg/Pkd1tm2Ggg
Tg(MMTV-cre)4Mam/0
(involves: 129S4/SvJae * FVB) 		liver cyst J:103719
Pkd1tm2Jzh/Pkd1+
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		liver cyst J:72627
Pkd2tm1.1Gwu/Pkd2tm1.1Gwu
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL) 		liver cyst J:265516
Pkd2tm1Dwo/Pkd2tm1Dwo
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal liver development J:77401
Pkd2tm1Gwu/Pkd2tm1Gwu
(involves: C57BL/6) 		abnormal liver morphology J:143124
dilated bile duct J:143124
liver cyst J:143124
Pkd2tm1Som/Pkd2tm1Som
(involves: 129/Sv * C57BL/6J * SJL) 		liver cyst J:47035
Pkd2tm1Som/Pkd2tm2Som
(involves: 129/Sv * C57BL/6J * SJL) 		abnormal cholangiocyte morphology J:158354
abnormal cholangiocyte primary cilium morphology J:158354
bile duct proliferation J:47035, J:158354
enlarged liver J:158354
increased cholangiocyte apoptosis J:158354
increased liver weight J:158354
liver cyst J:47035, J:158354
liver fibrosis J:158354
Pkd2tm2Som/Pkd2+
(involves: 129/Sv * C57BL/6J * SJL) 		liver cyst J:47035, J:59314
Pkd2tm2Som/Pkd2+
(involves: 129/Sv * C57BL/6 * SJL) 		liver cyst J:78422
Pkdccem1(IMPC)Mbp/Pkdcc+
(C57BL/6N-Pkdccem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pkhd1cyli/Pkhd1cyli
(D2.Cg-(D4Mit42-D4Smh6b) Pkhd1cyli/EiJ) 		abnormal bile duct development J:343537
abnormal bile duct epithelium morphology J:343537
abnormal biliary tract morphology J:343537
bile duct epithelium hyperplasia J:343537
biliary cyst J:343537
dilated bile duct J:343537
enlarged liver J:343537
liver cyst J:343537
Pkhd1em1Mrug/Pkhd1+
(involves: C57BL/6J) 		bile duct proliferation J:281464
biliary cyst J:281464
dilated bile duct J:281464
liver cyst J:281464
Pkhd1em1Mrug/Pkhd1em1Mrug
(involves: C57BL/6J) 		dilated bile duct J:281464
liver fibrosis J:281464
Pkhd1tm1.1Ggg/Pkhd1tm1.1Ggg
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		abnormal bile duct development J:125113
bile duct hyperplasia J:125113
bile duct inflammation J:125113
biliary cyst J:125113
liver cyst J:125113
liver fibrosis J:125113
Pkhd1tm1Cjwa/Pkhd1tm1Cjwa
(involves: 129S6/SvEvTac * FVB/N) 		abnormal cholangiocyte primary cilium morphology J:140302
abnormal liver morphology J:140302
bile duct proliferation J:140302
dilated bile duct J:140302
enlarged liver J:140302
liver cyst J:140302
liver fibrosis J:140302
Pkhd1tm1Gwu/Pkhd1tm1Gwu
(Not Specified) 		abnormal liver morphology J:143124
hepatic necrosis J:143394
liver cyst J:143394
liver fibrosis J:143394
Pkhd1tm1Rbu/Pkhd1tm1Rbu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal bile duct development J:112509
abnormal bile duct morphology J:112509
abnormal liver development J:112509
liver cyst J:112509
liver fibrosis J:112509
Pkhd1tm1Som/Pkhd1tm1Som
(involves: 129S/SvEv * C57BL/6) 		abnormal hepatobiliary system morphology J:131370
bile duct proliferation J:131370
biliary cyst J:131370
liver cyst J:131370
liver fibrosis J:131370
Pkhd1tm1Sswi/Pkhd1tm1Sswi
(B6.Cg-Pkhd1tm1Sswi) 		abnormal extrahepatic bile duct morphology J:186064
abnormal gallbladder morphology J:186064
abnormal hepatic duct morphology J:186064
abnormal intrahepatic bile duct morphology J:186064
dilated bile duct J:186064
liver fibrosis J:186064
Pkhd1tm2Cjwa/Pkhd1tm2Cjwa
(either: B6.129(Cg)-Pkhd1tm2Cjwa or C.129(Cg)-Pkhd1tm2Cjwa) 		increased liver weight J:187735
liver cyst J:187735
liver fibrosis J:187735
Pklrem1Appsc/Pklrem1Appsc
(involves: C57BL/6J) 		decreased susceptibility to diet-induced hepatic steatosis J:342736
Pkmyt1em1(IMPC)J/Pkmyt1em1(IMPC)J
(C57BL/6NJ-Pkmyt1em1(IMPC)J/Mmjax) 		pale liver J:211773
Pknox1Gt(OST71835)Lex/Pknox1Gt(OST71835)Lex
(B6.129S5-Pknox1Gt(OST71835)Lex) 		abnormal liver development J:111418
Pla1aem1Appsc/Pla1aem1Appsc
(C57BL/6J-Pla1aem1Appsc) 		enlarged liver J:333902
Pla2g1btm1Dyh/Pla2g1btm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6) 		decreased liver weight J:80216
Pla2g12bhlb218/Pla2g12bhlb218
(C57BL/6J-Pla2g12bhlb218/J) 		hepatic steatosis J:187708
Pla2g15tm1.1Jash/Pla2g15tm1.1Jash
(involves: 129S1/Sv * C57BL/6) 		hepatic steatosis J:111561
Plaat3tm1.1Hsul/Plaat3tm1.1Hsul
(B6.129P2-Pla2g16tm1.1Hsul) 		decreased liver triglyceride level J:239202
enlarged liver J:239202
hepatic steatosis J:239202
pale liver J:239202
Plautm1.1Bug/Plautm1.1Bug
(involves: C57BL/6) 		liver fibrosis J:164542
liver inflammation J:164542
Plautm1Mlg/Plautm1Mlg
(B6.129S2-Plautm1Mlg) 		decreased liver glycogen level J:164542
liver fibrosis J:164542
liver inflammation J:164542
Plaurtm1Jld/Plaurtm1Jld
(B6.129P2-Plaurtm1Jld) 		liver fibrosis J:164542
liver inflammation J:164542
Plbcq1M16i/?
(involves: FVB/NJ * M16i) 		increased liver weight J:132804
Plbcq6M16i/?
(involves: FVB/NJ * M16i) 		decreased liver weight J:132804
Plbcq7M16i/?
(involves: FVB/NJ * M16i) 		increased liver weight J:132804
Plcb1em1(IMPC)Mbp/Plcb1+
(C57BL/6N-Plcb1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Plcb4tm1b(EUCOMM)Wtsi/Plcb4tm1b(EUCOMM)Wtsi
(C57BL/6N-Plcb4tm1b(EUCOMM)Wtsi/Tcp) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Pld3em1Nemz/Pld3em1Nemz
Pld4tm1.2Nemz/Pld4tm1.2Nemz
(B6.Cg-Pld3em1Nemz Pld4tm1.1Nemz) 		hepatic steatosis J:281205
liver inflammation J:281205
Plekhn1tm1.1Hkon/Plekhn1tm1.1Hkon
(B6.Cg-Plekhn1tm1.1Hkon) 		increased liver weight J:251603
Plgtm1.1Fjc/Plgtm1.1Fjc
(involves: C57BL/6 * C57BL/6JJcl) 		liver fibrosis J:210802
Plgtm1Dco/Plgtm1Dco
(involves: 129S2/SvPas * C57BL/6J) 		liver fibrosis J:30174
Plgtm1Dco/Plgtm1Dco
(involves: 129S2/SvPas) 		liver fibrosis J:210802, J:120780
Plgtm1Dco/Plgtm1Dco
Tg(Alb-PLG)1Dgi/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL) 		liver/biliary system phenotype J:120780
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * NIH Black Swiss) 		abnormal liver morphology J:39419
hepatic necrosis J:39419
Plgtm1Jld/Plgtm1Jld
(B6.129P2-Plgtm1Jld) 		increased hepatocyte proliferation J:120368
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss) 		abnormal liver morphology J:36591
Plin1tm1Cdl/Plin1tm1Cdl
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:69629
Plin2tm1.1Asg/Plin2tm1.1Asg
(B6.129S2(Cg)-Plin2tm1.1Asg) 		decreased liver triglyceride level J:196302
decreased susceptibility to diet-induced hepatic steatosis J:196302
Plin2tm1Chan/Plin2tm1Chan
(B6.129-Plin2tm1Chan) 		decreased liver triglyceride level J:105572
decreased susceptibility to diet-induced hepatic steatosis J:105572
decreased susceptibility to hepatic steatosis J:105572
Plin4tm1.1(KOMP)Wtsi/Plin4tm1.1(KOMP)Wtsi
(C57BL/6N-Plin4tm1.1(KOMP)Wtsi/Ucd) 		abnormal liver morphology J:211773
Plin5tm1Tosu/Plin5tm1Tosu
(involves: C57BL/6JJcl) 		decreased liver free fatty acids level J:188390
decreased liver triglyceride level J:188390
increased liver free fatty acids level J:188390
increased liver triglyceride level J:188390
Plk3tm1Dai/Plk3tm1Dai
(involves: 129S4/SvJae * C57BL/6) 		increased liver tumor incidence J:136425
Plxna4em1(IMPC)Mbp/Plxna4em1(IMPC)Mbp
(C57BL/6NCrl-Plxna4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pmltm1Ppp/Pml+
Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		hepatosplenomegaly J:317504
Pmltm1Ppp/Pmltm1Ppp
Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		hepatosplenomegaly J:317504
Pmm2tm1.1Jins/Pmm2tm2.1Jins
(involves: 129S6/SvEvTac * C57BL/6J) 		Mallory bodies J:236704
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr) 		increased liver adenoma incidence J:162378
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver weight J:124658
Pnpla2tm1Gam/Pnpla2tm1Gam
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA) 		abnormal cholangiocyte morphology J:185116
abnormal hepatocyte morphology J:185116
increased liver triglyceride level J:185116
increased liver weight J:185116
macrovesicular hepatic steatosis J:185116
microvesicular hepatic steatosis J:185116
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:108546
increased liver triglyceride level J:108546
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd) 		increased liver triglyceride level J:176252, J:160725
Pnpla3tm1.1Hobb/Pnpla3tm1.1Hobb
(involves: 129 * C57BL/6J) 		hepatic steatosis J:264475
increased liver triglyceride level J:264475
Pnpla3tm2.1Hobb/Pnpla3+
(involves: 129 * C57BL/6J) 		increased liver triglyceride level J:264475
Pnpla3tm2.1Hobb/Pnpla3tm2.1Hobb
(involves: 129 * C57BL/6J) 		hepatic steatosis J:264475
increased liver triglyceride level J:264475
Pnpla7tm1.2Murm/Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm) 		decreased liver triglyceride level J:333442
increased liver glycogen level J:333442
Pnpla8tm1Rigr/Pnpla8tm1Rigr
(involves: 129X1/SvJ) 		decreased liver triglyceride level J:333442
Pnrc2tm1Shch/Pnrc2tm1Shch
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:130294
Pof1bem1(IMPC)Mbp/Pof1bem1(IMPC)Mbp
(C57BL/6N-Pof1bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Pogztm1.2Jrk/Pogztm1.2Jrk
(involves: 129S1/Sv * C57BL/6J) 		liver hypoplasia J:271614
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6) 		increased hepatocyte apoptosis J:183837
Pold4em1Zzho/Pold4em1Zzho
(C57BL/6-Pold4em1Zzho) 		decreased liver tumor incidence J:331883
Pole2em1(IMPC)Mbp/Pole2+
(C57BL/6NCrl-Pole2em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Polr1bem1(IMPC)Tcp/Polr1b+
(C57BL/6NCrl-Polr1bem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Polr2mtm1.1Rgr/Polr2mtm1.1Rgr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal hepatocyte physiology J:291184
increased hepatocyte karyomegaly J:291184
liver/biliary system phenotype J:291184
Polr2mtm1.1Rgr/Polr2mtm1.1Rgr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:291184
abnormal liver morphology J:291184
increased hepatocyte apoptosis J:291184
increased hepatocyte proliferation J:291184
Pomctm2Low/Pomctm2Low
(B6.129S4-Pomctm2Low) 		hepatic steatosis J:194013
increased liver weight J:194013
Pomctm2Low/Pomctm2Low
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		hepatic steatosis J:194013
increased liver weight J:194013
Pon3tm1Dmsh/Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh) 		abnormal bile composition J:234615
decreased liver triglyceride level J:234615
gallstones J:234615
increased hepatocyte apoptosis J:234615
increased liver cholesterol level J:234615
jaundice J:234615
liver inflammation J:234615
Portm1Ding/Portm1Ding
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		abnormal liver morphology J:84422
hepatic necrosis J:84422
hepatic steatosis J:84422
increased liver weight J:84422
pale liver J:84422
Portm1Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		enlarged liver J:82951
macrovesicular hepatic steatosis J:82951
microvesicular hepatic steatosis J:82951
pale liver J:82951
Portm2Ding/Portm2Ding
(involves: 129S1/Sv * C57BL/6) 		hepatic steatosis J:119630
Portm2Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		enlarged liver J:82951
macrovesicular hepatic steatosis J:82951
microvesicular hepatic steatosis J:82951
pale liver J:82951
Pou2af2em1Crva/Pou2af2em1Crva
(C57BL/6-Pou2af2em1Crva) 		abnormal gallbladder epithelium morphology J:325394
Pou2f1tm1Shrp/Pou2f1tm1Shrp
(involves: 129S4/SvJae * C57BL/6) 		small liver J:87664
Pou3f2tm1Tno/Pou3f2tm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		hepatic steatosis J:30429
Pou5f1tm1Scho/Pou5f1tm1Scho
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		liver/biliary system phenotype J:130248
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6N) 		abnormal hepatocyte morphology J:25516
decreased liver glycogen level J:50024
enlarged liver J:25516
hepatic steatosis J:50024, J:25516
Pparatm1Gonz/Pparatm1Gonz
(129S4/SvJae-Pparatm1Gonz) 		enlarged liver J:56056
hepatic steatosis J:72185, J:56056
Pparatm1Gonz/Pparatm1Gonz
(B6.129S4-Pparatm1Gonz) 		hepatic steatosis J:72185
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N) 		decreased liver cholesterol level J:89827
decreased liver triglyceride level J:89827
Ppargtm1Auw/Ppargtm1Auw
(either: 129 or C57BL/6J or (involves: 129 * C57BL/6J)) 		enlarged liver J:86705
increased liver triglyceride level J:86705
macrovesicular hepatic steatosis J:86705
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6) 		hepatic steatosis J:116568
increased liver weight J:116568
Ppargtm1Lja/Pparg+
(involves: 129S1/Sv * 129X1/SvJ) 		increased liver triglyceride level J:98786
macrovesicular hepatic steatosis J:98786
microvesicular hepatic steatosis J:98786
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA) 		decreased susceptibility to diet-induced hepatic steatosis J:58222
Ppargtm1Yec/Ppargtm1Yec
(involves: 129S4/SvJae * C57BL/6) 		liver/biliary system phenotype J:91479
Ppargtm2(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		abnormal hepatocyte morphology J:125992
enlarged liver J:125992
Ppargtm2Rev/Ppargtm2Rev
Tg(Fabp4-cre)1Rev/0
(involves: 129S4/SvJae * C57BL/6) 		enlarged liver J:88210
hepatic steatosis J:88210
Ppargtm2Rev/Ppargtm2Rev
Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL) 		pale liver J:123403
Ppargtm3(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		enlarged liver J:125992
Ppargc1atm1.1Javi/Ppargc1atm1.1Javi
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Ppargc1atm1.1Javi Tg(Fabp4-cre)1Rev) 		decreased liver weight J:180984
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N) 		decreased liver triglyceride level J:93896
Ppargc1atm1Dpk/Ppargc1atm1Dpk
(involves: 129X1/SvJ * C57BL/6) 		abnormal liver physiology J:96306
hepatic steatosis J:96306
Ppargc1btm1.1Avp/Ppargc1btm1.1Avp
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		hepatic steatosis J:116167
increased liver weight J:116167
Ppargc1btm1.1Rev/Ppargc1btm1.1Rev
(involves: 129 * C57BL/6J) 		increased liver triglyceride level J:120079
increased liver weight J:120079
macrovesicular hepatic steatosis J:120079
Ppargc1btm1Lowl/Ppargc1btm1Lowl
(involves: C57BL/6) 		increased liver triglyceride level J:129775
Ppdpftm1Nju/Ppdpftm1Nju
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		hepatic steatosis J:307283
increased liver triglyceride level J:307283
increased liver weight J:307283
increased susceptibility to diet-induced hepatic steatosis J:307283
Ppiatm1Lubn/Ppiatm1Lubn
(129S6.129P2-Ppiatm1Lubn) 		liver inflammation J:93591
Ppme1em1(IMPC)Rbrc/Ppme1+
(C57BL/6NJcl-Ppme1em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Ppp1r3ctm1Ars/Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars) 		decreased liver glycogen level J:83297
Ppp1r3gtm1Nju/Ppp1r3gtm1Nju
(B6.129-Ppp1r3gtm1Nju) 		decreased liver glycogen level J:249135
decreased susceptibility to diet-induced hepatic steatosis J:249135
Ppp1r8tm1.1Itl/Ppp1r8tm1Ave
Tg(Alb1-cre)7Gsc/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NTac * FVB/N) 		abnormal bile duct morphology J:238108
abnormal oval cell morphology J:238108
abnormal oval cell physiology J:238108
bile duct epithelium hyperplasia J:238108
bile duct hyperplasia J:238108
bile duct proliferation J:238108
dilated bile duct J:238108
liver inflammation J:238108
liver/biliary system phenotype J:238108
Ppp1r15btm1Dron/Ppp1r15btm1Dron
(involves: 129P2/OlaHsd) 		abnormal liver morphology J:144954
Ppp2catm1.1Nju/Ppp2catm1.1Nju
Tg(Tek-cre)12Flv/0
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal liver morphology J:171578
pale liver J:171578
Ppp2r5aGt(IST13127C10)Tigm/Ppp2r5aGt(IST13127C10)Tigm
(C57BL/6N-Ppp2r5aGt(IST13127C10)Tigm) 		enlarged liver J:254808
Ppp4r3btm1b(EUCOMM)Hmgu/Ppp4r3btm1b(EUCOMM)Hmgu
(C57BL/6N-Ppp4r3btm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
Ppt1tm1Aj/Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:95522
Ppt2tm1Hof/Ppt2tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal liver morphology J:86202
enlarged liver J:86202
Pptc7em1Pagd/Pptc7em1Pagd
(C57BL/6J-Pptc7em1Pagd) 		abnormal hepatocyte mitochondrial morphology J:277086
abnormal liver morphology J:277086
Pptc7em2Pagd/Pptc7em2Pagd
(C57BL/6J-Pptc7em2Pagd) 		abnormal hepatocyte mitochondrial morphology J:277086
abnormal liver morphology J:277086
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Tg(Adipoq-cre)1Evdr/0
(involves: 129/Sv * C57BL/6 * FVB/N) 		hepatic steatosis J:208683
increased liver triglyceride level J:208683
Prdx1tm1Rave/Prdx1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:84677
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6) 		increased hepatocellular carcinoma incidence J:84677
Prdx5tm1Dsle/Prdx5tm1Dsle
(involves: C57BL/6) 		increased liver triglyceride level J:294801
increased liver weight J:294801
increased susceptibility to diet-induced hepatic steatosis J:294801
Prdx6tm1Pgn/Prdx6tm1Pgn
(either: 129/Sv or (involves: 129/Sv * C57BL/6)) 		liver hemorrhage J:84376
PrepGt(RRM213)Byg/Prep+
(B6.129P2-PrepGt(RRM213)Byg) 		increased liver weight J:151643
Prex1tm1Hcew/Prex1tm1Hcew
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:102214
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J) 		liver inflammation J:92260
Prkab1tm1Eihl/Prkab1tm1Eihl
(involves: C57BL/6) 		abnormal hepatocyte physiology J:158295
decreased liver triglyceride level J:158295
decreased susceptibility to diet-induced hepatic steatosis J:158295
Prkab2tm1.1Grst/Prkab2tm1.1Grst
(involves: C57BL/6) 		decreased liver glycogen level J:167339
Prkacatm3Gsm/Prkacatm3Gsm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J) 		decreased liver glycogen level J:103418
Prkag1tm1.2Mfor/Prkag1tm1.2Mfor
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * FVB/N) 		abnormal Kupffer cell morphology J:167779
increased liver iron level J:167779
Prkag2tm1.1Geno/Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno) 		hepatic steatosis J:235379
Prkar1atm1Gsm/Prkar1a+
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:93393
Prkar2btm1Gsm/Prkar2btm1Gsm
(Not Specified) 		decreased susceptibility to diet-induced hepatic steatosis J:34751
Prkar2btm1Gsm/Prkar2btm1Gsm
(B6.129-Prkar2btm1Gsm) 		decreased liver triglyceride level J:72414
decreased susceptibility to diet-induced hepatic steatosis J:72414
Prkar2btm3Gsm/Prkar2btm3Gsm
(B6.Cg-Prkar2btm3Gsm) 		decreased liver triglyceride level J:196157
decreased susceptibility to hepatic steatosis J:196157
Prkcdtm1Qxu/Prkcdtm1Qxu
(B6.129P2-Prkcdtm1Qxu) 		decreased liver triglyceride level J:173902
Prkcitm1Rfar/Prkci+
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		hepatic steatosis J:123964
Prkcitm1Rfar/Prkcitm1Rfar
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		hepatic steatosis J:123964
Prkcshtm1Som/Prkcshtm1Som
Sec63tm1.1Som/Sec63tm1.1Som
Tg(Cdh16-cre)91Igr/0
(involves: 129 * C57BL/6 * ICR) 		liver cyst J:188763
Prkcshtm1Som/Prkcshtm1Som
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver cyst J:188763
Prkdchanky/Prkdchanky
(either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ)) 		liver inflammation J:104190
Prkdcscid/Prkdcscid
Gnrh1hpg/Gnrh1hpg
(STOCK Prkdcscid Gnrh1hpg/Bm) 		decreased liver weight J:138840
Prltm1Hmn/Prltm1Hmn
(involves: 129S2/SvPas) 		decreased liver weight J:83246
Prlhtm1Taon/Prlhtm1Taon
(B6N.129X1-Prlhtm1Taon) 		hepatic steatosis J:144729
increased liver triglyceride level J:144729
Prmt7tm1a(EUCOMM)Wtsi/Prmt7tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Prmt7tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal gallbladder morphology J:239583
abnormal liver vasculature morphology J:239583
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		focal hepatic necrosis J:50527
liver degeneration J:50527
liver fibrosis J:50527
liver inflammation J:50527
Prodh2em1Jkni/Prodh2em1Jkni
(involves: C57BL/6J) 		liver/biliary system phenotype J:283585
Pros1tm1.1Ansc/Pros1tm1.1Ansc
(involves: 129/Sv * C57BL/6J * FVB/N) 		decreased hepatocyte number J:152423
hepatic necrosis J:152423
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		hepatic steatosis J:102652
increased liver triglyceride level J:102652
Prox1tm1Gco/Prox1tm1Gco
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		abnormal liver development J:63128
decreased hepatocyte proliferation J:63128
small liver J:63128
Prrc2btm1a(EUCOMM)Wtsi/Prrc2btm1a(EUCOMM)Wtsi
(C57BL/6N-Prrc2btm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd) 		abnormal hepatocyte morphology J:113052
decreased liver weight J:106511
Psaptm1Suz/Psaptm2.1Juma
(involves: 129 * 129P2/OlaHsd * C57BL/6J * FVB/N) 		liver/biliary system phenotype J:283977
Psaptm2.1Juma/Psaptm2.1Juma
(involves: 129 * C57BL/6J * FVB/N) 		liver/biliary system phenotype J:283977
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J) 		abnormal liver morphology J:198242
Psaptm4.1Ggb/Psaptm4.1Ggb
(involves: 129S/SvEv * C57BL/6J) 		abnormal liver morphology J:198242
Psmb9tm1Stl/Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:73945
Psmd4tm2Smta/Psmd4tm2Smta
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: C57BL/6 * CBA * DBA) 		abnormal liver physiology J:126546
Psme4b2b1508Clo/Psme4b2b1508Clo
(C57BL/6J-Psme4b2b1508Clo) 		abnormal liver morphology J:175213
Psmg1tm1.1Smta/Psmg1tm1.1Smta
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * CBA * DBA) 		abnormal hepatic cord morphology J:162790
abnormal hepatocyte morphology J:162790
abnormal hepatocyte physiology J:162790
abnormal liver sinusoid morphology J:162790
Psphtm1a(EUCOMM)Hmgu/Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi) 		abnormal bile duct morphology J:239583
herniated liver J:239583
Pstpip1em1(IMPC)Ccpcz/Pstpip1em1(IMPC)Ccpcz
(C57BL/6N-Pstpip1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
Pstpip2em1(IMPC)Tcp/Pstpip2em1(IMPC)Tcp
(C57BL/6NCrl-Pstpip2em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Ptcd1tm1(KOMP)Vlcg/Ptcd1+
(C57BL/6N-Ptcd1tm1(KOMP)Vlcg) 		abnormal hepatocyte mitochondrial morphology J:256004
hepatic steatosis J:256004
liver fibrosis J:256004
Ptcd2Gt(RRF537)Byg/Ptcd2Gt(RRF537)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:143946
Ptentm1Hwu/Ptentm1Hwu
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) 		abnormal bile duct morphology J:111718
enlarged liver J:111718
hepatic steatosis J:111718
increased cholangiocarcinoma incidence J:111718
increased liver weight J:111718
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal liver morphology J:218587
enlarged liver J:171445, J:88441
hepatic steatosis J:88441, J:218587, J:160759
increased cholangiocarcinoma incidence J:218587
increased hepatocellular carcinoma incidence J:218587
increased hepatocyte apoptosis J:218587
increased hepatocyte proliferation J:218587
increased liver glycogen level J:88441
increased liver triglyceride level J:88441, J:160759
increased liver tumor incidence J:218587
increased liver weight J:88441, J:160759
macrovesicular hepatic steatosis J:171445
pale liver J:88441
Ptentm1Hwu/Ptentm1Hwu
Tg(Alb1-cre)1Dlr/0
(involves: 129S4/SvJae * FVB/N) 		bile duct hyperplasia J:111718
increased cholangiocarcinoma incidence J:111718
increased hepatocellular carcinoma incidence J:111718
Ptentm1Hwu/Ptentm1Hwu
Tg(Cdh5-cre)7Mlia/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N) 		enlarged liver J:135172
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Ptentm1Hwu) 		abnormal liver size J:232645
increased liver weight J:232645
Ptentm1Rps/Pten+
(involves: 129S1/Sv * C57BL/6J) 		increased liver adenoma incidence J:53065
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:138099
abnormal hepatocyte physiology J:220381
abnormal liver morphology J:138099
enlarged liver J:138099
hepatic steatosis J:138099
increased hepatocellular carcinoma incidence J:138099
increased hepatocyte proliferation J:138099
increased liver adenoma incidence J:138099
increased liver cholesterol level J:138099
increased liver triglyceride level J:138099
liver fibrosis J:138099
liver inflammation J:138099
Mallory bodies J:138099
pale liver J:138099
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA) 		abnormal hepatocyte morphology J:90905
abnormal liver sinusoid morphology J:90905
enlarged liver J:90905
increased hepatocellular carcinoma incidence J:90905
increased hepatocyte number J:90905
increased hepatocyte proliferation J:90905
increased liver adenoma incidence J:90905
increased liver triglyceride level J:90905
increased liver weight J:90905
Mallory bodies J:90905
microvesicular hepatic steatosis J:90905
pale liver J:90905
Ptentm2Mak/Ptentm2Mak
Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		hepatic steatosis J:143082
increased hepatocellular carcinoma incidence J:143082
increased liver weight J:143082
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv) 		liver vascular congestion J:44108
macrovesicular hepatic steatosis J:44108
microvesicular hepatic steatosis J:44108
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver morphology J:67208
Pth1rtm1a(EUCOMM)Hmgu/Pth1rtm1a(EUCOMM)Hmgu
(C57BL/6N-Pth1rtm1a(EUCOMM)Hmgu/Wtsi) 		dilated bile duct J:239583
herniated liver J:239583
Pthlhtm1a(KOMP)Wtsi/Pthlhtm1a(KOMP)Wtsi
(C57BL/6N-Pthlhtm1a(KOMP)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
Ptk2tm1Heen/Ptk2tm1Heen
(involves: 129/Sv * C57BL/6) 		abnormal liver development J:157804
delayed hepatic development J:157804
liver hemorrhage J:157804
Ptntm1Tmu/Ptntm1Tmu
(B6.Cg-Ptntm1Tmu) 		decreased liver weight J:102069
Ptpn11tm1.1Ics/Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		decreased liver triglyceride level J:216593
Ptpn11tm1Bgn/Ptpn11+
(involves: 129S4/SvJae * C57BL/6J) 		hepatic necrosis J:91609
Ptpn11tm1Bgn/Ptpn11tm1Bgn
(involves: 129S4/SvJae * C57BL/6J) 		hepatic necrosis J:91609
small liver J:91609
Ptpn11tm1Ckq/Ptpn11+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		enlarged liver J:177285
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:172422
abnormal liver morphology J:172422
abnormal liver parenchyma morphology J:172422
focal hepatic necrosis J:172422
hepatic necrosis J:172422
increased hepatocyte proliferation J:172422
increased liver adenoma incidence J:172422
liver fibrosis J:172422
liver hyperplasia J:172422
liver inflammation J:172422
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Stat3tm1Vpo/Stat3tm1Vpo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		liver inflammation J:172422
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal liver morphology J:94738
enlarged liver J:94738
hepatic steatosis J:94738
increased liver glycogen level J:94738
increased liver triglyceride level J:94738
Ptpn11tm6Bgn/Ptpn11+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal liver sinusoid morphology J:148430
enlarged liver J:148430
Ptpn12tm1Mtr/Ptpn12tm1Mtr
(involves: 129S4/SvJae * BALB/c) 		abnormal liver development J:119668
Ptpn22tm2Achn/Ptpn22tm2Achn
Ptprctm1Weis/Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn) 		liver inflammation J:147129
Ptprctm1Mak/Ptprctm1Mak
Ptprjtm1.2Weis/Ptprjtm1.2Weis
(B6.Cg-Ptprctm1Mak Ptprjtm1.2Weis) 		liver inflammation J:131736
Ptprctm1Weis/Ptprctm1Weis
(B6.129X1-Ptprctm1Weis) 		liver inflammation J:147129
Pwwp2btm1.1Bcgen/Pwwp2btm1.1Bcgen
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		abnormal liver morphology J:319940
Pxmp2tm1Jkh/Pxmp2tm1Jkh
(B6.129X1-Pxmp2tm1Jkh) 		abnormal liver physiology J:148171
Pygltm1a(KOMP)Wtsi/Pygltm1a(KOMP)Wtsi
(C57BL/6N-Pygltm1a(KOMP)Wtsi) 		abnormal hepatocyte morphology J:284765
abnormal liver physiology J:284765
abnormal liver sinusoid morphology J:284765
abnormal liver vasculature morphology J:284765
enlarged liver J:284765
increased liver glycogen level J:330539, J:284765
increased liver weight J:284765
liver fibrosis J:284765
liver inflammation J:284765
Pzptm1Vln/Pzptm1Vln
(involves: 129P2/OlaHsd * C57BL) 		abnormal bile color J:28328
enlarged liver J:28328
gallstones J:28328
hepatic steatosis J:28328
liver/biliary system phenotype J:28328
Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln) 		hepatic necrosis J:57485
liver inflammation J:57485
Rab39bem1(IMPC)Tcp/Rab39bem1(IMPC)Tcp
(C57BL/6NCrl-Rab39bem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Rac2em1(IMPC)Mbp/Rac2em1(IMPC)Mbp
(C57BL/6N-Rac2em1(IMPC)Mbp/Ucd) 		abnormal liver morphology J:211773
Rad17tm1Maas/Rad17tm1Maas
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:93156
Rad18tm1a(EUCOMM)Wtsi/Rad18tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		abnormal liver physiology J:213427
Rad50tm1Jpt/Rad50tm3Jpt
Tg(Mx1-cre)1Cgn/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:144766
decreased hepatocyte proliferation J:144766
liver hypoplasia J:144766
Rad50tm4.1Jpt/Rad50+
(involves: 129/Sv * C57BL/6) 		increased hepatoblastoma incidence J:209141
increased liver adenoma incidence J:209141
increased liver tumor incidence J:209141
Rad50tm4Jpt/Rad50+
(involves: 129/Sv * C57BL/6) 		increased liver adenoma incidence J:209141
increased liver tumor incidence J:209141
Raf1tm1Bacc/Raf1tm1Bacc
(involves: 129P2/OlaHsd * 129/Sv) 		abnormal hepatocyte morphology J:69056
abnormal liver sinusoid morphology J:69056
increased hepatoblast apoptosis J:69056
liver hypoplasia J:69056
pale liver J:69056
small liver J:69056
Raf1tm1Bacc/Raf1tm1Bacc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:69056
abnormal liver sinusoid morphology J:69056
increased hepatoblast apoptosis J:69056
liver hypoplasia J:69056
pale liver J:69056
small liver J:69056
Raf1tm1Ulb/Raf1tm1Ulb
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:89619
Rag1tm1Bal/Rag1tm1Bal
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Rag1tm1Mom/Rag1tm1Mom
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL) 		increased hepatocellular carcinoma incidence J:141515
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Cd4-NPM/ALK)N1Ingh/0
Tg(TcraTcrb)1100Mjb/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster) 		increased hepatocellular carcinoma incidence J:235890
Ralatm1a(EUCOMM)Wtsi/Ralatm1a(EUCOMM)Wtsi
(C57BL/6N-Ralatm1a(EUCOMM)Wtsi/Wtsi) 		abnormal cystic duct morphology J:239583
Ralgapa1tm1.1Schen/Ralgapa1tm1.1Schen
(involves: C57BL/6J) 		increased liver cholesterol level J:287672
increased liver triglyceride level J:287672
Ramp2tm1.1Tash/Ramp2tm1.1Tash
(involves: C57BL/6) 		abnormal liver morphology J:130931
liver hemorrhage J:130931
Ranbp2tm1Jvd/Ranbp2tm1.1Jvd
(involves: 129/Sv * C57BL/6) 		increased hepatocellular carcinoma incidence J:137482
Ranbp2tm1Jvd/Ranbp2tm1Jvd
(involves: 129/Sv * C57BL/6) 		increased hepatocellular carcinoma incidence J:137482
Rap1gds1tm1Ytk/Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA) 		increased liver weight J:62244
liver vascular congestion J:62244
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		pale liver J:165879
Rapgef2tm1.2Hous/Rapgef2tm1.2Hous
(involves: 129S1/Sv) 		abnormal liver development J:165879
Raratm3.1Ipc/Rara+
Trim24tm1.1Los/Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL) 		increased hepatocyte proliferation J:130210
Raratm3Ipc/Rara+
Speer6-ps1Tg(Alb-cre)21Mgn/?
Trim24tm1Los/Trim24tm1Los
(involves: 129/Sv * C57BL/6 * DBA * SJL) 		increased hepatocyte proliferation J:130210
Raratm3Ipc/Raratm3Ipc
Speer6-ps1Tg(Alb-cre)21Mgn/?
Trim24tm1Los/Trim24tm1Los
(involves: 129/Sv * C57BL/6 * DBA * SJL) 		increased hepatocyte proliferation J:130210
Rasa3tm1a(KOMP)J/Rasa3tm1a(KOMP)J
Tg(CMV-cre)1Cgn/?
((C57BL/6N-Rasa3tm1a(KOMP)J/J x B6.C-Tg(CMV-cre)1Cgn/J)F2) 		pale liver J:301035
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl) 		increased hepatocellular carcinoma incidence J:202603
increased liver tumor incidence J:202603
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6) 		enlarged liver J:85189
Rassf1tm1Gpp/Rassf1tm1Gpp
(involves: 129S1/SvImJ) 		abnormal oval cell morphology J:231761
increased hepatocellular carcinoma incidence J:231761
increased liver adenoma incidence J:231761
increased liver tumor incidence J:231761
Rassf1tm1Gpp/Rassf1tm1Gpp
Sav1tm1.1Gpp/Sav1+
(involves: 129S1/Sv * 129S1/SvImJ) 		abnormal oval cell morphology J:231761
bile duct hyperplasia J:231761
increased hepatoblastoma incidence J:231761
increased hepatocellular carcinoma incidence J:231761
increased liver adenoma incidence J:231761
increased liver tumor incidence J:231761
Rassf2tm1Dlim/Rassf2tm1Dlim
(B6.Cg-Rassf2tm1Dlim) 		liver fibrosis J:181952
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased hepatocellular carcinoma incidence J:168749
Rb1tm1Brd/Rb1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased hepatocyte number J:2516
dilated liver sinusoidal space J:2516
small liver J:2516
Rb1tm1Mlh/Rb1tm1Mlh
(either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		decreased hepatocyte number J:20542
dilated liver sinusoidal space J:2498
Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas) 		liver hypoplasia J:81643
Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		abnormal liver morphology J:2511
small liver J:2511
Rb1tm1Tyj/Rb1tm2Tyj
(chimera involves: 129S2/SvPas * C57BL/6) 		abnormal hepatocyte morphology J:59268
Rb1tm2Mlh/Rb1tm2Mlh
(either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		decreased hepatocyte number J:20542
dilated liver sinusoidal space J:2498
Rb1tm3Tyj/Rb1tm3.1Tyj
Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * FVB/N) 		liver/biliary system phenotype J:81643
Rb1tm3Tyj/Rb1tm3Tyj
Rbl1tm1Tyj/Rbl1tm1Tyj
Rbl2tm2.1Tyj/Rbl2tm2.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:177573
Rb1tm3Tyj/Rb1tm3Tyj
Tg(tetO-MYC)36aBop/0
Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		increased hepatocellular carcinoma incidence J:172430
increased liver tumor incidence J:172430
Rb1cc1tm1.1Guan/Rb1cc1tm1.1Guan
Tg(Tek-cre)12Flv/0
(B6.Cg-Rb1cc1tm1.1Guan Tg(Tek-cre)12Flv) 		abnormal liver morphology J:167258
pale liver J:167258
Rb1cc1tm1.2Guan/Rb1cc1tm1.2Guan
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:114498
abnormal liver morphology J:114498
decreased hepatocyte number J:114498
dissociated hepatocytes J:114498
increased hepatocyte apoptosis J:114498
liver degeneration J:114498
liver hemorrhage J:114498
Rbbp4em1(IMPC)Mbp/Rbbp4+
(C57BL/6NCrl-Rbbp4em1(IMPC)Mbp/Mmucd) 		abnormal gallbladder morphology J:211773
abnormal liver morphology J:211773
small liver J:211773
Rbck1tm1Kiwa/Rbck1tm1Kiwa
(B6.Cg-Rbck1tm1Kiwa) 		increased hepatocyte apoptosis J:158069
Rbl1tm1Mru/Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/c) 		hepatic steatosis J:129672
Rbm3tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Rbm3tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Rbm7em1Aki/Rbm7em1Aki
(B6.Cg-Rbm7em1Aki) 		liver fibrosis J:288329
Rbm10em1(IMPC)Mbp/Rbm10+
(C57BL/6NCrl-Rbm10em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Rbm22em1(IMPC)Mbp/Rbm22+
(C57BL/6NCrl-Rbm22em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Rbm38tm1.1Xch/Rbm38tm1.1Xch
(involves: C57BL/6 * FVB/N) 		increased hepatoma incidence J:216929
Rbm38tm1.1Xch/Rbm38tm1.1Xch
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		hepatic steatosis J:216929
Rbp1tm1Ipc/Rbp1tm1Ipc
(involves: 129S2/SvPas) 		abnormal liver morphology J:57825
abnormal liver physiology J:57825
Rc3h1Gt(CC0753)Wtsi/Rc3h1Gt(CC0753)Wtsi
(B6.129P2-Rc3h1Gt(CC0753)Wtsi) 		chronic liver inflammation J:199407
Rc3h1san/Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca)) 		liver inflammation J:98938
Rc3h1san/Rc3h1san
(involves: C57BL/6JSfdAnu) 		chronic liver inflammation J:199407
hepatic necrosis J:199407
Rcan2tm1Ypt/Rcan2tm1Ypt
(B6.129-Rcan2tm1Ypt) 		decreased liver weight J:169558
decreased susceptibility to diet-induced hepatic steatosis J:169558
Rcbtb2tm1.1Xyw/Rcbtb2+
(involves: C57BL/6 * CBA) 		increased liver tumor incidence J:282928
Rcbtb2tm1.1Xyw/Rcbtb2tm1.1Xyw
(involves: C57BL/6 * CBA) 		increased liver tumor incidence J:282928
Rce1tm2Kim/Rce1tm2Kim
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		liver/biliary system phenotype J:87958
Rdh1tm1.1Jln/Rdh1tm1.1Jln
(B6.129P2-Rdh1tm1.1Jln) 		increased liver weight J:134843
Rdh10tm1.1Ics/Rdh10tm1.1Ics
(involves: C57BL/6 * SJL) 		liver hypoplasia J:177362
Rdh10tm2Ics/Rdh10tm2Ics
(Not Specified) 		liver hypoplasia J:177362
Rdh10trex/Rdh10trex
(involves: 129S1/Sv * C57BL/6 * FVB/NJ) 		abnormal liver parenchyma morphology J:121229
small liver J:121229
Rdxtm1Sts/Rdxtm1Sts
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:77485
Recktm1Ito/Recktm1.1Noda
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal liver vasculature morphology J:163845
Reg2tm1Lchr/Reg2tm1Lchr
(involves: 129P2/OlaHsd * C57BL/6) 		decreased hepatocyte proliferation J:140235
delayed liver regeneration J:140235
Reg3bem1(IMPC)Mbp/Reg3bem1(IMPC)Mbp
(C57BL/6NCrl-Reg3bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Reltm1Brv/Reltm1Brv
(involves: 129S1/Sv) 		abnormal liver morphology J:46911
Reltm1Grd/Reltm1Grd
Relatm1Bal/Relatm1Bal
(B6.129S-Reltm1Grd Relatm1Bal) 		increased hepatocyte apoptosis J:111325
Relatm1.2Gho/Relatm1.2Gho
(involves: 129S6/SvEvTac * C57BL/6) 		increased hepatocyte apoptosis J:134684
Relatm1Bal/Relatm1Bal
(involves: 129S4/SvJae * C57BL/6J) 		increased hepatocyte apoptosis J:28390
liver degeneration J:28390
Relatm1Bal/Relatm1Bal
(B6.129S4-Relatm1Bal) 		increased hepatocyte apoptosis J:111325
Relatm1Bal/Relatm1Bal
Tg(SERPINA1-BCL2)1Pva/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased hepatocyte apoptosis J:126292
Relatm1Bal/Relatm1Bal
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S4/SvJae * C57BL/6) 		focal hepatic necrosis J:60742
liver inflammation J:60742
Relatm1Yuo/Relatm1Yuo
(involves: 129S/SvEv) 		abnormal hepatocyte morphology J:63099
abnormal liver morphology J:63099
Relatm2.1Gho/Relatm2.1Gho
(involves: 129S6/SvEvTac * C57BL/6) 		hepatic necrosis J:163663
liver fibrosis J:163663
liver hypoplasia J:163663
liver inflammation J:163663
Relatm2.1Gho/Relatm2.1Gho
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * 129S6/SvEvTac) 		liver fibrosis J:163663
liver inflammation J:163663
Relbshep/Relbshep
(A;C-Relbshep/GrsrJ) 		decreased liver function J:171971
liver cirrhosis J:171971
liver failure J:171971
liver inflammation J:171971
pale liver J:171971
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri) 		liver fibrosis J:76450
liver inflammation J:76450
pale liver J:76450
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6) 		abnormal bile duct morphology J:22675
abnormal hepatobiliary system morphology J:22675
liver fibrosis J:22675
liver inflammation J:22675
Retntm1Laz/Retntm1Laz
(involves: 129S/SvEv * C57BL/6) 		decreased liver triglyceride level J:90033
Retnlbtm1Lex/Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex) 		enlarged liver J:235058
liver inflammation J:235058
Rexo1em1(IMPC)J/Rexo1em1(IMPC)J
(C57BL/6NJ-Rexo1em1(IMPC)J/Mmjax) 		pale liver J:211773
Rfx5tm1.1Ifo/Rfx5tm1.1Ifo
(involves: 129 * C57BL/6) 		abnormal Kupffer cell morphology J:67941
Rgl1em1(IMPC)Mbp/Rgl1+
(C57BL/6N-Rgl1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Rgntm1Aish/Y
(involves: 129P2/OlaHsd) 		abnormal hepatocyte mitochondrial morphology J:88791
abnormal hepatocyte morphology J:88791
abnormal liver vasculature morphology J:88791
hepatic steatosis J:88791
increased liver cholesterol level J:88791
increased liver triglyceride level J:88791
Rgntm1Aish/Rgntm1Aish
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocyte apoptosis J:79342
Rhbdd1tm1.1Mfm/Rhbdd1tm1.1Mfm
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to hepatic steatosis J:325547
Rhbdd3tm1Caox/Rhbdd3tm1Caox
(B6.129S6-Rhbdd3tm1Caox) 		hepatic necrosis J:197348
liver inflammation J:197348
Rhbdf2tm1Mak/Rhbdf2tm1Mak
(B6.129P2-Rhbdf2tm1Mak) 		abnormal liver physiology J:179653
Rictortm1.1Mnh/Rictortm1.1Mnh
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev) 		increased liver weight J:150064
macrovesicular hepatic steatosis J:150064
Rigiem1(IMPC)Mbp/Rigiem1(IMPC)Mbp
(C57BL/6N-Rigiem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Rigitm1Aki/Rigitm1Aki
(Not Specified) 		liver degeneration J:100539
Rint1tm1Whl/Rint1+
(Not Specified) 		increased hepatocellular carcinoma incidence J:122805
Ripk1tm1.1Vmd/Ripk1+
Ripk3tm2Vmd/Ripk3tm2Vmd
(involves: C57BL/6N) 		decreased liver glycogen level J:209137
Rnaseh2btm1a(EUCOMM)Wtsi/Rnaseh2btm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		liver hypoplasia J:186986
Rnd2em1(IMPC)Mbp/Rnd2em1(IMPC)Mbp
(C57BL/6NCrl-Rnd2em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Rnf5tm1.1(KOMP)Vlcg/Rnf5+
(C57BL/6N-Rnf5tm1.1(KOMP)Vlcg/Ccpcz) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Rnf139tm1(KOMP)Wtsi/Rnf139tm1(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		increased hepatocyte apoptosis J:231404
liver fibrosis J:231404
liver inflammation J:231404
Rnf208em1(IMPC)Ccpcz/Rnf208em1(IMPC)Ccpcz
(C57BL/6N-Rnf208em1(IMPC)Ccpcz/Ccpcz) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Rpeem1(IMPC)Mbp/Rpe+
(C57BL/6NCrl-Rpeem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Rpgrip1ltm1a(EUCOMM)Wtsi/Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
liver cyst J:239583
liver hemorrhage J:239583
Rpgrip1ltm1Urt/Rpgrip1ltm1Urt
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal bile duct development J:123018
liver fibrosis J:123018
Rpl5Skax23-Jus/Rpl5+
(129S6.B6-Rpl5Skax23-Jus) 		liver hypoplasia J:330162
Rpl12em1(IMPC)Mbp/Rpl12+
(C57BL/6NCrl-Rpl12em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Rplp1tm1.1Melt/Rplp1tm1.2Melt
(Not Specified) 		abnormal liver morphology J:218949
Rps6tm1Gtho/Rps6tm1Gtho
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		impaired liver regeneration J:62795
Rps6tm1Om/Rps6tm1Om
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal hepatocyte morphology J:100952
Rps6ka3tm1.1Kry/Rps6ka3+
(involves: 129X1/SvJ) 		liver/biliary system phenotype J:89403
Rps6ka3tm1.1Kry/Rps6ka3tm1.1Kry
(involves: 129X1/SvJ) 		liver/biliary system phenotype J:89403
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
(C57BL/6-Rps27lGt(IST11658B7)Tigm) 		liver hypoplasia J:223276
small liver J:223276
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6N) 		enlarged liver J:223276
Rptortm1.1Dmsa/Rptortm1.1Dmsa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:167208
abnormal liver physiology J:167208
small liver J:167208
Rptortm1Rueg/Rptortm1Rueg
Tg(Fabp4-cre)1Rev/0
(involves: 129S1/SvImJ * C57BL/6J) 		decreased liver triglyceride level J:143749
Rr28tm1Tilg/Rr28+
Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		increased hepatocyte proliferation J:77413
increased liver weight J:77413
Rr28tm1Tilg/Rr28+
Tg(CRP-TAg)60-3Urt/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		increased liver tumor incidence J:138826
Rr104tm1.2Mym/Rr104tm1.2Mym
(Not Specified) 		abnormal liver morphology J:175070
abnormal liver physiology J:175070
pale liver J:175070
small liver J:175070
Rr143tm1.1Sson/Rr143+
Zbed6tm1.2Sson/Zbed6tm1.2Sson
(involves: BALB/c * C57BL/6) 		increased liver weight J:265506
Rr249tm1.1Ebres/Rr249tm1.1Ebres
(involves: 129 * BALB/cJ * C57BL/6) 		liver hypoplasia J:191756
small liver J:191756
Rr250em1Ebres/Rr250em1Ebres
(C57BL/6N-Rr250em1Ebres) 		decreased liver weight J:270526
Rr320tm1.1Mkg/Rr320+
(involves: 129) 		pale liver J:60714
Rr347em1Prdns/Rr347em1Prdns
(CBA/Ca-Rr347em1Prdns) 		liver/biliary system phenotype J:281171
Rr349tm1Wgw/Rr349tm1Wgw
(involves: 129P2/OlaHsd) 		abnormal liver development J:80121
Rragcem1Efe/Rragc+
(Not Specified) 		abnormal hepatocyte physiology J:320567
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		liver/biliary system phenotype J:186071
Rrm2btm1Ynak/Rrm2btm1Ynak
(involves: 129 * C57BL/6J) 		abnormal liver morphology J:84841
Rtn4rl1Gt(OST188035)Lex/Rtn4rl1Gt(OST188035)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal bile duct morphology J:103485
abnormal hepatocyte morphology J:103485
hepatic steatosis J:103485
Rtp4tm1b(EUCOMM)Hmgu/Rtp4tm1b(EUCOMM)Hmgu
(C57BL/6N-Rtp4tm1b(EUCOMM)Hmgu/Kmpc) 		abnormal liver morphology J:211773
Rttnem1(IMPC)Tcp/Rttn+
(C57BL/6NCrl-Rttnem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Rubcnlem1Qsun/Rubcnlem1Qsun
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Rubcnlem1Qsun) 		abnormal liver physiology J:272052
hepatic steatosis J:272052
increased liver glycogen level J:272052
increased liver triglyceride level J:272052
increased liver weight J:272052
liver fibrosis J:272052
Rundc1tm1b(EUCOMM)Wtsi/Rundc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Rundc1tm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
Runx1tm1.1(RUNX1*)Homy/Runx1tm1.1(RUNX1*)Homy
(B6.129P2-Runx1tm1.1(RUNX1*)Homy) 		pale liver J:164806
Runx1tm1.1Gss/Runx1tm1.1Gss
(involves: 129S4/SvJae * C57BL/6) 		pale liver J:157660
Runx1tm1Dow/Runx1tm1Dow
(involves: 129P2/OlaHsd * C57BL/6) 		pale liver J:31130
Runx1tm2Dow/Runx1+
(involves: 129P2/OlaHsd * C57BL/6) 		pale liver J:79160
Runx1tm3Spe/Runx1tm3Spe
Tg(Cdh5-cre)1Spe/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6) 		pale liver J:145700
Runx2tm1Kish/Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:53069
small liver J:53069
Rxfp2tm1b(EUCOMM)Wtsi/Rxfp2tm1b(EUCOMM)Wtsi
(C57BL/6N-Rxfp2tm1b(EUCOMM)Wtsi/Ieg) 		abnormal liver morphology J:211773
Rxratm1Rev/Rxratm1Rev
(involves: 129S4/SvJae * C57BL/6) 		decreased hepatocyte proliferation J:18047
delayed hepatic development J:18047
small liver J:18047
Rxratm4Ipc/Rxratm4Ipc
Rxrbtm1Pcn/Rxrbtm1Pcn
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S2/SvPas) 		enlarged liver J:102470
S100a4tm1Amba/S100a4tm1Amba
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased hepatocellular carcinoma incidence J:89563
S100a16em1.1Gpt/S100a16+
(involves: C57BL/6JGpt * FVB/N) 		liver fibrosis J:330793
Saa3tm1(KOMP)Vlcg/Saa3tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased liver weight J:220630
Safbtm1So/Safbtm1So
(involves: 129 * C57BL/6J) 		abnormal liver morphology J:97633
Samd1tm1Pfi/Samd1tm1Pfi
(involves: C57BL/6J * C57BL/6N) 		abnormal liver development J:333561
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr) 		hepatic steatosis J:208616
Samd8tm1.1Kwi/Samd8tm1.1Kwi
(involves: 129P2/OlaHsd) 		liver/biliary system phenotype J:228568
Samd8tm1Jia/Samd8tm1Jia
(involves: 129S6/SvEvTac * C57BL/6J) 		liver/biliary system phenotype J:220024
sar/sar
(BTBR-sar) 		liver/biliary system phenotype J:37
Sar1bem2Emle/Sar1b+
(C57BL/6N-Sar1bem2Emle) 		increased liver cholesterol level J:319817
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi
Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N) 		abnormal hepatocyte physiology J:337869
increased susceptibility to age-related hepatic steatosis J:337869
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi
Tg(Sim1-cre)1Lowl/0
(involves: 129 * C57BL/6 * FVB) 		liver/biliary system phenotype J:337869
Sat1tm1Alh/Sat1tm1Alh
(B6.129X1-Sat1tm1Alh) 		abnormal liver physiology J:120870
Sav1tm1.1Gpp/Sav1+
(involves: 129S1/Sv) 		abnormal oval cell morphology J:231761
bile duct hyperplasia J:231761
increased hepatocellular carcinoma incidence J:231761
increased liver adenoma incidence J:231761
increased liver tumor incidence J:231761
Sav1tm1.1Rjo/Sav1tm1.1Rjo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL) 		increased hepatocellular carcinoma incidence J:156531
increased hepatocyte proliferation J:156531
increased liver weight J:156531
Sav1tm1.1Rjo/Sav1tm1.1Rjo
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * CD-1 * SJL) 		increased liver tumor incidence J:156531
Sav1tm1.1Rjo/Sav1tm1.1Rjo
Tg(MMTV-cre)4Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL) 		increased liver tumor incidence J:156531
Sav1tm1Dlim/Sav1+
(involves: 129S1/Sv * 129X1/SvJ) 		increased hepatoma incidence J:160325
increased liver tumor incidence J:160325
Sav1tm1Dlim/Sav1tm1Dlim
(involves: 129S1/Sv * 129X1/SvJ) 		increased liver tumor incidence J:160325
Sav1tm2.1Dlim/Sav1tm2.1Dlim
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal hepatocyte morphology J:160325
abnormal liver morphology J:160325
abnormal oval cell morphology J:160325
abnormal oval cell physiology J:160325
abnormal portal lobule morphology J:160325
enlarged liver J:160325
increased hepatocellular carcinoma incidence J:238319
increased hepatoma incidence J:160325
increased liver weight J:160325
liver/biliary system phenotype J:160325
Sbdstm1Aljw/Sbdstm1.1Aljw
Tg(Mx1-cre)1Cgn/0
(involves: BALB/cJ * C57BL/6 * DBA) 		abnormal hepatocyte physiology J:171416
abnormal liver morphology J:171416
hepatic necrosis J:171416
Sbf1em1(IMPC)Mbp/Sbf1em1(IMPC)Mbp
(C57BL/6N-Sbf1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Sc5dtm1Fdp/Sc5dtm1Fdp
(involves: 129S1/Sv * 129X1/SvJ) 		decreased liver glycogen level J:84450
increased liver weight J:84450
Scaptm1Mbjg/Scaptm1Mbjg
Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL) 		decreased liver cholesterol level J:69592
decreased liver triglyceride level J:69592
Scara5tm1Ktry/Scara5tm1Ktry
(B6N.129X1-Scara5tm1Ktry) 		liver inflammation J:195536
Scarb1Hlb398/Scarb1Hlb398
(C57BL/6J-Scarb1Hlb398) 		abnormal liver physiology J:152482
Scd1tm1Ntam/Scd1tm1Ntam
(involves: C57BL/6) 		decreased liver triglyceride level J:130441
decreased susceptibility to diet-induced hepatic steatosis J:130441
Scd1tm1Ntam/Scd1tm1Ntam
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver triglyceride level J:178653
Scd1tm2Ntam/Scd1tm2Ntam
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Scd1tm2Ntam) 		abnormal liver physiology J:130441
decreased liver glycogen level J:130441
decreased liver triglyceride level J:130441
decreased susceptibility to diet-induced hepatic steatosis J:130441
Scd2tm1Myz/Scd2tm1Myz
(129S6.129-Scd2tm1Myz) 		abnormal liver physiology J:101158
decreased liver triglyceride level J:101158
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		enlarged liver J:77510
hepatic necrosis J:77510
hepatic steatosis J:53349, J:77510
increased liver glycogen level J:77510
Scmh1tm1e.1(EUCOMM)Hmgu/Scmh1tm1e.1(EUCOMM)Hmgu
(C57BL/6N-Scmh1tm1e.1(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
Scn5atm1.1Iba/Scn5a+
(involves: 129 * C57BL/6) 		liver vascular congestion J:266290
Sco1tm1c(KOMP)Wtsi/Sco1tm1c(KOMP)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		abnormal liver morphology J:222036
decreased liver copper level J:222036
hepatic steatosis J:222036
increased liver cholesterol level J:222036
increased liver iron level J:222036
increased liver triglyceride level J:222036
Sco2tm1.1Easc/Sco2tm2.1Easc
(129X1/SvJ-Sco2tm1.1Easc/Sco2tm2.1Easc) 		increased liver copper level J:155116
Scp2tm1Fsch/Scp2tm1Fsch
(B6.129P2-Scp2tm1Fsch) 		abnormal hepatocyte morphology J:126573
Scp2tm1Kier/Scp2tm1Kier
(involves: 129P2/OlaHsd * C57BL/6NCr) 		abnormal liver morphology J:124895
decreased hepatocyte number J:124895
decreased liver triglyceride level J:124895
enlarged liver J:124895
liver inflammation J:124895
Scp2tm1Usee/Scp2tm1Usee
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal bile secretion J:73460
decreased liver cholesterol level J:73460, J:47280
decreased liver triglyceride level J:47280
Sec24atm1a(KOMP)Wtsi/Sec24atm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		abnormal liver physiology J:213427
Sec24dem1(IMPC)Rbrc/Sec24d+
(C57BL/6NJcl-Sec24dem1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek) 		enlarged liver J:164159
hepatic steatosis J:164159
increased hepatocyte apoptosis J:164159
increased hepatocyte proliferation J:164159
liver cirrhosis J:164159
pale liver J:164159
Sec61a1m1Gek/Sec61a1m1Gek
Tg(Ins2-Sec61a1)#Gek/0
(C57BL/6-Sec61a1m1Gek Tg(Ins2-Sec61a1)#Gek) 		enlarged liver J:164159
hepatic steatosis J:164159
liver cirrhosis J:164159
Sec63tm1Som/Sec63tm1Som
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6) 		liver cyst J:188763
Secisbp2tm1c(EUCOMM)Wtsi/Secisbp2tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		liver/biliary system phenotype J:213080
Sel1lGt(CA0017)Wtsi/Sel1lGt(CA0017)Wtsi
(involves: 129P2/OlaHsd) 		decreased hepatocyte proliferation J:158780
Seletm2Alb/Seletm2Alb
Selltm2Alb/Selltm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver physiology J:106550
hepatic necrosis J:106550
Selenbp1tm1Hyama/Selenbp1tm1Hyama
(C57BL/6-Selenbp1tm1Hyama) 		decreased liver weight J:202420
Selenoftm1Vgla/Selenoftm1Vgla
(involves: 129 * C57BL/6) 		abnormal liver physiology J:176744
Selenoptm1Rfb/Selenoptm1Rfb
(B6.129-Selenoptm1Rfb) 		decreased liver function J:134536
increased hepatocyte apoptosis J:134536
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * C57BL/6) 		liver/biliary system phenotype J:106550
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J) 		hepatic necrosis J:101979
Sema6cem1(IMPC)Mbp/Sema6cem1(IMPC)Mbp
(C57BL/6N-Sema6cem1(IMPC)Mbp/MbpMmucd) 		small liver J:211773
Senp1Gt(XG001)Byg/Senp1Gt(XG001)Byg
(involves: 129P2/OlaHsd) 		small liver J:141453
Senp1tm1.1Wami/Senp1tm1.1Wami
(involves: 129 * C57BL/6) 		abnormal liver physiology J:163428
decreased liver weight J:163428
pale liver J:163428
small liver J:163428
Sephs1tm1.1Dhat/Sephs1tm1.1Dhat
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver iron level J:245139
decreased liver manganese level J:245139
Serac1em1Bcgen/Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen) 		abnormal hepatocyte morphology J:326672
abnormal liver morphology J:326672
decreased hepatocyte mitochondrial DNA content J:326672
increased liver cholesterol level J:326672
increased liver glycogen level J:326672
increased liver triglyceride level J:326672
Serpina6tm1Tew/Serpina6tm1Tew
(involves: 129/SvEmcTer * C57BL/6N) 		liver/biliary system phenotype J:112974
Serpina12tm1Jwada/Serpina12+
(B6JJcl.129P2-Serpina12tm1Jwada) 		increased liver triglyceride level J:208508
Serpina12tm1Jwada/Serpina12tm1Jwada
(B6JJcl.129P2-Serpina12tm1Jwada) 		increased liver triglyceride level J:208508
increased liver weight J:208508
Serpinb10em1(IMPC)Mbp/Serpinb10em1(IMPC)Mbp
(C57BL/6NCrl-Serpinb10em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Serpinc1tm1Dwr/Serpinc1tm1Dwr
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver morphology J:115658
abnormal liver regeneration J:115658
hepatic necrosis J:115658
liver inflammation J:115658
macrovesicular hepatic steatosis J:115658
portal hypertension J:115658
Serpinc1tm1Sai/Serpinc1tm1Sai
(involves: 129S2/SvPas * C57BL/6J) 		liver degeneration J:65092
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		decreased liver triglyceride level J:87982
Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129S2-Serpine1tm1Mlg/J) 		liver fibrosis J:123733
liver/biliary system phenotype J:123733
Sertad2Gt(OST98734)Lex/Sertad2Gt(OST98734)Lex
(B6.129S5-Sertad2Gt(OST98734)Lex) 		decreased liver triglyceride level J:194928
decreased liver weight J:194928
decreased susceptibility to diet-induced hepatic steatosis J:194928
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd) 		decreased hepatocyte mitochondrial DNA content J:189021
increased liver triglyceride level J:189021
macrovesicular hepatic steatosis J:189021
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
Sesn3tm1a(EUCOMM)Wtsi/Sesn3tm1a(EUCOMM)Wtsi
(involves: 129P2/OlaHsd * C57BL/6N) 		liver/biliary system phenotype J:189021
Setd5tm1a(EUCOMM)Wtsi/Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
Sfmbt2em1(IMPC)Mbp/Sfmbt2+
(C57BL/6NCrl-Sfmbt2em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
SfnEr/SfnEr
(involves: 129/Sv * C57BL/6) 		abnormal liver morphology J:6200
Sgms1Gt(E201D11)Wrst/Sgms1Gt(E201D11)Wrst
(B6.129P2-Sgms1Gt(E201D11)Wrst) 		decreased liver weight J:249941
Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129 * C57BL/6) 		abnormal hepatocyte physiology J:162192
Sgms2tm1Kenw/Sgms2tm1Kenw
(B6.129S2-Sgms2tm1Kenw) 		decreased susceptibility to diet-induced hepatic steatosis J:175924
Sgshmps3a/Sgshmps3a
(involves: 129X1/SvJ * CD-1 * C57BL/6 * SJL) 		enlarged liver J:72142
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J) 		liver inflammation J:117880
Sh3pxd2atm1b(EUCOMM)Wtsi/Sh3pxd2atm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi) 		abnormal liver morphology J:239583
abnormal liver vasculature morphology J:239583
dilated bile duct J:239583
dilated liver sinusoidal space J:239583
herniated liver J:239583
liver hypoplasia J:239583
Shank1em1(IMPC)Mbp/Shank1em1(IMPC)Mbp
(C57BL/6N-Shank1em1(IMPC)Mbp/MbpMmucd) 		abnormal gallbladder morphology J:211773
abnormal liver morphology J:211773
enlarged gallbladder J:211773
small liver J:211773
Sharpincpdm/Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm) 		abnormal liver morphology J:31745, J:14539
Shhtm1(EGFP/cre)Cjt/Shh+
Sox17tm1Ysk/Sox17+
(involves: 129S1/Sv * C57BL/6) 		abnormal gallbladder smooth muscle morphology J:241569
Shhtm1(EGFP/cre)Cjt/Shhtm1(EGFP/cre)Cjt
(Not Specified) 		abnormal cystic duct morphology J:241569
abnormal gallbladder smooth muscle morphology J:241569
abnormal liver development J:241569
small gallbladder J:241569
Shisal1em1(IMPC)Ccpcz/Shisal1em1(IMPC)Ccpcz
(C57BL/6N-Shisal1em1(IMPC)Ccpcz/Ccpcz) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Shld1em1(IMPC)Mbp/Shld1em1(IMPC)Mbp
(C57BL/6NCrl-Shld1em1(IMPC)Mbp/Mmucd) 		enlarged liver J:211773
Shmt1tm1.1Stov/Shmt1+
(129S/SvEv-Shmt1tm1.1Stov) 		abnormal liver physiology J:141998
Shmt1tm1.1Stov/Shmt1tm1.1Stov
(involves: 129S7/SvEvBrd * BALB/cJ * C57BL/6) 		abnormal liver physiology J:141998
Shmt1tm1.1Stov/Shmt1tm1.1Stov
(129S/SvEv-Shmt1tm1.1Stov) 		abnormal liver physiology J:141998
Shpkem1(IMPC)Mbp/Shpkem1(IMPC)Mbp
(C57BL/6NCrl-Shpkem1(IMPC)Mbp/Mmucd) 		liver/biliary system phenotype J:351905
Shpkem1Scher/Shpkem1Scher
(C57BL/6J-Shpkem1Scher) 		liver/biliary system phenotype J:351905
Shroom3Gt(ROSA53)Sor/Shroom3Gt(ROSA53)Sor
(involves: 129S4/SvJaeSor) 		herniated liver J:58691
Siah1atm1Ddlb/Siah1atm1Ddlb
(involves: 129S1/Sv * C57BL/6J) 		small liver J:75489
Sidt1tm1.1(KOMP)Vlcg/Sidt1tm1.1(KOMP)Vlcg
(C57BL/6N-Sidt1tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal hepatocyte morphology J:236042
abnormal liver morphology J:236042
hepatic necrosis J:236042
hepatic steatosis J:236042
increased liver free fatty acids level J:236042
increased liver triglyceride level J:236042
liver fibrosis J:236042
liver inflammation J:236042
Sik3tm1Htake/Sik3tm1Htake
(involves: C57BL/6JJcl * C57BL/6N) 		abnormal bile color J:183827
abnormal bile composition J:183827
abnormal gallbladder epithelium morphology J:183827
abnormal gallbladder morphology J:183827
abnormal hepatocyte morphology J:183827
abnormal liver morphology J:183827
cholestasis J:183827
decreased liver cholesterol level J:183827
decreased liver triglyceride level J:183827
decreased liver weight J:183827
decreased susceptibility to diet-induced hepatic steatosis J:183827
enlarged gallbladder J:183827
increased liver cholesterol level J:183827
intrahepatic cholestasis J:183827
Sin3btm1.2Rdp/Sin3btm1.2Rdp
(involves: 129 * C57BL/6 * FVB/N * SJL) 		pale liver J:154855
Sinhcaftm1.2Hmd/Sinhcaftm1.2Hmd
(involves: 129 * C57BL/6) 		small liver J:313620
Sirpatm1Nog/Sirpatm1Nog
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:79592
Sirt1tm1.2Cxd/Sirt1tm1.2Cxd
Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * FVB/N) 		hepatic steatosis J:179193
increased liver triglyceride level J:179193
Sirt2tm1.1Cxd/Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss)) 		increased hepatocellular carcinoma incidence J:177486
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac) 		increased liver cholesterol level J:178653
increased liver triglyceride level J:178653
liver fibrosis J:178653
liver inflammation J:178653
macrovesicular hepatic steatosis J:178653
Sirt6tm1.1Cxd/Sirt6tm1.1Cxd
Tg(Alb1-cre)1Dlr/0
(involves: 129S6/SvEvTac * FVB/N) 		abnormal liver morphology J:166368
hepatic steatosis J:166368
increased liver weight J:166368
Sirt7tm1Fwa/Sirt7tm1Fwa
(involves: 129S1/Sv) 		abnormal hepatocyte morphology J:205529
abnormal liver physiology J:205529
enlarged liver J:205529
hepatic steatosis J:205529
increased liver triglyceride level J:205529
liver inflammation J:205529
pale liver J:205529
Sisem1(IMPC)J/Sisem1(IMPC)J
(C57BL/6NJ-Sisem1(IMPC)J) 		decreased liver triglyceride level J:344683
skimp/skimp
(involves: C3H/HeH) 		abnormal liver morphology J:77535
Skp2tm1Kin/Skp2tm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:75027, J:62130
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/?
(involves: 129/Sv * C57BL/6) 		increased liver glycogen level J:75418
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL) 		hepatic steatosis J:43650
macrovesicular hepatic steatosis J:43650
Slc2a9tm1Khm/Slc2a9tm1Khm
Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J) 		hepatic steatosis J:221544
increased liver free fatty acids level J:221544
increased liver triglyceride level J:221544
liver fibrosis J:221544
Slc5a6tm1.1Said/Slc5a6tm1.1Said
Tg(Vil1-cre)997Gum/?
(involves: C57BL/6) 		liver/biliary system phenotype J:194700
Slc5a7tm1a(KOMP)Wtsi/Slc5a7tm1a(KOMP)Wtsi
(C57BL/6N-Slc5a7tm1a(KOMP)Wtsi/Wtsi) 		herniated liver J:239583
Slc5a10tm1Csk/Slc5a10tm1Csk
(C57BL/6-Slc5a10tm1Csk) 		hepatic steatosis J:199406
increased liver triglyceride level J:199406
increased liver weight J:199406
Slc7a7em1Lbu/Slc7a7em1Lbu
(involves: 129/SvEv * C57BL/6) 		delayed hepatic development J:293773
Slc9b1em1(IMPC)Mbp/Slc9b1em1(IMPC)Mbp
(C57BL/6N-Slc9b1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Slc10a1em1(IMPC)Mbp/Slc10a1em1(IMPC)Mbp
(C57BL/6N-Slc10a1em1(IMPC)Mbp/MbpMmucd) 		abnormal gallbladder morphology J:211773
abnormal liver morphology J:211773
enlarged gallbladder J:211773
Slc10a1tm1Tac/Slc10a1tm1Tac
(either: B6.Cg-Slc10a1tm1Tac or (involves: 129S/SvEv * C57BL/6J)) 		abnormal bile secretion J:274149
liver/biliary system phenotype J:274149
Slc10a2tm1Pda/Slc10a2tm1Pda
(either: (involves: 129P2/OlaHsd * 129S6/SvEv) or (involves: 129P2/OlaHsd * C57BL/6J)) 		abnormal bile composition J:85312
abnormal liver physiology J:85312
Slc11a2mk/Slc11a2mk
(MK/ReJ) 		liver/biliary system phenotype J:5167
Slc11a2mk/Slc11a2mk
(129S6.MK-Slc11a2mk) 		increased liver iron level J:98088
Slc11a2mk/Slc11a2mk
(SEC.Cg-Slc11a2mk) 		liver/biliary system phenotype J:5167
Slc11a2tm1Nca/Slc11a2+
(involves: 129S6/SvEvTac * 129S6.129S4-Slc11a2tm1Nca) 		decreased liver iron level J:98088
Slc11a2tm2Nca/Slc11a2tm2Nca
Tg(Vil1-cre)20Syr/?
(involves: 129S6.129S4-Slc11a2tm2Nca * C57BL/6 * DBA/2) 		decreased liver iron level J:98088
Slc13a1tm1Mark/Slc13a1tm1Mark
(involves: 129T2/SvEms * C57BL/6J) 		increased liver weight J:86561
Slc13a5tm1.2Helf/Slc13a5+
(B6.Cg-Slc13a5tm1.2Helf) 		abnormal liver physiology J:176732
Slc13a5tm1.2Helf/Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf) 		abnormal hepatocyte mitochondrial morphology J:176732
abnormal hepatocyte physiology J:176732
abnormal liver morphology J:176732
abnormal liver physiology J:176732
decreased liver triglyceride level J:176732
Slc15a5em1(IMPC)H/Slc15a5em1(IMPC)H
(C57BL/6NTac-Slc15a5em1(IMPC)H/H) 		enlarged gallbladder J:211773
Slc16a1tm2.1Lupel/Slc16a1+
(B6.129P2-Slc16a1tm2.1Lupel) 		decreased liver weight J:205481
decreased susceptibility to diet-induced hepatic steatosis J:205481
Slc16a13em1Tac/Slc16a13em1Tac
(C57BL/6N-Slc16a13em1Tac) 		decreased susceptibility to diet-induced hepatic steatosis J:309785
liver/biliary system phenotype J:309785
Slc19a1tm1Gold/Slc19a1tm1Gold
(involves: 129/Sv * C57BL/6 * SJL) 		pale liver J:68666
Slc19a3tm1Said/Slc19a3tm1Said
(involves: C57BL/6) 		abnormal liver parenchyma morphology J:170952
chronic liver inflammation J:170952
hepatic necrosis J:170952
Slc20a1tm1.2Lbek/Slc20a1tm1.2Lbek
(involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J) 		abnormal liver development J:157997
decreased hepatocyte proliferation J:157997
dilated liver sinusoidal space J:157997
increased hepatocyte apoptosis J:157997
liver hypoplasia J:157997
pale liver J:157997
small liver J:157997
Slc20a1tm1Lbek/Slc20a1tm1.2Lbek
(involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J) 		liver hypoplasia J:157997
Slc20a2tm1a(EUCOMM)Wtsi/Slc20a2tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc20a2tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal liver vasculature morphology J:239583
Slc22a1tm1Ahs/Slc22a1tm1Ahs
(involves: 129P2/OlaHsd * FVB) 		abnormal hepatobiliary system physiology J:70604
abnormal liver physiology J:70604
Slc22a5jvs/Slc22a5jvs
(C3.OH-H2o2 Slc22a5jvs) 		abnormal hepatocyte morphology J:31026
hepatic steatosis J:31000
pale liver J:14288
Slc22a18tm1Tgot/Slc22a18tm1Tgot
(B6.Cg-Slc22a18tm1Tgot) 		decreased liver triglyceride level J:349247
Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.129-Slc25a13tm1Lct) 		hepatic steatosis J:124766
increased liver triglyceride level J:124766
Slc25a17Gt(XB686)Byg/Slc25a17Gt(XB686)Byg
(involves: 129P2/OlaHsd * C57BL/6 * Swiss Webster) 		abnormal Kupffer cell morphology J:291257
enlarged liver J:291257
hepatic steatosis J:291257
increased hepatocyte apoptosis J:291257
liver inflammation J:291257
Slc25a20tm1a(EUCOMM)Wtsi/Slc25a20tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc25a20tm1a(EUCOMM)Wtsi/Wtsi) 		herniated liver J:239583
Slc25a24tm1Sinos/Slc25a24tm1Sinos
(B6(Cg)-Slc25a24tm1Sinos) 		decreased liver triglyceride level J:312208
decreased liver weight J:312208
Slc25a28tm1.1Dwrd/Slc25a28tm1.1Dwrd
Slc25a37tm1.1Kapl/Slc25a37tm1.1Kapl
Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA) 		decreased liver iron level J:300667
Slc25a28tm1.1Dwrd/Slc25a28tm1.1Dwrd
Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA) 		decreased liver iron level J:300667
Slc25a28tm1.2Dwrd/Slc25a28tm1.2Dwrd
(involves: 129S6/SvEvTac * C57BL/6NCrl) 		decreased liver iron level J:300667
Slc25a28tm1.2Dwrd/Slc25a28tm1.2Dwrd
Slc25a37tm1.1Kapl/Slc25a37tm1.1Kapl
Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA) 		impaired liver regeneration J:300667
Slc25a34em1Duna/Slc25a34em1Duna
(C57BL/6J-Slc25a34em1Duna) 		hepatic steatosis J:344152
increased liver weight J:344152
Slc25a37tm1.1Kapl/Slc25a37tm1.1Kapl
Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA) 		decreased liver iron level J:300667
impaired liver regeneration J:300667
Slc25a37tm1.1Kapl/Slc25a37tm1.2Kapl
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * DBA) 		cholestasis J:173284
enlarged liver J:173284
liver fibrosis J:173284
Slc26a1tm1Mark/Slc26a1tm1Mark
(involves: 129X1/SvJ * CD-1) 		abnormal liver physiology J:158567
hepatic necrosis J:158567
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129/Sv * C57BL/6) 		abnormal hepatocyte morphology J:124917
abnormal liver physiology J:124917
decreased liver cholesterol level J:124917
decreased liver triglyceride level J:124917
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129) 		abnormal bile composition J:124916
Slc29a3em1(IMPC)Mbp/Slc29a3em1(IMPC)Mbp
(C57BL/6NCrl-Slc29a3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
increased liver weight J:211773
Slc30a8tm1.1Htwt/Slc30a8tm1.1Htwt
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * CBA/JNCrlj * DBA) 		liver/biliary system phenotype J:204003
Slc30a10tm1.1Sommu/Slc30a10tm1.1Sommu
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA) 		abnormal hepatocyte morphology J:243657
decreased liver glycogen level J:243657
increased liver manganese level J:243657
liver degeneration J:243657
Slc31a1tm1Djt/Slc31a1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased liver iron level J:69897
Slc31a1tm2Djt/Slc31a1tm2Djt
Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * FVB/N * SJL) 		abnormal liver copper level J:129741
Slc37a1tm1b(EUCOMM)Hmgu/Slc37a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc37a1tm1b(EUCOMM)Hmgu/Orl) 		abnormal liver morphology J:211773
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6) 		enlarged liver J:86005
increased liver glycogen level J:86005
Slc38a10tm1a(EUCOMM)Wtsi/Slc38a10tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		abnormal liver physiology J:213427
Slc39a2tm1Gka/Slc39a2tm1Gka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal liver iron level J:121899
Slc39a4tm2Gka/Slc39a4tm2Gka
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal liver morphology J:187178
decreased liver copper level J:187178
increased liver copper level J:187178
increased liver iron level J:187178
Slc39a5tm1.1Gka/Slc39a5tm1.1Gka
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal liver zinc level J:209760
Slc39a5tm1Gka/Slc39a5tm1Gka
Tg(Cela1-cre/ERT)1Lgdn/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased liver iron level J:209760
Slc39a14tm1Lex/Slc39a14tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal liver zinc level J:236296
decreased hepatocyte proliferation J:236296
decreased liver weight J:236296
impaired liver regeneration J:236296
Slc39a14tm1Thir/Slc39a14tm1Thir
(involves: 129 * C57BL/6) 		abnormal liver zinc level J:171670
Slc40a1ffe/Slc40a1+
(either: (involves: 129X1/SvJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6J)) 		increased liver iron level J:118592
Slc40a1Pcm/Slc40a1+
(A.Cg-Slc40a1Pcm) 		decreased liver iron level J:98335
Slc40a1Pcm/Slc40a1Pcm
(A.Cg-Slc40a1Pcm) 		decreased liver iron level J:98335
increased liver iron level J:89185
Slc40a1tm1.1Mmfe/Slc40a1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver iron level J:215585
Slc40a1tm1.1Mmfe/Slc40a1tm1.1Mmfe
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:215585
abnormal liver physiology J:215585
increased liver iron level J:215585
Slc40a1tm1Nca/Slc40a1+
(involves: 129S4/SvJae * 129S6/SvEvTac) 		decreased liver iron level J:129846
Slc40a1tm2Nca/Slc40a1tm2Nca
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased liver iron level J:129846
Slc43a2Gt(258C1)Cmhd/Slc43a2Gt(258C1)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1) 		abnormal liver physiology J:237439
liver inflammation J:237439
Slc47a1Gt(IST12634F2)Tigm/Slc47a1Gt(IST12634F2)Tigm
(B6.B6N-Slc47a1Gt(IST12634F2)Tigm) 		abnormal liver morphology J:206792
Slc48a1em1Ih/Slc48a1em1Ih
(involves: 129 * C57BL/6J) 		abnormal liver morphology J:282829
increased liver iron level J:282829
Slco1a1tm1Dgen/Slco1a1tm1Dgen
(B6N.129P2-Slco1a1tm1Dgen) 		abnormal hepatocyte physiology J:174999
Slco1a4tm1Dgen/Slco1a4tm1Dgen
(B6N.129P2-Slco1a4tm1Dgen) 		abnormal hepatocyte physiology J:174999
Slco1b2tm1Cdk/Slco1b2tm1Cdk
(involves: 129S1/Sv * C57BL/6) 		abnormal liver physiology J:133919
Slco1b2tm1Cdk/Slco1b2tm1Cdk
(B6.129S1-Slco1b2tm1Cdk) 		abnormal liver physiology J:133919
Slit3tm1.1Dor/Slit3tm1.1Dor
(involves: 129S1/Sv * C57BL/6J) 		herniated liver J:83292
Slit3tm1Dor/Slit3tm1Dor
(involves: 129S1/Sv * C57BL/6J) 		absent falciform ligament J:83292
herniated liver J:83292
Slntm1Peri/Slntm1Peri
(involves: C57BL/6J) 		hepatic steatosis J:193427
Smad2tm1.1Epb/Smad2tm1.1Epb
Smad3tm1Cxd/Smad3tm1Cxd
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * DBA * SJL) 		liver/biliary system phenotype J:119642
Smad2tm1.1Epb/Smad2tm1.1Epb
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129/Sv * C57BL/6 * DBA * SJL) 		abnormal hepatocyte morphology J:119642
abnormal hepatocyte physiology J:119642
increased hepatocyte proliferation J:119642
liver/biliary system phenotype J:119642
Smad2tm1Cxd/Smad2+
Smad3tm1Cxd/Smad3+
(involves: 129S6/SvEvTac * NIH Black Swiss) 		abnormal hepatic cord morphology J:70388
abnormal hepatoblast migration J:106308
abnormal hepatocyte physiology J:70388
abnormal liver morphology J:70388
decreased hepatocyte proliferation J:70388
delayed hepatic development J:106308
dilated liver sinusoidal space J:70388
liver hypoplasia J:70388, J:106308
small liver J:70388
Smap1tm1.1Sata/Smap1tm1.1Sata
(B6.Cg-Smap1tm1.1Sata) 		enlarged liver J:196385
Smarca4enu1/Smarca4tm1Mag
(involves: 129S/Sv * C57BL/10 * CBA/Cbi) 		abnormal liver morphology J:103896
Smarcb1tm1Mya/Smarcb1tm2Mya
Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N) 		abnormal hepatocyte morphology J:103919
decreased liver glycogen level J:103919
dissociated hepatocytes J:103919
increased hepatocyte proliferation J:103919
Smarcb1tm1Sho/Smarcb1tm3Sho
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal liver morphology J:80224
enlarged liver J:80224
Smarcd1tm1.1Jddl/Smarcd1tm1.1Jddl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased liver cholesterol level J:228944
Smg1Gt(AG0297)Wtsi/Smg1+
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:193626
hepatic steatosis J:193626
Smg9tm1b(EUCOMM)Wtsi/Smg9tm1b(EUCOMM)Wtsi
(C57BL/6N-Smg9tm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
liver cyst J:239583
Smpd1tm1Wst/Smpd1tm1Wst
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:26748
hepatosplenomegaly J:26748
Smurf2Gt(RRA098)Byg/Smurf2Gt(RRA098)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocellular carcinoma incidence J:189320
Snap25tm1.1Bark/Snap25tm1.1Bark
(Not Specified) 		hepatic steatosis J:226064
Snhg15tm1Nju/Snhg15tm1Nju
(involves: C57BL/6J) 		liver/biliary system phenotype J:291983
Snord50a/Snord50btm1.1Soen/Snord50a/Snord50btm1.1Soen
(B6.129P2-Snord50a/Snord50btm1.1Soen) 		decreased liver weight J:206419
Snord50a/Snord50btm1.1Soen/Snord50a/Snord50btm1.1Soen
(B6.129P2-Snord50a/Snord50btm1.1Soen) 		decreased liver weight J:206419
Snord116tm1.1Uta/Snord116+
(involves: C57BL/6J) 		decreased liver weight J:131662
small liver J:131662
Snord116tm1Uta/Snord116+
Tg(Zp3-cre)93Knw/0
(involves: C57BL/6J) 		decreased liver weight J:131427
small liver J:131427
Snrktm1.1Hxu/Snrktm1.1Hxu
Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr) 		hepatic steatosis J:257980
Snx27tm1Lslo/Snx27tm1Lslo
(involves: 129P2/OlaHsd) 		small liver J:171001
Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * C57BL/6) 		abnormal liver morphology J:37049
Soat2tm1.1Llr/Soat2tm1.1Llr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA) 		decreased liver cholesterol level J:184908
decreased liver triglyceride level J:184908
Soat2tm1.1Llr/Soat2tm1.1Llr
Tg(Vil1-cre)997Gum/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL) 		decreased liver cholesterol level J:184908
decreased liver triglyceride level J:184908
Soat2tm1Far/Soat2tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		abnormal bile composition J:82032
abnormal gallbladder physiology J:82032
decreased susceptibility to diet-induced hepatic steatosis J:82032
Socs1tm1Jni/Socs1+
(Not Specified) 		abnormal liver morphology J:91651
increased hepatoma incidence J:91651
Socs1tm1Kish/Socs1tm1Kish
(involves: 129P2/OlaHsd * C57BL/6J) 		enlarged liver J:51685
Socs1tm1Kish/Socs1tm1Kish
(B6.129P2-Socs1tm1Kish) 		enlarged liver J:69472
liver inflammation J:69472
Socs1tm1Kish/Socs1tm1Kish
Stat1tm1Rds/Stat1tm1Rds
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		enlarged liver J:69472
liver inflammation J:69472
Socs1tm1Kish/Socs1tm1Kish
Stat6tm1Aki/Stat6tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:69472
liver inflammation J:69472
Socs1tm1Wehi/Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6) 		hepatic necrosis J:57474
hepatic steatosis J:57474, J:51281
liver degeneration J:51281
liver inflammation J:51281
Socs1tm2Wehi/Socs1tm2Wehi
(C57BL/6-Socs1tm2Wehi) 		liver inflammation J:72528
Socs2tm1Wehi/Socs2tm1Wehi
(C57BL/6-Socs2tm1Wehi) 		abnormal hepatobiliary system morphology J:63006
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J) 		decreased liver triglyceride level J:186227
decreased susceptibility to diet-induced hepatic steatosis J:186227
liver inflammation J:186227
Socs3tm1Jni/Socs3tm1Jni
(involves: 129P2/OlaHsd) 		abnormal liver morphology J:57476
Socs3tm1Wsa/Socs3tm1Wsa
(either: C57BL/6-Socs3tm1Wsa or (involves: 129 * C57BL/6)) 		liver hypoplasia J:70667
small liver J:70667
Socs3tm1Wsa/Socs3tm2Wsa
Tg(Vav1-cre)1Awr/0
(involves: C57BL/6) 		liver inflammation J:89785
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J) 		abnormal liver morphology J:219360
increased hepatocellular carcinoma incidence J:219360
increased liver tumor incidence J:219360
liver inflammation J:219360
Sod1tm1Cep/Sod1tm1Cep
(involves: 129S1/Sv * 129X1/SvJ) 		hepatic steatosis J:71134
Sod2tm1Cje/Sod2+
(involves: C57BL/6J * CD-1) 		increased hepatocyte apoptosis J:67874
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * CD-1) 		abnormal liver physiology J:29899
hepatic steatosis J:29899
increased liver weight J:29899
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J) 		hepatic steatosis J:45913
Sod2tm1Cje/Sod2tm1Cje
(D2.Cg-Sod2tm1Cje) 		hepatic steatosis J:73998
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * DBA/2J) 		liver/biliary system phenotype J:73998
Sod2tm1Leb/Sod2tm1Leb
(B6.129S7-Sod2tm1Leb/J) 		abnormal hepatocyte morphology J:36148
Sod2tm1Shs/Sod2tm1Shs
(involves: C57BL/6 * DBA) 		liver/biliary system phenotype J:78889
Sowahaem1(IMPC)Mbp/Sowahaem1(IMPC)Mbp
(C57BL/6N-Sowahaem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Sox4em1(IMPC)Mbp/Sox4+
(C57BL/6NCrl-Sox4em1(IMPC)Mbp/MbpMmucd) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Sox7tm1.1Dsco/Sox7+
(involves: 129S/SvEv * C57BL/6) 		abnormal gallbladder morphology J:187416
Sox9em1(cre/ERT2)Smoc/Sox9+
Tnfsf18em1Pwan/Tnfsf18em1Pwan
(involves: C57BL/6J) 		decreased hepatoblast number J:346395
Sox17SHIVA/Sox17+
(either: C57BL/6-Sox17SHIVA or (involves: C57BL/6 * C3H/HeN)) 		decreased liver triglyceride level J:219119
Sox17tm1Jaw/Sox17tm1Jaw
Tg(Foxa3-cre)1Khk/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		abnormal bile duct development J:151981
abnormal common bile duct morphology J:151981
absent gallbladder J:151981
Sox17tm1Jaw/Sox17tm1Jaw
Tg(Pdx1-cre)6Tuv/0
(involves: 129S6/SvEvTac * FVB/N) 		abnormal bile duct development J:151981
Sox17tm1Jaw/Sox17tm1Sjm
Tg(Foxa3-cre)1Khk/0
(involves: 129 * C57BL/6 * DBA) 		abnormal bile duct development J:151981
Sox17tm1Jaw/Sox17tm1Sjm
Tg(Pdx1-cre)6Tuv/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB/N) 		abnormal bile duct development J:151981
absent gallbladder J:151981
Sox17tm1Sjm/Sox17tm1Sjm
(BKa.129-Sox17tm1Sjm) 		liver hypoplasia J:123050
Sox17tm1Sjm/Sox17tm1Sjm
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal bile duct development J:151981
Sox17tm1Ysk/Sox17+
(involves: 129S1/Sv * C57BL/6) 		abnormal extrahepatic bile duct morphology J:194071
abnormal gallbladder morphology J:194071
liver inflammation J:194071
Sox17tm1Ysk/Sox17+
(B6.129S1-Sox17tm1Ysk) 		abnormal bile duct development J:194071
abnormal extrahepatic bile duct morphology J:194071
abnormal gallbladder epithelium morphology J:194071, J:241569
abnormal gallbladder morphology J:194071, J:241569
abnormal gallbladder physiology J:241569
abnormal gallbladder smooth muscle morphology J:241569
abnormal hepatocyte morphology J:194071
abnormal liver development J:194071
abnormal liver lobule morphology J:194071
biliary atresia J:241569
cholestasis J:194071, J:241569
decreased liver weight J:194071
extrahepatic cholestasis J:194071
gallbladder inflammation J:241569
liver inflammation J:194071
small gallbladder J:241569
Sox17tm2Sjm/Sox17+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal cystic duct morphology J:241569
abnormal gallbladder epithelium morphology J:241569
abnormal gallbladder size J:241569
abnormal liver morphology J:241569
biliary atresia J:241569
cholestasis J:241569
liver inflammation J:241569
Sox21em1(IMPC)Mbp/Sox21em1(IMPC)Mbp
(C57BL/6NCrl-Sox21em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Sp1tm1Phi/Sp1+
Sp3tm1Sus/Sp3+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver sinusoid morphology J:123073
decreased liver weight J:123073
small liver J:123073
Sp3tm1Sus/Sp3tm1Sus
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:84837
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(CAG-cat,-Creg1)#Yal/0
(involves: C57BL/6J * DBA) 		decreased liver cholesterol level J:263073
decreased liver free fatty acids level J:263073
decreased liver triglyceride level J:263073
decreased liver weight J:263073
increased liver glycogen level J:263073
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(CAG-Dusp26)#Jhxia/0
(involves: C57BL/6 * DBA) 		decreased liver cholesterol level J:279111
decreased liver free fatty acids level J:279111
decreased liver triglyceride level J:279111
decreased liver weight J:279111
decreased susceptibility to diet-induced hepatic steatosis J:279111
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tor1aip1tm1.1Wtd/Tor1aip1tm1.1Wtd
(Not Specified) 		abnormal hepatocyte morphology J:345574
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Trmutm1Tomik/Trmutm1Tomik
(involves: C57BL/6 * DBA) 		abnormal hepatocyte mitochondrial morphology J:235644
hepatic necrosis J:235644
increased hepatocyte karyomegaly J:235644
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tspotm1.1Maf/Tspotm1.1Maf
(involves: C57BL/6 * DBA) 		liver/biliary system phenotype J:214129
Spentm1Hon/Spentm1Hon
(involves: 129P2/OlaHsd * C57BL/6J) 		liver hypoplasia J:82332
small liver J:82332
Spi1tm1.1Dgt/Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ) 		enlarged liver J:90331
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6) 		abnormal liver morphology J:90331
increased liver weight J:90331
liver hyperplasia J:90331
Spi1tm1Ram/Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6) 		abnormal liver morphology J:36473
Spi1tm1Rpd/Spi1tm1Rpd
(involves: 129/Sv * C57BL/6 * Black Swiss) 		liver hyperplasia J:123079
Spin4em1Jbn/Y
(involves: C57BL/6J) 		increased liver weight J:347154
Spin4em2Jbn/Y
(involves: C57BL/6J) 		increased liver weight J:347154
Spp1tm1Rit/Spp1tm1Rit
(B6.129S7-Spp1tm1Rit) 		abnormal liver morphology J:93915
Spred2em1(IMPC)Mbp/Spred2em1(IMPC)Mbp
(C57BL/6N-Spred2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Spta1ihj/Spta1ihj
(involves: HRS/J * LAH) 		enlarged liver J:105409
jaundice J:105409
Spta1sph-2Bc/Spta1sph-2Bc
(involves: SELH) 		jaundice J:7048
Spta1sph-3J/Spta1sph-3J
(NOD.Cg-H2b Spta1sph-3J) 		increased liver iron level J:157766
Spta1sph-4J/Spta1sph-4J
(C57BL/6J-Spta1sph-4J/Llp) 		increased liver iron level J:157766
Spta1sph-Dem/Spta1sph-Dem
(CcS3/Dem-Spta1sph-Dem) 		jaundice J:66966
liver degeneration J:66966
Spta1sph-ha/Spta1sph-ha
(involves: DBA/1J) 		enlarged liver J:30699
jaundice J:30699, J:24729, J:14946
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1) 		gallstones J:12830
Spta1sph-ha/Spta1sph-ha
((WB.D1-Spta1sph-ha/Brk x B6.D1-Spta1sph-ha/Brk)F1) 		enlarged liver J:162532
jaundice J:162532
Spta1sph/Spta1sph
(involves: C3H) 		abnormal liver morphology J:12276
dilated liver sinusoidal space J:12276
enlarged liver J:12276
jaundice J:12276
liver vascular congestion J:12276
Spta1sph/Spta1sph
((WB.C3-Spta1sph x B6.C3-Spta1sph)F1) 		enlarged liver J:162532
focal hepatic necrosis J:44313
increased liver iron level J:44313
jaundice J:162532
Sptbja/Sptbja
(129/Sv-Sptbja) 		enlarged liver J:305
jaundice J:305
multifocal hepatic necrosis J:305
Sptbja/Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1) 		enlarged liver J:162532, J:44313
jaundice J:162532
Sptbm1Jus/Sptbm1Jus
(involves: 129S6/SvEvTac * C57BL/6) 		enlarged liver J:159750
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6) 		decreased hepatocyte proliferation J:132133
increased hepatocellular carcinoma incidence J:132133
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac) 		abnormal liver morphology J:166879
increased hepatocellular carcinoma incidence J:166879
increased liver tumor incidence J:166879
Sptbn1tm1Mish/Sptbn1tm1Mish
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		abnormal liver morphology J:81747
liver hypoplasia J:81747
Sptlc2tm2.1Jia/Sptlc2tm2.1Jia
(involves: 129S4/SvJaeSor * C57BL/6) 		abnormal liver physiology J:155507
Sqstm1em1Kmts/Sqstm1+
(involves: C57BL/6N) 		enlarged liver J:342766
Sqstm1tm2.1Jmos/Sqstm1tm2.1Jmos
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		liver/biliary system phenotype J:194291
Sqstm1tm2.1Jmos/Sqstm1tm2.1Jmos
Tg(Fabp4-cre)1Rev/0
(Not Specified) 		hepatic steatosis J:194291
Sra1tm1a(EUCOMM)Hmgu/Sra1tm1a(EUCOMM)Hmgu
(involves: C57BL/6J * C57BL/6N) 		abnormal liver morphology J:214131
decreased liver free fatty acids level J:214131
decreased liver triglyceride level J:214131
decreased liver weight J:214131
decreased susceptibility to diet-induced hepatic steatosis J:214131
Srebf1Gt(XC354)Byg/Srebf1Gt(XC354)Byg
(either: B6.129P2-Srebf1Gt(XC354)Byg or (involves: 129P2/OlaHsd * C57BL/6)) 		decreased liver triglyceride level J:152612
Srebf1tm1Jdh/Srebf1tm1Jdh
(involves: 129S/SvEvBrd * C57BL/6) 		increased liver cholesterol level J:43570
Srebf1tm1Mbr/Srebf1tm1Mbr
(involves: 129S6/SvEvTac) 		increased liver cholesterol level J:75320
Srebf1tm2Jdh/Srebf1tm2Jdh
(involves: 129S/SvEvBrd * C57BL/6) 		increased liver cholesterol level J:43570
Srebf2lop13/Srebf2lop13
(STOCK Srebf2lop13/J) 		decreased liver cholesterol level J:176249
Srebf2tm1Jdh/Srebf2tm1Jdh
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased liver cholesterol level J:241873
decreased liver triglyceride level J:241873
Srpxtm1Hzi/Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased hepatoma incidence J:119999
Srsf3tm1Pjln/Srsf3tm1Pjln
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA) 		abnormal bile canaliculus morphology J:205756
abnormal hepatobiliary system development J:205756
abnormal hepatocyte morphology J:205756
abnormal liver morphology J:205756
abnormal liver sinusoid morphology J:205756
decreased liver cholesterol level J:205756
decreased liver glycogen level J:205756
decreased liver triglyceride level J:205756
increased hepatocyte apoptosis J:205756
pale liver J:205756
small liver J:205756
Srsf10tm1Jalm/Srsf10tm1Jalm
(involves: 129P2/OlaHsd * C57BL/6) 		liver degeneration J:149480
Ssr1em1(IMPC)Mbp/Ssr1+
(C57BL/6N-Ssr1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Ssr2tm1b(EUCOMM)Wtsi/Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
Ssu72tm1Cwl/Ssu72tm1Cwl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal hepatocyte morphology J:309624
abnormal hepatocyte physiology J:309624
abnormal Ito cell morphology J:309624
abnormal liver development J:309624
abnormal liver morphology J:309624
hepatic necrosis J:309624
hepatic steatosis J:309624
increased hepatocyte apoptosis J:309624
increased hepatocyte karyomegaly J:309624
increased hepatocyte proliferation J:309624
increased liver weight J:309624
liver fibrosis J:309624
liver inflammation J:309624
St14tm1.1(KOMP)Vlcg/St14tm1.1(KOMP)Vlcg
(C57BL/6N-St14tm1.1(KOMP)Vlcg/MbpMmucd) 		abnormal liver size J:211773
pale liver J:211773
Stab1tm1.1Cger/Stab1tm1.1Cger
Stab2tm1.1Cger/Stab2tm1.1Cger
(B6.129S2-Stab2tm1.1Cger Stab1tm1.1Cger) 		abnormal liver physiology J:171818
liver fibrosis J:171818
Stab1tm1.1Cger/Stab1tm1.1Cger
Stab2tm1.1Cger/Stab2tm1.1Cger
(C.129S2-Stab2tm1.1Cger Stab1tm1.1Cger) 		abnormal liver physiology J:171818
liver fibrosis J:171818
Stab2tm1Ami/Stab2tm1Ami
(B6.Cg-Stab2tm1Ami) 		abnormal hepatocyte physiology J:182239
Stag1Gt(P099A04)Wrst/Stag1+
(involves: 129S2/SvPas) 		increased hepatocellular carcinoma incidence J:184720
Stard3tm1Jfs/Stard3tm1Jfs
(involves: 129X1/SvJ * C57BL/6J) 		increased liver cholesterol level J:89362
Stard4tm1.2Bres/Stard4tm1.2Bres
(involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL) 		abnormal bile composition J:160807
decreased liver weight J:160807
Stard10tm1Saaa/Stard10tm1Saaa
(B6.Cg-Stard10tm1Saaa) 		abnormal bile composition J:198860
abnormal bile secretion J:198860
decreased liver cholesterol level J:198860
decreased liver triglyceride level J:198860
decreased liver weight J:198860
decreased susceptibility to diet-induced hepatic steatosis J:198860
Stat1tm1Dlv/Stat1tm1Dlv
(either: (involves: 129S/SvEv * C57BL/6) or (involves: 129S/SvEv * C57BL/6 * CD-1)) 		multifocal hepatic necrosis J:31325
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac) 		decreased hepatocyte apoptosis J:122801
Stat3tm1Flv/Stat3tm1Flv
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		enlarged liver J:89242
hepatic steatosis J:89242
Stat3tm1Flv/Stat3tm1Flv
Tg(Tek-cre)12Flv/0
(involves: 129 * C3H * C57BL/6) 		liver inflammation J:81973
Stat3tm1Jbha/Stat3tm1Jbha
Tg(Fabp4-cre)1Rev/0
(involves: 129S/SvEv * C57BL/6) 		increased liver weight J:136030
Stat3tm1Xyfu/Stat3tm1.1Xyfu
Tg(Ttr-cre)10-3Xyfu/?
(involves: 129S1/Sv * C57BL/6) 		decreased hepatocyte proliferation J:128719
Stat5atm1Jni/Stat5atm1Jni
Stat5btm2Jni/Stat5btm2Jni
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ)) 		abnormal liver physiology J:77412
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased liver iron level J:138904
Stat5btm1Hwd/Stat5btm1Hwd
(involves: 129 * BALB/c) 		abnormal liver physiology J:41784
enlarged liver J:41784
pale liver J:41784
Stat5btm1Jni/Stat5btm1Jni
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ)) 		abnormal liver physiology J:77412
Stat5btm1Mam/Stat5btm1Mam
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased liver iron level J:138904
Stat6tm1Gru/Stat6tm1Gru
(involves: 129S2/SvPas * BALB/c) 		liver/biliary system phenotype J:85386
Steap3fred/Steap3fred
(C57BL/6-Steap3fred) 		increased liver copper level J:145194
increased liver iron level J:145194
Steap3tm1.1Mdf/Steap3tm1.1Mdf
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J) 		increased liver iron level J:103440
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd) 		hepatic steatosis J:187736
increased liver triglyceride level J:187736
increased liver weight J:187736
Stk3tm1.1Jav/Stk3+
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
liver hyperplasia J:153945
Stk3tm1.1Jav/Stk3tm1.1Jav
Stk4Gt(AJ0315)Wtsi/Stk4+
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
Stk3tm1.1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
increased hepatocyte proliferation J:153945
liver hyperplasia J:153945
Stk3tm1.1Rjo/Stk3tm1.1Rjo
Stk4tm1.1Rjo/Stk4tm1.1Rjo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * DBA * SJL) 		abnormal hepatocyte morphology J:156531
abnormal liver morphology J:156531
abnormal liver sinusoid morphology J:156531
increased hepatocellular carcinoma incidence J:156531
increased hepatocyte apoptosis J:156531
increased hepatocyte proliferation J:156531
increased liver tumor incidence J:156531
increased liver weight J:156531
Stk3tm1.1Yy/Stk3+
Stk4tm1.1Yy/Stk4tm1.1Yy
(involves: C57BL/6 * CBA) 		abnormal liver physiology J:156541
decreased hepatocyte apoptosis J:156541
Stk3tm1.1Yy/Stk3tm1.1Yy
Stk4tm1.1Yy/Stk4tm1.1Yy
(involves: C57BL/6 * CBA) 		decreased hepatocyte apoptosis J:156541
Stk3tm1.1Yy/Stk3tm1Yy
Stk4tm1.1Yy/Stk4tm1.1Yy
(involves: C57BL/6 * CBA) 		abnormal liver physiology J:156541
decreased hepatocyte apoptosis J:156541
Stk3tm1.1Yy/Stk3tm1Yy
Stk4tm1.1Yy/Stk4tm1.1Yy
(involves: C57BL/6 * CBA) 		increased liver tumor incidence J:156541
Stk3tm1.1Yy/Stk3tm1Yy
Stk4tm1.1Yy/Stk4tm1.1Yy
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * CBA * DBA) 		abnormal hepatocyte morphology J:156541
abnormal liver morphology J:156541
enlarged liver J:156541
increased hepatocyte apoptosis J:156541
increased hepatocyte proliferation J:156541
Stk3tm1.1Yy/Stk3tm1Yy
Stk4tm1.1Yy/Stk4tm1.1Yy
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA) 		enlarged liver J:156541
increased hepatocellular carcinoma incidence J:156541
increased hepatocyte proliferation J:156541
increased liver tumor incidence J:156541
Stk3tm1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
increased hepatocyte proliferation J:153945
liver hyperplasia J:153945
Stk3tm1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6) 		increased hepatocellular carcinoma incidence J:153945
liver hyperplasia J:153945
Stk3tm1Jav/Stk3tm1Jav
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:238319
Stk11tm1.1Mlfr/Stk11+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J) 		enlarged liver J:104347
Stk11tm1Mmt/Stk11+
(involves: 129X1/SvJ) 		increased hepatocellular carcinoma incidence J:76202
Stk11tm1Mmt/Stk11+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * 129X1/SvJ) 		abnormal hepatocyte morphology J:107275
increased hepatocellular carcinoma incidence J:107275
increased liver tumor incidence J:107275
Stk11tm1Tpm/Stk11+
(Not Specified) 		increased hepatocellular carcinoma incidence J:79074
increased liver adenoma incidence J:79074
Stx2tm1Dcru/Stx2tm1Dcru
(involves: 129X1/SvJ * C57BL/6J) 		increased liver weight J:110376
Sucla2Gt(IST10208H1)Tigm/Sucla2+
(involves: 129S/SvEv * C57BL/6N) 		decreased hepatocyte mitochondrial DNA content J:241325
Sucla2Gt(IST10208H1)Tigm/Sucla2+
Suclg2Gt(Ayu21-KBW131)Imeg/Suclg2+
(involves: 129S/SvEv * C57BL/6 * C57BL/6N) 		decreased hepatocyte mitochondrial DNA content J:241325
Sufutm1b(KOMP)Wtsi/Sufutm1b(KOMP)Wtsi
(C57BL/6N-Sufutm1b(KOMP)Wtsi/Ucd) 		abnormal liver size J:211773
pale liver J:211773
Sugcttm1.2Kald/Sugcttm1.2Kald
(B6.Cg-Sugcttm1.2Kald) 		hepatic steatosis J:293423
Sugp1em1(IMPC)Mbp/Sugp1+
(C57BL/6NCrl-Sugp1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
small liver J:211773
Sult1a1em1(IMPC)Ccpcz/Sult1a1em1(IMPC)Ccpcz
(C57BL/6NCrl-Sult1a1em1(IMPC)Ccpcz/Ccpcz) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Sult1a1tm1Glatt/Sult1a1tm1Glatt
(FVB.Cg-Sult1a1tm1Glatt) 		abnormal liver physiology J:208180
Sult1a1tm1Glatt/Sult1a1tm1Glatt
Tg(SULT1A1,SULT1A2)1Glatt/0
(FVB.Cg-Sult1a1tm1Glatt Tg(SULT1A1,SULT1A2)1Glatt) 		abnormal liver physiology J:208180
Sumf1Gt(RST760)Byg/Sumf1Gt(RST760)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased hepatocyte apoptosis J:120146
Sun5em1(IMPC)Mbp/Sun5em1(IMPC)Mbp
(C57BL/6N-Sun5em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Surf4em1Bcgen/Surf4em1Bcgen
(C57BL/6J-Surf4em1Bcgen) 		increased liver cholesterol level J:302969
Syktm1.1(cre)Fkfr/Syktm1.1(cre)Fkfr
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sortm1(EYFP)Cos
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal liver development J:159112
decreased liver weight J:159112
liver hypoplasia J:159112
Syt1tm1a(EUCOMM)Wtsi/Syt1tm1a(EUCOMM)Wtsi
(C57BL/6N-Syt1tm1a(EUCOMM)Wtsi/Wtsi) 		biliary cyst J:239583
dilated bile duct J:239583
T(2;10)67Gso/T(2;10)67Gso
(involves: 101 * C3H * C3H/Rl * C57BL/RlGso * SEC/RlGso) 		biliary cyst J:75799
jaundice J:75799
Taar8bem1(IMPC)Mbp/Taar8bem1(IMPC)Mbp
(C57BL/6N-Taar8bem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Taar8cem1(IMPC)Mbp/Taar8cem1(IMPC)Mbp
(C57BL/6N-Taar8cem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Tab2tm1Aki/Tab2tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte morphology J:81816
liver hemorrhage J:81816
Tacc3tm1Jni/Tacc3tm1Jni
(involves: 129P2/OlaHsd * C57BL/6) 		liver hypoplasia J:74762
Tanktm1Aki/Tanktm1Aki
(involves: 129/Sv * C57BL/6) 		liver inflammation J:151757
Tbc1d10atm2a(EUCOMM)Wtsi/Tbc1d10atm2a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		abnormal liver physiology J:213427
Tbk1tm1Yeh/Tbk1tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6J) 		liver degeneration J:91653
liver hemorrhage J:91653
Tbl1xr1tm1.1Arte/Tbl1xr1tm1.1Arte
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		increased liver triglyceride level J:198124
Tbl1xr1tm1b(EUCOMM)Hmgu/Tbl1xr1+
(C57BL/6N-Tbl1xr1tm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
enlarged liver J:211773
Tbx3tm1Pa/Tbx3tm1Pa
(either: (involves: 129 * 129S1/Sv * 129X1/SvJ) or (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6NTac)) 		small liver J:82458
Tcea1tm1Skmz/Tcea1tm1Skmz
(involves: 129P2/OlaHsd * C57BL/6JJcl) 		liver hypoplasia J:107421
pale liver J:107421
Tcf3tm1(PBX1)Mlc/Tcf3+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged liver J:226241
Tcf3tm1(PBX1)Mlc/Tcf3+
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6) 		enlarged liver J:226241
Tcf3tm1(PBX1)Mlc/Tcf3+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J) 		enlarged liver J:226241
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2+
(C57BL/6-Tcf7l2tm1a(EUCOMM)Wtsi) 		abnormal hepatocyte physiology J:190447
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi) 		dilated liver sinusoidal space J:239583
Tchptm1Inag/Tchptm1Inag
(B6.129P2-Tchptm1Inag) 		decreased susceptibility to diet-induced hepatic steatosis J:304307
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi) 		abnormal hepatocyte morphology J:135830
decreased hepatocyte apoptosis J:135830
focal hepatic necrosis J:135830
liver inflammation J:135830
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		impaired liver regeneration J:105977
liver inflammation J:105977
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal liver morphology J:93915
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tcra-Jtm1Tgi Tg(Pklr-Myc)73Ak) 		increased hepatocellular carcinoma incidence J:184496
TcraLn1Ogu/Tcra+
(involves: 129/Sv * C57BL/6) 		abnormal liver morphology J:152041
Tdgtm1.1Abc/Tdgtm1.1Abc
(B6.129-Tdgtm1.1Abc) 		liver hemorrhage J:174772
Tent4atm1b(EUCOMM)Hmgu/Tent4atm1b(EUCOMM)Hmgu
(C57BL/6N-Tent4atm1b(EUCOMM)Hmgu/Ccpcz) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Tent5ctm1b(KOMP)Wtsi/Tent5ctm1b(KOMP)Wtsi
(C57BL/6N-Tent5ctm1b(KOMP)Wtsi/Wtsi) 		abnormal bile duct morphology J:239583
Terf2tm1Tdl/Terf2tm1.1Tdl
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal hepatocyte morphology J:112957
Terf2iptm1.2Tdl/Terf2iptm1.2Tdl
(involves: C57BL/6J * FVB/N) 		hepatic steatosis J:199372
Terttm1Rdp/Terttm1Rdp
(B6.Cg-Terttm1Rdp) 		decreased liver tumor incidence J:108914
Tet1tm1.1Gxu/Tet1tm1.1Gxu
(involves: 129 * 129P2/OlaHsd * C57BL/6J) 		increased liver iron level J:315675
Tet2Gt(AN0709)Wtsi/Tet2+
(B6.129P2-Tet2Gt(AN0709)Wtsi) 		enlarged liver J:174052
liver fibrosis J:174052
liver inflammation J:174052
Tet2Gt(AN0709)Wtsi/Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi) 		enlarged liver J:174052
liver inflammation J:174052
Tet2tm1.1Mjxu/Tet2tm1.1Mjxu
(involves: 129 * C57BL/6) 		enlarged liver J:178415
Tet2tm1Ics/Tet2tm1Ics
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		abnormal liver sinusoid morphology J:174052
enlarged liver J:174052
Tfr2em1(IMPC)Rbrc/Tfr2em1(IMPC)Rbrc
(C57BL/6N-Tfr2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Tfr2tm1.1Anro/Tfr2tm1.1Anro
(129.Cg-Tfr2tm1.1Anro) 		increased liver iron level J:160785
Tfr2tm1.1Nsub/Tfr2tm1.1Nsub
(involves: 129T2/SvEms * C57BL/6) 		increased liver iron level J:114330
Tfr2tm1.1Nsub/Tfr2tm1.1Nsub
(involves: 129T2/SvEms) 		increased liver iron level J:160785
Tfr2tm1Slu/Tfr2tm1Slu
(involves: 129X1/SvJ * C57BL/6J) 		increased liver iron level J:78360
Tfrctm1Nca/Tfrc+
(either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S4/SvJae * C57BL/6)) 		decreased liver iron level J:54107
Tg(Abcg1)80-90Ssf/?
(C57BL/6-Tg(Abcg1)80-90Ssf) 		increased liver cholesterol level J:94077
Tg(Abcg1)123Ssf/?
(C57BL/6-Tg(Abcg1)123Ssf) 		increased liver cholesterol level J:94077
Tg(ABCG5/ABCG8)14-2Hobb/0
(involves: C57BL/6J * SJL) 		abnormal bile composition J:78963, J:100491
decreased susceptibility to diet-induced hepatic steatosis J:78963
Tg(Ace2-ACE2)1Cqin/0
(involves: ICR) 		hepatic necrosis J:141460
Tg(ACTB-Eif4e)#Ppp/?
(Not Specified) 		increased liver adenoma incidence J:89878
Tg(Actb-Ptma)T12Clwu/Tg(Actb-Ptma)T12Clwu
(involves: FVB/N) 		increased liver weight J:128557
Tg(ACTB-TNFRSF6B)754Jwu/?
(B6.Cg-Tg(Actb-TNFRSF6B)754Jwu) 		abnormal liver physiology J:148162
Tg(Adipoq-LPL)1Fnln/?
(B6.Cg-Tg(Adipoq-LPL)1Fnln) 		decreased liver triglyceride level J:226970
increased liver triglyceride level J:226970
Tg(Alb1-cre)7Gsc/0
Tfr2tm1.1Anro/Tfr2tm1.1Anro
(involves: 129/Sv * C57BL/6 * FVB/N) 		increased liver iron level J:160785
Tg(Alb1-GP33/H2-Kb)1Hpi/0
Tg(Alb1-HBV)66Bri/0
(involves: C57BL/6 * C57BL/10 * DBA/2) 		liver inflammation J:162605
Tg(Alb1-GP33/H2-Kb)1Hpi/0
Tg(Alb1-HBV)66Bri/0
Tg(TcrLCMV)318Sdz/0
(involves: C57BL/6 * C57BL/10 * DBA/2) 		liver inflammation J:162605
Tg(Alb1-Myc)#Sst/0
(involves: C57BL/6 * CBA) 		abnormal hepatocyte morphology J:34434
increased hepatocellular carcinoma incidence J:34434
increased liver adenoma incidence J:34434
increased liver weight J:34434
Tg(Alb1-Myc)#Sst/0
Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		abnormal hepatocyte morphology J:34434
increased hepatocellular carcinoma incidence J:34434
increased hepatocyte apoptosis J:34434
increased hepatocyte karyomegaly J:34434
increased liver adenoma incidence J:34434
increased liver weight J:34434
multifocal hepatic necrosis J:34434
Tg(Alb1-Myc)#Sst/0
Tg(MtTGFA)Lmb/0
(involves: C57BL/6 * CBA * CD-1) 		increased hepatocellular carcinoma incidence J:176432
Tg(Alb1HBV)43Bri/0
(involves: C57BL/6J) 		abnormal liver morphology J:86165
increased liver tumor incidence J:86165
Tg(Alb1HBV)44Bri/0
(involves: C57BL/6J * SJL/J) 		abnormal liver morphology J:86165
increased hepatocellular carcinoma incidence J:86165
increased liver adenoma incidence J:86165
increased liver tumor incidence J:86165
Tg(Alb1HBV)44Bri/0
(C57BL/6J-Tg(Alb1HBV)44Bri/J) 		increased hepatocellular carcinoma incidence J:223921
increased liver adenoma incidence J:223921
increased liver tumor incidence J:223921
liver inflammation J:223921
Tg(ALB-cre,CMV-rtTA)#Wcyy/0
Tg(CMV-EGFP,Rnu6-siAbca1)#Wcyy/0
(involves: ICR) 		hepatic steatosis J:93624
Tg(Alb-E2F1)8Sst/0
(involves: C57BL/6J * CBA/J) 		increased hepatocellular carcinoma incidence J:65354, J:101128
increased hepatocyte proliferation J:65354
increased liver adenoma incidence J:65354
increased liver tumor incidence J:65354, J:101128
macrovesicular hepatic steatosis J:65354
Tg(Alb-HBx)A112Tfts/0
(involves: C57BL/6) 		abnormal liver morphology J:104728
hepatic steatosis J:104728
impaired liver regeneration J:104728
increased hepatocellular carcinoma incidence J:104728
liver hyperplasia J:104728
Tg(Alb-HRAS*G12V)28Yu/0
(involves: C57BL/6J * CBA/J) 		abnormal hepatocyte physiology J:107083
increased hepatocellular carcinoma incidence J:107083, J:238319
increased hepatocyte apoptosis J:107083
increased liver adenoma incidence J:107083, J:238319
increased liver tumor incidence J:107083, J:238319
Tg(Alb-Nos2)1Mkan/?
(FVB-Tg(Alb-Nos2)1Mkan) 		decreased liver glycogen level J:177591
increased liver triglyceride level J:177591
Tg(Alb-PDGFC)#Jcam/0
(involves: C57BL/6) 		abnormal Ito cell morphology J:96979
abnormal liver morphology J:96979, J:211984
abnormal liver physiology J:211984
abnormal liver sinusoid morphology J:96979, J:211984
abnormal liver vasculature morphology J:211984
chronic liver inflammation J:211984
enlarged liver J:96979
hepatic steatosis J:96979
increased hepatocellular carcinoma incidence J:96979, J:211984
increased hepatocyte proliferation J:96979
liver fibrosis J:96979, J:211984
liver vascular congestion J:211984
macrovesicular hepatic steatosis J:96979
microvesicular hepatic steatosis J:96979
Tg(Alb-REG3A)24Lchr/0
(involves: C57BL/6 * CBA) 		abnormal liver physiology J:84698
enhanced liver regeneration J:84698
increased hepatocyte proliferation J:140235, J:84698
Tg(Alb-SND1)3aDsar/0
(involves: C57BL/6 * CBA) 		abnormal hepatocyte physiology J:242582
chronic liver inflammation J:242582
increased hepatocellular carcinoma incidence J:242582
Tg(Alb-SREBF1_ic)#Jkot/0
(involves: C57BL/6) 		abnormal liver morphology J:249664, J:185313
enlarged liver J:249664, J:185313
hepatic steatosis J:249664, J:185313
Tg(Alb-TAg)1Gjh/0
(C3.Cg-Tg(Alb-TAg)1Gjh) 		increased hepatocellular carcinoma incidence J:105110
Tg(Alb-TAg)#Arnd/0
(C3Fe.Cg-Tg(Alb-TAg)#Arnd) 		increased hepatocellular carcinoma incidence J:171880
Tg(Amy1TAg)354Knw/0
(C57BL/6J-Tg(Amy1TAg)354Knw) 		increased hepatoma incidence J:90326
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL) 		abnormal hepatocyte morphology J:50770
abnormal liver lobule morphology J:50770
abnormal liver morphology J:249664
enlarged liver J:50770, J:249664
hepatic steatosis J:50770, J:249664
increased liver triglyceride level J:50770
increased liver weight J:50770
liver inflammation J:249664
pale liver J:50770
Tg(APCS-Ifng)5Imeg/0
(involves: C57BL/6 * DBA/2) 		abnormal liver morphology J:16979
chronic liver inflammation J:135124
liver fibrosis J:16979
liver inflammation J:16979
liver vascular congestion J:135124
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2) 		decreased liver glycogen level J:57075
decreased liver triglyceride level J:57075
decreased liver weight J:57075
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N) 		small liver J:69591
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(C57BL/6-Tg(APOC1)1Lmh) 		enlarged liver J:65036
Tg(APOE-ABCA1)30Ssf/?
(C57BL/6N-Tg(APOE-ABCA1)30Ssf) 		increased liver cholesterol level J:70494
Tg(APOE-ABCG1)1Ssf/?
(C57BL/6-Tg(APOE-ABCG1)1Ssf) 		increased liver cholesterol level J:94077
Tg(APOE-DGAT1)1Far/0
(involves: C57BL/6NHsd) 		increased liver triglyceride level J:124005
liver inflammation J:124005
Tg(APOE-DGAT2)1Far/0
(involves: C57BL/6NHsd) 		enlarged liver J:124005
hepatic steatosis J:124005
liver inflammation J:124005
pale liver J:124005
Tg(APOE-DGAT2)24Far/0
(involves: C57BL/6NHsd) 		enlarged liver J:124005
hepatic steatosis J:124005
pale liver J:124005
Tg(Apoe-Fgf21)1Sakl/0
(Not Specified) 		increased liver glycogen level J:150831
Tg(APOE-NPC1L1)20Lqyu/0
(involves: C57BL/6 * DBA/2) 		abnormal bile composition J:124193
Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
(involves: C57BL/6 * DBA) 		hepatic steatosis J:172091
increased liver triglyceride level J:172091
Tg(APOE-SGMS2)#Jia/0
(involves: C57BL/6 * C57BL/6J * CBA) 		abnormal hepatocyte physiology J:162192
Tg(AR*100Q)C25Als/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver morphology J:89772
Tg(AZIP/F)1Vsn/0
(involves: FVB/N) 		hepatic steatosis J:50807
increased liver triglyceride level J:50807
increased liver weight J:50807
Tg(CAG-Btc)2Ewo/0
(FVB/N-Tg(CAG-Btc)2Ewo) 		increased liver weight J:103364
Tg(CAG-Btc)4Ewo/0
(FVB/N-Tg(CAG-Btc)4Ewo) 		increased liver weight J:103364
Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6 * FVB/N) 		hepatic necrosis J:142212
small liver J:142212
Tg(CAG-DPP4)4Yuzh/0
(C57BL/6-Tg(CAG-DPP4)4Yuzh) 		liver inflammation J:286175
Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N) 		increased liver tumor incidence J:158388
Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB) 		dilated gallbladder J:80609
hepatic steatosis J:80609
Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB) 		dilated gallbladder J:80609
hepatic steatosis J:80609
Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB) 		dilated gallbladder J:80609
hepatic steatosis J:80609
Tg(CAG-S100a16)#Gpt/0
(C57BL/6J-Tg(CAG-S100a16)#Gpt) 		liver fibrosis J:330793
Tg(CAG-SAC/EGFP)35Rang/0
(involves: C3H * C57BL/6) 		decreased liver tumor incidence J:125633
liver/biliary system phenotype J:125633
Tg(CAG-Ubqln1)2Hmw/0
(involves: C57BL/6 * SJL) 		abnormal hepatocyte physiology J:206930
decreased hepatocyte apoptosis J:206930
Tg(CD2-NPM/ALK)4Sudt/0
(involves: C57BL/6J * CBA) 		increased liver tumor incidence J:181238
Tg(Cd3d-Il5)NJ.1638Nal/?
(involves: C57BL/6J * CBA/J) 		abnormal liver morphology J:123440
increased liver weight J:123440
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6) 		liver inflammation J:217939
Tg(Cd4-NPM/ALK)N1Ingh/0
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster) 		increased hepatocellular carcinoma incidence J:235890
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd) 		liver inflammation J:97554
Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6) 		abnormal liver morphology J:79703
Tg(Cebpb-tTA)5Bjd/0
Tg(tetO-MYC,-OVAL)#Gtgm/0
(B6J.Cg-Tg(Cebpb-tTA)5Bjd Tg(tetO-MYC,-OVAL)#Gtgm) 		increased hepatocellular carcinoma incidence J:186226
Tg(CETP)5203Tall/0
(involves: C57BL/6 * CBA/J) 		decreased liver triglyceride level J:117482
Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr) 		increased liver triglyceride level J:71205
Tg(CMV-cre)1Cgn/0
Tg(Kit*D814V)1Roer/0
(involves: BALB/cJ * C57BL/6) 		abnormal liver morphology J:169611
Tg(CMV-cre)1Cgn/0
Tg(Kit*D814V)3Roer/0
(involves: BALB/cJ * C57BL/6) 		abnormal liver morphology J:169611
Tg(CMV-tTA)3Bjd/0
Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		increased liver adenoma incidence J:94953
increased liver tumor incidence J:94953
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove) 		enlarged liver J:94602
Tg(CTSG-PML/RARA)135Ley/?
(Not Specified) 		enlarged liver J:77881
Tg(CTSG-ZBTB16/RARA)#Sjch/0
(involves: C57BL/6) 		abnormal liver morphology J:55196
Tg(Ela1-Myc)158Bri/0
(involves: C57BL/6 * SJL) 		jaundice J:76992
Tg(Ela1-Myc)159Bri/0
(involves: C57BL/6 * SJL) 		jaundice J:76992
Tg(Ela1-Myc)160Bri/0
(involves: C57BL/6 * SJL) 		jaundice J:76992
Tg(Fabp1-Ccnd1)2Rdb/0
(C57BL/6-Tg(Fabp1-Ccnd1)2Rdb) 		abnormal hepatocyte morphology J:70394
increased liver adenoma incidence J:70394
increased liver weight J:70394
Mallory bodies J:70394
Tg(Fabp1-Ccnd1)4Rdb/0
(C57BL/6-Tg(Fabp1-Ccnd1)4Rdb/J) 		abnormal hepatocyte morphology J:70394
increased hepatocellular carcinoma incidence J:70394
increased hepatocyte apoptosis J:70394
increased liver adenoma incidence J:70394
increased liver weight J:70394
Mallory bodies J:70394
Tg(Fabp1-Nr1h3)#Wexi/?
(involves: 129X1/SvJ * C57BL/6) 		enlarged liver J:135594
hepatic steatosis J:135594
increased liver triglyceride level J:135594
Tg(Fabp1-Nr1h3)#Wexi/?
Tg(Fabp1-NR1I2)#Wexi/?
(involves: 129X1/SvJ * C57BL/6) 		enlarged liver J:135594
increased liver triglyceride level J:135594
Tg(Fabp1-NR1I2)#Wexi/?
(involves: 129X1/SvJ * C57BL/6) 		enlarged liver J:135594
hepatic steatosis J:135594
increased liver triglyceride level J:135594
Tg(Fabp4-Apol6)#Hsul/0
(C57BL/6J-Tg(Fabp4-Apol6)#Hsul) 		increased liver triglyceride level J:344362
increased susceptibility to diet-induced hepatic steatosis J:344362
Tg(Fabp4-Ccl2)BYt/0
(involves: C57BL/6N) 		increased liver triglyceride level J:110277
Tg(Fabp4-ENPP1)#Naba/0
(involves: C57BL/6J) 		hepatic steatosis J:182179
increased liver triglyceride level J:182179
Tg(Fabp4-LEP)F8Ffc/0
(involves: C57BL/6J * DBA/2J) 		small liver J:67311
Tg(Fabp4-Phb)#Smis/0
(involves: CD-1) 		hepatic steatosis J:230172
Tg(Fabp4-Serpina12)1Jwada/0
(involves: C57BL/6JJcl) 		decreased liver triglyceride level J:208508
decreased liver weight J:208508
decreased susceptibility to diet-induced hepatic steatosis J:208508
Tg(Fabp4-SREBF1)#Dajl/0
(involves: FVB) 		enlarged liver J:189510
Tg(Fabp4-TLE3)#aPton/0
(involves: C57BL/6) 		decreased liver weight J:172245
decreased susceptibility to diet-induced hepatic steatosis J:172245
Tg(Gh-Gal)4599Vron/Tg(Gh-Gal)4599Vron
(B6.Cg-Tg(Gh-Gal)4599Vron) 		enlarged liver J:210298
hepatic steatosis J:210298
pale liver J:210298
Tg(H2-D-Il15)3304Clgr/?
(FVB/N-Tg(H2-D-Il15)3304Clgr) 		abnormal liver morphology J:67478
enlarged liver J:67478
Tg(H2-K-Fosl1)1Wag/0
(involves: C57BL/6 * CBA) 		liver cirrhosis J:64494
Tg(H2-K-Fosl2,-EGFP)13Wag/0
(either: 129.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag or B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag) 		liver fibrosis J:139032
Tg(HBV)10Imeg/0
(involves: C57BL/6) 		liver/biliary system phenotype J:95283
Tg(HBV-HCV)21Kko/0
(C57BL/6N-Tg(HBV-HCV)21Kko) 		hepatic steatosis J:94426, J:52686
increased hepatocellular carcinoma incidence J:52686
increased liver adenoma incidence J:52686
Tg(HBV-HCV)49Kko/0
(C57BL/6N-Tg(HBV-HCV)49Kko) 		hepatic steatosis J:94426, J:52686
increased hepatocellular carcinoma incidence J:52686
increased liver adenoma incidence J:52686
Tg(HBV-HCV)Kko/0
(C57BL/6N-Tg(HBV-HCV)Kko) 		abnormal hepatocyte morphology J:69727
abnormal liver physiology J:69727
hepatic steatosis J:94426, J:52686
increased hepatocellular carcinoma incidence J:52686
increased liver adenoma incidence J:52686
Tg(HBVX*,-Myc)#Skp/0
(Not Specified) 		increased hepatocellular carcinoma incidence J:81098
Tg(HBVX*,-Myc)#Skp/Tg(HBVX*,-Myc)#Skp
(Not Specified) 		abnormal hepatocyte mitochondrial morphology J:202732
abnormal hepatocyte morphology J:81098
abnormal liver lobule morphology J:81098
abnormal liver morphology J:81098
abnormal liver sinusoid morphology J:81098
decreased liver glycogen level J:81098
enlarged liver J:81098
focal hepatic necrosis J:81098
increased hepatocellular carcinoma incidence J:81098
increased liver iron level J:81098
increased liver weight J:81098
liver vascular congestion J:81098
microvesicular hepatic steatosis J:81098
Tg(HBx)3Yu/0
(involves: C57BL/6 * DBA) 		abnormal liver morphology J:56196
increased hepatocellular carcinoma incidence J:56196
Tg(Hnf1a-RB1*)XMiu/?
(Not Specified) 		abnormal hepatocyte morphology J:180294
increased liver adenoma incidence J:180294
Tg(Hnrnpa2b1-rtTA2S*M2)9Jstr/0
Tg(tetO-FMR1*,-EGFP)#Rkhu/0
(involves: C57BL/6JRj * FVB/N) 		abnormal liver morphology J:229379
hepatic steatosis J:229379
pale liver J:229379
Tg(IGFBP2)1Miel/0
(FVB/N-Tg(IGFBP2)1Miel) 		liver/biliary system phenotype J:121961
Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified) 		enlarged liver J:178816
Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6) 		enlarged liver J:76574
Tg(IghMyc)22Bri/0
Tg(Igk-V21-Bax)1967Bvn/0
(involves: C57BL/6 * FVB/N) 		abnormal liver morphology J:89049
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * C57BLKs/J * SJL) 		hepatic steatosis J:141527
Tg(IRS1)1Mhep/0
(FVB-Tg(IRS1)1Mhep) 		increased hepatocyte proliferation J:92999
increased liver weight J:92999
Tg(IRS1)1Mhep/0
Tg(SERPINA1-HBVX)1655Jtsb/0
(involves: C3H * C57BL/6 * FVB * ICR) 		hepatic steatosis J:227278
increased hepatocellular carcinoma incidence J:227278
Tg(ITGAM-HBEGF/EGFP)34Lan/0
(involves: FVB/N) 		liver fibrosis J:95141
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J) 		liver inflammation J:300960
Tg(KB1430A10)1Ped/0
(involves: BALB/cJ * C57BL/6) 		decreased liver triglyceride level J:117028
Tg(KRT14-Tslp)1Pcn/0
(involves: C57BL/6 * SJL) 		enlarged liver J:102470
Tg(KRT18*R89C)22Rgo/0
(involves: FVB/N) 		abnormal hepatocyte morphology J:241700
abnormal liver vasculature morphology J:241700
chronic liver inflammation J:241700
hepatic necrosis J:241700
liver hemorrhage J:241700
Tg(KRT18*R89C)30Rgo/0
(involves: FVB/N) 		abnormal hepatocyte morphology J:241700
abnormal liver vasculature morphology J:241700
chronic liver inflammation J:241700
hepatic necrosis J:241700
liver hemorrhage J:241700
Tg(KRT18*R89C)50Rgo/0
(involves: FVB/N) 		abnormal hepatocyte morphology J:241700
abnormal liver vasculature morphology J:241700
chronic liver inflammation J:241700
hepatic necrosis J:241700
liver hemorrhage J:241700
Tg(Lck-LMO1)11Sjk/0
Tg(STIL-TAL1)A5(3)Alpa/0
(involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros) 		enlarged liver J:40868
Tg(Lck-Tal1)4709Led/0
(FVB/N-Tg(Lck-Tal1)4709Led) 		enlarged liver J:36076
Tg(Lck-Tax)53Hall/0
(involves: C57BL/6) 		enlarged liver J:129531
hepatosplenomegaly J:129531
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf) 		abnormal liver morphology J:120962
liver inflammation J:129951
Tg(Lck-Tslp)1Chea/0
(B6.Cg-Tg(Lck-Tslp)1Chea) 		increased liver weight J:72982
liver inflammation J:72982
Tg(Ly6a-BCR/ABL1)IS1AIsg/0
(involves: C57BL/6J * CBA) 		abnormal liver morphology J:144382
increased hepatoma incidence J:144382
Tg(Ly6a-BCR/ABL1)IS1BIsg/0
(involves: C57BL/6J * CBA) 		abnormal liver morphology J:144382
increased hepatoma incidence J:144382
Tg(Mafg-Nfe2l1)1Mym/0
(involves: C57BL/6J * DBA/2) 		increased liver weight J:230118
Tg(Mafg-Nfe2l1)6Mym/0
(involves: C57BL/6J * DBA/2) 		increased liver weight J:230118
Tg(Mt1-GH1)#Jjk/0
(C57BL/6J-Tg(Mt1-GH1)#Jjk) 		increased liver weight J:132437
Tg(Mt1-IL6)28Gci/0
(involves: C57BL/6 * DBA/2) 		enlarged liver J:177825
Tg(MtTGFA)42Lmb/0
(involves: C57BL/6 * CD-1) 		increased liver tumor incidence J:2578
Tg(MtTGFA)42Lmb/0
(involves: CD-1 * FVB/N) 		increased liver tumor incidence J:2578
Tg(MtTGFA)42Lmb/Tg(MtTGFA)42Lmb
(involves: CD-1) 		abnormal hepatocyte morphology J:28452
abnormal liver morphology J:28452
enlarged liver J:28452
increased hepatocellular carcinoma incidence J:28452
increased hepatocyte karyomegaly J:28452
Tg(Mup3-Plau)350-2Eps/0
(involves: C57BL/6) 		increased liver tumor incidence J:66132
pale liver J:66132
Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps) 		abnormal hepatocyte morphology J:233146
hepatic necrosis J:233146
hepatic steatosis J:233146
increased hepatocellular carcinoma incidence J:233146
increased hepatocyte apoptosis J:233146
increased liver adenoma incidence J:233146
increased liver cholesterol level J:233146
increased liver free fatty acids level J:233146
increased liver triglyceride level J:233146
increased liver tumor incidence J:233146
liver fibrosis J:233146
liver hyperplasia J:233146
liver inflammation J:233146
Tg(Mx1-cre)1Cgn/0
Thoc5tm1Tate/Thoc5tm1Tate
(involves: C57BL/6 * CBA) 		pale liver J:169944
Tg(Myh6-ACE2)1Rbre/0
(involves: FVB/N) 		focal hepatic necrosis J:128793
Tg(Myh6-ACE2)2Rbre/0
(involves: FVB/N) 		focal hepatic necrosis J:128793
Tg(Myh6-CREB1*S133A)1Jml/0
(involves: CD-1) 		abnormal liver morphology J:133881
hepatic necrosis J:133881
liver vascular congestion J:133881
Tg(Myh6-Cryab*R120G)708Rbns/0
(FVB/N-Tg(Myh6-Cryab*R120G)708Rbns) 		liver vascular congestion J:133093
Tg(Myh6-GAL4)G#2Vmc/0
(FVB-Tg(Myh6-GAL4)G#2Vmc) 		abnormal liver parenchyma morphology J:330678
Tg(Myh6-Gnaq*Q209L)52Ejne/?
(involves: FVB) 		liver vascular congestion J:204274
Tg(Myh6-IGF1)34Pia/0
(FVB/N-Tg(Myh6-IGF1)34Pia) 		increased liver weight J:35215
Tg(Myh6-Med13)1Eno/0
(B6.Cg-Tg(Myh6-Med13)1Eno) 		abnormal liver triglyceride level J:186193
Tg(Myh6-Mef2d)2Eno/0
(Not Specified) 		liver vascular congestion J:130825
Tg(Myh6-Pln*R9C)#Ces/0
(involves: FVB/N) 		enlarged liver J:82353
Tg(Myh6-STK4)28Jusa/0
(involves: C57BL/6) 		increased liver weight J:139414
liver vascular congestion J:139414
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
(involves: C57BL/6 * CBA) 		liver vascular congestion J:131245
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB) 		abnormal liver morphology J:76323, J:77160
decreased liver triglyceride level J:76323
increased hepatocellular carcinoma incidence J:187236, J:77160
increased hepatocyte proliferation J:77160
increased liver tumor incidence J:77160
Tg(Neurog3-cre)C1Able/0
Tg(RNU6-EGFP,-RNAi:Dpp7)#Bhub/0
(involves: 129 * C57BL/6 * CD-1) 		hepatic steatosis J:158215
increased liver weight J:158215
Tg(Pkd1)6Mtru/0
(involves: C57BL/6J * CBA/J) 		increased hepatocyte proliferation J:157952
liver cyst J:157952
liver fibrosis J:157952
Tg(Pkd1)26Mtru/0
(involves: C57BL/6J * CBA/J) 		increased hepatocyte proliferation J:157952
liver cyst J:157952
liver fibrosis J:157952
Tg(Pklr-HRAS*G12V)23Ak/0
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:44803
increased hepatoma incidence J:44803
Tg(Pklr-Myc)73Ak/0
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:185488
increased hepatoma incidence J:185488
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tg(Pklr-Myc)73Ak) 		increased hepatocellular carcinoma incidence J:184496
Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA) 		increased hepatocellular carcinoma incidence J:185488
increased hepatoma incidence J:185488
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA) 		decreased susceptibility to diet-induced hepatic steatosis J:182671
Tg(RP23-291P1)1Flp/?
(involves: 129S1/SvImJ * FVB/NJ) 		abnormal bile composition J:104062
gallstones J:104062
Tg(RP23-326M22)760She/0
(B6.Cg-Tg(RP23-326M22)760She) 		abnormal hepatocyte morphology J:161765
Tg(rPEPCKSREBF2)788Reh/0
(Not Specified) 		increased liver cholesterol level J:86518
increased liver triglyceride level J:86518
pale liver J:86518
Tg(SERPINA1*E342K)#Slcw/0
(involves: C57BL/6 * ICR) 		abnormal hepatocyte morphology J:208016, J:149132
hepatic necrosis J:149132
liver inflammation J:149132
Tg(SERPINA1*E342K)#Slcw/Tg(SERPINA1*E342K)#Slcw
(involves: C57BL/6 * ICR) 		liver fibrosis J:208016
Tg(SERPINA1-HBVX)1655Jtsb/0
(involves: C3H * C57BL/6 * ICR) 		abnormal liver morphology J:90305
liver inflammation J:90305
Tg(SERPINA1-TAg)1812Jtsb/0
(involves: C3H * C57BL/6 * ICR) 		bile duct hyperplasia J:101633
increased hepatocellular carcinoma incidence J:101633
Tg(SERPINA1-Tnfsf12)1Biib/0
(involves: C57BL/6 * DBA/2) 		abnormal liver physiology J:100907
abnormal oval cell morphology J:100907
abnormal oval cell physiology J:100907
increased hepatocyte apoptosis J:100907
Tg(SERPINC1-SV40)A1Pbr/0
(involves: C57BL/6 * DBA/2) 		abnormal hepatocyte physiology J:101541
abnormal liver morphology J:101541
increased hepatocellular carcinoma incidence J:101541
Tg(SERPINC1-SV40)A1Pbr/Tg(SERPINC1-SV40)A1Pbr
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:101541
X/Tg(SERPINC1-SV40)BPbr
(involves: C57BL/6 * DBA/2) 		increased hepatocellular carcinoma incidence J:84204, J:101541
increased liver adenoma incidence J:84204
Tg(Sirt1)ASrn/?
(involves: C57BL/6 * CBA) 		decreased susceptibility to diet-induced hepatic steatosis J:137868
Tg(SREBP1a)7343Reh/0
(involves: C57BL/6J * SJL/J) 		abnormal hepatocyte morphology J:35770
enlarged liver J:35770
increased liver cholesterol level J:35770
increased liver triglyceride level J:35770
increased liver weight J:35770
liver/biliary system phenotype J:35770
pale liver J:35770
Tg(SREBP1a)7343Reh/0
(B6.Cg-Tg(SREBP1a)7343Reh) 		enlarged liver J:100328
Tg(SREBP1a)7343Reh/0
(Not Specified) 		impaired liver regeneration J:129886
Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL) 		enlarged liver J:93775
Tg(SULT1A1,SULT1A2)1Glatt/0
(FVB-Tg(SULT1A1,SULT1A2)1Glatt) 		abnormal liver physiology J:208180
Tg(SV40-Ahr)1Poe/0
(involves: C57BL/6 * CBA) 		increased liver weight J:77977
Tg(Tal1-cre/ERT)1Jrg/0
Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6) 		increased liver tumor incidence J:231316
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * MRL/Mp) 		increased hepatocyte apoptosis J:72817
liver inflammation J:72817
pale liver J:72817
Tg(Tek-cre)1Ywa/0
Thbdtm2Rdr/Thbdtm2Wlr
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal liver morphology J:71269
liver hemorrhage J:71269
Tg(Tek-Tnf*)5382Mcla/0
(B6.Cg-Tg(Tek-Tnf*)5382Mcla) 		chronic liver inflammation J:71622
Tg(tetO-BCR/ABL1)2Dgt/0
Tg(Tal1-tTA)19Dgt/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		enlarged liver J:96511
Tg(tetO-Kdr*)4377.5Rwng/0
Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		abnormal hepatocyte morphology J:100427
abnormal liver morphology J:100427
abnormal liver physiology J:100427
jaundice J:100427
liver/biliary system phenotype J:100427
Tg(tetO-MET)23Rwng/0
Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		abnormal hepatocyte morphology J:69731
enlarged liver J:69731
focal hepatic necrosis J:69731
hepatic steatosis J:69731
increased hepatocellular carcinoma incidence J:69731
jaundice J:69731
Tg(tetO-MYC)36aBop/0
Tg(Cebpb-tTA)5Bjd/0
(involves: FVB/N * NMRI) 		increased hepatoblastoma incidence J:93899
increased hepatocellular carcinoma incidence J:172430, J:186226, J:190067, J:93899
increased liver tumor incidence J:172430, J:93899
Tg(Tlr7)1Boll/0
(involves: C57BL/6) 		liver inflammation J:127600
X/Tg(Tlr7)6Boll
(involves: C57BL/6) 		liver inflammation J:127600
Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1) 		decreased liver weight J:73757
Tg(Ttr-Cdkn1a)36Tvd/?
(B6.Cg-Tg(Ttr-Cdkn1a)36Tvd) 		abnormal oval cell morphology J:94077
decreased hepatocyte proliferation J:94077
Tg(Ttr-IGF1)1Sykr/0
(FVB/N-Tg(Ttr-IGF1)1Sykr) 		increased liver weight J:157350
Tg(Ttr-KLF6)1Fdmn/?
(Not Specified) 		decreased hepatocyte number J:122903
decreased hepatocyte proliferation J:122903
decreased liver weight J:122903
Tg(Ttr-SMYD3)1Ital/?
(Not Specified) 		hepatic steatosis J:82809
pale liver J:82809
Tg(Vav1-Asxl1*Y588X)#Fcy/0
(C57BL/6-Tg(Vav1-Asxl1*Y588X)#Fcy) 		hepatosplenomegaly J:257690
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * CF-1) 		liver inflammation J:2892
multifocal hepatic necrosis J:2892
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * BALB/c * CF-1) 		liver inflammation J:69346
liver/biliary system phenotype J:69346
Tgfb1tm1Doe/Tgfb1tm1Doe
(C.129S2-Tgfb1tm1Doe) 		hepatic necrosis J:69346
liver inflammation J:69346
Tgfb1tm1Jmu/Tgfb1tm1Jmu
(involves: 129S6/SvEvTac * C57BL/6) 		liver inflammation J:120085
Tgfb1tm1Jmu/Tgfb1tm1Jmu
(involves: 129S6/SvEvTac * C57BL/6 * Swiss Webster) 		abnormal liver morphology J:120085
Tgfb1tm1N/Tgfb1tm1N
(involves: 129S/SvEv) 		abnormal liver morphology J:120085
Tgfb1tm1N/Tgfb1tm1N
(involves: 129S/SvEv * C57BL/6J * NIH/Ola) 		delayed hepatic development J:26913
Tgfbr2em1(IMPC)Rbrc/Tgfbr2+
(C57BL/6NJcl-Tgfbr2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
small liver J:211773
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		liver inflammation J:148747
Tgfbr2tm1Karl/Tgfbr2tm1Karl
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		liver inflammation J:77844
Tgfbr2tm1Sjkm/Tgfbr2+
(Not Specified) 		increased hepatocyte proliferation J:71591
Tgfbr3em1(IMPC)Mbp/Tgfbr3em1(IMPC)Mbp
(C57BL/6N-Tgfbr3em1(IMPC)Mbp/MbpMmucd) 		pale liver J:211773
Tgfbr3tm1Stv/Tgfbr3tm1Stv
(involves: 129/Sv * C57BL/6) 		abnormal liver development J:83727
Thtm1Rpa/Thtm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		liver vascular congestion J:24347
Thtm2Rpa/Thtm2Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		liver vascular congestion J:24347
Thap1tm1.1Meeh/Thap1tm1.2Meeh
(involves: 129S/SvEv * BALB/cJ * C3H * C57BL/6) 		absent liver J:226849
Thap1tm1.2Meeh/Thap1tm1.2Meeh
(involves: 129S/SvEv * BALB/cJ * C3H * C57BL/6) 		absent liver J:226849
Thbs1tm1.1(KOMP)Vlcg/Thbs1tm1.1(KOMP)Vlcg
(C57BL/6N-Thbs1tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Thbs1tm1Hyn/Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6)) 		abnormal cystic duct morphology J:48446
dilated gallbladder J:48446
Thbs1tm1Hyn/Thbs1tm1Hyn
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased liver adenocarcinoma incidence J:72391
Them4tm1Hem/Them4tm1Hem
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatocyte mitochondrial morphology J:149552
Them5tm1Hem/Them5tm1Hem
(involves: 129P2/OlaHsd * C57BL/6) 		hepatic steatosis J:186657
ThimTg(Myh6-TGFB1)1Ljf/Thim+
(involves: C3HeB/FeJ) 		abnormal liver morphology J:59903
Thoc2em1Gecz/Y
(C57BL/6JArc-Thoc2em1Gecz) 		decreased liver weight J:345229
small liver J:345229
Thratm4.1Ven/Thratm4.1Ven
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N) 		decreased liver weight J:166513
Thrap3tm1c(KOMP)Wtsi/Thrap3tm1c(KOMP)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA) 		abnormal hepatocyte physiology J:339439
abnormal liver physiology J:339439
decreased liver cholesterol level J:339439
decreased liver triglyceride level J:339439
decreased susceptibility to diet-induced hepatic steatosis J:339439
increased hepatocyte mitochondrial DNA content J:339439
Ticam1Lps2/Ticam1Lps2
(C57BL/6J-Ticam1Lps2) 		decreased susceptibility to alcohol-induced hepatic steatosis J:138963
Timm13em1(IMPC)Tcp/Timm13+
(C57BL/6NCrl-Timm13em1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Timo/Timo
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ)) 		hepatic steatosis J:127183
Timp3tm1Rkho/Timp3tm1Rkho
(B6.129-Timp3tm1Rkho) 		abnormal liver lobule morphology J:92948
hepatic necrosis J:92948
impaired liver regeneration J:92948
increased hepatocyte apoptosis J:92948
liver inflammation J:92948
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J) 		enlarged liver J:250417
hepatic steatosis J:250417
liver degeneration J:250417
Tjp1tm1.1Whun/Tjp1tm1.1Whun
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * C57BL/6NTac * DBA/2) 		liver/biliary system phenotype J:306936
Tjp1tm1.1Whun/Tjp1tm1.1Whun
Tjp2tm2Whun/Tjp2tm2Whun
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * C57BL/6NTac * DBA/2) 		abnormal bile canaliculus morphology J:306936
abnormal hepatic cord morphology J:306936
abnormal hepatic duct morphology J:306936
abnormal hepatocyte morphology J:306936
abnormal liver morphology J:306936
abnormal liver physiology J:306936
abnormal liver sinusoid morphology J:306936
increased hepatocyte proliferation J:306936
increased liver weight J:306936
small liver J:306936
Tjp2tm2Whun/Tjp2tm2Whun
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * DBA/2) 		liver/biliary system phenotype J:306936
Tk1tm1Vnd/Tk1tm1Vnd
(involves: 129P2/OlaHsd * C57BL/6) 		liver inflammation J:101669
Tk2tm1Anka/Tk2tm1Anka
(involves: 129X1/SvJ * C57BL/6) 		abnormal hepatocyte morphology J:137664
Tkttm1Jpi/Tkt+
(involves: 129X1/SvJ * C57BL/6J) 		decreased liver weight J:78430
Tle4em1(IMPC)Mbp/Tle4em1(IMPC)Mbp
(C57BL/6NCrl-Tle4em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Tll1tm1Dgr/Tll1tm1Dgr
(involves: 129S6/SvEvTac * Black Swiss) 		liver hemorrhage J:54910
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki) 		decreased liver tumor incidence J:143870
hepatic steatosis J:158035
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd) 		abnormal hepatocyte morphology J:135830
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir) 		decreased susceptibility to hepatic steatosis J:162168
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d) 		abnormal hepatocyte morphology J:135830
abnormal liver physiology J:98036
decreased hepatocyte apoptosis J:135830
decreased liver triglyceride level J:126488
focal hepatic necrosis J:135830
liver inflammation J:135830
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6) 		hepatic steatosis J:158055
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu) 		liver inflammation J:324448
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu) 		liver inflammation J:324448
Tm6sf2em1Yech/Tm6sf2em1Yech
(C57BL/6-Tm6sf2em1Yech) 		liver/biliary system phenotype J:235704
Tm6sf2tm1a(KOMP)Wtsi/Tm6sf2+
(C57BL/6N-Tm6sf2tm1a(KOMP)Wtsi) 		increased liver triglyceride level J:234195
Tm6sf2tm1a(KOMP)Wtsi/Tm6sf2tm1a(KOMP)Wtsi
(C57BL/6N-Tm6sf2tm1a(KOMP)Wtsi) 		hepatic steatosis J:234195
increased liver triglyceride level J:234195
Tmc7em1(IMPC)Mbp/Tmc7em1(IMPC)Mbp
(C57BL/6NCrl-Tmc7em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Tmcc2em1(IMPC)Mbp/Tmcc2+
(C57BL/6N-Tmcc2em1(IMPC)Mbp/MbpMmucd) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Tmed6em1(IMPC)Rbrc/Tmed6em1(IMPC)Rbrc
(C57BL/6NJcl-Tmed6em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
enlarged liver J:211773
Tmem14cGt(E295C12)Wrst/Tmem14cGt(E295C12)Wrst
(B6;129P2-Tmem14cGt(E295C12)Wrst/Llp) 		pale liver J:212530
Tmem30atm1.1Xjz/Tmem30atm1.1Xjz
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * DBA) 		abnormal liver morphology J:249038
bile duct proliferation J:249038
decreased liver weight J:249038
intrahepatic cholestasis J:249038
jaundice J:249038
liver fibrosis J:249038
liver inflammation J:249038
Tmem63cem1(IMPC)Rbrc/Tmem63cem1(IMPC)Rbrc
(C57BL/6NJcl-Tmem63cem1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Tmem67tm1Dgen/Tmem67tm1Dgen
(B6.129P2-Tmem67tm1Dgen) 		abnormal hepatobiliary system development J:193837
Tmem68tm1a(EUCOMM)Wtsi/Tmem68tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem68tm1a(EUCOMM)Wtsi) 		decreased liver triglyceride level J:339870
Tmem107schlei/Tmem107schlei
(C3Fe.B6-Tmem107schlei) 		liver/biliary system phenotype J:186552
Tmem132bem1(IMPC)Ccpcz/Tmem132bem1(IMPC)Ccpcz
(C57BL/6N-Tmem132bem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Tmem150bem1(IMPC)Ccpcz/Tmem150bem1(IMPC)Ccpcz
(C57BL/6N-Tmem150bem1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Tmem240em1(IMPC)Ccpcz/Tmem240em1(IMPC)Ccpcz
(C57BL/6N-Tmem240em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
Tmem248tm1.1(KOMP)Vlcg/Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd) 		decreased liver weight J:211773
Tmem263em1Gww/Tmem263em1Gww
(C57BL/6J-Tmem263em1Gww) 		decreased liver weight J:345905
Tmod3Gt(RRF004)Byg/Tmod3Gt(RRF004)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal liver morphology J:208725
small liver J:208725
Tmprss6hem8/Tmprss6hem8
(C57BL/6J-Tmprss6hem8) 		decreased liver iron level J:237155
Tmprss6hem8/Tmprss6tm1Dgen
(involves: C57BL/6 * C57BL/6J) 		decreased liver iron level J:237155
Tmprss6tm1Dgen/Tmprss6+
(B6.129P2-Tmprss6tm1Dgen/Crl) 		decreased liver iron level J:160248
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(B6.129P2-Tmprss6tm1Dgen/Crl) 		decreased liver iron level J:237155, J:160248
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6) 		decreased liver iron level J:160248
Tnftm1.1Sned/Tnftm1.1Sned
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		hepatic necrosis J:95684
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv * C57BL/6J) 		liver/biliary system phenotype J:112797
Tnftm1Sek/Tnftm1Sek
(involves: C57BL/6 * CBA) 		abnormal liver physiology J:120559
Tnftm2Jods/Tnftm2Jods
(involves: C57BL/6 * C57BL/6J) 		decreased liver free fatty acids level J:112797
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl
Tg(Vil1-cre)997Gum/0
(B6.Cg-Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum) 		liver degeneration J:163410
Tnfaip3tm1Ama/Tnfaip3tm1Ama
(Not Specified) 		liver inflammation J:92931
Tnfaip3tm1Homy/Tnfaip3tm1Homy
Tg(Mx1-cre)1Cgn/?
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J) 		enlarged liver J:212681
liver inflammation J:212681
Tnfaip8l1em1(IMPC)Mbp/Tnfaip8l1em1(IMPC)Mbp
(C57BL/6N-Tnfaip8l1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
small liver J:211773
Tnfaip8l2tm1Yhcn/Tnfaip8l2tm1Yhcn
(129S6/SvEvTac-Tnfaip8l2tm1Yhcn) 		liver inflammation J:139785
Tnfrsf1atm1.1Gkl/Tnfrsf1a+
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129/Sv * C57BL/6) 		liver inflammation J:92470
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx) 		abnormal oval cell physiology J:66448
Tnfrsf11adel8/Tnfrsf11adel8
(involves: 129) 		enlarged liver J:111512
Tnfrsf12atm1Biib/Tnfrsf12atm1Biib
(B6.129S4-Tnfrsf12atm1Biib) 		abnormal oval cell physiology J:100907
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd
(involves: C57BL/6) 		liver inflammation J:82331
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs) 		liver inflammation J:87620
Tnip1tm1.1Ama/Tnip1tm1.1Ama
(involves: C57BL/6J) 		increased hepatocyte apoptosis J:145539
liver hypoplasia J:145539
Tnip1tm1.1Pcoh/Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6) 		bile duct hyperplasia J:176826
liver fibrosis J:176826
Tnk1tm1Sksuf/Tnk1+
(involves: 129X1/SvJ * C57BL/6) 		increased hepatocellular carcinoma incidence J:140639
increased hepatoma incidence J:140639
Tnk1tm1Sksuf/Tnk1tm1Sksuf
(involves: 129X1/SvJ * C57BL/6) 		increased hepatocellular carcinoma incidence J:140639
Tnnem1(IMPC)Mbp/Tnnem1(IMPC)Mbp
(C57BL/6NCrl-Tnnem1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Tnnt3tm2a(KOMP)Wtsi/Tnnt3tm2a(KOMP)Wtsi
(involves: C57BL/6N) 		liver hemorrhage J:204474
Top1mttm1.1Hlzh/Top1mttm1.1Hlzh
(Not Specified) 		abnormal liver physiology J:189886
Top2aem2(IMPC)Tcp/Top2a+
(C57BL/6NCrl-Top2aem2(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Tor1atm3.1Wtd/Tor1a+
Tor1aip1tm1.1Wtd/Tor1aip1tm1.1Wtd
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		abnormal hepatocyte morphology J:345574
hepatic steatosis J:345574
Tor1atm3.1Wtd/Tor1atm3.1Wtd
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		hepatic steatosis J:345574
Tor1atm3.1Wtd/Tor1atm3.1Wtd
Tor1aip1tm1.1Wtd/Tor1aip1+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		hepatic steatosis J:345574
Tor1atm3.1Wtd/Tor1atm3.1Wtd
Tor1aip1tm1.1Wtd/Tor1aip1tm1.1Wtd
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		abnormal hepatocyte morphology J:345574
abnormal liver physiology J:345574
hepatic steatosis J:345574
Tor1aip2tm1.1Wtd/Tor1aip2tm1.1Wtd
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * DBA) 		liver/biliary system phenotype J:345574
Toxtm1b(KOMP)Wtsi/Toxtm1b(KOMP)Wtsi
(C57BL/6N-Toxtm1b(KOMP)Wtsi/Tcp) 		decreased liver weight J:211773
Tpd52l2tm1a(KOMP)Wtsi/Tpd52l2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		abnormal liver physiology J:213427
Tph2em1(IMPC)Mbp/Tph2+
(C57BL/6N-Tph2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Tprg1em1(IMPC)Mbp/Tprg1em1(IMPC)Mbp
(C57BL/6N-Tprg1em1(IMPC)Mbp/MbpMmucd) 		abnormal gallbladder morphology J:211773
enlarged gallbladder J:211773
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		increased hepatocellular carcinoma incidence J:184948
Traf3tm1Bshp/Traf3tm1Bshp
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL) 		abnormal liver morphology J:124329
Traf6tm1Mak/Traf6tm1Mak
(involves: 129P3/J) 		enlarged liver J:54467
Traf6tm2a(EUCOMM)Wtsi/Traf6tm2a(EUCOMM)Wtsi
(C57BL/6N-Traf6tm2a(EUCOMM)Wtsi/Wtsi) 		dilated bile duct J:239583
herniated liver J:239583
Traj18em1Hwata/Traj18em1Hwata
(C57BL/6-Traj18em1Hwata) 		abnormal liver morphology J:256533
Trap1Gt(E150H04)Wrst/Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:226880
liver hyperplasia J:226880
Trappc1em1(IMPC)Mbp/Trappc1+
(C57BL/6NCrl-Trappc1em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal cystic duct morphology J:239583
Trex1em1(IMPC)Ccpcz/Trex1em1(IMPC)Ccpcz
(C57BL/6NCrl-Trex1em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
Trex1tm1.1Fwpe/Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac) 		liver vascular congestion J:220965
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd) 		hepatic necrosis J:92264
Trib1tm1Aki/Trib1tm1Aki
(involves: 129P2/OlaHsd) 		increased liver iron level J:196449
Trim24em1Schen/Trim24em1Schen
(C57BL/6J-Trim24em1Schen) 		decreased susceptibility to diet-induced hepatic steatosis J:345293
Trim24em2Schen/Trim24em2Schen
(C57BL/6J-Trim24em2Schen) 		decreased susceptibility to diet-induced hepatic steatosis J:345293
Trim24tm1.1Los/Trim24tm1.1Los
(involves: 129/Sv * C57BL/6 * SJL) 		increased hepatocellular carcinoma incidence J:130210
increased hepatocyte proliferation J:130210
increased liver adenoma incidence J:130210
increased liver tumor incidence J:130210
Trim27tm1Sis/Trim27tm1Sis
(B6.Cg-Trim27tm1Sis) 		decreased hepatocyte apoptosis J:206755
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg) 		abnormal liver morphology J:232482
dilated liver sinusoidal space J:232482
enlarged liver J:232482
hepatic steatosis J:232482
increased liver triglyceride level J:232482
Trim55tm1Slbt/Trim55tm1Slbt
Trim63tm1Slbt/Trim63tm1Slbt
(involves: 129 * C57BL/6) 		abnormal liver morphology J:130921
Trim61em1(IMPC)Mbp/Trim61em1(IMPC)Mbp
(C57BL/6N-Trim61em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Trim62tm1Akil/Trim62+
(involves: 129S/SvEv * C57BL/6) 		increased hepatocellular carcinoma incidence J:204336
increased liver adenocarcinoma incidence J:204336
Trim62tm1Akil/Trim62tm1Akil
(involves: 129S/SvEv * C57BL/6) 		increased liver adenocarcinoma incidence J:204336
Trim72tm1Rpx/Trim72tm1Rpx
(involves: 129/SvJ * C57BL/6) 		decreased susceptibility to diet-induced hepatic steatosis J:342778
Trmt1tm1b(EUCOMM)Hmgu/Trmt1+
(C57BL/6N-Trmt1tm1b(EUCOMM)Hmgu/Ics) 		abnormal liver morphology J:211773
Trp53tm1.1Xlu/Trp53tm1.1Xlu
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * FVB/N) 		increased liver tumor incidence J:166152
liver hyperplasia J:166152
Trp53tm1.2Awbr/Trp53+
(involves: C57BL/6) 		hepatic steatosis J:173271
liver cirrhosis J:173271
liver inflammation J:173271
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6) 		hepatic steatosis J:173271
liver cirrhosis J:173271
liver inflammation J:173271
Trp53tm1Ldo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased liver weight J:73757
liver hypoplasia J:73757
Trp53tm1Tyj/Trp53+
Trp73tm1Fmc/Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased hepatocellular carcinoma incidence J:98958
Trp53tm1Yjc/Trp53tm1Yjc
(B6.129S1-Trp53tm1Yjc) 		enlarged liver J:195018
Trp53tm3.1Glo/Trp53+
(B6.129S7-Trp53tm3.1Glo) 		hepatosplenomegaly J:317504
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae) 		increased hepatocellular carcinoma incidence J:95316
Trp53inp1tm1Acar/Trp53inp1tm1Acar
(involves: 129/Sv * C57BL/6) 		hepatic steatosis J:233434
increased liver weight J:233434
Trp53inp2em1(IMPC)Mbp/Trp53inp2em1(IMPC)Mbp
(C57BL/6N-Trp53inp2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Trpc4apem1Cya/Trpc4apem1Cya
(C57BL/6J-Trpc4apem1Cya/Cya) 		decreased susceptibility to diet-induced hepatic steatosis J:300649
Trpm2tm1.1Alp/Trpm2tm1.1Alp
(B6.129P2-Trpm2tm1.1Alp) 		liver abscess J:174397
Trpv1tm1Jul/Trpv1tm1Jul
(involves: 129X1/SvJ) 		decreased susceptibility to diet-induced hepatic steatosis J:137026
Tsc1tm1.1Djk/Tsc1+
(either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J)) 		increased hepatic hemangioma incidence J:75243
Tsc1tm1.1Djk/Tsc1tm1.1Djk
(either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J)) 		liver hypoplasia J:75243
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * C57BL/6JOlaHsd) 		increased hepatic hemangioma incidence J:99796
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * Balb/cOlaHsd * C57BL/6JOlaHsd) 		increased hepatic hemangioma incidence J:99796
Tsc1tm1Chdl/Tsc1+
(involves: 129P2/OlaHsd * C3H/HeNHsd * C57BL/6JOlaHsd) 		increased hepatic hemangioma incidence J:99796
Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6) 		abnormal hepatocyte morphology J:167208
abnormal liver physiology J:167208
enlarged liver J:167208
Tsc1tm1Djk/Tsc1tm1Djk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:171445
abnormal hepatocyte physiology J:171445
enlarged liver J:171445
liver/biliary system phenotype J:171445
Tsc1tm1Hin/Tsc1+
(involves: 129S4/SvJae * C57BL/6J) 		increased hepatic hemangioma incidence J:70463
Tsc1tm1Hin/Tsc1tm1Hin
(involves: 129S4/SvJae * C57BL/6J) 		liver hypoplasia J:70463
Tsc2tm1Djk/Tsc2+
(either: (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6J)) 		increased hepatic hemangioma incidence J:57631
Tsc2tm1Djk/Tsc2tm1Djk
(either: (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6J)) 		liver hypoplasia J:57631
Tsc2tm1Tno/Tsc2+
(involves: 129S4/SvJae * C57BL/6J) 		increased hepatic hemangioma incidence J:52464
Tsc2tm2.2Djk/Tsc2tm2.2Djk
(involves: 129S4/SvJae * C57BL/6) 		liver hypoplasia J:149326
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ) 		decreased susceptibility to diet-induced hepatic steatosis J:223992
Tspan32em1(IMPC)Mbp/Tspan32em1(IMPC)Mbp
(C57BL/6N-Tspan32em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Tspan33tm1Stsa/Tspan33tm1Stsa
(involves: 129S1/Sv * 129X1/SvJ) 		increased liver tumor incidence J:143158
Ttc7fsn-Jic/Ttc7fsn-Jic
(C3.INT-Ttc7fsn-Jic) 		liver hypoplasia J:115742
liver inflammation J:115742
pale liver J:115742
Ttc7fsn/Ttc7fsn
(CByJ.A-Ttc7fsn) 		enlarged liver J:29200
Ttc7hea/Ttc7hea
(WBB6F1) 		abnormal hepatocyte morphology J:92699
Tubtub/Tubtub
(C57BL/6J-Tubtub) 		hepatic steatosis J:13772
increased liver glycogen level J:13772
Tulp4tm1a(KOMP)Wtsi/Tulp4+
(involves: C57BL/6N * C57BL/6NRj) 		abnormal liver vasculature morphology J:344151
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ) 		abnormal hepatocyte morphology J:81485
decreased liver glycogen level J:81485
TxnipHyplip1/Txnip+
(involves: CAST/Ei * HcB19/Dem) 		increased hepatocellular carcinoma incidence J:112292
TxnipHyplip1/TxnipHyplip1
(HcB19/Dem-TxnipHyplip1) 		increased hepatocellular carcinoma incidence J:112292
TxnipHyplip1/TxnipHyplip1
(involves: CAST/Ei * HcB19/Dem) 		increased hepatocellular carcinoma incidence J:112292
TxnipHyplip1/TxnipHyplip1
(B6.HcB19-TxnipHyplip1) 		increased liver weight J:102224
Txniptm1Jjy/Txniptm1Jjy
(involves: C57BL/6 * CBA) 		hepatic steatosis J:104563
liver degeneration J:104563
macrovesicular hepatic steatosis J:104563
microvesicular hepatic steatosis J:104563
Txnrd2tm1.1Marc/Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:94136
Tysnd1tm1.1Arte/Tysnd1tm1.1Arte
(involves: C57BL/6J * C57BL/6N) 		abnormal hepatocyte morphology J:223054
enlarged liver J:223054
hepatic steatosis J:223054
pale liver J:223054
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy) 		abnormal Kupffer cell morphology J:157049
enlarged liver J:157049
increased hepatocellular carcinoma incidence J:157049
liver inflammation J:157049
Ubctm1Rrk/Ubctm1Rrk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal liver development J:122574
Ube2fem1(IMPC)Mbp/Ube2f+
(C57BL/6NCrl-Ube2fem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Ube2g1tm1b(EUCOMM)Hmgu/Ube2g1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ube2g1tm1b(EUCOMM)Hmgu/Rbrc) 		small liver J:211773
Ube2j2em1(IMPC)Rbrc/Ube2j2em1(IMPC)Rbrc
(C57BL/6NJcl-Ube2j2em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Ubqln4em1(IMPC)Mbp/Ubqln4em1(IMPC)Mbp
(C57BL/6NCrl-Ubqln4em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Ubr2tm1e.1(KOMP)Mbp/Ubr2+
(C57BL/6N-Ubr2tm1e.1(KOMP)Mbp/Tcp) 		abnormal liver morphology J:211773
Ubr4tm1.2Nkt/Ubr4tm1.2Nkt
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL) 		abnormal liver parenchyma morphology J:203460
abnormal liver vasculature morphology J:203460
dilated liver sinusoidal space J:203460
liver hypoplasia J:203460
Ubtfem1(IMPC)Mbp/Ubtf+
(C57BL/6NCrl-Ubtfem1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Uchl1gad/Uchl1gad
(involves: CBA/Nga * RFM/Nga) 		liver/biliary system phenotype J:30954
Ucn3tm1Pbl/Ucn3tm1Pbl
(Not Specified) 		decreased susceptibility to diet-induced hepatic steatosis J:119417
Ucp2tm1Lowl/Ucp2tm1Lowl
(B6.129S4-Ucp2tm1Lowl) 		liver cyst J:272325
Ufl1tm1a(EUCOMM)Wtsi/Ufl1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		small liver J:238253
Uggt1em1(IMPC)Mbp/Uggt1+
(C57BL/6N-Uggt1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
Uggt2tm1b(KOMP)Wtsi/Uggt2tm1b(KOMP)Wtsi
(C57BL/6N-Uggt2tm1b(KOMP)Wtsi/Ieg) 		abnormal liver morphology J:211773
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(involves: 129 * C57BL/6 * SJL) 		abnormal gallbladder morphology J:182805
jaundice J:182805
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(B6.Cg-Ugt1tm1.1Afmu) 		jaundice J:216224
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(FVB.Cg-Ugt1tm1.1Afmu) 		jaundice J:216224
Ugt1tm1Rhtu/Ugt1tm1Rhtu
(involves: 129 * C57BL/6) 		jaundice J:133790
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver morphology J:174308
liver failure J:174308
liver inflammation J:174308
multifocal hepatic necrosis J:174308
Unc119tm1.1(KOMP)Vlcg/Unc119tm1.1(KOMP)Vlcg
(C57BL/6N-Unc119tm1.1(KOMP)Vlcg/Ucd) 		abnormal liver morphology J:211773
Uqcc3em1Hya/Uqcc3em1Hya
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA/2) 		liver/biliary system phenotype J:306534
Urahplt2/Urahplt2
(C57BL/6-Urahplt2) 		abnormal liver physiology J:164423
increased hepatocellular carcinoma incidence J:164423
increased liver weight J:164423
Uri1tm1.1Ndj/Uri1tm1.1Ndj
Albtm1(cre/ERT2)Mtz/Alb+
(B6.Cg-Albtm1(cre/ERT2)Mtz Uri1tm1.1Ndj) 		abnormal liver morphology J:217463
hepatic necrosis J:217463
increased hepatocyte apoptosis J:217463
liver failure J:217463
liver hemorrhage J:217463
liver inflammation J:217463
Urostm1Cged/Urostm1Cged
(involves: 129S2/SvPas) 		enlarged liver J:105776
hepatic steatosis J:105776
Usp8tm1.1Kpk/Usp8tm1.1Kpk
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N) 		abnormal hepatocyte morphology J:122732
hepatic necrosis J:122732
increased hepatocyte apoptosis J:122732
jaundice J:122732
liver failure J:122732
Usp20em1Gpt/Usp20em1Gpt
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6JGpt * DBA) 		abnormal liver morphology J:299971
decreased liver cholesterol level J:299971
decreased liver triglyceride level J:299971
decreased liver weight J:299971
Usp24Gt(XB614)Byg/Usp24+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver tumor incidence J:303991
Usp44tm1.2Pjgl/Usp44tm1.2Pjgl
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		increased hepatoma incidence J:193965
Uts2tm1Ags/Uts2tm1Ags
(B6.129P2-Uts2tm1Ags) 		decreased susceptibility to diet-induced hepatic steatosis J:214289
Vasntm1Zgl/Vasntm1Zgl
(B6.Cg-Vasntm1Zgl) 		increased hepatocyte apoptosis J:173568
Vdac3em1(IMPC)Hmgu/Vdac3em1(IMPC)Hmgu
(C57BL/6N-Vdac3em1(IMPC)Hmgu/Ieg) 		abnormal liver morphology J:211773
Vegfatm2Gne/Vegfatm2Gne
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA) 		abnormal liver development J:52793
Vhltm1.1Jae/Vhl+
(involves: 129S4/SvJae * BALB/c) 		hepatic steatosis J:67505
increased hepatic hemangioma incidence J:67505
Vhltm1.1Lss/Vhl+
(involves: BALB/c) 		increased hepatic hemangioma incidence J:85513
Vhltm1.1Lss/Vhl+
(involves: A/J) 		abnormal liver morphology J:85513
Vhltm1.1Whkr/Vhltm1.1Whkr
(involves: 129S4/SvJae * C57BL/6) 		liver/biliary system phenotype J:198361
Vhltm1.1Wkr/Vhl+
(involves: 129S4/SvJae * C57BL/6) 		liver/biliary system phenotype J:157369
Vhltm1Jae/Vhltm1Jae
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA) 		abnormal liver morphology J:67505
enlarged liver J:67505
hepatic steatosis J:67505, J:97652
Vhltm1Jae/Vhltm1Jae
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal hepatocyte morphology J:144666
abnormal liver morphology J:144666
hepatic steatosis J:144666
increased hepatocyte proliferation J:144666
increased liver weight J:144666
Vhltm1Lss/Vhltm1.1Lss
(involves: 129X1/SvJ * C57BL/6) 		increased hepatic hemangioma incidence J:85513
Vhltm1Lss/Vhltm1.1Lss
Tg(ACTB-cre)1Tes/0
(involves: 129X1/SvJ * C3H * C57BL/6) 		abnormal liver morphology J:85513
increased hepatic hemangioma incidence J:85513
Vhltm1Lss/Vhltm1.1Lss
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ) 		focal hepatic necrosis J:110518
Vhltm1Mcs/Vhltm1Mcs
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		abnormal liver morphology J:130780
Vmbic8C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		increased liver iron level J:87918
Vps13bem1(IMPC)Tcp/Vps13bem1(IMPC)Tcp
(C57BL/6N-Vps13bem1(IMPC)Tcp/Tcp) 		abnormal liver morphology J:211773
Vps26cem1(IMPC)J/Vps26cem1(IMPC)J
(C57BL/6NJ-Vps26cem1(IMPC)J/Mmjax) 		pale liver J:211773
Vps54wr/Vps54wr
(multiple strains) 		abnormal hepatocyte morphology J:6388
Vrk3em1(IMPC)Mbp/Vrk3em1(IMPC)Mbp
(C57BL/6NCrl-Vrk3em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Vsirtm1Lex/Vsirtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		hepatic necrosis J:222944
Vti1btm1Gfvm/Vti1btm1Gfvm
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal hepatocyte morphology J:84574
enlarged gallbladder J:84574
gallstones J:84574
liver cyst J:84574
Wars1tm1b(EUCOMM)Hmgu/Wars1+
(C57BL/6N-Warstm1b(EUCOMM)Hmgu/Ieg) 		abnormal liver morphology J:211773
enlarged liver J:211773
increased liver weight J:211773
Wasf1Gt(VICTR37)1Kwak/Wasf1Gt(VICTR37)1Kwak
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal hepatocyte morphology J:83377
Wasf2tm1Fwa/Wasf2tm1Fwa
(129S/SvEv-Wasf2tm1Fwa) 		liver/biliary system phenotype J:84642
Wbp11em1Gcha/Wbp11+
(involves: C57BL/6J * FVB/N) 		small liver J:300837
Wdfy2tm1.1Wgz/Wdfy2tm1.1Wgz
(involves: C57BL/6J) 		decreased liver glycogen level J:296933
hepatic steatosis J:296933
increased liver cholesterol level J:296933
increased liver triglyceride level J:296933
increased liver weight J:296933
Wdfy3em1(IMPC)Mbp/Wdfy3+
(C57BL/6N-Wdfy3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
enlarged liver J:211773
Wdhd1em1(IMPC)Rbrc/Wdhd1+
(C57BL/6NJcl-Wdhd1em1(IMPC)Rbrc/Rbrc) 		abnormal liver morphology J:211773
Wdr11em1(IMPC)Mbp/Wdr11em1(IMPC)Mbp
(C57BL/6NCrl-Wdr11em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
Wdr11Gt(Ayu21-KBW205)Imeg/Wdr11+
(B6.Cg-Wdr11Gt(Ayu21-KBW205)Imeg) 		increased liver weight J:257035
microvesicular hepatic steatosis J:257035
Whrnwi/Whrnwi
(involves: C57BL/6J * STOCK a Tyrp1b Myo5ad Oca2p Ednrbs) 		decreased liver glycogen level J:5538
increased liver weight J:5037
Wipi1em1(IMPC)Mbp/Wipi1em1(IMPC)Mbp
(C57BL/6NCrl-Wipi1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Wnt5atm1Amc/Wnt5atm1Amc
(involves: 129S7/SvEvBrd) 		abnormal liver morphology J:153152
enlarged liver J:153152
Wt1tm1Mlh/Wt1tm1Mlh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal liver development J:135449
liver hypoplasia J:135449
Wwc1tm1Arsc/Wwc1tm1Arsc
Wwc2tm1.1Arte/Wwc2tm1.1Arte
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * C57BL/6J * DBA) 		abnormal liver morphology J:305034
abnormal liver physiology J:305034
abnormal portal triad morphology J:305034
increased liver tumor incidence J:305034
increased liver weight J:305034
liver fibrosis J:305034
liver inflammation J:305034
Wwc2tm1.1Arte/Wwc2tm1.1Arte
Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: C57BL/6 * DBA) 		liver/biliary system phenotype J:305034
Wwoxem1Mald/Wwoxem1Mald
(FVB/N-Wwoxem1Mald) 		cholestasis J:339564
enlarged gallbladder J:339564
liver degeneration J:339564
Wwoxtm1.1Mald/Wwoxtm1.1Mald
(involves: C57BL/6 * FVB/N) 		decreased liver weight J:155406
Xbp1tm1Glm/Xbp1tm1Glm
(involves: 129S2/SvPas) 		abnormal liver development J:59916
decreased hepatocyte proliferation J:59916
increased hepatocyte apoptosis J:59916
liver hypoplasia J:59916
small liver J:59916
Xcl1tm1.1Dnax/Xcl1tm1.1Dnax
(either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6)) 		liver inflammation J:176844
Xirp2tm1Jl/Xirp2tm1Jl
(B6.129-Xirp2tm1Jl) 		decreased liver weight J:158491
Xpatm1Hvs/Xpatm1Hvs
(involves: 129P2/OlaHsd * C57BL/6) 		small liver J:28710
Xpatm1Tnka/Xpatm1Tnka
(C3.Cg-Xpatm1Tnka) 		increased liver adenoma incidence J:76206
increased liver tumor incidence J:76206
Xpnpep1tm1a(KOMP)Wtsi/Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi) 		abnormal bile duct morphology J:239583
dilated liver sinusoidal space J:239583
Xrcc5em1(IMPC)Ccpcz/Xrcc5em1(IMPC)Ccpcz
(C57BL/6NCrl-Xrcc5em1(IMPC)Ccpcz/Ccpcz) 		increased liver weight J:211773
Xrn1em1Tya/Xrn1em1Tya
Tg(Camk2a-cre)2Gsc/0
(involves: C57BL/6N * FVB/N) 		abnormal liver morphology J:342928
increased liver weight J:342928
Xylt2tm1Meh/Xylt2tm1Meh
(involves: 129P2/OlaHsd) 		abnormal biliary tract morphology J:122291
abnormal liver physiology J:122291
increased liver weight J:122291
liver cyst J:122291
liver fibrosis J:122291
liver hyperplasia J:122291
Yap1tm1.1Dupa/Yap1tm1.1Dupa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal bile duct development J:162628
abnormal bile duct morphology J:162628
abnormal hepatocyte morphology J:162628
enlarged liver J:162628
increased hepatocyte apoptosis J:162628
increased hepatocyte proliferation J:162628
liver cirrhosis J:162628
liver fibrosis J:162628
macrovesicular hepatic steatosis J:162628
pale liver J:162628
Ybx1tm1Ley/Ybx1tm1Ley
(either: 129X1/SvJ-Ybx1tm1Ley or (involves: 129X1/SvJ * C57BL/6)) 		liver hypoplasia J:99099
Ybx1tm1Tuch/Ybx1tm1Tuch
(involves: 129S/SvEv * C57BL/6) 		small liver J:117725
Ythdf3em1(IMPC)Mbp/Ythdf3em1(IMPC)Mbp
(C57BL/6N-Ythdf3em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Ywhabem1Gpt/Ywhabem1Gpt
Albem1(icre)Gpt/Alb+
(C57BL/6JGpt-Ywhabem1Gpt Albem1(icre)Gpt) 		decreased liver glycogen level J:323777
Zbed6tm1.2Sson/Zbed6tm1.2Sson
(involves: BALB/c * C57BL/6) 		increased liver weight J:265506
Zbtb16em1(IMPC)Mbp/Zbtb16em1(IMPC)Mbp
(C57BL/6NCrl-Zbtb16em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Zbtb20tm1.1Wpjz/Zbtb20tm1.1Wpjz
(involves: 129S4/SvJae * C57BL/6) 		decreased liver glycogen level J:148992
Zbtb20tm1Wpjz/Zbtb20tm1Wpjz
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL * C57BL/6 * DBA) 		liver/biliary system phenotype J:140053
Zbtb22em1Yga/Zbtb22em1Yga
(Not Specified) 		decreased liver triglyceride level J:344976
decreased liver weight J:344976
decreased susceptibility to diet-induced hepatic steatosis J:344976
Zc3h8em1(IMPC)Ccpcz/Zc3h8+
(C57BL/6N-Zc3h8em1(IMPC)Ccpcz/Ccpcz) 		abnormal liver morphology J:211773
enlarged liver J:211773
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6N) 		liver/biliary system phenotype J:304105
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		abnormal bile duct epithelium morphology J:304105
abnormal bile duct physiology J:304105
abnormal liver parenchyma morphology J:304105
bile duct hyperplasia J:304105
bile duct inflammation J:304105
enlarged liver J:304105
intrahepatic cholestasis J:304105
liver fibrosis J:304105
liver inflammation J:304105
Zc3hav1ltm1b(EUCOMM)Wtsi/Zc3hav1ltm1b(EUCOMM)Wtsi
(C57BL/6N-Zc3hav1ltm1b(EUCOMM)Wtsi/Tcp) 		abnormal liver morphology J:211773
Zdhhc13skc4/Zdhhc13skc4
(involves: 129S6/SvEvTac * C3H * C57BL/6) 		abnormal Kupffer cell morphology J:161519
enlarged liver J:161519
Zfc3h1em1(IMPC)Mbp/Zfc3h1+
(C57BL/6N-Zfc3h1em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Zfp14tm1Xch/Zfp14+
(involves: C57BL/6) 		hepatic steatosis J:331393
Zfp14tm1Xch/Zfp14tm1Xch
(involves: C57BL/6) 		hepatic steatosis J:331393
Zfp36tm1Pjb/Zfp36tm1Pjb
(Not Specified) 		liver inflammation J:33986
Zfp36tm4.1Pjb/Zfp36tm4.1Pjb
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		focal hepatic necrosis J:188677
Zfp36l2tm2Pjb/Zfp36l2tm2Pjb
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:152911
pale liver J:152911
Zfp236em1(IMPC)Mbp/Zfp236+
(C57BL/6NCrl-Zfp236em1(IMPC)Mbp/Mmucd) 		abnormal liver morphology J:211773
small liver J:211773
Zfp521tm1Nohk/Zfp521tm1Nohk
(B6J.Cg-Zfp521tm1Nohk) 		decreased liver weight J:214267
Zfp871tm1a(EUCOMM)Wtsi/Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd) 		hepatic steatosis J:317166
liver inflammation J:317166
Zfpm1tm1Sho/Zfpm1tm1Sho
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6)) 		pale liver J:47281
small liver J:47281
Zfpm1tm2Sho/Zfpm1tm2Sho
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6)) 		pale liver J:47281
small liver J:47281
Zfpm2tm1Sho/Zfpm2tm1Sho
(involves: 129S1/Sv) 		small liver J:62879
Zic3tm1Bca/Y
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:75951
Zic3tm1Bca/Zic3+
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:75951
Zic3tm1Bca/Zic3tm1Bca
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal liver morphology J:75951
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6) 		liver/biliary system phenotype J:79501
Zmynd11em1(IMPC)Wtsi/Zmynd11em1(IMPC)Wtsi
(C57BL/6N-Zmynd11em1(IMPC)Wtsi/WtsiIeg) 		abnormal biliary ductule morphology J:239583
abnormal cystic duct morphology J:239583
dilated liver sinusoidal space J:239583
herniated liver J:239583
Zrsr2em1(IMPC)Mbp/Zrsr2em1(IMPC)Mbp
(C57BL/6N-Zrsr2em1(IMPC)Mbp/MbpMmucd) 		abnormal liver morphology J:211773
small liver J:211773
Zscan10Gt(285B6)1.1Cmhd/Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased liver weight J:221010
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory